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FOREWORD 
Research at the Institute of Bioinorganic and Radiopharmaceutical Chemistry of the Research Center 
Rossendorf Inc. is focused on radiotracers as molecular probes for diagnosis of disease. Denved from 
an awareness of the very important role modern nuclear medicine is playing, as expressed explicitly 
in the synonym in vivo biochemi~stry, this research effort has two main components: 
positron emission tomography (PET) 
technetium chemistry and radiopharmacology. 
To make positron emission tom~ography available also in the eastern part of Germany, a PET center 
was established at Rossendorf. As envisaged in a contract signed in February 1995 between the 
Research Center Rossendorf and the Dresden University of Technology, the lnstitute is closely linked 
to the University Hospital in this PET center. A joint team of staff mernberc from both the lnstitute and 
the Department of Nuclear Medicine with the University Hospital has been working at the Rossendorf 
PET Center. 
To contribute to further exploitiation of technetium-99m with its ideal nuclear properties for single 
photon emission tomography (SPECT), great commitment to interdisciplinary research into 
technetium tracers is required. The Institute's projects therefore address new approaches to tracer 
design. 
The research activities of our Institute have been performed in three administrative1 classified 
groups. A PET tracer group is engaged in the chemistry and radiopharmacy of 'G and "F 
compounds and in the setup of the PET center, which is jointly tun by the lnstitute and the Clinic and 
Polyclinic of Nuclear Medicine at the University Hospital. A SPECT tracer group deals with the 
design, synthesis and chernical characterization of metal coordination compounds, primarily rhenium 
and technetium cornplexes. A biochemical group is working on SPECT and PET-relevant biochemical 
and biological projects. This includes the characterization and assessment of new cornpounds 
developed in the two synthetically oriented groups. 
The annual report presented here Covers the research activities of the Institute of Bioinorganic and 
Radiopharmaceutical Chemistry in 1996. 
The achievements attained so far have only been possible because of the dedication and 
commitment of the permanent and temporary staff, the Ph.D. students and collaborators inside and 
outside the Rossendorf Research Center Inc. I would like to extend my thanks to all of them. 
Bemd Johannsen 
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I .  RESEARCH REPORTS 
1. Serotonin Receptor-Binding Technetium and Rhenium Complexes 
9. Synthesis and Characterization of Ligands Derived from Partial Structures of 
Ketanserin, Cisapride and MDL 72832 
M. Scheunemann, H.-J. Pietzsch, H. Spies, P. Brust, B. Johannsen 
lntroduction 
The design of both potent and selective receptor-binding technetium tracers has been a subject of 
intense efforts during the last eight years, especially in the field of brain receptor research [I]. 
As part of our ongoing Programme of developing technetium and rhenium coordination compounds 
capable of binding to the 5-HT2 receptor, we found that compounds I and II are potent ligands to the 
ketanserin binding sites with ICw values of 19 nM and 14 nM. 
Thus, starting from these previously described compounds which contain single structural elements of 
the antagonist ketanserin [2] a novel series of structurally modified oxorhenium complexes as well as 
oxotechnetium complexes was constructed in Order to expand our knowledge of the electronic and 
spatial factors necessary for affinity and selectivity at 5-HT2A receptors. 
In vitro, the usability of ""'TC complexes as brain imaging agents has been limited not only by their 
lack of selectivity, but also because of inadequate iipophilicity and molecule size leading to an 
unsatisfactory blood-brain transfer. It was hoped in particular that synthetic modifications originally 
intended to improve the HT2A receptor selectivity would also allow access to new complex structures 
with increased blood-brain transfer. 
We therefore extended this work by exploring other structures such as cisapride [3] and MDL 72832 
[4]. Both compounds possess a 3-phenoxypropyl amine unit as an obvious structural similarity. 
Ketanserin Cisapride MDL 72832 
Among the variations made on these structures was replacement of the ring system beanng the 
amide structure by a small spacer, in most cases a propylene chain with a terminal thiol function. 
Here we describe the synthesis and characterzation of a novel series of monodentate thiol ligands 
derived from these three representative serotonin antagonists. 
Experimental (Selected examples) 
Method A: 
1-(3-mercaptopropy1)-4-benzylpiperidine 1 1 
A mixture of I (17.5 g, 0.1 rnol), triethylamine (15.2 g, 0.15 rnol), I-bromo-3-chloro propane and 
toluene (75 ml) was heated to 60 - 65 "C for 8 h. 
The woled suspension was treated with an aqueous Solution of NaHC03 (10 %, 50 ml) and the 
resulting two-phase mixture was stirred for 10 min. The organic layer was separated, dried (MgS04), 
filtered and evaporated. The crude product was purified by bulb to bulb distillation to give 20.1 g 
(80 %) of I-(3-chloropropyl)-4-benzylpiperidine as an oil: n226D = 1.5304; 'H NMR (300.13 MHz, 
CDCl3; standad SiMe4): &I 7.3 - 7.0 Ern, 5H, Ar-H], 3.51 ft-like, J = 6.6 Hz, 2H, -CH2CI], 2.80 Ern, 2H, 
piperidine: C2-H„ C6-H,], 2.47 [2H, piperidine: C2-H„ C6-HJ, 2.37 [m, 2H, -CH2-CH2-CH2Cl], I .92 
- 1.77 [m, 4H, PhCH2CH, CH2-CH2-CH2CI], 1.59 - 1.54 [m, 2H, piperidine: C3-H„ C5-H,], 1.5 - 1.39 
[m, IH, piperidine: C4-H], I .22 [m, 2H, piperidine: C3-H„ CS-Ha. 
A mixture of the intermediate chloride (5.04 g, 20 mmol), thiourea (1.85 g, 24.3 mmol), hydrogen 
chloride as a solution in ethanol (18 %, 4 g, 20 mmol) and 2-ethoxy ethanol (25 ml) was heated to 115 
- 125 "C for 5 h. The resulting mixture was evaporated to an oily residue which was dissolved in water 
(40 ml). The aqueous solution was treated with NaOH (3.2 g, 80 mmol) and heated at 120 "C for 2 h. 
After cooling the pH was adjusted to ca. 8 with H3PO4 (6 N, 3.4 ml), and the resulting oil was 
extracted with methyl terf-butyl ether (3 X 15 ml). After evaporation the crude product was distilled to 
give 3.0 g (60 %) 11 as a colourless oil; b.p. 126 - 128 "Cl6 Pa; n2"OD = 1.5456; 
'H NMR (300.13 MHz, CDCI3; standard SiMe4): 6H 7.25 - 7.05 [m, 5H, Ar-H], 2.81 [m, 2H, piperidine: 
C2-H„ C6-H,], 2.47 [4H, CH2SH, piperidine: C2-H„ C6-HJ, 2.32 [m, 2H, GHz-CH2- 
CH2SH], 1.9 - 1.7 [m, 4H, PhCH2CH, CH2-CH2-CH2SH], I .59 - 1.54 [m, 2H, piperidine: C3- 
H„ C5-H,], 1.5 - 1.39 [m, 2H, CHzSH, pip.: C4-H], 1.22 [m, 2H, pip.: C3-H„ C5-Hd. 
13c NMR (75.475 MHz, CDCl3; standard SiMe4): 6c 22.87, 31.20, 32.22, 37.95,43.21, 54.00, 57.36, 
125.73, 128.11, 129.09, 140.70. 
0.265 g 11 free base (1.06 mmol) was transformed into the oxalate salt by treating a solution in 
2-PrOH with oxalic acid. It was recrystallized from MeOHl2-PrOH mixtures: 0.302 g (84 %) 
l l~oxalate; m.p. 139 "C. 
Elemental analysis: (Found C, 60.18; H, 7.40; N, 4.09; S, 9.45, C15H23NS~C2H204 requires 
C, 60.15; H, 7.42; N, 4.13; S, 9.44 %). 
Method B: 
(2RS) I-(3-phenoxypmpyl)-2-(2-mercaptoethypiie 1 9 
An etheral solution of hydrogen chloride (22 %, 3.1 g, 18.6 mmol) was added to a solution of 9 (4.9 g, 
18.6 mmol) in chloroform (50 ml) was. The resultant homogeneous mixture was cooled to -30 "C and 
thionyl chloride (3.1 g, 26.1 mmol) was added in one portion. The mixture was allowed to warm to 
room temperature and then refluxed for 3 - 5 h. The solvent was removed in vacuo to give a viscous 
oil which was used without further purification. 
The conversion of the chloride into the isothiouronium salt and its subsequent saponification to the 
desired thiol was camed out in the Same manner as described for the preparation of I I. 
This procedure gives an oily residue which was finally purified by short-path distillation at 10 Pa to 
yield 3.5 g (68 %) 9 as a colourless oil; n23-7D = 1.5473. 
'H NMR (500.13 MHz, CDCl3; standard SiMed: 6~ 1.26, 1.42, 1.48, 1.57 (4m, 7H, SH, piperidine: 
CH2-3, CH2-4, CH2-5); 1.68 (dddd, J = 17.2, 9.7, 7.6, 5.45 HZ, IH, -CH-HCH-CH2-SH); 1.79 
(dddd, J = 17.8, 10.1,6.4,4.0 Hz, IH, -CH-HCH-CH2-SH); 1.85 (m, 2H, -0CH2-CH2-CH2-N); 
2.19 (ddd, J = 11 -8, 9.6, 3.3 Hz, IH, PhO-CH2-CH2-HCH-N); 2.34 (m, IH, piperidine: CH-2); 
2.41 (ddd, J =12.7, 9.8,6.5 Hz, IH, -CH2-HCH-SH); 2.45 (m, IH, PhO-CH2-CH2-HCH-N); 
2.53 (ddd, J = 13.1, 10.0, 5.45 Hz, IH, -CH2-HCH-SH); 2.76 (m, 2H, piperidine: CH2-6); 3.93 
(t-like, J = 6.2 Hz, 2H, Ph0-CH2-)6.85,7.20 (2m, 5H, AM). 
13c NMR (75.475 MHz, CDCl3; standard SiMe4): ZiC 21.13; 23.20; 24.96; 26.10; 29.62; 35.71; 49.63, 
51.24; 58.93; 65.94; 114.45; 120.50; 129.37; 158.91. 
LRMS (CI, iso-butane): rnlz 280 (MH', 100 %). 
(EI): rnlz 218 (100 %), 98 (38 %), 279 (M', 3 %). 
HRMS 279.1693 (requires 279.1657). 
Method C: 
(2RS)2-mercaptomethyl-4-(3-phenylpropyl) 20 
Methansulphonyl chloride (2.2 g, 19.2 mmol) dissolved in methylenchloride (10 ml) at -5 "C was 
added drop by drop to a stirred mixture of 10 (2.82 g, 12 mmol) and triethylamine (2.43 g, 24 mmol) 
in methylene chloride (50 ml). The mixture was allowed to warm to room temperature and washed 
with H20 (20 ml), 5 % aqueous NaHC03 solution (20 ml) and brine (20 ml). The organic layer was 
dried over MgS04, filtered and concentrated to give a yellowish viscous oil (4.7 g). 
The cnide material was dissolved in DMF (10 ml) and added to a solution of potassium thioacetate in 
DMF (15 ml) at 5 "C. The mixture was stirred and allowed to warm to room temperature and finally at 
45 - 50 "C for 1 h. The mixture was partitioned between CH2CI2 (6Q ml) and 5 % aqueous NaHC03 
solution (80 ml). The layers were separated, and the aqueous layer was extracted with CH2CI2 (30 
ml).The organic layers were combined, washed with 5 % aqueous NaHC03 solution (20 ml), 15 % 
aqueous NaCl solution (20 ml) and concentrated to a red oil (4.8 g). 
A solution of this crude material in MeOH (12 ml) was cooled to 5 "C and saponified by dropwise 
addition of an aqueous NaOH solution (4N, 9 ml, 36 mmol). After 30 min the solvent was evaporated. 
The residue was dissolved in H20 (20 ml), extracted with MTBE (8 ml), and the pH was adjusted to 
ca. 8 with H3PO4 (0.3N). The resuiting oil was extracted with MTBE (3 X 10 ml) and dned over 
MgS04. After filtration and evaporation the crude product was finally purified by short-path distillation 
at 10 Pa to yield 1.46 g (48 %) 20 as a slightly coloured oil; n25.6D = 1.5454. 
'H NMR (500.13 MHz, CDC13; standard SiMe4): 6H 7.29 - 7.17 [m, 5H, Ar-H], 3.88 [ddd, J = 11.4, 3.2, 
1.7, 1 H, morpholine: C6-H,], 3.67 [dt, J = 11.3, 2.5, 1 H, morpholine: C6-HA, 3.56 [m, I H, 
morpholine: C2-H], 2.87 [m, 1 H, morpholine: C3-H,], 2.7 - 2.6, 2.5 [2m, 5H, morpholine: C3- 
H„ CH2-5, PhCH2-CH2-CH2-NI, 2.36 [m, 2H, PhCH2-1, 2.1 [m, IH, -CHHSH], 1.88 - 1.78 [m, 
3H, -CHHSH, PhCH2-CH2-1, 2.35 [IH, SH]. 
I3c NMR (125.77 MHz, CDCI3; standard SiMe4): Fc 27.41,28.19, 33.46, 52.90, 57.24, 57.99, 66.78, 
76.59, 125.72, 128.24, 128.31, 141.93. 
LRMS (CI, iso-butane): mlz 252 (MH', 100 %). 
(EI): mlz 91 (100 %), 218 (28 %), 251 (M', 8 %). 
HRMS 251 .I 350 (requires 251 .I 344). 
Results and Discussion 
The target thiols were prepared by three different routes starting from commercially available amines 
1 and 2 or aminoalcohols 3 - 10 (Scheme I and Table I). 
The preparation of the aminoalcohols 3 - 9 is based on standard procedures similar to those 
described in our previous report [2]. In these are included the alkylation of the corresponding phenol: 
i.e. pfluoro phenol, phenol and catechol with the appropriate halogenide or epichlorohydrine to give 
the aryloxy alkylhalide [5] or after chlorination (SOC12-pyridine), 2-chloromethyl-I ,Cbenzodioxane [6] 
as an in~termediate. 
Scheme I: Synthesis of target thiols 11 - 20 
Method A: 1. Br(CH2)3CI, base; 2. thiourea; 3. NaOH 
Method B: I. SOC12; 2. thiourea; 3. NaOH 
Method C: I. CH3S02CI, triethylamine, CH2C12; 2. CH3COSK, DMF; 3. NaOH 
Afterwards the halide intermediate was reacted either with 2-methylamino ethanol or with racemic 2- 
(2-hydroxyethyl) piperidine to give the aminoalcohols 3 and 9. All other N-methyl derivatives were 
synthesized in a two-step procedure. First the starting halides were reacted with 3-aminopropanol to 
afford the secondary amines in good yield, then the secondary amines were converted to the tertiary 
amines 4 - 8 following the Eschweiler-Clark Procedure. The morpholine derivative 10 was 
synthesized from 3-phenylpropyl aminoethanol and tert-butyl glycidyl ether F]. 
Thiols 11 and 12 were prepared in three steps from 4-benzyl piperidine (1) or 4-benzoyl piperidine (2) 
representing method A as depicted in scheme I. Alkylation of 1 and 2 with I-bromo-3-chloro propane 
at 60 - 80 "C in toluene in the presence of triethylamine (for the preparation of 11) or (for the 
preparation of 12) afforded the corresponding bchloropropyl amine. These compounds were 
converted to their isothiouronium salts by reaction with thiourea at elevated temperatures in ethanol 
or 2-ethoxy ethanol as a solvent. Finally, saponification of these isothiouronium salts with aqueous 
NaOH at 120 "C gave the desired thiols 11 and 12. 
The o-chforo alkylamine intermediates for the synthesis of 13 - 19 were obtained from the 
corresponding substituted aminoalcohols 3 - 9 by chlorination with thionyl Chloride in chloroform 
(Scheme 1: method B). The conversion of the chloride into the isothiouronium salt and its subsequent 
saponification to the desired thiol was carried out in the Same manner as described for the 
preparation of 11 and 12. 
Method C (Scheme I )  was used for the preparation of the racemic morpholine derivative 20. It 
consists of activation of the hydroxy group with methansulphlonyl chloride and triethylamine at 0 "C in 
methylene chloride. Its nucleophilic substitution by means of potassium thioacetate in dimethyl 
formamide gave the S-acetyl-protected derivative of 20. Finally the acetyl group was removed by 
treatment with diluted aqueous NaOH solution at 5 "C. 
The thiols were purified by distillation (Kugelrohr or Vigreux column). In part they were converted to 
their crystalline oxalate salts. To our knowledge all target thiols were prepared for the first time. They 
are hornogeneous on TLC and show satisfying high resolution mass spectra and correct elemental 
analyses (oxalate salts). 
Table 1: Physicochemical properties of target thiols 11 - 20 











' overall yield siarting from compounds 1 - 10, refers to isolated free base; oxalate salt; free base; demental analysis \C,H,N,S). 
experimental wiws were within 0.4 % oi theoretical values; . M' (calc. for C~ZHI~NOS) 225.1 187, M+ (found) 225.1p; M+ (calc. 
foa C*3H2aFNOS) 257.1250, M' (found) 257.1245; M' (calc. for C I~H~FNS)  241.1301, M* (found) 241.1286; ; M' fcalc. for 
C,IM25NQS) 279.1657. M* (fwnd) 279.1693; ; ' M+ (calc. for Ct4HttNOS) 251.1344, M+ (found) 251.1350. 
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2. Serotonin Receptor-Binding Technetium and Rhenium Complexes 
10. Synthesis and Characterization of Rhenium and Technetium Complexes Derived 
from Partial Structures of Ketanserin, Cisapride and MDL 72832 
M. Scheunemann, H.-J. Pietzsch, H. Spies, P. Brust, B. Johannsen 
lntroduction 
Previously we descnbed the synthesis of severai rnixed-ligand oxorhenium(V) and oxotechnetium(V) 
complexes which show significant affinity to the ~ - H T ~ A  receptor [I]. Based on these results, in order 
to improve both the affinity and selectivity to different subtypes of the 5-HT receptor, new hybrid 
molecules were to be developed starting from three serotonin receptor-binding substances, i.e. 
ketansenn and cisapnde, which have affinity to the ~ - H T ~ A  receptor, and MDL 72832, a highly affine 
and selective 5-HTtA receptor antagonist [2]. 
Cisapride Hybrid Complex 
After having described the synthesis of the corresponding monothiol ligands 11 - 20 [2], in this paper 
we are dealing with the synthesis and characterization of novel oxorhenium(V) and oxotechnetium0l) 
complexes obtained with these ligands according to the "3+Im concept. 
Experimental (Selected examples) 
(3-thiapentane- l , 5 - d i f h i o l a t o ) [ 3 - N - - ( 3 - p h e n o x y p r o p y l ) - N - ~  P5 
A solution of 15 (45 mg, 0.188 mmol) in acetonitrile (0.5 ml) was added to a suspension of 21 [3] 
(58.2 mg, 0.15 mmol) in acetonitriie (6 ml). The colour of the mixture immediately tumed from deep 
blue to red. After stining for one hour at 22 "C the solvent was evaporated to give an oily residue. The 
raw material was partitioned between CHCb (I0 ml) and 5 % aqueous NaHC03 solution (8 mi). The 
organic layer was separated and concentrated to yieid a crude product which was finaily purified by 
passing it through a silica gel column with chloroforrnlMeOH (1r):l) as eluent. 
The eluate was evaporated to give 97 mg 25 (free base: 95 %) M ich  was transfomed hto the 
oxalate satt by treating a solution in MeOH with oxalic acid. Crystallization was induced by eautious 
addition of MTBE to give 87 mg (85 %) 25moxalate as brown ctyctals; rn-p. 147 - 150 "C. 
1R absorption: vlcm-' (KBr) 960 s (Re=O). 
'H NMR (200.13 MHz, D,-DMSO; standard SiMe4): 664 9.75 Ibr, IH, HOOC-CUOJ, 7.4 - 7.2,J.O - 6.88 
[2m, 5H, Ar-H], 4.32 [dd, J = 13.0,4.3, S(C2H&: 2H],4.13 - 4.01 frn, 4H, PhOCH2-C&-, 
S(GH4j2: ZHj, 3.70 [m, ZH, -CH2-CU2-SI, 3.21 - 2.98 fm, 6H, -CH2-CH2NH(CH3)CH2-, 
S(C2H4)2: 2H], 2.74 [s, 3H, NHCH3], 2.35 - 2.12 [m, 6H, -CH2-CH2NH(CH&H2-C&-, 
S(C2H4)2: 2H]. 
13 C NMR (75.475 MHz, DG-DMSO; standard SiMe4): 6c 23.70, 27.30, 32.89,40.40,43.20,45.74, 
52.68, 54.45,64.73, 114.53, 120.87, 129.62, 158.29, 164.44, 172.21. 
Elemental analysis: (Found C, 33.42; H, 4.43; N, 2.05; S, 18.78 Ci7H28NRe02S4.C2H204 KXluire~ 
C, 32.58; H, 4.25; N, 2.08; S, 18.98%). 
Preparaiion of the 9 9 / 9 9 m ~ ~  complexes 
Complexes were prepared with "carrier" "TC in order to facilitate their complete analytical 
characterization, which is a prerequisite for studies of structure-activity relationships. 
"TC as NH4Tc04 was obtained from Amersham as 0.3 M aqueous solution. 9 9 m ~ ~ 0 i  was eluted from 
a Mallinckrodt generator. 
99199rn T c 0  gluconate was prepared by gradual additiomof stannous chloride to an aqueous solution of 
9 9 ~ ~ 0 4 - ~ 9 9 r n ~ ~ 0 ~  (2 pmollabout 5 MBq) in an excess of sodium gluconate. 
Im l  of the Tc gluconate solution was diluted with 1 ml of ethanol. A solution of 2 pmol of 3-thiapen- 
tane-1,5-dithiol ("HSSSH") and 2 pmol of the appropriate thiol in 0.2 ml ethanol was added. The 
colour of the mixture tumed reddish-brown. 
After stirring for 30 min and adding 2 ml of water, the Tc compound was isolated by selective 
extraction of the reaction mixture with 2 ml of chloroform. The organic phase was washed twice with 
1 ml of water and dried over Na2S04. 
The yields are in the range from 75 to 80 percent (related to technetium gluconate). 
Quality control 
The radiochemical purity (>98 %) of the technetium complexes was determined by HPLC in a Perkin 
Elmer 250 binary pump gradient elution system equipped with a radiation detector. A Hamilton PRP 1 
reversed phase column (25 Cm, 10 pm) was used for separation and the mobile phases were 
acetonitrile and ammonium acetate buffer (0.05 M, adjusted to pH 4.0 with acetic acid). The initial 
elution was for 2 min with 50 % acetonitrile and 50 % buffer. During the next 20 min a gradient was 
applied so that at the end of that time the eluting solution was 100 % acetonitrile. A flow rate of 
2 milmin was maintained throughout the separation. 
For receptor binding and biodistribution studies a stock solution of the appropriate complex was 
prepared by evaporating the organic solvent under nitrogen and redissolving the residue in 1 ml of 
DMSO. 
Results and Discussion 
In general the ligand-exchange procedures for preparing the oxorhenium0 complexes were carried 
out as Wo-step procedures. The precursor [ReO(S(C2H4S)2)CI] (21) was prepared from 3-thiapentane- 
I ,5dithiol and [N(C4H9)4]ReOC14 and was reacted with the thiol in a subsequent step 131. 
Scheme 1: Synthesis of oxorhenium(V) complex 25. 
Reaction of several terminal thiols (11 - 20) bearing both an amino and an aromatic portion with 
chloro-(3-thiapentane-1,5-dithiolato)oxorhenium0l) 21 (Scheme 1: synthesis of 25) resulted in new 
neutral complexes 22 - 23. 
The complexes are soluble in choroform and acetonitrile, less soluble in MTBE and alcohols but 
insoluble in water and various alkanes. 
All rhenium complexes were characterized by elemental analysis, infrared, Proton and carbon NMR 
spectroscopy (lable I). The IR spectra of all,rhenium complexes show a strong and characteristic 
stretching vibration band in the 900 - 1000 cm- region indicating the ~ e = 0 ~ '  core. 
99199m Tc complexes were also obtained by a two-step procedure starting with the reaction of the 
appropriate thiol as the monodentate ligand with 9 9 ' 9 9 m ~ ~  gluconate followed by addition of the 
tridentate chelator. 
Table I: Physicochemical properties of target oxorhenium(V) complexes 22 - 29 
No. Structure Starting Yield [%Ia M.p. ["clb Analysis C 
57 dec. Ct7HsReNO3S4 HCI * 
' refers to isolated oxalate sait; oxalate sait or hydrochlonde; elementai anaws (C,H,N,S): experimental values wem within 0.4 % 
oftheoretical values, unless stated othenrrice; Ci7H&'?eN0S4 C2H204 calc: C, 33.32; H, 4.27; N, 2.05: S, 18.72 
found: C, 33.44, H, 4.67; N, 2.14; S, 18.34 %. 
An additional paper of this report describes the in vitro binding of some of the complexes to the 
serotonin LI-HT,A, serotonin S-HT~A and doparnin D2 recepfor 141. 
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3. Serotonin Receptor-Binding Technetium and Rhenium Complexes 
11. Affinity and Selectivity of Oxorhenium(V) Complexes Derived from Ketanserin, 
Cisapride and MDL 72832 
H.-J. Pietzsch, M. Scheunemann, P. Brust, J. Wober, HSpies, B. Johannsen 
lntroduction 
After having described the synthesis and characterization of oxorhenium0l) complexes bearing 
pharmacophores derived from ketanserin, cisapride and MDL 72832 [I, 21, we here summarize their 
affinities to the serotonin (5-HT1~, S-HT~A) and doparnine (D2) receptors, including the selectivity 
ratios. 
Experimental 
Rhenium complexes were synthesized and characterized as previously described [ I  - 31. 
Preparation of rat cortex and hippocampus 
The rat brain cortices and hippocampi were homogenised with an Ultra-Turrax T25 in 10fold volumes 
of ice-cold tris/HCI buffer (50 mM, pH 7.6). The homogenate was centrifuged at 20,000 g for 10 min. 
The resulting pellet was resuspended and centrifuged at 20,000 for another 10 min. After repeating 
the Same procedure the pellet was resuspended in 10 volumes of buffer and stored at -70 "C until 
used in the binding studies. 
5-HTfA and 5-HT2A receptor-binding assay 
To determine the IC= values for ~ - H T ~ A  receptor, various concentrations of the complexes were 
incubated with trisIHCI buffer (50mM, pH 7.6) containing 0.12 nM [3~]ketanserin and about 20 ~ g l m l  
protein in a final volume of 5 ml. 
Unspecific binding was determined by 1 FM mianserin. For determination of the IC50 values for ~ - H T ~ A  
trislHCI buffer (50mM, pH 7.4) was used containing 0.1 percent ascorbic acid, 2 mM CaCI2, 0.13 nM 
[ 3 ~ ] - 8 - ~ ~ - ~ ~ ~ ~ ,  and about 20 vglml protein in a final volume of 5 ml. Unspecific binding was 
determined by 10 PM serotonin. The tests were incubated at 25 "C for 60 min (~-HT~A) and for 120 
min (5-HTIA) [4, 51. 
The binding assays were terminated by rapid filtration through GFIB glass fibre filters vhatman). 
The filters were rapidly washed with four 4 ml portions of ice-cold buffer, transferred into 5 ml of 
scintillation fluid (Ultima-Gold, Packard) and analysed for radioactivity. The protein content of the 
membrane and cell suspensions was estimated according to the method of Lowry et al. [6]. 
4 receptor-binding assay 
[3~]spiperone (684.5 GBqlmmol) was used as the radioligand. The binding assay was canied out in a 
final volurne of 5 ml tris-HCI buffer, pH 7.4, containing 10 mM MgC12, I mM EDTA, 0.27 nM 
[3~]spiperone, 1 unit of cloned D2 receptor and various concentrations of the rhenium or technetium 
complexes. The complexes were dissolved as described above. Nonspecific binding was defined as 
the amount of [3~]spiperone bound in the presence of 10 pM haloperidol and ranged from 8 percent 
to 12 percent of the total binding. Incubation, filtration and counting of the samples were the Same as 
described above. 
Results and Discussion 
!Cm data of in vifro binding affinity of the complexes for S-HTIA, 5-HTiA and ffr D2 receptors, as 
determined by their ability to displace [ 3 ~ ] - 8 - ~ ~ - ~ ~ ~ ~ ,  [3~]ketanserin and [ H]spiroperidol, are 
shown in Table I. 
For all complexes a moderate to high nanomolar affinity to the S-HT2A receptor is observed. 
Interestingly, the replacement of the standard ethyiene spacer between the basic nitrogen atom and 
the mordinated sulphur atom in 1 by propylene units in 3, 5 and 8 - 10 resulted in a considerabte 
improvement in receptor binding. This effect suggests that a longer distance between the protonable 
nitrogen and the chelate unit allows the ligand to better conform to structurat constraints imposed by 
the 5-HTzA receptor. Fluorine substitution at the 4-position of the aromatic moiety increases the effect. 
The D2 affinity is more differentiated than the 8HTW one. A significant l o s  in D2 affinity 
accompanies the fiuonne substiiution at the 4-position of the phenyl ring, which was similiary 
observed for compfex 4, in mich  the nitrogen atom is an element of a piperidine ring System. This 
result is remarkable because both compounds include st~ctural features which are usually associated 
with strong 5-HTZA receptor-binding agents. 
Alterations in the immediate surroundings of the meta1 core were also ~en~itively recognized by 
different receptor types. This is shown by the exceptional binding profile of 11 and 12 within the 
second senes of rhenium complexes. Replacing the small tridentate dithiol ligand in 1 by a more 
bulky Schiff base ligand to give 11 causes a complete shift in profile. 
Replacement of the tridentate ligand by a tripodal one (complexes 13 and 14) leads to a significant 
l o s  in 5-HT affinity. From these finding the Re=O core appeafi to be essential for serotonin receptor 
binding. 
Table 1 : Affinity to the serotonin (5-HTiA15-HT2d and dopamine (D2) receptorc and sekctivity 
ratios of rhenium complexes (results are expressed as means I SD). Cornplexes 1 - 4 
and 11,12 were described previously [I]. For 13 arid 14 See Glaser ef al. [3] 
lCso (nM) 
Compiex ~ - H T ~ A  5-HTa D2 
Selectivity ratios 
Table 1 cont. 
lCso (nM) 
Complex ~-HT<A 5-HTm D2 
Selectivity ratios 
Table 1 cont. 
lC50 (nM) I Selectivity ratios 
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12. Structural Modification of Receptor-Binding Technetium-99m Complexes in 
order to lmprove Brain Uptake 
B. Johannsen, R. Berger, P. Brust, H.-J. Pietzsch, M. Scheunemann, S. Seifert, H. Spies, R. Syhre 
lntroduction 
Low brain uptake is a generally accepted problem in developing 99m~c  brain receptor imaging agents. 
For a class of potential 5-HT2A receptor binding agents exemplified in Fig. 1, we tried to improve the 
original low brain uptake by modifying the lipophilic properties of the molecules, particularly by 
insertion of ether-oxygen and by lowering the apparent pK values [I]. 
Fig. 1. Example of an 5-HTZA receptor binding 9 9 m ~ ~  complex designed according to the 
mixed-ligand (3+1), integrated approach [2, 31 
Experimental 
Ligands and complexes 
Monodentate thiol ligands containing ether-oxygen atoms were synthesized as described in Part 9 of 
our report 141. 
Tc-99 complexes were prepared as previously reported [3]. To prepare n.c.a. %"'TC complexes, Iigand 
exchange reactions starting from 99m~c  gluconate or ' 9 c  ethylene glycolate were camed out [5]. 
Distribution coefficients 
Log D were determined at pH 7.4 from the capacity factors log k values obtained by HPLC using a 
Perkin-Elmer HPLC Controller System equipped with a UVNIS spectrometric detector (254 nm) and a 
Hamilton PRP-1 column (250 X 4.1 mm; 10 pm). As mobile phase an isocratic eluent (acetonitrile and 
0.01 M phosphate or citrate buffer, 75:25, viv) was applied with a flow rate of 1.5 miimin. Aniline, 
benzene, and bromobenzene were used as intemal Standards. 
Brain uptake 
Animal experiments were carried out according to the relevant national regulations. 0.5 MBq of -TC 
complex was injected into the tail vein of 5 - 6 week old Wistar rats. 
At 2 and 5 min p.i. the rats were sacrificed by heart puncture under ether anesihesia. Selected Organs 
were isolated for weighing and counting [6]. 
Results and Discussion 
A series of new complexes 2 - 6, derived from the class of bHT2A binding complexes illustrated 
in Fig. 2, were synthesized and characterized 14 - 71. All the compounds contain an ether-oxygen 
atom which can be considered an isosteric replacement of a methylene group. Complex 6 contains an 
additional oxygen atom. 
Fig.2: Receptor binding complexes "functionalized" with ether-oxygen atoms 141. 
For complex 1 See ref. [3] 
Table 1 reveals that the ether-oxygen function in the technetium complex molecules has a profound 
effect on the pK value, lipophilicity in terms of Ehe distribution coefficient at pH 7.4, and brain uptake. 
The successful increase in brain uptake achieved by the structural modification is related to a 
decrease in the apparent pK value of the nitrogen which, in turn, increases the lipophilic portion of the 
tracer at physiological pH. 
Table I :  Apparent pKHPLC, lo D and brain uptake (% IDIorgan) in rats 
of receptor binding 'Tc complexes 1 - 6 (for complex 1 See ref. [3D. 
Complex no. 
PKHPLC 10.01 8.94 9.45 9.36 8.97 8.31 
log D 0.70 1.48 1.40 1.60 1.48 2.32 
Brain uptake 
2 min* 0.52f0.12 1.4710.11 0.57f0.10 0.9910.18 1.01 10.14 2.13 
f 0.18 
Brain uptake 
5 min* 0.36 f 0.07 0.94 f 0.09 0.45 f 0.06 0.78 f 0.12 0.76 k0.06 1.31 
f 0.14 
- 
* Data shown are the mean f SEM of three rats 
The relationship obtained between brain uptake in rats and pK value is shown in Fig. 3. 
2 min p.i. 5 min p.i. 
% dose brain % dose brain 
Fig. 3: Relationship of brain uptake in rats at 2 and 5 min. p. i. vs. apparent pK 
of the 9 9 m ~ c  complexes 
It is a common assumption that there is a good correlation between blood-brain barrier penetration 
and lipid solubility of a drug, the latter being classically expressed as its partition coefficient between 
an organic solvent, such as octanol, and water. Other factors may also contribute, such as the 
molecular volume and charge of the drug, and the extent to which it makes hydrogen bonds. In order 
to define the factors responsible for the low uptake (up to 0.4 % in rats at 5 min p.i.) of our receptor 
binding ""TC complexes of the type 1 and to elucidate whether modification of the molecular 
structure will lead to an increased brain uptake without loss of the high receptor binding affinity, the 
molecular size, lipophilicity and charge of the candidates were considered. 
For CNS agents an optimum octanollwater partition coefficient (log P) of around 2 f 0.5 was found for 
various classes of compounds. Such a log P value, which is at the peak of a parabolic dependence of 
uptake, is also usually considered to be required for some types of neutral '"TC chelates [8, 91. 
However, for one class of 9 9 m ~ c - ~ 2 ~ 2  complexes containing an amide group, only a low brain uptake 
was reported, regardless of lipophilicity (log P from 8.56 to 1.75) [IO]. 
In the neutral form, our complexes exhibit log PHPLC values between 3.2 and 3.6, similar to ketanserin 
131. However, the protonable nitrogen atom as an essential constituent of the pharmacophore causes 
the technetium complexes to be almost completely ionized at the physiological pH. The propodion of 
ionizable technetium compounds which are neutral in solution is govemed by the difference in pH of 
the solution and the pK of the molecule, according to the Henderson Hasselbalch equation. With 
ionizable molecules, the lipophilicity is better described by the distribution coefficient (log D), i.e. the 
pK-corrected log P values. We suggest that an excessivety high pK value is responsibie for the low 
uptake of our technetium complexes. Ts test this hypothesis, apparent pK and log D values were 
determined and structural modifications, i.e. introduction of ether-oxygen atoms, performed in oder 
to lower the pK value in the complex molecules. The resutts clearly demonstrate fhe usefufness of Zhe 
hypothesis. The eledronic effects of ether-oxygen two or three carbon atoms away from the 
protonable nitrogen in the Iigand backbone are obviously strong enough to produce the desired 
decrease in pK value. Thus, the introduction of oxygen atoms proved to be a valuable tool in the 
design of certain 99"Tc brain irnaging agents. In view of the still relatively high pK vafues, the increase 
in brain uptake cannot be explained merely by a higher proportion of neutral, diffusible species. In this 
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5. Serotonin Receptor-Binding Technetium and Rhenium Complexes 
13. No Carrier Added Preparations of "3+1" 9 9 m ~ c  Complexes 
S. Seifert, H.-J. Pietzsch, M. Scheunemann, H. Spies, R. Syhre, B. Johannsen 
lntroduction 
Oxotechnetium01) complexes with tridentate dithiols "HS-C2H4-X-C2HrSHu (X = S, 0, N) and 
functionalized monodentate thiols, so-called "3+Iw complexes of the general formula [MOL3L2] (L1 = 
tridentate dithiol ligand, L2 = rnonothiol ligand), play an important role in the development of receptor- 
binding technetium complexes [I, 2, 31. While the preparation of these complexes at c.a. level (or 
with rhenium) is possible without any difficulties by stoichiometric ligand-exchange reaction starting 
with [TcOC14]-, Tc gluconate or [ReOCI4]', [R~OLICI] and Re gluconate [41, the n.c.a. preparation 
generally results in a mixture of various partially unidentified cornplex compounds. Moreover, the 
prepared "3+In complexes are not stable in the reaction solution containing an enormous ligand 
excess. 
Furthermore, direct reduction of pertechnetate generator eluate in the ligand mixture solution leads to 
a lot of unknown products besides small amounts of the desired cornplex. Therefore, it was the aim of 
this work to find reaction conditions allowing reliable and reproducible preparation of "3+1" technetium 
complexes at n.c.a. fevel with yields and stabilities high enough for animal expenments. 
We studied the complexation reactions at n.c.a. level with the tridentate ligand L1 = 3-thiapentane- 
I ,5-dithiol (HS-(CH2)2-C-(CH2)2-SH) or, in one case, with 3-ethylaza-pentane-l,5-dithiol (HS-(CH2)T 
N(C2H5)-(CH&-SH) and a series of monodentate thiols L2, e.g. small ligands such as ethanethiol 
(C~HSSH), 2-propanethiol (C3H7SH), or larger monothiols like: 
The identity of the prepared n.c.a. complexes was examined by comparison of the chromatographic 
behaviour (TLC, HPLC) of these preparations with Re or 3 c  reference wrnplexes as well as Organ 
distribution data of c.a. and n.c.a. Tc preparations. 
Experimental 
General 
The tridentate ligand and both small thiols are wmmercial substances and were used without further 
purification. The other monothiois were prepared as described previously 151. 
Pertechnetate generator eluate was obtained from a commercial 9 9 ~ o / 9 9 m ~ ~  generator (Mallinckroclt). 
A 0.3 M aqueous solution of ammonium [?c]pertechnetate was used for c.a. preparations. The 
comparative ?C and Re substances were prepared according to the general procedure described in 
[2, 41. 
N. C. a. preparations 
In order to prepare n.c.a. -C complexes 3 - 8, Iigand exchange reactions starting from 99m~c  
gluconate or ethylene glycotate were carried out. Both precursor solutions were prepared by 
gradual addition of 20 NI stannous chloride solution (1.0 mg dissolved in 10 ml ethanol) to an 
aqueous solution of [99m~c]pertechnetate eluate in an excess of sodium gluconate (10 mg) Or ethylene 
glycol (10 NI). 0.5 mg of the monodentate thiol ligand dissolved in ethanol was added t0 1.0 ml 0f the 
precursor solution adjusted to pH 8 - 9 and 1.0 rnl acetone or acetonitrile. 0.05 mg 0f the tridentate 
ligand dissolved in acetone was added after one minute arid the formation of the desired mixed-ligand 
complex was completed by heating the reaction solution at 40 "C in a water bath fOr 15 - 20 minutes 
(yields: 80 - 90 %). For separation of byproducts arid ligand excess the reaction solution was given 
onto a semi-preparative PRP-1 column (Hamilton, 305 X 7 mm, 10 Fm, flow rate 2.0 mllmin) and 
eluted using a linear gradient system (t[min]l%A): (5150), (1 OIOO), (51100) of acetonitrile (A)lwater (B) 
with 0.1 % trifluoroacetic acid (pH 2). After adding 100 NI propylene glycol and removing acetonitrile 
by vacuum evaporation, the separated neutralized complex fraction is stable for more than 8 h. 
For the preparation of complexes 1 and 2 only 0.2 mg of the monothiol ligand are added to the 
precursor solution. After addition of 0.1 mg of the tridentate ligand the reaction solution is heated to 
60 "C for I h. 
Analytical methods 
TLC and HPLC analyses were used for the determination of the radiochemical purity and stability of 
the preparations. 
TLC analyses were performed using silica gel strips (Silufol) developed with n-butanollmethanol/wa- 
terlconc. ammonia (6012012011) (method I) as well as methanoll0.l N HCI (311) (method II) as 
solvents. 
In addition to the above-mentioned conditions for separation of ligand excess (PRP-1, pH 2.0), HPLC 
analyses were mainly carried out with a Superspher 100 RP-18 column (250 X 4 mm) using an 
isocratic gradient mixture of 80 % methanol and 20 % 0.01 M phosphate buffer of pH 7.4 and a flow 
rate of 1.0 mllmin. The effluent from the column was monitored by UV absorbance at 254 nm for 
rhenium complexes or y-detection for the ""'TC cornplexes. For the biological studies the solutions of 
the complexes were diluted with propylene glycol and sodiurn chloride for injection to adjust the 
desired radioactive concentration. 
In viv0 biodistnbution in rats 
The animal experirnents were carried out according to the relevant national regulations. Organ 
distribution studies were performed on male Wistar rats (5 - 6 weeks old). 0.5 ml complex solution 
was injected into the tail vein. 1 - 120 min. p.i. the rats were sacrificed by heart puncture under ether 
anaesthesia. The selected Organs were isolated for weighing and counting. The percentage doselg 
values were computed from the percentage doselorgan values and the corresponding mean Organ 
weights. 
Results and Discussion 
Preparafion of n. C. a. complexes 
As found for c.a. preparations, the complexation reaction to rnixed-ligand "3+Iw complexes proceeds 
with better yields when an excess of the monodentate ligand is added at first. After rapid formation of 
the Tc complex with only the monodentate ligand L2, the tridentate dithiol ligand LI is added and the 
"3+1" complex is formed in a slow reaction. 
+ L2 + L1 
Tc gluconate ----b (TCO(L2)4]- ---+ [TcOLI L21 
The formation of 1:4 complexes of technetium with sterically hindered or bulky monothiols is 
described in f6, 71. A simitar reaction should take place with the above-mentioned bulky ligands used 
for the formation of complexes 3 - 8, 
The formation of mixed-ligand complexes 3 - 8 Iisted in Table I from the intermediate technetiurn 
complexes represents a slow reaction (Fig. 1). 
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Fig. 1. HPLC analyses of formation of ""'TC complex 4 at room temperature. 
(Superspher RP-18, methanol/0.01 M phosphate buffer pH 7.4 (80/20), 1.0 mllmin) 
a: 5 min, b: 30 min, C: 80 min, d: 120 min after preparation 
Without heating between two to three hours are needed for completion of the reaction depending On 
the ligand used. The successful formation of complex 7 is remarkable despite the voluminous 
monothiolato ligand. 
Generally, the reaction is acceterated by careful heating. 15 - 20 minutes in a water bath at 40 "C is 
enough for yields of 80 - 90 % (Fig. 2). Heating over 40 "C results in a competing reaction, probably 
to complexes containing only the tridentate ligand. Similar reaction products were found when more 
than 1 mg of the tridentate ligand was added for preparing the "3+1" complex. That shows that the 
ligand concentration plays an important role conceming the Course and kinetics of the reaction. Only 
microgram amounts are needed for the n.c.a. preparations. The use of milligram amounts of both 
ligands results in low yields of the desired complex and the formation of mostly unknown products. 
The best results were obtained with 0.5 - 0.2 mg of the monothiolato ligand and 0.05 - 0.02 mg of the 





Fig. 2. HPLC analyses of formation of '%TC compiex 6 
(Superspher RP-18, methanoll0.01 M phosphate buffer pH 7.4 (80120), 1.0 mllmin) 
a: after 5 min, b: after 20 min heating at 40°C. 
These low ligand quantities are also responsible for the relatively high stability of the complex 
preparations. While preparations with h i g h  yields of ligands are unstable and undergo secondary 
reactions at higher temperatures or with time, Ehe optimized preparations are stable for at least 2 h at 
room temperature, even without separation of the Iigand excess. If the ligand excess is separated, 
e.g. by HPLC, the complex solutions are stable for more than 8 h. 
It was found that the monothiols used for complexation change with time, probably by formation of 
disulphides. That results in a delay of reaction at room temperature. T0 accelerate the reaction, 
heating at 40 "C for 20 minutes is needed to obtain yields of 80 - 90 % of the desired complex. 
Using freshly prepared monothiolato ligand, e.g. (213s) 2-IN-(3-mercaptopropy1)-N-methylamino- 
methyll-I ,4-benzodioxane, for preparing compiex 3 results in a yield of 73 % even after 5 minutes 
reaction time at room temperature. After 30 minutes the reaction is finished and yields of 75 - 90 ?!Y 
are obtained. 
To protect the monothiol ligand, the very stable oxalate was formed and isolated as a white powder. 
This allows better Storage and represents a first step to a W-like" preparation Of the "3+Iw complex. 
For preparing the complex a certain content of sodium hydroxide has to be added t0 the reaction 
solution to deprotonate the nitrogen atom of the monothiolato ligand. Without adding NaOH the 
solution has a pH value of about 6, and only less than 10 % of the complex are formed. 
The best yields were obtained by adding 100 pl 0.1 n NaOH to the w m ~ c  gluconate solution (pH = 11) 
and complexation with 0.3 - 0.5 mg oxalate of the monothiolato ligand and 0.05 mg of the tridentate 
HS-C-SH ligand. Without heating 3 h are needed to obtain more than 70 % of the desired complex. 
The same result is achieved by heating at 40 "C for at least 60 minutes (Fig. 3). 
Fig. 3: Reaction conditions for preparing the "3+1" ""'TC complexes using the oxalate of the mono- 
thiolato ligand. 1: 100 pl O.1n NaOH, 20 "C, pH 11, 11: 100 p1 0.1 n NaOH, 40 "C, pH I I, 
111: 150 pI 0.1 n NaOH. 20 "C, pH 12. 
The preparation of the %"'Tc wmplexes 1 and 2 needs other reaction conditions. For instance, Tc 
gluconate reacts immediately with ethanethiol or 2-propanethiol to the intermediate complex. The 
exchange with the tridentate ligand using the Same conditions as for complexes 3 - 8, however, 
proceeds very slowly at room temperature. 5 - 6 h reaction time results in yields of only 40 - 60 % of 
the mixed-ligand complex. It was found that a diminished monothiol ligand concentration of 0.2 mg 
and an increased wntent of 0.08 - 0.1 mg per via1 of the S-S-S ligand lead to shorter reaction times 
of 1 - 2 h and higher yields of 80 - 90 %. 
As already found for complexes 3 - 8 a higher temperature also accelerates the formation of the "3+Iw 
complex. The optimum temperature for formation of complexes 1 and 2 was determined to be 60 "C. 
The stability of ""'TC complexes with thiols like ethanethiol or 2-propanethiol is probably higher than 
that of cornplexes with bulky ligands. The ligand exchange between these smal monothiol ligands 
and the tridentate ligand proceeds therefore much slower. 
Reaction with the tridentate S-N-S ligand instead of the S-S-S ligand leads to complex 8. No 
significant differences were observed concerning the optimum parameters for the formation of the 
n.c.a. complex and the kinetics of complexation. 
Chemical and biological evaluation of n. C. a. preparations 
Two TLC methods were performed for identification of the 9 9 m ~ c  preparations. The Rf values of the 
n.c.a. complexes 3 - 8 determined with method I (Rf = 0.6 - 0.7) as well as method II (Rf = 0.4 - 0.5) 
are in accordance with the Rf values of the c.a. preparations. 
The HPLC data obtained with an RP-18 and a PRP-1 column also show the identity of the n.c.a. and 
c.a. preparations (Table 1). In some cases rhenium complexes were also investigated. As expected, 
the Same Rt values were obtained. 
Table I. Comparison of Rt values of n.c.a. and c.a. Tc complexes 
Complex No. Rt value [min] 
RP-18 PRP-1 (prep.) 
n.c.a. c.a. n.c.a. c.a. 
Organ distribution studies carried out with selected c.a. and n.c.a. technetium complexes also confim 
the identity of preparations. In Table 2 the data for complexes 3, 5 and 6 are presented. 
Table 2: Comparison of biodistribution data of c.a. arid n.c.a. ""'TC complexes 5 min. p.i. in rats 
P 
Complex Brain S E M  Ig SEM Blood &SEM Heart *SEM Lungs &SEM 
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6. Serotonin Receptor-Binding Technetium and Rhenium Complexes 
14. Distribution and Brain Uptake in Rats of Serotonin Receptor-Binding 
Oxotechnetium(V) Complexes at the c.a. (99m9 TC) and the n.c.a. (''"'TC) Level 
R. Syhre, H.-J. Pietzsch, M. Scheunemann, S. Seifert, H. Spies, B. Johannsen 
lntroduction 
Neutral lipophilic 9 9 m ' 9 9 ~ ~  oxotechnetium0l) complexes of various structures show affinity to serotonin 
receptors (5-HTZA; 5-HTIA) as determined by in vitro binding studies on rat cortex [ I ,  2, 3, 4, 51. These 
complexes all contain a protonable nitrogen in the molecule, which might prevent brain uptake. As 
reported in [2, 61 the complexes studied are nevertheless able to Cross the intact blood-brain barrier of 
the rat. However, the levels of the initial brain uptake were observed to be relatively low (0.2 - 0.5 % 
doselorgan at 2 min. p.i.). A slow washout from the brain and a retention into receptor-rich brain 
regions were found. A high and prolonged background activity in the blood stream was determined in 
biodistribution studies. This unfavourable characteristic may result from ionization at the blood pH 7.4 
as well as from interaction of the complexes with plasma proteins and blood cells [7]. 
In the following we report the biodistribution of receptor-binding 9 9 m ' 9 9 ~ ~  oxotechnetium0l) complexes 
which have been modified to overcome the low brain uptake. Besides the protonable nitrogen these 
complexes contain ether-oxygen atom(s) in the side chain. This modification has a profound effect on 
lipophilicity parameterc such as the distribution coefficient log D and the pK,values 14, 81. 
Experimental 
Animal studies 
Animal experiments were carried out according to the relevant national regulations. 
The studies were performed on male Wistar rats (5 - 6 weeks old). 0.5 ml of the complex solution 
(propylene glycol I sodium chloride ) were injected in the tail vein. 2 - 180 min. p.i. the rats were 
sacrificed by heart puncture under ether anaesthesia. The selected Organs were isolated for weighing 
and counting. For the studies of brain regions the whole brain was removed, and cortex, caudate 
putamen hippocampus and cerebellum were dissected on an ice-cold glass plate, weighed and 
counted, and the percentage dose per gram was calculated. 
Binding on erythrocytes 
After in vivo or in vifro incubation, red blood cells and plasma were separated by centrifugation of 
heparinized whole blood. The cells were washed plasma-free (sodium chloride for injection) and the 
radioactivity of the red cell fraction was counted and calculated. 
Results and Discussion 
The preparation and chemical characterization, the physicochemical charadenzation and the charac- 
terization of the biological in vifro behaviour of the ether-oxygen containing Tc-complexes have been 
described previously [ IO,  1 I]. The complexes under investigation are listed in Table I. 
Table 1 : Structure oLtxygen-containing oxotechnetium(V) cornplexes at the c.a. (Sm'99 Tc) 
and n.c.a. ( Tc) level 
Complex Complex 
4 FGOk cH3 (?!.o I Q F$ (xo M: ~ + 9 ~ / 9 9  N s - a ~  
O ' L N  s-!?? 
\s' = 
M: Tc 4a 
The results of the animal studies indicate that the ether-oxygen containing complexes are capable of 
crossing the blood-brain bamer. The distribut~ion data show a successful increase in brain activity up 
to 2.1 % dose (complex 6) at 2 minutes P. i. and a prolonged retention in the rat brain within 10 - 120 
min. post-injection of these new tracers (Fig. 1; Table 2). 
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Flg.1: Time Course of brain uptake in rats after injection of oxygen-containing complexes 
(mean values 2 - 120 minutes p-i.; n = 3 - 6) 
The injtial bsain uptake of mosi of the complexes shows a good inverse correlation to the pK, values 
of the cnrnplexes (F@. 2). Interestingly, cornplex 5 (morpholinyl derivatives) does not fit into this 
comlation. Complex 5 displayed a significantly lower brain uptake than complex 6 despite similar 
Iipophilicity parameterc of both wmplexes [$J]. This obsewation cannot yet be explained. 
Another paint of inierei in the design of potential receptorbinding agents is the regional distribution in 
the btain, inciuding target (receptor-rich 1 to nontarget (receptor-poor) ratios. 
Table 2: Biodistribution of 9 9 m ' 9 9 ~ ~  1 99m Tc oxotechnetiumw complexes in rats 
(mean % dose &SEM, n = 3 - 6) 
Comolex Time Brain Blood Heart Lung Kidney Liver 
Table 3: Calculated ratio of receptor-rich regions vs cerebellum 5 minutes after injection 
of the 9 9 m / 9 9 ~ ~  complexes 1 - 6 in rats (% doselg; n = 3 corrected by the blood 
activity portion in the regions according to Cremer [I21 
Complex Cortex/ Caudate putamenl Hippocampus/ 
cerebellum cerebellum cerebellum 
The ratios of regional brain uptake to cerebellum for complexes 1 - 6 at 5 minutes P-i. are listed. In 
Table 3. In vitro, complex 6 proved to be selective for 5-HTi~ receptor, the complexes 1 - 5 for the 
~ - H T ~ A  receptor [4, 51. 
Table 4: Ratio of receptor-rich region and cerebelium 5 - 180 minutes afier injection 0f the 
'"'/99Tc complexes (column A) and ="'TC complexes (column B) in rats (% doselg; n = 3) 
Complex Time p.i. Cortex/ Caudate putamenl Hippocampusl 
[min] cerebellum cerebellum cerebellum 
A B A B A B 
As shown in the preliminary studies, the unblocked in vivo distribution in rat brain exhibits remarkable 
heterogene with the moderate region to cerebellum ratios in the ranges of 0.7 - 1.4 at 5 minutes p.i.. 
caudate putamen 
0,8 r hippocampus 
0.8 r cerebellum 
min. p.i. 
+ complex 5 
03 
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Fig. 3: Time Course of radioactivity in various brain regions after injection of 99m199 TC complexes (A) 
and ''"'TC cornplexes (B) in rats (rnean values; n = 3) 
For the complexes 5 and 6 the time Course of radioactivity in selected brain regions ( 5 to 180' p.i.), 
especially in the cortex (frontal), the caudate putamen, the hippocampus and the cerebellum is 
demonstrated in Fig. 3A. The accurnulation of radioactivity was highest in the brain regions at 5 min 
p-i. and declined gradually over the 180 min. period. The washout appears to be somewhat slower 
from the serotonin receptor-rich regions (cortex and hippocampus) compared with the other brain 
park (caudate piitamen; Cerebellum). A moderate rise of the regional contrast ratio cortexlcerebellum 
and hippocampus/cerebellum at 180 min ai3er injection of these 9 9 m / 9 9 ~ ~  cornplexes was observed 
(Table 4, column A). 
These results suggest a long-term retention of the complexes in selected rat brain structures. In viv0 
receptorbinding as well as specific brain uptake in the regions of interest cannot be derived from the 
few results. 
In Table 2 the results of the biodistribution of the 9 9 m ' 9 9 ~ ~  complexes (1 - 6) in the rat are summarized. 
The various complexes do not drastically differ in the distribution pattems in the peripheral tissue of 
lung, kidney, heart and liver. The enhanced activity in the lung was cleared VeV slow, while 
accumulation in the liver and kidney increased with time. 
Unfortunately, the distribution data display a high blood activity and a slow blood ~b l ' ance  (Fig. 4; 
Table 2). About 70 % of the blood activity was always concentrated in the rat erythrocSes 5 min p.i. 
of the lipophilic complexes. In vivo the percentage bound to erythrocytes decreases slowly up to 
approx. 50-% at 120 kin. p.i. (Table 5). 
. 
Fig. 4: Blood clearance curves of 99m1?~ cornplexes after injection in rats 
(mean values; n = 3 - 6) 
The binding on erythrocytes as well as the elimination from the blood pool seem to correspond to the 
initial uptake and retention characteristics of the complexes in the liver. Especially complexes 5 and 
6 show a relatively low blood activity (Fig. 4) and a correspondingly higher initial liver uptake (Table 
2) compared the other oxygen-containing complexes under study. 
Table 5: Radioactivity of erythrocytes after injection of oxygen-containing 99m/99 TC complexes 
and 99m TC complex 6a in rats (mean % uptake I SEM ; n = 3 - 6) 
Com~lex Time of Radioactivity of 
incubation erythrocytes 
[min.] [% f SEM 
Apparently, binding and retention of the oxygen-containing complexes in the penpheral Organs and in 
the blood pool can be explained in the form of strong, unspecific binding On proteins of the rat plasma 
and tissues. 
Table 6: In vitro binding to erythrocytes 5 minutes after incubation of 9 9 T c  complexes in whole 
blosd of different species (mean values t. SEM ; n = 3 - 6) 
Complex Rat Pig Human 
% radioactivity + SEM % radioactivity I SEM % radioactivity f SEM 
For the interpretation of the biodistnbution data it is important to note the species dependence of 
erythrocyte binding (Table 6; 5). The results discussed so far relate to c.a. -C complexes. 
For further evaluation of the favourable uptake of the new oxygen-containing complexes in the rat 
brain it is necessary to compare the results with those obtained at the no cameradded level -C. 
The identity of the complexes at both tracer level~ was proved by HPLC Illj, also the biological 
behaviour is similar as follows: 
0 60 120 180 
minutes p. i .  
0 60 120 180 
minutes p.i. 
Fig. 5: Time Course of distribution of % T c  complexes 5 and ""'TC complexes 5a 
compared in rats (mean % dose I SEM ; n = 3 - 6) 
As shown in Table 2 and Fig. 5, similar distribution data were obtained at both tt'acer levels. The 
regional brain distribution (Fig. 3) as well as the target nontarget rati0s Vable 4, column B) were 
found to be similar also for the c.a and n.c.a. preparations of the complexes. The binding data to rat 
erythrocytes confirm the identity of the c.a. and the n.c.a. complexes (Table 5). 
In Summary, insertion of ether-oxygen in the complex structures dramatically impr0ve the initial 
uptake in the rat brain. In all other aspech there is no significant difference in biodi~tributio~ 
compared with the corresponding oxygen-free, nitrogen-containing %-TC complexes [6, 71. 
These results indicate that the adjusted lipophilicity of the modified complexes S ~ O W S  an effect only 
on the initial brain uptake of the rat. The distribution pattern appears to be identical in in viv0 
behaviour for the camer-added and no-camer-added oxotechnetium0l) complexes. 
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7. Serotonin Receptor-Binding Technetium and Rhenium Complexes 
15. Synthesis and Characterization of Oxorhenium(V) Complexes with 
N-functionalized Tridentate SNS Ligands 
H.-J. Pietzsch, M. Scheunemann, R. Berger, P. Brust, H. Spies, B. Johannsen 
Introduction 
We previously reported on mixed-ligand Tc and Re complexes that show substantial 5-HT2 serotonin 
receptor binding. In this class of compounds the protonable nitrogen of the side-chain is a crucial 
structural feature, which is, on the one hand, an essential constituent for 5-HT2 affinity but, On the 
other restricts the blood-brain transfer, depending on the nature and pK of the amine functionality [I]. 
After having described our efforts to improve the low brain uptake of the complexes by insertion of 
oxygen into the pharmacophore [2], we now report on a further way to influence the pK value of the 
nitrogen by changing the position of the pharmacophore portion with respect to the meta1 centre. 
Experimental 
pK values, partition and distribution coefficients were determined as previously described [3, 41 from 
the capacity factors log k values obtained by HPLC using a Perkin-Elmer HPLC Controller System 
equipped with a UVIVIS spectrometric detector (254 nm) and a Hamilton PRP-I C O I U ~ ~  (250 X 4.1 
mm; 10 pm). As mobile phase an isocratic eluent (acetonitrile and 0.01 M phosphate or citrate buffer, 
75:25, viv) was applied with a flow rate of 1.5 mllmin. Aniline, benzene, and bromobenzene were 
used as internal standards. 
General synthesis procedure for the tridentate ligands d - f 
A solution of the appropriate amine a - C (0.1 mol) in 30 ml of dry toluene was mixed with a solution of 
ethylene sulphide (0.2 mol) in 10 ml of dry toluene and allowed to stand 6 h at ambient temperature 
(sealed tube, argon flushed). The reaction mixture was then heated to 110 'C for 10 h, cooled, and 
filtered to remove a small amount of polyethylene sulphide. The solvent was removed to give the raw 
product as a neariy colourless tiqiud. 
The ligands were isolated as hydrochlorides and purified by recrystallization from ethanolldiethylether. 
Yietds: 65 - 70 %. 
Elemental analysis: 
d: (Found: C, 51 .I; H, 8.0; N, 7.0; S, 16.0; CI, 17.8, C17H32N2S2C12 requires 
C, 49.9; H, 8.1; N, 6.8; S, 15.5; CI, 18.0 %) 
e: (Found: C, 53.6; H, 8.0; N, 6.6, S, 15.1; CI, 16.7, Cf9H34N2S2C12 requires 
C, 52.8; H, 7.7; N, 6.4; S, 14.8; CI, 17.1 %) 
f: (Found: C, 47.9; H, 7.5; N,7.0; S, 16.0; CI, 17.7, C&'30N20S2C12 requires 
C, 47.3; H, 7.2; N, 6.8; S, 16.3; CI, 18.0 %) 
General synthesis procedure for the complexes 1 - 4 
A mixture of 0.3 mmol of the tndentate Iigand d - f and 0.3 mmol of 4-methoxythiophenol (for 1, 3 
and 4) or sodium methylthiolate (for 2) was added to a stirred suspension of [ReOC13(PPh3)2] 
(250 mg, 0.3 mmol) in 0.15 N sodium acetateJ20 ml of methanol. The reaction mixture was refluxed 
for 45 min, at which time the metal precursor dissolved. The colour changed from greenish-yellow to 
greenish-brown. After cooling to ambient temperature, the mixture was diluted with 50 ml of dichloro- 
methane and washed three times with 10 ml of water. The organic phase was separated from the 
mixture and dried over sodium sulphate. After evaporation of the solvent the product was isolated by 
column chromatography (silica gel, CHC13/methanol (90f10) as eluent). 
Yields: 60 - 65 %. 
Efementai analysis: 1: (Found: C, 43.3; H, 5.3; N, 4.2; S, 14.4, C24H35N202S3Re requires 
C, 43,2; H, 5.0; N, 4.1; S, 14.3 %) 
2: (Found: C, 37.7; H, 5.4; N, 4.9; S, 16.8, C ~ B H ~ ~ N ~ O S ~ R ~  requires 
C, 37.7; H, 5.5; N, 4.9; S, 16.6 %) 
3: (Found: C, 45.2; H, 5.4; N, 4.1; S, 13.9, C~H37N202S3Re requires 
C, 44.9; H. 5.7, N, 4.0. S, 14.0 %) 
4: (Found: C, 39.R H, 4.5; N, 3.7; S, 12.7, C25H34N207S3Re requires 
C, 39.2; H, 4.6; N, 3.8; S, 12.4 %) 
Results and Discussion 
A series of novel mixed-ligand oxorhenium(V) complexes 1 - 4, derived from the class of 5-HT2A 
binding complexes, exemplified in Fig. I, were synthesized and characterized. 
Fig. 1 : Example of 5-HT2~ receptor-binding Re complex (4) 
All the compounds differ from the original receptor-binding complexes in the position of the N-contain- 
ing pharmacophore. In this respect the substances are comparable with the recently described 
analogous Tc and Re complexes [5,6]. 
Table 1 reveals that the change in position of the N-containing pharmacophore portion in the complex 
molecule has a considerable effect on the pK value of the nitrogen (compare with complexes 5 and 6 
in Table 1). The successful decrease in apparent pK value achieved by the structural modification is 
related to a significant increase in lipophilicity in terms of the distribution coefficient at pH 7.4. 
Apart from the possibility of lowering the pK value by insertion of oxygen into the pharmacophore 
group [2], this finding presents a further way of influencing the pK value by modifying the coordination 
sphere. 
Table 1: pK values, partition (P) and distribution (D) coefficients of N-functionalized Re chelates de- 
termined by HPLC 
DHPLC log log 
Complex PKHPLC (PH 7.4) PHPLC PHPLC DHPLC 
Table 1 cont. 
DHPLC log log 
Complex PKHPLC (PH 7.4) PHPLC PHPLC DHPLC 
0 
6 9.70 5 4150 3.62 0.70 
ref. [1 ] 
Synthesis of the tridentate ligands 
The generai synthesis procedure is illustrated in Scheme 1. Starting from the appropriate amino 
alcohols [6], the primary amines a - C were prepared by standard procedures using thionyl chloride 
and sodium diformyl amide. 
Subsequent addition of ethylene sulphide to a, b and C following a procedure described by Corbin et 
al. [7] yielded the tridentate ligands d, e and f. The products were isolated as hydrochlorides and 
purified by recrystallisation from ethanolldiethylether 
Scheme 1 : General synthesis procedure for the tridentate S, NR, S ligands d - f to form 
oxortienium(V9 complexes according to the [3+1] mixed ligand approach 
OHC. - 
OH~'N N.' 
Synthesis of the complexes I - 4 
The oxorhenium0 complexes 1 - 4 in Table 1 were prepared by ligand exchange reaction of 
[ReOC13(PPh3)2] with equimolar amounts of the appropriate SNS ligand (C - 9 and Cmethoxythio- 
phenol (for 1, 3, 4) or sodium methylthiolate (for 2), following a modified procedure described by 
Papadopoulos et al. [5]. 
After column chromatography of the raw material only the syn-isomer (side-chain on the N-donor 
atom is directed to the oxygen of the Re-0 core) was isolated and investigated. 
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8. Synthesis of Neutral Amine Group Bearing "3+Iu Mixed-Ligand Oxorhenium(V) 
Compiexes 
M. Friebe, M. ~a~ado~oulos' ,  S. ~hiotellis', H. Spies, R. Berger, B. Johannsen 
1 Institute of Radioisotopes and Radiodiagnostic Products of the National Center for Ccientific 
Research "Demokritos", Athens (Greece) 
Introduction 
The synthesis of amine-group ttearing rhenium complexes was performed in oder to study the 
relationships between structural Parameters such as lipophilicity or basicity (expressed in terms of k g  
P and pK) and the brain uptake of oxometal0l) complexes (Re; Tc). The compouncls shown in 
Scheme 1 are tertiary amine bearing mixed-ligand '3+In complexes where the tertiary amine group is 
part of the monodentate ligand. fhe  tridentate dithiolate ligand is variable with respect to the neutral 
donor group X. Tc complexes of this type have been the subject of eariier studies 111. 
The firn report informs on the preparation and charaeterization of a seties of rhenium complexes 
where the tridentate ligand (HS-CH$H2-X-CH2CH&3H) contains 0, S, or N-alkyl as the neutral cfonor 
group X, and the pendent amino group bears dimethyi, diethyl and di-n-butyl groups or Is a pipendinyl 
or morphoiinyl arnine. 
Scheme 1: General formula and numbering scheme of complexes [R~O(SXS)(S-CH~CH~-NR~)] 
(Pip = Piperidine; Mo = morpholine) 
NR2 X: S 0 NMe NEt NNu 
NMe2 l a  2a 3a 4a 5a 
NEt2 jb 2b 3b 4b 5b 
NBuz I c  2~ 3~ 4~ 5~ 
Pip l d  2d 3d 4d 5d 
Mo l e  2e 3e 4e Se 
Reparation of [MO(SXS)(S-CH~CHTNR~)] la - fe (X= S) f~nef'al ~ c e d u f e )  
A fourfold molar excess of NR~-ethylene thiol (X mg, 0.3 mmol) in acetonitrile (2 ml) was added to 
dirred arid refluxed solution of chloro(3-thiapentane-1,~-dithio~ato)oxorheniurn(v) (29 mg, 74 pmol) 
acetonitrile (4 ml). After a period of 30 minutes the feaction mixture was evaporated to dryness. rhe 
residue was dissolved in trichloromethane and purified by liquid chromatography over silica gel60 
with trichloromethane as the mobile phase (eluent: trichforomethanelmethanol (1 9:l)) Complexes 
were precipitated as brown powder afier the volUme 0f the elution tll i~tufe had been reduced by 
evaporation. For Q and B, the solvent was removed, the residue redissolved in dichloromethane, 
and - after adding methanol - the solution was slowly evaporated. 
Reparation of [MO(SXS)(S-CH2CHrNR2)] Pa - 2e (X = 0) (general procedure) 
Tetrabutylammonium tetrachlorooxorhenate01) (87.9 mg, 0.15 fnmol) was dissolved in trichloro 
methane (5 ml), stirred and cooled to 0 "C. A solution 0f 3-0xapentane-1,5-dithiol (20.5 mg, 0.1: 
mmol) arid NR~-ethylene thiol (0.20 mmol) in trichloromethane (2 ml) was added, After stining far 31 
minutes the reaction mixture was evaporated to dryness. The residue was dissolved in acetone 
reduced in volume by slow evaporation and the purple solid obtained was first washed with a smal 
portion of methanol and then with ether (3 X 5ml). 
Complexes 2a, Zc, 2e could not be obtained in a solid state. 
Reparation of [MO(SXS)(S-CH2CHrNRd] 3a - 3e. 4a - 4e. 5a - 5e (X = N(-CHd; N(-C2Hd and 
N(-C&) (general procedure) 
A mixture of the SNS ligand (0.2 mmol) and the monodentate ligand (0.2 mrnol) in rnethanol (2 ml 
was added to a stirred suspension of trans-monooxotiichlorobis(triphenylphosphine)um (1st 
mg, 0.2 mmol) in methanol (20 ml). The suspension was stirred and heated to 70 "C for 60 minutes 
by Wich time the greenish-yellow colour 0f the PreCUrsOr compound had turned a dark greenish 
brown. After cooling to room temperature, the reaction mixture was diluted with dichloromethane an( 
waterlhydrochloiic acid (pH z 4) was added. The aqueous phase was reextracted with trichloro 
methane, the organic extract was separated and dried over sodium sulphate. 
After purification by liquid chromatography over silica gel, first with trichlorornethane and then witl 
trichioromethanelmethanol (19:1), the complexes were precipitated as green solids by SIOW evapo 
ration of the mixtures: - trichloromethanelethanol 4c, 4d, 5d, 5e' 
- trichloromethaneln-heptane 3a, 3b. 3d. Je, & 
- diethyletherln-heptane &!, 4b 
Results and Discussion 
The rhenium complexes containing SSS and SOS donors were obtained by reaction of tetrabutyl- 
ammonium tetrachlorooxorhenium(V) [2, 51 with the tri- and monodentate ligands in a one-pot reac- 
tion [6, 71 (see Scheme 1). As an alternative route rheniumo complexes containing SSS donors 
were also synthesized using a Wo-step reaction by addition of an excess of the appropriate monoden- 
tate ligand to chloro(3-thiapentane-1,5-dithiolato)oxorhenium0/) as described by Fietz et al. [5, 31. 
This procedure resulted in an increased yield. Analogous intermediates of the other tridentate ligands 
(X = 0. N-R) with the chlorooxometal core are unknown and our efforts to prepare such stable precur- 
sors failed [6]. 
For preparation of the SNS-containing rhenium complexes transmonooxotrichlorobis(triphenyl- 
phosphine)rhenium(V) [4] was used as a precursor, yielding complexes 3a - 3e. 4a - 4e and 5a - 5e in 
the reaction with an equimolar mixture of tri- and monodentate ligands (see Scheme 2). 
Scheme 2: Pathways to "3+1" oxortienium(V) complexes 
The yields of crystallized complexes for the various donor ligands differ considerably (9 - B2 % 
I 
theor.). The best yields were achieved for SSS-containing complexes obiained by the two-step 
procedure. The crystallization tendency decreases with more Iipophilic complexes. 
The Wo precursors used for the synthesis differ in their reactivity, which should match that of the 
tridentate ligand. So we obtained pure stable products in higher yields with the tetrabutylammonium 
tetrachlorooxorhenium~ precursor in the case of HSSSH and HSOSH figands. fo r  preparation of 
SNS-containing complexes the t r a n s - m o n o o x o t r i c h l o r o b i s ( t r i p h e n y l p h o s ~  precursor 
gave the best yields. 
All the resulting complexes were characterized by eelemental analysis, 1R spectroscopy, HPLC and 
I melting point. Data are summarized in Table I. 
One of the compounds f2d) was examined by EXAFS to determine the stnicturat paiameters, 
Table 1 : Data of complexes [ReO(SXS)(S-CH2-CH2-NR;)] 
Complex Molecular M.p. IR Morphology 

































Complex Molecular M.p. IR Morphology 
No. mass ["Cl v(Re=O) [cm"] 
4e - 51 1.7 170 - 173 948 green 
compact 
crystals 
5a 497.8 - green 
precipitate 
5b 525.8 - green 
precipitate 
5d - - 537.8 952 green 
precipitate 
5e - 539.8 135 - 138 952 green powderl 
compact 
crystals 
Correct elemental analyses were determined for all complexes with the exception for fi and s, 
which contained impurities; and 2- ; and 2e, which could not be obtained as solids. 
The infrared spectra (in KBr) of all rhenium complexes showed the expected Re=O Stretch for the 
monooxo species in the range of 948 - 976 cm*' (Table 1). 
EXA FS 
The expected structure of compound was confirmed by the EXAFS investigations. lndeed an 
oxydation state of +V for rhenium could be evidenced by a short bound oxygen at 1.65 A, typical f0r 
the Re=O core. The donor atoms of the first coordination shell were identified as three sulphur atoms 
with an average bond distance of about 2.27 A (mercaptide sulphur atoms) and one oxygen atom with 
a bond distance of 2.06 A, corresponding to an ether oxygen. 
Table 2: Final fit 
Coordination Atom R [Al 0 LA2] 
number (Debye-Waller-factor) 
Detailed description of the method will be published next time. I am grateful to R. Jankowsky for his 
help. 
The rheniurn COmple~eS are soluble in tnchtoromethane, dichloromethane and acetone - 5e), 
slightly soluble in methanol and ethanol (la - W, and insoluble in ether (- - 3e. 4c - rle),heptane (la 
- 4e) and water (la - 5e). Whereas all the compounds were found to be stable in the solid state and 
solution, decomposition was observed for complexes 2b and when applied to a silica gel column 
and in the solute state. 
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9. Preparation of Amine Group Bearing "3+1" Mixed-Ligand Oxotechnetium(V) 
Complexes at the Carrier-Added Level 
M. Friebe, M. ~apadopoulos', E. ~hiotellis', H. Spies, R. Berger, B. Johannsen 
'lnstitute of Radioisotopes and Radiodiagnostic Products of the National Center for Scientific 
Research "Demokritos", Athens (Greece) 
lntroduction 
Even in the early 1990s, neutral tertiary amine bearing "3+lU oxotechnetium0l) complexes were 
synthesized by Spies et al. [I] and Chiotellis et al. [2], and pretiminary studies on the relationships 
between structural Parameters and lipophilicity as well as basicity (expressed in terms of log P and 
pK) were camed out [I]. 
For some of these complexes a considerable brain uptake was found 121. In order to obtain more 
inforrnation on the structure dependence of brain uptake it was necessary to make available and to 
study more technetium0 complexes belonging to different classes of substances. 
Here we describe the preparation and characterization of a series of oxotechnetium complexes at the 
c.a. level. Tri- and monodentate ligands and, therefore, the composition of the Tc complexes is analo- 
gous to the Re compounds described in the preceding article. 
Scheme 1: General formula and numbering scheme of complexes [TcO(SXS)(S-CH2CH2-NR2)] 








For radiolabeliing a ( 5 9 ~ ~ P ~ ~  generator "Ultra Techne Cow" (Mallinckrodt) was used. 
A mixture d sodium [*c]pertechnetate (150 MBq in 1.0 ml of saiine) and ammonium [99~c]per- 
technetate (1.2 pmol in 0.12 ml af saiine) was reduced by 0.12 ml of a stannous chlonde solution (120 
pmoE in 0.1N hydrochloslc acid) in the presence of 0.1 M sodium giuconate solution (1.6 ml) to give 
TcO/) gluconate. The purity of the precursor was analysed by thin layer chromatography over silica 
gel plates in acetone with a radioactivity detector. An activity peak at the starting range of the plate 
indicates complete reduction of pertechnetate. 
Preparation of [TcO(SXS)(S-CH2CH2-NR2)] 4a-5e 
T c 0  gluconate (1.2 mol; 150 MBq in 22 ml) and a mixture of tridentate ligands (1.2 pmol) and P monodentate ligands (1.8 pmol) in ethanol (0.6 ml) were vortexed and kept at room temperature for 
10 minutes. The colour of the mixture changes from colourless to yellow. The pH value of the solution 
was enhanced to 11 by 0.1 N sodium hydroxide2 and dichloromethane (1 ml) was added quickly. The 
organic portion was separated and reextracted with water/hydrochloric acid (pH E 4). 
The purity of the complexes was analysed by thin layer chromatography over silica gel plates in 
methanoll0.1 N hydrochloric acid (4:l) with an activity detector. Three radioactive compounds were 
detected in the reaction mixture. After extraction one major peak (95 - 99 %) and impurities (< 5 %) 
were detected. 
' an equimolar tri- and monodentate ligand mixture was used for complex and &. 
the pH values of the complex solutions ; & ; & ; and were enhanced to 8.5. 
Results and Discussion 
New [99'99m~cjtechnetium complexes were obtained in a Wo-step reaction, starting from pertechnetate 
via a ligand intermediate complex according to Scheme I. 
As the first step the precursor T c 0  gluconate was prepared. The oxotechnetium complexes were 
obtained by a ligand exchange reaction of T c 0  gluconate with a tridentate monodentate ligand mix- 
ture. The complexes were purified by extraction into the organic phase (dichloromethane), reextrac- 
tion into an aqueous phase (pH = 4), and were not iaolated at solid state. Radiochemical purity was 
deterrnined by thin layer chromatography (Fig. 2) and HPLC. 
Rf values for all technetium complexes were determined and are listed in Table I. 
In oder to elucidate for the expected composition of the complexes, one representative was prepared 
as a crystalline technetium complex and the structure Parameters were obtained by XRD. 
Table 1 : Rf data of complexes [TcO(SXS)(S-GHz-CH2-NR2)] on silica gel plates in methanoV 
hydrochloric acid (4:l) 
Complex R t Complex R t Complex Rr 
No. value No. value No. value 
l a  - 0.2 - 2e 0. - 4d 0.2 
I b  - 0.3 - 3a 0.3 - 4e 0.3 
I C- 0.5 - 3b 0.4 - 5a 0.3 
I d  - 0.3 - 3c 0.6 - Sb 0.4 
l e  - 13.3 - 3d 0.3 - 5c 0.7 
2a - 0.3 3e 0.3 - 5d 0.2 
The technetiurn cornplexes are stabie for days in acidicJaqueous solution. Extraction from the 
reaction mixture in dichloromethane at pH 11 was not successful in any case, because of the relative 
instability of some complexes in alkaline solution. The yields aller reextraction from dichloromethane 
in water/hydrochloric acid (pH 4) were different for the considered complexes. Best yields were 
obtained for & - & (about 70 % theor.). 
Fig. 1 : TLC-pattem of complex before extraction (a) and after reextraction (b) 
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10. Lipophilicity and lonization Properties of Some Amine-Bearing Technetium and 
Rhenium "3+lU Mixed-Ligand Chelates of the same Ligand Structure 
R. Berger, M. Friebe, H.-J. Pietzsch, M. Scheunemann, B. Noll, T. Fietz, H. Spies, B. Johannsen 
lntroduction 
In the design of brain (radio)pharmaceuticaIs special attention should be paid to lipophilicity and 
ionizability of the molecules. In the last ten years studies have been focused on 99m~c brain perfusion 
radiopharrnaceuticals able to pass the blood-brain bamer and be accumulated within the brain. 
Neutral amino groups containing Tc complexes appear to be most favoured for this purpose. 
Nowadays, research proceeds towards specific brain receptor binding agents. Binding to the 
receptor site may require a positively charged nitrogen atom in the molecule, e.g. in 5-tlT2~ receptor 
ligands. Such an essential constituent heavily affects the lipophilicity at physiological pH and hence 
diffusion through the BBB. For a better understanding of how physicochemical and structural 
properties such as (log) P and pK, values of a Tc tracer influence its transport through the BBB, 
evaluation of the IipophilicityIpH relations of neutral, a protonable tertiary amine group containing 
"3+Iw mixed-ligand Tc and analogous Re chelates has been aimed at. 
Advances in reversed-phase high-performance liquid chromatography (RP-HPLC) and diverse publi- 
cations on this topic [I - 61 have encouraged us to use HPLC for the determination of both lipophilicity 
and ionizability of series of TdRe complexes. 
The P and pK, values were determined by means of IipophilicityIpH profiles [7]. 
Throughout this wo* all P values determined by RP-HPLC are notated as P H ~ C .  The pKa values are 
rneasured as pKHPLC and after correction for the infiuence of organic solvent in the solution by means 
of the calibration curve (Fig. 1) they are given the denotation pKa(cl. 
Experimental 
Experiments were performed and evaluated under almost the Same conditions as described 
elsewhere in this Annual Report [8] for the determination of partition coefficients, i.e. with identical 
materials, reagent-grade chemicals, and methods. Samples were dissolved in a mixture of methanoll 
acetonitrile or dimethyl sulphoxide (Re complexes: about 2 mglml, Tc complexes about 0.5 mglml). 
The deterrnination of pKHPLC involves the use of mobile phases of various pH values. 
A PRP-1 column was used, and the elutions were carried out with a mixture of acetonitrile and buffers 
of definite pH values (volume ratio 3:l). 
For a test series, buffers (frequently about ten or more) were employed to cover the pH range of 
about 2 to 10. The buffer components KH2P04 and Na2HP04 were completed by citric acid as weil as 
3-(cyclohexylamino)-l-propanesulphonic acid (CAPS) and a certain expansion of the pH range was 
achieved by adding either 0.1 M HCI or 0.1 M NaOH. Before each application the pH values of the 
eluents were measured after preparing the appropriate mixture of buffer and acetonitrile by using a 
glass electrode. At such a well defined pH value several samples with various chelates and the 
solution of reference substances were sequentially injected. Before injecting the first sample Of a new 
eluent series with changed pH value, the time for equilibration of the colurnn was at least 10 min at a 
flow rate of 2.5 mllmin 171. 
Fig. I: Calibration curve PKJPKHPLC using amines as standards, pK, values for 12 amines were taken 
from [9]. (Foundlliterature): 1) o-toluidine (2.6714.44), 2) aniline (3.4314.63), 3) ptoluidine 
(3.78/5.08), 4) N-ethylaniline (3.8115.12), 5) N, N'dimethylaniline (3.8115.15), 6) Pyridine 
(3.8315.25), 7) a-picoline (4.4515.97), 8) 2,4-lutidine (5.1 3/6.99), 9) N, N'-diethylaniline 
(5.2616.61). 10) collidine (5.87/7.43), I I )  brucine (6.9618.28), 12) benzylamine (7.9819.33) 
Resuits and Discussion 
Table I surnmarizes the PHKC, 109 PHPLC and pKa(@ values of several analogous neutral technetium 
and rhenium cornplexes as well as TdRe PHRC ratios. 
Table 1 :PHp~c. log PHPLC and pKa(c) values of several analogous neutral technetium (M = Tc) and 
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Table I: PHPLC, log PHPLC and PKHPLC values of several analogous neutral technetium (M = Tc) and 








In Table I ,  an always higher lipophilicity for the Tc complex can be deduced from the TdRe PHPLC 
value pairs of the Same ligand structure. A mean value of 1.72 results for the TdRe PHPLC ratios. The 
mean difference between the Iipophilicities of Tc and Re complexes is also demonstrated in Fig. 2, in 
which the log PHKC values Of TC On Re complexes are plotted. An almost parallel Course of the linear 
regression function to the additional function y = X can be observed. 
Looking at the tridentate ligand Parts of these complexes it can be Seen that most of the complexes 
with an (SSS) chelate have lower TdRe PHKC ratios than (SN(R)S) chelates, exceptions are Nos. 1, 
2, 5. 
Considering the monodentate ligand park of the complexes, a benzene ring in the ligand seems to 
have a less enhancing effect (TdRe PHKC ratio: 1.5 - 1.6) than piperidinyl or morpholinyl ligands 
(1.7 - 2.4). 
An analogous difference between Re and Tc complexes has not been found for the pK,(„ values. 
It is likely that Tc compounds compared to Re compounds have a higher lipophilicity as observed. 
However these results remain to be proven in detail. 
Fig. 2: A plot of the iogarithm of PHPLC(TC) on P~plc(Re) vaiues 
Our systematic studies enable us to establish rules of thumb: 
1) Replacement of the central heteroatom in the tridentate ligand increases PHPLC in the rank order 
N-Me < N-Et - S - 0 < N-Bu. A similar dependence is not evident for the pKa(@ values. 
2) Lengthening of the N-alkyl side chains in the monodentate ligand increases the pK,(„ as well as 
the PHPLC values. 
Apart from the morpholine derivatives the lipophilicity grows as expected with the number of the 
carbon atom in the amine group according to Mor - NMe2 < NEt2 Pip NBu2. 
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11. Retropane - a New Rhenium Complex as a Potential Ligand for Labelling the 
Dopamine Transporter 
A. Hoepping, H. Spies 
lntroduction 
Radiolabelled phenyltropanes as a class of ligands with a high affinity to the dopamine transporter 
offer many possiblities for nuclear medical diagnosis of dopamine-receptor-depending alterations of 
the brain. So far, "C, 1 8 ~ ,  and '231-labelled ß-CIT [I, 21 and IPT [3] have been proposed as PET and 
SPECT tracers for the diagnosis of Parkinson's disease. 
Recently, some cocaine derivatives containing technetium or its congener fieniurn 14, 51 have been 
published. They represent substiiuted phenyitropanes bearing a chelate rnoiety at the tropane 
nitrogen. Neumeyer [6] has recently reported on the attachment of a tetradentate N2S2 chelating mit 
to the ß-CIT system by substitution of the methoxy group in the ester functionality. 
We would like to report on the synthesis of the first rhenium colmplex, "retropane', altemati~ely 
derived from the basic skeleton of the tropane molecule modified at the C3 position [Y]. This 
contribution is Part of our work to make available Tc tropane complexes with high affmities to 
dopamine transporters as potential radiophamaceuticals. 
Experimental 
(3-thiawntane-1. sairhiolato)(3-thiolato-panoi acid trop-3a-yl-estc3r) oxorftenim(V) 
34.4 mg (150 pmol) 3-thiopropanoic acid trop3a-yl ester were added to a boiling soiution of 38.9 mg 
(100 pmol) chloro(3-tiapentane-l,5-dithiolatß)oxorheniurn01) in 5 rnl acetonitrile whiie stimng. After 
adding 3 drops of triethylamine the rnixture was refiuxed for 5 minutes, The solvent was removed in 
vacuo and the residue was punfied by flash-chromatography using methanol/chloroform = 1 :4 as an 
eluent. 
The dark red oil obtained was clystallized as oxalic salt. 
Yield: 28.6 mg (49 %, free base) 
1 H NMR data: (500 MHz, CD30D): 6 2.13-2.15 (m, 4H), 2.32-2.36 (m, 2H), 2.43-2.47 (m, 2H), 2.52- 
2.57 (m, 2H), 2.85 (s, 3H, CH3), 2.98 (t, J = 6.85Hz 2H, CH2), 3.1 3 (td, J1 = 13.65 Hz, 
J2=2.78Hz 2H), 3.93(bs, 2H), 4.06(t, J=6.85Hz, 2H, CH2), 4.12 (dd, J1= 10.74Hz, 
J2= 3.37 Hz, 2H), 4.37 (dd, Jl= 13Hz, J2=4.77Hz), 5.13 (t, J = 4.6Hz, 1H) 
13c NMR data: (125.77 MHz, CD30D): 6 24.89, 32.60, 36.03, 39.07, 39.46, 47.41, 48.49, 63.88, 
65.63, 165.46, 172.97 
Mass spectrum: mlz 582 (M+, 54.3 %), 583 (10.5), 584(100) M++1, 585(19), 586(17), 587(3), 588(1.4) 
IR absorption (KBr): v„,/cm" 960 (Re=O). 
Elernental analysis (oxalate): (Found: C, 30.41 ; H, 4.33; N, 2.20; S, 17.92; C17H28N07S4Re r quires 
C,30.31; H,4.19; N,2.08; S, 19,00%). 
Results and Discussion 
The introductioni of a mercapto group was achieved in the form of w-mercapto-substituted esters of 
tropanol. Starting from a-tropanol hydrochloride the 3-bromopropionic acid tropyl ester was synthe- 
sized by a very simple procedure [8]. The resulting hydrochlonc salt was reacted with triphenyl- 
methanthioi in DMF to yield the S-protected mercaptan in a good yield. The deprotection of the 
mercapto group was accomplished by reacting the thiotritylated compound with mercury acetate in 
trifluoro acetic acid and cleaving the mercury-rnercaptide with hydrogen sulphide. 
Scheme I: 




IT~SH, KOtBu; DMF 
1. TFA; Hg(OAc),. Anisol 
2. H2S, EtOH 
3 O 7  
STr 
The rbenium complex was obtained in a typieal 3+1-reaction [9], in which the thioi as the 
monodentate Iigand was reacted with [ReO(SSS)CI]. 
Scheme 2: 
1 .ReOSSSCIIMeCN 




To summarize, we were able to synthesize the first rhenium complex based on an 0-substituted 
tropanol derivative. Continuation of the work will refer to other esters of tropane, preparation of the 
congener technetium complexes and testing of the affinity to the dopamine transporter (DAT). 
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12. Preparation and Structure of Neutral 0x0-Re(V)-Complexes with L-Cysteine Methyl 
Ester and D-Penicillamine Methyl Ester 
S. Kirsch, B. Noll, H. Spies, P. ~eibnitz', D. schelle*, B. Johannsen 
'~undesanstalt für Materialforschung, Beriin 
21nstitut für Analytische Chemie, Technische Universität Dresden 
lntroduction 
In former studies [I] the neutral R e 0  complexes of penicillamine and cysteine were prepared by 
ligand exchange of R e 0  gluconate, and its crystal structure determined. The N- and S-atoms in the 
basal plane of the six-coordinate complex [ReO(-S-C(CH3)2-CH(COOH)-NH2-)(-S-C(CH3)2-CH(COO-)- 
NH2-)] are cis coordinated, and one of the carboxyl groups is bound trans to the 0x0 group. 
In order to obtain more information about the complexation behaviour of ligands of the 2(N,S,O) type, 
investigations were carried out in the following study into the penicillamine methyl ester and cysteine 
methyl ester moiety, where the 0-donor is blocked. 
Three different complexes were obtained with D-penicillamine methyl ester. Besides the two diester 
complexes [ReO(-S-C(CH3)2-CH(COOCH3)-NH-)(-S-CH(-COOCH3)-NH2-)] (2) and [ReO(-S-C(CH3)2- 
CH(COOCH3)-NH-)(-S-CH(-COOCH3)-NH2-)(H20)] (3  the mixed-ligand complex [ReO(-S-C(CH3)2- 
CH(COOCH3)-NH2-)(-S-CH(-COO-)-NH2-)1 (1) was forrned, containing tridentate D-penicillamine, 
obviously generated upon coordination, and bidentate D-penicillamine methyl ester in a coordination 
geometry similar to that of the Re penicillamine complex. According to 'H NMR studies in solution, (2) 
and (3) are surprisingly characterized by both a deprotonated and a neutral nitrogen donor atom in the 
ReO(NS)2 system. This feature, USUally attributed to complexes of [TC=O]~' and [R~=o]~'  with 
tetradentate aminethiols, is consistent with a neutral five-coordinate 0x0 metal complex of D-penicill- 
amine methyl ester. In the case of L-cysteine methyl ester only the mixed-ligand complex [ReO(-S- 
cH2-CH(COOCH3)-NH2-(-S'CH(COO-)-NH2-)] (4  with a similar structure to (1) could be isolated and 
its structure determined by X-ray analysis. 
Experimental 
fleO(-S-C(CH3)rCH(COOCH3)-NHr)(-S-C(CH3)rCH(-COO-)-NH2-)] (1) 
40 mg (0.2 mmol) of D-penicillamine methyl ester-HCI in 2 ml of water were added to 2 ml (0.1 mmol) 
Re gluconate solution. A reddish-brown residue was obtained, separated by filtration and redissolved 
in 2 - 3 mi of acetone. 3 ml of water were added and the solution was allowed to crystallize by slow 
evaporation at 25 "C. 
Yieid: 25 mg of dark violet needles suitable for X-ray analysis. 
Elemental analysis: (Found: C, 25.28; H, 4.14; N, 5.48; S, 12.58 ReCi1H2,O5N2S2 requires. 
C, 26.00; H, 4.08; N, 5.39; S, 12.64 %). 
IR absorptions: v,&m" (KBr) 976 (Re=O), 1732 (C=O-OCHS) and 1624 (C=O, trans coordinated). 
UVNlS absorptions: h,,,lnm (water) 345 with a shoulder at 290,508. 
Mass spectrum (DCI): m/z 512 (M', 100%). 
[ReO(-S-C(CH3)rCH(COOCH3)-NHr)(-S-C(CH3)rCH(COOCH3)-NH-)(2) and 
[ReO(-S-C(CH3)rCH(COOCH3)-NHr)(-S-C(CH3)~CH(COOCH3)-NH-)(H2O)] (3. 
40 mg (0.2 mmol) of D-penicillamine methyl ester-HCI in 2 ml of water were added to 2 ml(O.l mmol) 
Re gluconate sofution. The reddich-brown residue was filtered off and redissolved in 2 - 3 ml of 
acetone. The solution was purified by flash-chromatography on silica gel6O in acetone. Two fractions 
can be isolated: (2) was obtained as a violet powder and (3) as light red powder, soluble in almost all 
organic solvents. The total yield of (3) depends on its contact time with water. 
Anailytical data for (2): 
Elemental analysis: (Found: C, 27.37; H, 4.59; N, 5.32; S, 12.17 ReC$2H2305N2S2 requires 
C. 28.03; H, 4.80; N, 5.10; S, 11.90 %). 
fR absorptions: vml cm*' (KBr) 940 (Re=O) and 1728s (C=O-OCH& 
UVNtS absorptions: km/nm (in CH2C12) 358, 523 
Mass spectrum (FAB, neg.): mlz 525 (CO%), 396 (20%), -i 83 (I 00%). 
AnalgRicaE data for (3): 
Elementa'L analysic: (Found: C, 26.32, H, 455, N, 5.10, S, 11.69 ReC12H23O5N2S2(H2O) requires 
C,26.51,H,4.63,N,5.15,S,ll.79%) 
IR absorptions: V,/ cm-' (KBr) 936 (Re=O) and 1728s (C=O, free ester). 
UVNIS absorptions: Xm/nm (in CH2C12) 526, 350 with a small shoulder at 310. 
peO(-S-C(CH3)2-CH(COOH)-NH2-)(-S-C(CH3)2-CH(-COO-)-NHr)] (4) 
34.33 mg (0.2 mmol) of L-cysteine methyl ester-HCI in 2 ml of water were added to 2 ml (0.1 mmol) 
Re gluconate solution. A dark brown residue was obtained after stirring for 45 min. The residue was 
separated by filtration and was washed twice with ethyl alcohol and ether. 
After recrystallization in methyl alcohol dark brown cryctals suitable for X-ray analysis were obtained. 
Elemental analysis: (Found C, 18.46; H, 2.88; N, 6.15; S, 14.08, R ~ O ~ C ~ H I ~ N ~ S ~  requires 
C, 18.63, H 2.82; N, 5.98; S, 13.95 %). 
IR absorptions: V,, , /  cm-' (KBr) v(C=O-OCH3) 1744 and v(C=O-O-, trans) 1644 and v(Re=O) 976. 
UVNIS absorptions: h„$nm (water) 345 with a shoulder at 290,495. 
Mass spectrum (DCI neg.): mlz 456 (M', 100%) 
NMR data: (300 Mhz; solvent DMSO-DG): 2.75 [IH, d], 3.13[1H, q], 3.5 [3H, T of fine structure], 
3.72 [3H, ~ 1 , 4 0 3  [IH, s],6.11 [IH, d],6.97[1H, t],7.63[1H, d]and7.86[lH, d] 
Results and Discussion 
L-cysteine methyl ester and D-penicillamine methyl ester react with Re gluconate in acidified water 
according to Scheme 1. 
Scheme 1 : Reaction of Re gluconate with D-penicillamine methyl ester and L-cysteine methyl ester in 
acidified water resulting in the monoester complexes (1) and (4). 
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R = CH, for penicillamine methyl ester ( I )  
R = H for cysteine methyl ester (4) 
Furthermore, another type of a neutral rhenium complex with D-penicillamine methyl ester as ligating 
moiety occurred (2 and 3) starting from rbenium gluconate. They were immediatly extracted with 
organic solvents and isolated as powders after flash-chromatography on silica gel60 in acetone. 
When the products, without chromatographic separation, were allowed to react with water and then to 
crystallize, needles of complex { I )  suitable for X-ray analysis were obtained. In Tables I and 2 
selected bond distances and bond angles of (1) and (4) are compared. 
The molecular structure of Re penicillamine methyl ester and cysteine methyl ester as ligating moiety 
resemble that of Re penicillamine at low pH [I]. One methyl group was saponified during comptex 
formation in water to form the neutral monoester complexes (1, 4) with almoct the same crystal 
structure. The S- and N-donor atoms are cis coordinated and the carboxyl graup is involved in the 
compiex formation trans to the Re-oxo-group.The structure comprises a distorted octahedron as 
shown in Figs. I and 2. 
Fig.1: Crystal structure of Re penicillamine methyl ester determined by X-ray analysis 
Fig.2: Crystal structure of Re cysteine methyf ester determined by X-ray analysis 
Table I :Comparison of selected bond 
distances of (1) and (4) 
Bond distances for 
Table 2: Comparison of selected bond angles 
of ( I  ) and (4) 














84.03 (1 1) 
82.22 (14) 
92.67 (6) 
' H  NMR data 
Re penicillamine methyl ester complexes were recorded in DMSO-DG. In Table 3 the chemical shifts 
of (1) and (2) are compared. NMR data obtained for (4) are comparable to those of complex (I). 
The postulated structure of (2) is shown in Fig. 3. In contrast to (1) with only one methoxy signaf at 8 = 
3.81 pprn two methoxy signals can be observed in the NMR spectrum of (2) with 8 = 3.71 pprn and 6 
= 3.79 ppm. Furthermore, there are only three NH signals in the spectrum of (2): a triplet at 6.23 ppm, 
a doublet at 8.46 pprn and a singlet at 8.50 pprn in contrast to (1) with four NH signals belonging to 
the two protonated amine groups (NH2). These fack prove that one amine group was deprotonated 
during complex formation of (2). 
Table 3: 'H NMR chemical shiffs (6 in ppm) of (I), (2) 
. . I monomethyiester ( I )  dimethylester (2) I 
I 3.10,dd CH I 3.47, dd CHy 3.64, s CH 3.91, s CHx 
Re penicillamine dimethylester - 
H20 (3) 
33.3% 
D.94, s CH3 
1.08, s CH3 
1.69, s CH3 
1.81, s CH3 
3.74, dd CHy 
4.01, s CHx 
3.74, S ocH3 
3.76, s OCHS 
5.82, t N(2)t-l 
8.34, d N(2)H 
3.78, s N(1)H 
Fig. 3: Postulated structure of (2) 
The magnetic anisotropy of the Re=O core is responsible for the great differences in the chemical 
shifts of the NHx and CH3 groups. The nonequivalence of the four CH3 and the two OCH3 groups are 
caused by the chirality of the ligands and the asymmetry of the complex. For the Same reason the two 
protons of the NH2 group are chemically nonequivalent. For the N~H'*' group a pair of doublets is 
obtained at 6 = 8.5 ppm. ~ t s  coupiing constant 3 ~ H H  with CH") is reiativeiy smaii (3.5 HZ) and 
therefore, with respect to the Karplus-Conroy curve, the dihedral angle between these protons must 
be neariy 50". The coupling constants 3~~~ of N ~ H ' ~ )  with CH(~) and 2 ~ H ~  for the two protons of the NH2 
group are of quite the Same size, which causes a triplet at 6 = 6.2 pprn instead of the expected pair of 
doublets. ~ t s  coupling constant 3 ~ H H  = 12.5 HZ is quite iarge. This fact indicates a dihedral angle of 
180" between the N ~ H ' ~ )  and the CH") proton. 
Between the CH'" group at 6 = 3.9 pprn and the neighboring deprotonated N'H(~) group at 6 = 8.5 
pprn no coupling can be observed. These two Signals are therefore not doublets, as expected, but 
singlets. Consequently the dihedral angle between these two protons must be nearly 90". 
In the 2D-NOESY-NMR spectrum of this complex cross peaks are obtained between N~H(*) and 
N ~ H ' ~ )  The last three cross peaks with CHs groups indicate that the CH'" group belongs to cH3(*) and 
CHJ4). cH3(') and C H ~ ( ~ )  therefore belong to the deprotonated ligand. 
For complex (3) we firci recorded the 'H NMR spectrum in CDCI3 and found besides the expected CH 
and NH signals similar to complex (2) a water signal at 1.60 pprn integrating two protons. Therefore 
the trans position of complex (3) seems to be occupied with one molecule of water. This shows a 
great effect on the coordinatively bonded deprotonated NIH group, which becornes apparent in the 
extremely shifted singlet at 6 = 10.94 pprn belonging to this proton. After the measurement CDCI3 was 
evaporated and the residue was resolved in DMSO-D6. The recorded spectrum shows a mixture of 
complex (2) and (3). Only about 33 % of the former complex (3) still exists with the extremely shifted 
NIH group at 6 = 9.77 ppm. For the other 67 % the coordinated water in trans position is replaced by 
DMSO and the belonging chemical shifts are identical with those of complex (2). Thus, in coordi- 
nating solvents like DMSO or water a dynamical equilibnum seems to exist with varying replacement 
of solvent molecules in the trans position of these kind of complexes. 
Conclusions 
The studies on Re complexes of D-penicllamine methyl ester and L-cysteine methyl ester confirm a 
great tendency of 2(N,S) aminethiol ligands to form neutral Re oxocomplexes. Accordingly, in aprotic, 
non coordinating solvents such as CH2C12 one amine group in the 1 :2 ReO/) oxocomplex (2) is depro- 
tonated and thus contributes to the compensation of the positive charge at the Re-0x0-core. In the 
presence of coordinating solvents, the trans position is occupied with a solvent molecule, without any 
change of the NHINH:! coordination mode (3). In water, however, also an alternative form of the 
complex occurs, avoiding NH deprotonation. Unlike tetradentate DADT ligands, such as ethylenedi-L- 
cysteine diethyl ester (L,L-€CD) which form neutral species with the ester groups remaining intact [2], 
one of the ester groupbeanng Iigands in penicillamine methyl ester and cysteine methyl ester is 
hydrolyzed and assumes a higher denticity. The generated carboxyl group binds trans to the 0x0 
ligand. The coordination geometry of the mixed-ligand complexes (1,4) is similar to that of the known 
Tc and Re D-penicillamine complexes [ I ,  31. It is evident that a NH2/NH2 coordination is preferred to 
the asymmetric NHINH2 coordination if charge compensation can be provided by an appropriate 
donor group, such as carboxyl that Mnds trans to the 0x0 group. 
The whole reaction scheme and structures of the complexes are illustrated in Fig. 4. 
Re gluconate 
penicillamine rnethyl ester or 
cysteine methyl ester 
Occurrence of (2) and (3) 
depends on contact with water 
in aquauis solutim 0 R 
\ I /  / 
\ - tS  Re '$:OOG'H3 
,.-= N H2N : N 
H 
'I 'Hpg H OH, 
COOCH, 
neutral, complex (2) 
/ neutrai, conrplex (3) 
within a few days in &O J 
b-- 0 
0 
neutrai, complexes (3,4) 
Fig. 4: Reaction scheme and structures of the obtained complexes 
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13. Formation o f  Mixed-Ligand Ester Complexes of Rhenium and Technetium with 
SISIS-N o r  S-SIS-N Coordination 
S. Seifert, H. Spies 
Introduction 
A number of anionic S4 coordinate rhenium and technetium complexes have been recently described 
[I, 21. Substitution of a thiol donor atom by a nitrogen atom should make the resulting complexes 
neutral within a defined pH range. Such an NS3 coordination can be achiewed by combination of, for 
example, a dimercapto-succinic acid diethyl ester ligand (DMSEt2) or two ~monomercaptoacetic acid 
ethyl ester ligands (MAEt) with cysteamine (CYSA), provided that the amine group of the cysteamine 
moiety is not deprotonated in the resulting complex. The formation of such rnixed-ligand complexes is 
described as well as the transformation of complexation to the n.c.a. level of ""'TC. 
Experimental 
The precursor compounds [ReO(gluc)~l- or [ReOCI4]- were prepared for the formation of mixed-ligand 
rhenium complexes according to the well-known procedures. 
In the case of complexes with monothiols and cysteamine, the mercaptocarboxylic acid or the ethyl 
ester complex was at first formed as described in [3]. The desired mixed-ligand complex was 
prepared in a following step by adding the stoichiometric quantity of cysteamine to the solution. 
The preparation of rhenium complexes containing DMSEt2 and cysteamine was carried out in a one- 
pot reaction with equimolar quantiiies of the ligands in aqueouslethanolic or ethanolic/acetonic 
solutions by preparing at first the cysteine or cysteamine complex and then exchanging one CYS 
Iigand for DMSEt2. 
The corresponding ''"TC complexes were obtained by stannous chloride reduction of pertechnetate in 
aqueous/acetonic ligand solutions. 1.2 mg CYSA and 0.05 mg DMSEt2 were added to 1 .O ml pertech- 
netate eluate containing 7.0 mg NaHC03. The reduction proceeded with 0.01 ml of an ethanolic 
stannous chloride solution (1 -0 - 2.0 mgllO ml). 
It is also possible to prepare the mixed-ligand 99m~c complex via ligand exchange starting with 99m~c  
gluconate and succesively adding CYSA and DMSEt2 in a similar way as described for the forrnation 
of n.c.a. "3+In complexes [4]. 
The complexes were analysed in solution by thin layer chromatography (TLC), paper electrophoresis 
(PE), high perforrnance liquid chromatography (HPLC) and some rhenium complexes also by mass 
spectrometry (MS). 
TLC: Silufollacetone 
PE: acetonitnlelwater (1 -0 % NaC104) at pH 7.0 and 2.0 adjusted with HClO4, 500 V 
HPLC: PRP-1 (250 X 4.1 mm, 10 Pm. flow rate 2.0 mllmin), acetonitrile (A)l20 mM phosphate 
buffer pH 7.4 (B), gradient 1 .O, (t[min]l%A): (WO), (1 O/5O), (5150), (Iff5), (5l75) 
MS: MAT 95 spectrometer (Finnigan), fast atom bornbardment (FAB-MS) and chemical 
ionization (CI-MS) 
Results and Discussion 
Prior to the studies of mixed-ligand complexes involving the ligands cysteamine, cysteine and 
cysteine methyl ester, complexes of each of the ligands were only synthesized and analysed by 
HPLC. It was found that the rhenium cysteine methyl ester complex (Rt = 11.2 min) is immediately 
hydrolysed to the monoester COmplex (% = 6.7 rnin) and that in a following slower hydroiysis step the 
cysteine complex (Rt = 2.1 min) is formed. Considering this behaviour and the fact that no free 
carboxylate groups should be in the desired mixed-ligand complexes, cysteine ester does not appear 
to be suitable as a co-ligand. However, mono or dimercapto Iigands containing one or two ester 
groups are suitable for this purpose. 
The reactions of the rhenium complexes [ReO(MAA)2]- and [ReO(MAEt)2MAA]- (MAA = mercapto- 
acetic acid) with cysteine show, that cysteine is able to substiiute a bidentately bound MAA ligand 
molecule and a mixed-ligand complex is forrned according to the following route: 
fReO(MM)& + CYS ---b fReO(CYS/MAA)1' + MAA 
The Same complex with a Rt value of 4.1 min is detected after reaction of [ReO(MAA)2]- with cysteine 
methyl ester and waiting for some hours while the ester complex hydrolyses to [ReO(CYS/MAA)]-. 
lnitially cysteamine (CYSA) reacts with [ReO(MAA)2]- to form an anionic mixed-ligand complex. An 
excess of CYSA leads to complete substitution of MAA, and the Re-CYSA complex is formed 
accordingly (Rt = 9.2 min). 
Using the ester complex [ReO(MAEt)2MAA]-, ligand exchange with CYS or CYSA results in products 
which are stable in a phosphate buffer of pH 7.4 but can be hydrolysed by pig liver esterase (PLE). 
The hydrolysis products are the mixed-ligand mercapto acetic acid complexes [ReO(CYSIMAA)]- and 
[ReO(CYSA/MAA)]-. 
Electrophoresis studies show an anionic mobility at pH 7.0 for both ester complexes. The complex 
containing cysteamine moves only a very short distance at pH 2.0, possibly indicating the existence 
of a neutral compound in acidic solution. 
Unfortunately, mass spectrometry failed for both ester complexes. 
The mixed-ligand rhenium complexes containing DMSEt2 and CYS or CYSA as ligands were 
prepared either by a stoichiometric ligand exchange in a one-pot reaction starting with [ReOC14]- or Re 
gluconate or by adding one equivalent of DMSEt2 to the cysteine or cysteamine complex. The 
reaction mixture consisting of the mixed-ligand complex and the anionic complex [ReO(DMSEt2)2]- 
can be separated by HPLC. As found by HPLC, the mixed-ligand complexes are unstable and 
decompose mainly to the DMSEt2 complex. 
A neutral complex should be expected for the combination of a DMSEt2 with a CYSA ligand. Actually, 
HPLC separation yields an anionic first fraction (Rt = 10.8 min) and a neutral second fraction (Rt = 
12.1 min) as found by electrophoresis of the separated fractions and the reaction mixture at pH 7.0 
and 2.0. 
The fractions I and 2 were analysed by FAB-MS and CI-MS. The molecule ion peaks of the mixed- 
ligand complex [ReO(CYSA/DMSEt2)] and the complex 
methods. 
0 
[ReO(DMSEt2)J were detected by both 
EtOOC 
The (M-I) value (mh = 51U514) of the negative molecule ion was found with FAWMS as well as CI-- 
MS. 
The corresponding 99n"Tc complex was prepared either by direct reduction of pertechnetate eluate in 
the ligand solution or by ligand exchange, starting with gluconate. 
The formation of the mixed-ligand complex by direct reduction of pettechnetate was monitored by 
TLC and HPLC. Three dominant peaks were detected in TLC: 
peak I: Rf = 0-0.5 ""'TC cysteamine complex 
peak II: Rf = 0.65 mixed-ligand complex 
peak lll: Rf = 0.9 [~~"~co(DMsE~~)~] -  
The product distribution changes with time. The start activity decreases with time white peaks 11 and 
III increase. On the other hand, Peak 11 increases faster than peak 111. Then the mixed-ligand complex 
decomposes mainly to the DMSEt2 complex and other unknown species. The optimum quantities of 
ligands for direct reduction were determined to be in the range of 0.8 - 1.5 rng CYSA and 0.04 - 0.06 
mg DMSEt2. The maximum yield of the desired complex is obtained at different times, depending On 
the quantiiy of cysteamine used for preparation. Fig. 1 shows the wurse of readion for different 
contents of cysteamine in the reaction mixture. 
0.8 mg cysteamine 1.2 mg cyämmine I .5 mg cysteamine 
Fig. I: Formation of [ 9 9 m ~ ~ ~ ( ~ ~ ~ ~ / ~ ~ ~ ~ t 2 ) ]  with 0.05 mg DMSEt2 and 0.8 mg, 
I .2 mg or 1.5 mg cysteamine as monitored by TLC. 
The diagrams show that the cysteamine complex is mainly formed in a first fast step and that the 
DMSEt2 attacks in a second step. It was observed that higher yields of cysteamine in the preparation 
deia the formation of the mixed-ligand complex. Amounts lower than 0.8 mg promote the forrnation & of [ TcO(DMSEt2)&. 
To examine the stability of the %"'TC complex, the ligand excess was separated by HPLC. The 
complex fraction was re-injected at different times and analysed by TLC. It was found that the 99m~c  
complex decomposes within a few hours to [ 9 9 m T ~ ~ ( ~ ~ ~ ~ t 2 ) 2 ] -  and to the 9 9 m ~ ~  cysteamine complex. 
After only 1 h about 50 % of the mixed-ligand complex could still be determined in the solution. 
Attempts were made to improve the yield of mixed-ligand complex, using other preparation routes. 
For this reason the ligand exchange reaction starting with %"'TC gluconate was tested. This method 
led to satisfactory results in the preparation of "3+lW m ~ c  complexes. Despite a variation of ligand 
quantities and reaction temperature, only less than 50 % of the desired complex were obtained. 
To sum up, we were able to prove the formation of mixed-ligand complexes containing two 
mercaptocarboxylic ester ligands or a dimercaptocarboxylic ester or diester ligand in combination with 
a cysteine or cysteamine ligand. In the case of the combination CYSA/DMSEt2 a neutral complex 
molecule is formed which might be of interest in the search for complexes which are able to Cross the 
blood-brain bamer. 
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14. A Novel Amide Thioether Dithiolate Ligand Derived from Cysteine 
B. Noll, S. C. ~ilger', P. ~eibnitz~, H. Spies, L. ~inkelborg', B. Johannsen 
1 Schering AG Berlin, 2~undesanstalt für Materialforschung und -prüfung Berlin 
Efforts in the search for new chelators that are able both to coordinate radioactive metals and to bind 
the resulting complexes at biologically relevant anchor groups have been focused so far On 
tetradentate N2S2 ligands, N being an amide or amine functionality [I]. In the present paper we 
describe the synthesis of an alternative, cysteine-derived S,N,S,S ligand in which a nitrogen 
functionality in the above N2S2 ligands is substituted by a thioether group, as well as the formation of 
the corresponding oxorhenium0l) and oxotechnetium(\l) complex. 
Experimental 
General 
'H NMR spectra were measured on a Bruker AC 400 (400 MHz), standard tetramethylsilane. IR 
spectra were measured by a Nicolet 710 spectrometer. The mass spectrum was recorded by a ZAB-E 
spectrometer, VG Analytical, Manchester (FAB Cs' gun, 3-nitrobenzyl alcohollglycerinelDM~S0). The 
X-ray crystallographic data were obtained at 294 K on an Enraf-Nonius CAD-4 diffractometer, using 




was prepared according to Larson et al. [2] by reaction of 48 ml (0.6 mol) chloroacetyl chloride with 
51 ml (0.6 mol) 1.2-dimercaptoethane in 900 ml dichloromethane and 169 ml (1 -2 mol) triethylamine. 
Yield: 52 g (65 %) of a yellow powder. 
N-(5-mercapto-l-oxo-3-thia-pent-l-yl)-L-cysteine methylester (I) 
6.7 g (50 mmol) 2.5-dithiacyclohexanone was added to a solution of 8.58 g (50 mmol) L-Cysteine 
methyl ester hydrochloride and 13.86 ml (I00 mmol) triethylamine in 250 ml dichloromethane. The 
mixture was stirred ovemight at room temperature under an argon atmosphere. For working-up the 
mixture was treated with 300 m15 % aqueous citric acid solution, twice with 300 ml 1 % aqueous citric 
acid solution and with 300 ml saturated sodium hydrocarbonate solution. After drying of the organic 
phase with sodium sulphate, the solvent was removed in vacuo. The remaining yellow oil was purified 
by column chromatography (silica gel KG 60, 0.04 X 0.063 mm, Merck; eluent dichlorarnethanel 
methanol 99:l). Yield: 10.6 g (79 %) of a yellow powder. Melting point: 46 - 50 'C (from dichloro- 
methanelmethanol 99:l). 
TLC (KG 60~254 Merck, eluent dichloromethane/methanol 955): Rf 0.75. 
Elemental analysis: (Found: C, 35.90; H, 5.88, N, 5.1 1; S, 36.2; CBHI5NO3S3 requires 
C, 35.67; H, 5.61; N, 5.20; S, 35.70 %) 
IR absorptions: v,,,lcm" 3325 (NH), 2950 and 2940 (CH), 2580 and 2550 (SH), 1740 (COOMe), 1638 
(amide-I), 1530 (amide-11). 
1 H NMR: SH (400 MHz, solvent CDCb, standard SiMe4) 1.42 (t, J = 10 Hz, 1 H), 1.72 (t, J = 8 Hz, IH), 
2.75-2.81 (m, 2H), 2.85-2.90 (m, 2H), 2.97-3.12 (m, 2H), 3.32 (s, 2H). 3.81 (s, 3H), 4.85-4.91 
(m, 1 H), 7.59 (d, J = 8 Hz), broad, 1 H). 
M a s  spectrum: mlz = 270 (M++H, 35 %), 157 (13), 136 (17). 93 (IO), 79 (100). 
Rhenium complex [ReO(SNSS)] (2) 
268 mg (I mmol) of I in 4 ml MeOH was dropped into a solution of 725 mg { I  mmol) Ph4As[ReOCId 
in 15 ml chloroform and 4 ml MeOH (kept under nitrogen) and the mixture was stirred for 30 rnin. The 
brown precipitate formed was filtered off and washed wlth chloroform. Yield: 319 mg (0.7 mmok 
70 %). Recrystallization from isopropanol yields reddish-brown crystals. Mettirtg Pint: 223 - 225 'C. 
Elemental analysis: (Found: C, 20.80; H, 2,75; N, 3.16; S, 20.70; CBHI9NO4S3Re requires 
C, 20.51, H, 2.58; N, 2.99; S, 20,53 %) 
IR absorptionc (KBr): v„&cm*' 964 (ReO), 1740 (COOMe); 
Labelling with technetium 
Compound 1 was complexed with technetium-99 by ligand exchange with Tc gluconate. 9 9 ' 9 9 m ~ ~  
gluconate was prepared by addition of 100 pI 0.01 M stannous chloride solution (1 X 10" mol) in 0.1 M 
HCI to 100 1 0 01 M potassium pertechnetate (1 X 10" mol) in 1 ml 0.1 M sodium gluconate solution 
and 100 pI 4 C generator eluate. 
50 p1 stock solution containing 2.17 mg 1 dissolved in 400 pI 0.05 M NaOH are given to the 9 9 ' 9 9 m ~ ~  
gluconate solution. After 30 min the exchange is complete. 
Results and Discussion 
The new ligand was obtained according to reaction scheme 1. 
Reaction scheme 1 : Synthesis of 1 
HCI - 
HS CH2CI, 
Reaction of the ligand with [ReOC141- (Scheme 2) resulted in an oxorhenium complex which is 
uncharged because of the presence of the thioether group. The complex is stable on exposure to air 
and soluble in common organic solvents. 
Reaction scheme 2: Formation of the rhenium complex 2 
Fig. 1 : POWDER CELL diagram of the molecular stnicture of 2. 
Selected bond lengths [Al and angies n: Re-01 1.676(4), Re-N 1.991 (4)' Re-Si 2.359(2), 
Re-S2 2.266(2), Re-S3 2.290(2), C4-02 1.2010; 01-Re-N -1 l7.8(2), 
01 -Re-SI 100.7(2), 01-Re42 11 5.0(2), 01-Re-S3 107.0(2). 
Analytical data of 2 confirm the composition as a mono-ligand complex and a strong band in the 
infrared spectrum shows the presence of the Re0 bond as expected for an oxorhenium0l) species. 
A single-crystal structure analysis revealed that the thioether sulphur is involved in coordination, 
possessing the equatorial plane together with the amide nitrogen and the two thiolate sulphur atoms 
to form a square-pyramidal arrangernent at the central atom. Re-NmW, and Re-S distances are of the 
oder generally found for these groups. 
The formation of complexes with the radioactive technetium was accomplished by ligand Substitution 
on Tc(V) gluconate at a concentration level of 1 mM and increasing molar ratios of ligand : Tc. 
lnspection of the reaction mixture after 30 rnin by HPLC and TLC shows complete conversion of the 
T c 0  precursor into a complex cornponent 3. Three components being a small portion of Tc 
gluconate and two complexed species were observed in neutral media. The main product is 
extractable from the rnixture by methylene chloride. The Rt value (14.0 min) of this radiochemically 
pure product is practically identical with that of the rhenium complex 2. 
Fig. 2: Product pattem of the reaction of Tc gluconate with 2, 
(a): reaction mixture, (Q: methylene chloride e!xtra& 
The second component (R, = 9.8 min) is assumed to be the free acid of 2 as deduced from its 
chromatographic properties and the non-extractability into organic soivents. 
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15. Novel Oxorhenium(V) Complexes with Cysteinylglycine and Glycylglycylcysteine: 
Preparation and Characterization in Solution 
S. Kirsch, R. Jankowsky, B. Noll, H. Spies, B. Johannsen, D. scheller' 
'lnstitut für Analytische Chemie, Technische Universität Dresden 
lntroduction 
""'TC peptide complexes have aroused increasing interest in recent years. Direct labelling of peptides 
without a conjugated chelating moiety is possible because of the variety of potential donor groups 
present in peptides. An outstanding role in ligating technetium or its Surrogate rhenium plays the 
sulphur atom of cysteine (Cys). 
In the following work investigations were made into studying the complexation behaviour in solution of 
the sulphur-containing di- and tripeptides cysteinylglycine (CysGly) and glycylglycylcysteine 
(Gly2Cys), (Fig. I), with rhenium. 
cysteinylglycine glycylglycylcysteine 
Fig. 1 : Molecular formulas of the ligands CysGly and Gly2Cys 
Besides the thiol group, the amine, the amide and the carboxyl group are present in these molecules 
as potential ligating donors. In this report we are trying to answer the following questions: 
- What kind of donating groups are involved in the complex formation? 
- Does the complex fomation depend on the pH? 
- What is the structure of the complexes to be formed? 
To determine the molecular structure of the complexes we camed out some EXAFS (extended 
absorption fine structure) studies in solution (at pH 2 - 3) and examined the complexation behaviour 
at various pH values (pH 2 - 12) by capillary electrophoresis. 
Experimental 
Mefhods 
The influence of the molar ratio of the ligands on the occurence of products was studied by HPLC 
(RP 18 column, Eurospher 100-C18, 25 Cm, ID 4 mm, eluents: phosphate buffer pH 5.8, acetonitrile; 
gradient 0 + 90 % acetonitrile, 15 min, 1 mllmin). 
Capillary electrophoresis (CE) was canied out on a fused silica gel capillary (ID = 50 Fm, Jen. = 56 cm, 
extended light path, non-coated) at a voltage of 30 kV with the following buffer solutions pH 2.0 - 
12.0: 
pH 2.0 - 6.4: Citrate buffer SÖRENSEN (0.03 m) 
pH 6.4 - 9.0: Borax-KH2P04 buffer KOLTHOFF (0.01 5 m) 
pH 9.0 - 12.0: Glycine buffer SÖRENSEN (0.03 m) 
Components were detected by UV absorption at 200, 254, 350 and 450 nm. Acetone was used as a 
neutral marker and the tetraphenylarsonium cation as a + I  marker. 
Synfhesis of Re-GysGIy and Re-Gly2Cys 
Thts Re complexes were prepared by Iigand exchange, starting from the gluconate precursor with a 
molar ratio of S : 2 (Re : CysGly) and 1 : 1 (Re : Gly2Cys). Both complexes were purified by HPLC 
(eluents: water acidified with 2 - 3 mt acetic acidfl = pH 2 - 3; acetonitrile; gradient: 5 min 100 % 
wate& 7 rnin 0 -+ 70 % acetonitrile, 5 min 70 % acetonitriie; 5 min 100 % water) and lyophilized 5 
times. 
Results and Discussion 
Re-CysGly 
HPLC results show that only one Re-CysGly complex was formed irrespective of the additon of 
ligand. At a molar ratio of Re : peptide = 1 : 2 all Re gluconate was used up. A solid complex was 
obtained in a 40 % yield. 
Analytical data for Re-CysGly: 
Elemental analysis: (Found: C, 21.62; H, 3.08; N, 10.08; S, 11.54, ReC10Hi707N4S2 requires 
C, 21.15; H, 3.10; N, 9.81; S, 11.21 %) 
Mass spectrum (FAB, neg.): m/z 555 (1 00 %), 482 (80 %) 
UVNIS absorptions: hm&m (water) 493, 340 with a shoulder at 298. 
IR absorptions: (KBr) vm,/cm4 976 (Re=O) and several intensive overlapping absorptions from 
1750 to 1550. 
UVNIS and IR data indicate a quite similar structure to that found for the Re cysteine complex [I] 
with two coordinating SH and amine groups. 
Capillaty electrophoresis 
With the help of capillary electrophoresis it is possible to determine protonable groups in the Re- 
CysGly complex at different pH to learn more about the complexation behaviour in solution. An 
additional advantage of this method is that there is no need to isolate the received complex(es). 
Analytical data were collected in buffer solutions from pH 2.5 to 11.6 in 0.4 pH units. To exclude the 
electroosmotic flow (EOF) a neutral marker was used (acetone). Furthermore we utilized a cationic + I  
marker (Ph4As') to determine the rel. mobility of the analyte, which consequently depends On its 
absolute charge, as follows: The time distance between + I  marker and neutral marker, d~ ' ,  as well as 
the distance between neutral marker and the analyte, dTa, were determined according to sheme 1 and 
the ratio of dTa to dT' (rel. mobility of the analyte) was pointed against the pH (Fig. 3). A rel. mobility 
< 0 indicates a cationic charge of the analyte, a rel. mobility = 0 a neutral complex and a rel. mobility 
> 0 an anionic charge. 
Scheme 1 : Determination of the rei. mobility of the analyie 
P h4~s+  acetone analyte 
fi time 
In Fig. 2 Re-CysGly was compared with the free ligand CysGly. It is shown that ihe Iigand possesses 
3 protonabie groups, which belong to COOH, NH~+ and SH but only 2 protonable groups exist in the 
complex (pKt = 3.0, pK2 = 5.9). The rel. mobility (which is correlated to the absolute charge of the 
analyte) increases with the pH and seems to reach its maxirnurn at pH r 12 (measurements above pH 
12 were not possible because of the instability of the cornplex), which chndicaies an alteration in Charge 
at the Re 0x0 core. 
-C- Cys-Gly 
4- Re Cys-Giy 
Fig. 2: Rel. mobility of Re-CysGly and CysGly depending on pH 
Upon a pH value of 8 the UV spectrum of the detected Re complex changes (L„ 345 nm at pH < 8, 
Lmax 290 nm at pH > 8) and this change is reversible with the pH. In Fig. 3 the postulated 1 : 2 Re 





cornplex not detectable 
because of instability - 
CO0 - 
Fig. 3: Postulated 1 : 2 complex of Re-CysGly in Solution with its different forms depending on pH 
Re-Gly2Cys 
Capiilary elecfrophoresis 
Data from CE were collected as descnbed above. HPLC results indicate a 1:1 complex. The rel. 
mobility of this Re-Gly2Cys complex and the free ligand Gly2Cys versus the pH is shown in Fig. 5. At 
a pH range < 4.5 the rel. mobility of the complex is 0 (neutral). Then the rel. mobiiiiy increases 
between pH 4.5 and 5.5 (anionic behaviour, deprotonation of COOH) and reaches a plateau. At a pH 
range > 8.5 the rel. mobility of the complex (and its absolute charge) increases again which could be 
the result of deproto-nation of the NH2 group. No cationic complex is formed even at a low pH. In Fig. 
4 the different forms depending on the pH of the postulated 1 : 1 complex are shown. 
Fig. 4: Solution behaviour of the postulated Re-Gly2Cys complex 
Fig. 5: Rel. mobility of Re-Gly2Cys and Gly2Cys depending on pH 
XAS measurements on Re-Gly2Cys and Re-CysGiy 
Rhenium Llll edge data were collected as described elsewhere 121. Measurements were taken in 
aqueous solution, pH 2 - 3. 
U(AFS hvestigations 
In Fig. 6 and Table 1 EXAFS data for the two Re complexes are shown and the following 
characteristic features were found: 
Both complexes possess the characteristic short bound oxygen atom at 1.69 A. 
In case of Re-Gly2Cys a SN3 coordination was proven. Detection of protonated amine atoms. U S U ~ ~ ~ Y  
bound at a distance of 2.2 A, is not possible because no discrimination can be made between 
coordination shells that differ in less than 0.15 A. This fact is due to a fimited K-range. ThuS, Re is 
complexed by Gly2Cys in a I :I complex. 
Re-CysGly has a C2N2 coordination where the Wo amine nitrogen atoms are at a mean distance of 
2.14 A from each other. This is an a typical short value for amine nitrogen atoms and therefore 
perhaps an indication of the partial deprotonation of one amine group. Further measurements at 
various pH values must be camed out to prove this postulation. However, for Re-CysGly a compfex 
stoichiometry of 1 :2 could be demonstrated by the S2N2 coordination. 
Fig. 6: EXAFS best fit data for Re-Gly2Cys and Re-CysGly. 
Table 1 : EXAFS data for Re-Gly2Cys and Re-CysGly 
Coordination Distance to Re central DEBYE-WELLER- 
number atom (A) factor 
Re-CysGly 0 (Re=O) I 1.3 I .69 N (amine) 2 2.14 S (mercapto) 2 2.33 
Re-Gly2Cys 
Conclusions 
The results obtained by EXAFS and capillary electrophoresis show that the tripeptide Gly2Cys builds a 
1 : 1 complex with Re (Fig. 4) and the dipeptide CysGly a 1:2 complex (Fig. 3) with a similar stucture 
to that of Re-cysteine [I]. Furthermore, CE results prove that the carge changes with increasing pH, 
indicating that at pH > 2.5 the carboxyl groups are deprotonated. At pH > 8 another increase in 
charge is obsewed which could be caused by the deprotonation of an amine group. Thus, both types 
of complexes seem to exist in different forrns, depending on pH. 
0 (Re=O) 1 1.69 0.001 
N (amidelamine) 3 2.01 0.004 
S (mercapto) 1 2.27 0.002 
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16. Synthesis and Characterization of Technetium and Rhenium Oligoglycine 
Complexes and Technetium Tartrate 
R. Jankowsky, B. Noll, H. Spies, B. Johannsen 
lntroduction 
Peptide molecules as technetium ligands have attracted increasing interest in nuclear medicine [I, 21. 
To investigate the complexing properties of these ligators, systematic investigations into the complex 
structure of simple peptide complexes are necessary. Studies of sulphur-containing amino acids were 
therefore carried out by Kirsch [3]. More studies were required to find out about the complexing 
behaviour of sulphur-free peptides. Several assumptions were put forward concerning the structure of 
Tc oligoglycine complexes [4]. 
In the following study technetium arid rhenium complexes of tri, tetra, penta and hexaglycine were 
synthesized and characterized. Capillary electrophoresis (CE) was applied as well as classical 
techniques like HPLC and elemental analysis. 
Experimental 
Synthesis of technetium tri, tetra, penta and hexaglycine 
The complexes were synthesized by direct labelling procedure starting from 0.01 M ' ' ~ ~ 0 4  using 
sodium tartrate and SnC12 in alkaline solutions. The complex-foming reactions resulted in dark yellow 
solutions. 
Synthesis of technetium tartrate 
The synthesis procedure corresponds to the synthesis of Tc oligoglycine complexes, with the 
oligoglycine ligand omittted. The reaction yielded a dark red solution. 
Synthesis of rhenium tetra-, penta- and hexaglycine 
The synthesis was performed according to the Tc oligoglycine complexes and resulted in a brownish 
yellow solution. 
HPLC separation of the Tc and Re Complexes 
HPLC separation was carried out using an RP 18 semiprep. column with an aqueous acetic acid- 
acetonitrile gradient and radioactivity I UV 220 nm detection. Preparative separation was performed 
by collection of the fractions. 
Elemental analysis of the Tc and Re complexes 
The collected HPLC fractions were united and lyophilized 3 times to evaporate the HPLC eluent 
residues. The darkish powder obtained was analysed by a LECO CHNS elemental analysis device. 
lnfrared spectroscopy of Tc complexes 
HPLC-isolated, lyophilized complexes were compressed into KBr pellets and measured on a CARL 
ZElSS JENA infrared spectrometer against air. 
UV spectroscopy of Tc complexes 
Lyophilized Tc complex powder was dissolved in water and measured on a CARL ZEISS JENA 
UVNIS spectrometer against a water reference. 
Capillary electrophoresis of Tc and Re complexes 
Capillary electrophoresis was petformed using a HEWLETT PACKARD device equipped with a diode 
array UV detection System. A non-coated fused silica capillary was used. 
T0 study the Tc pentaglycine complex behaviour over the pH range, the following buffer ~YstemS 
were used: 
pH 2.0 - 6.4 citrate buffer SÖRENSEN (0.03 M) 
pH 6.4 - 9.0 borax-K2HP04 buffer KOLTHOFF (0.01 5 M) 
pH 9.0 - 12.0 glycine buffer SÖRENSEN (0.03 M) 
Results and Discussion 
Complexes of the following structures were assumed to be obtained: 
Table 1: Proposed complex structures (M = Re, Tc) 
Proposed structure Proposed structure 
Technetium and rhenium show similar complexing properties to oligoglycine ligands. In both cases it 
was not possible to synthecize the complexes by common ligand exchange procedure starting from 
gluconate, glucoheptonate or citrate precursors because of only weak donor properties of the peptide 
ligand atoms. Furthermore, triglycine was not able to form a stable complex with rhenium. 
Table 2 showc the HPLC separation results. 
Table 2: HPLC results 
Complex Retention time Radiochemical yield 
Tc-Gly3 10.5 min 95 % 
Tc-Glv4 12.3 min 92 % 
11.6 min 91 % 
9.8 rnin 
Tc-Tartrate 1.8 min 92 % 
Re-Gly4 10.2 min 
Re-Gly5 11.7 min 
Re-GI 8.6 min 
Collected fractions of technetium complexes possessed a yellow colour, whereas rhenium complexes 
turned red. Lyophilization of the HPLC-isolated technetium complexes produced brown powders, 
which resulted in a yellaw solution when dissolved in water. Rhenium complexes obviously decom- 
posed, because only a biack powder was obtained giving a black suspension when dissolved. It is 
asurned that the rhenium cornpfexes are not stable under the acidic separation conditions used. 
In the following elementar analysis resuits are given, with Re-Gly6 excluded from elemental analysis 
because of its rapid decomposition after HPLC separation. 
Tc-Gly3: Found: C, 23.46; H, 3.10; N, 13.14, TcC6H8N305 requires 
C, 24.01; H, 2.69; N, 14.00 %. 
Tc-Gly4: Found: C, 27.21; H, 2.90; N, 16.54, requires 
C, 26.90; H, 3.10; N, 15.69 %. 
Tc-Gly5: Found: C, 25.30; H, 2.98; N, 13.99, TcCq0HI4N5O7 requires 
C, 28.99; H, 3.41; N, 16.91 %. 
TC-Gly6: Found: C, 27.92; H, 3.27; N, 15.71, T c C ~ ~ H I ~ N ~ O ~  requireS 
C, 30.58; H, 3.64; N, 17.83 %. 
Re-Gly4: Found: C, 19.99; H, 3.63; N, 12.99, ReC8H1~N406 requires 
C, 21.57; H, 2.49; N, 12.58 %. 
Re-Gly5: Found: C, 21.71 ; H, 2.93; N, 11.61, TcCIoHl4N5O7 requires 
C, 23.90; H, 2.81; N, 13.94 5. 
Roughly, all complexes show agreement as to the estimated atomic compositions. However, the 
complex forrnulas could not be clearly determined by elemental analysis. 
Thel IR spectra showed no Tc=O absorption, which was estimated at wave numbers of around 950 
Cm- . The Tc complexes obviously decornposed by being compressed into KBr pellets. 
As it was not possible to properly isolate the Re complexes, UVNIS spectra could only be recorded of 
the Tc complexes. Fig. 1 shows the UVNIS spectra of the Tc complexes. 
Fig. I: UVNIS spectra of the Tc complexes 
All complexes investigated show similar UV absorption Pattern, thus indicating similar atomic environ- 
ments of the central atom. 
Capillary electrophoresis monitoring of the Tc and Re complex-fomting reactions also indicates 
sirnilar relationships. At pH 2.5 all complexes are noncharged, at pH 7 and pl-i 3.3 they are ~ ~ a t i ~ e l ~  
charged. Tc tartrate could not be detected in CE, possibly due to its decomposition in the €?lectrlG 
field. 
Except for ToGly3, these results support the stnictural assunptions shown in TaMe 1. fn the case of 
Tc-Gly3 a neutral compfex was expected, Because oof the negative Charge found at the neutrat pH 
either a deprotonation of the coordinating amine group or an additional coordination of an OH- group 
to the Tc core must have taken place. 
To obtain more information about the complex behaviour over the pH range, the Tc pentaglycine 
complex was investigated, using a novel capillary electrophoresis method. A solution of Tc-Gly5 
containing tetraphenyl arsonium chloride and acetone was measured at buffer pH from 2.6 to 12.5. 
The migration times of the free ligand (Gly~), the complex (ToGly5), the tetraphenyl arsonium 
chloride and acetone were detected. Identification of solution partics was perforrned, using the diode 
anay detector UV fingerprint. Fig. 2 shows a capillary electrophero~ram of the Tc-Gly5 sample at 
buffer pH 7.78. 
migration t ime  (min)  
Fig. 2: Capillary electropherogram of ToGly5 sample 
To exclude the electro-osmotic flow (EOF), which equally influences all particles in the analyte 
solution, the acetone migration time was Set to 0. Assuming that the tetraphenyl arsonium cation's 
charge is +1 all over the pH range, the conected migration time of this cation may serve as an 
intemal standard. Migration time differentes between analytes (Gly5 and Tc-Gly5) and acetone were 
divided by the migration time difference between the cation standard and acetone to give relative 
mobilities of the analytes. Relative mobilities of the analytes relate to the amount of protonable 
groups in the complex, i.e. every step in the resulting graph corresponds to one protonable group. Fig. 
3 shows the results of the investigated T~Gly5  complex. 
The free Gly5 ligand has Wo protonable groups, although the second (amino) step could not be 
properly detected because of its location at pH > 13. The first (carboxyl) group is detected at acidic 
pH below pH 3. 
In the case of Tc-Gly5 two significant steps were measured. The first step is situated at pH 5 and can 
be considered to be the free carboxyl group. The increase in relative mobility at high pH vaiues can 
be explained both by a deprotonating amine group or a supplemental trans coordination of an OH- 
group. 
Fig. 3: Relative mobilities of Gly5 and Tc-Gly5 
Conclusions 
Except for Tc-Gly3, the obtained analytical data support the above-mentioned stmctural assumptions. 
Tc-Gly3 seems to coordinate either via the carboxylic group or via an O H  group. 
Re complexes of oligoglycine ligands are not stable at neutral and acidic wnditions. 
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17. XAS lnvestigations o n  Tc and Re Complexes of Oligoglycine Ligands and Tc 
Tartrate 
R. Jankowsky, B. Noll, H. Spies, B. Johannsen 
Introduction 
X-ray absorption measurements were employed to obtain more information about the Tc and Re 
complexes of oligoglycine ligands and Tc tartrate in solution. XAS is a well established technique in 
structural analysis of Tc complexes [I, 21 and has been shown to be a valuable tool in research on 
both metal peptide complexes [3] and radiopharmaceutically relevant complexes [4]. 
Because we were unable to obtain crystals, XAS was the method of choice to investigate the complex 
structures. Although XAS cannot provide structural parameters of the entire complex, irnportant 
information on metal oxidation states and the metal environment was obtained. 
Experimental 
XAS measurements of the Tc and Re complexes 
Technetium complex samples for XAS measurements were prepared by upscaled synthesis of the 
rnethod described elsewhere [5] (60 p1 of 0.291 M "TCO~ in water were reacted) and lyophilization to 
a volume of 2.2 ml. Samples were filled into 2.2 ml EPPENDORF tubes under nitrogen heat sealed. 
The tubes were contained in a triple PE containment and immediately frozen at -10 "C. 
Rhenium complexes were synthesized immediately before the measurements by mixing the reactants 
(using 1.4 rng NaRe04) in 2.2 ml EPPENDORF tubes. 
XAS data of the Tc complexes were collected at HASYLAB,Hamburg, at the bending magnet 
beamline X1.l (ROEMO II monochromator). The DORlS III storage ring ran at 4.5 GeV with a 
positron current of 30 to 80 mA during measurements. Tc measurements were taken in transmission 
mode at room temperature, using ionization chambers against an aqueous KTc04 reference. An Si 
(31 1) double crystal monochromator was used to monochromatize the X-ray beam to the Tc K edge 
(21 044 eV). For energy calibration, the first maximum (pre-edge peak [2]) in reference spectra 
derivatives was set to 21 044 eV. 
Rhenium measurements were taken at the Stanford Synchrotron Radiation Laboratory at beamline 2- 
3, which was equipped with a double crystal Si (220) monochromator. The SPEAR storage ring was 
operated with an electron current of 30 to 70 mA. A four-channel solid-state fluorescence detector 
was used to collect the Re LIII edge data. No reference sample data could be collected bacause the 
Re concentration was obviously too high. The Software package EXAFSPAK [6] was used to process 
the data obtained. Energy calibration was performed using the first derivative method. In the case of 
Tc complexes, the first maximum in the reference spectrum derivative was defined as 21 044 eV. For 
Re cornplexes, the first maximum in the sample spectrum derivative was Set at 10 535 eV. The 
theoretical phase and amplitude scattering functions were calculated with the program FEFF 5.05 F]. 
Measurements of Tc-Gly3 failed because of decomposition of the sample during transport. 
Results 
XAS measurements provided valuable structural results. The Tc oxidation states can be denved from 
the maximum of the spectra derivatives, as listed in Table 1. Because Tc +5 complexes do not 
possess the characteristic pre-edge peak as KTc04 complexes [2], edge energy determinations 
yielded a higher absorption edge energy for Tc +5 cornplexes than the KTc04 reference. 
Table 1 : XANES data of the Tc complexes 
complex position of derivative maximum (eV) 
21 053.8 
Tc-Gly~ 21 053.8 
21 054.47 
Tc-Tartrate 21 053.44 
A Tc-MAG3-derived complex (Tc-N-rnethyl-MAG3 ) was used as a standard with a Tc oxidation state 
of +5. XANES data indicate the sarne oxidation state as the standard for all Tc complexes. It could be 
confirrned that tartrate is able to chelate Tc at an oxidation state of +5. 
As there were no reference data for the Re measurement, no determinations of the Re oxidation 
state in the complexes were possible. 
EXAFS analysis showed very similar patterns for the Tc-Gly, complexes. Fig. 1 shows the Fourier 
filtered EXAFS [8] of the Tc cornplexes and their Fourier transforms. 
Fig. 1 : EXAFS and Fourier transforms of the Tc complexes 
In Table 2 best EXAFS fit results for the Tc complexes are listed. 
Table 2: EXAFS fit results 
Complex Backscattering Coordination 
atom number* 
0 (Tc=O) 
* Estimated uncertainty: 30 % " Estirnated uncerta 
Distance to Tc central DEBYE-WALLER- 
atom [Q** factor 
1.99 0.006 
2.50 0.01 
ity: 0.02 A N were hsld constant during fit. 
These data confinn the Tc oxidation state of +5 for alt complexes. The Tc=O $end can be proved in 
all complexes. Furthermore, in all Gly, cornplexes four nitrogen atorns with averaged bond ienghts of 
around 2.05 A could be detected. This averaged values are believed to represent 3 amide and 1 
amine nitrogen atoms. This gives rise to the assumption, that the peptide N termini are involved in 
the metal complexation. Astonishingiy, a distant technetium atom is detected at distanws of around 
2.85 A at ail complexes. A further coordination shell is visible at distances of around 4 A, being 
probably represented by the peptide backbone carbonyl oxygen atoms, which are detectable due to 
focussing multiple-scattering effects. These phenomena have to be further analyzed. 
Tc tartrate was determined to have a short-bound oxygen atom at the Tc central atom and an 
additional o5 coordination. Thus, a 1 :2 complex stoichiometry and a trans coordination of a tartrate 
carboxylic oxygen can be assumed. The bridging carbons are located significantly closer to the Tc 
than in the Tc peptide complexes. 
The two rhenium samples, Re-Gly4 and Re-Gly~, also showed very similar EXAFS and Fourier 
transforms, they are shown in Fig. 2. 
Fig. 2: EXAFS and Fourier transforms of Re-Gly4 and Re-Gly5 
Table 3 shows the EXAFS best fit results for the Re complexes. 
Table 3: EXAFS fit results for Re-Gly4 and Re-Gly5 
The Re complxes show very similar fit results compared to the Tc fit resuiis. Again, the +5 Re 
Oxidation state could be proven by the detection of a short-bound oxygen atom. Four nitrogens are 
bound at averaged values of around 1.97 A. Obviously, a deprotonation of the coordinating amine 
nitrogen atom takes place. A distant Re atom is detected at around 2.9 A as well as a more distant 
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Technetium an Rhenium are obviously complexated by sulphur-free oligopeptides in a complicated 
way. An involvement of the N termini in case of the Tc complexes could be shown. In case of Re, this 
unique evidence could not be obtained. The detected metal atoms at distances of under 3 A give rise 
to the assumption, that the peptides cause a forming of dinuclear complexes. All complex EXAFS 
data have to be analyzed with regard to the detection of the distant metal atoms and possible multiple 
scattering effects in the future. 
References 
~lmahamid I., Bryan J. C.,Bucher J. C., Burell A. K., Edelstein N. M., Hudson E. A., Kaltsoyannis 
N., Lukens W. W., Shuh D., Nitsche H. and Reich T. (1995) Electronic and structural investi- 
gations of technetium compounds by X-ray absorption spectroscopy. Inorg, Chem. 34, 193 - 198. 
Allen P. G., Siemering G. S., Shuh D. K., Bucher J. J., Edelstein N. M., Langton C. A., Clark S. 
B., Reich T. and Denecke, M. A. (1 996) Technetium speciation in cement wage forms deter- 
mined by X-ray absorption fine structure spectroscopy. Radiochim. Acta, in press. 
Foerster M., Brasack I., Duhme A.-K., Nolting H.-F. and Vahrenkamp H. (1996) Zinc complexes 
of oligopeptides containing histidine at both termini. Chem. Ber. 129, 347 - 353. 
Martin J. L., Yuan J., Lunte C. E. Elder R. C., Heineman W. R. and Deutsch E. (1989) 
Technetium diphosphonate skeletal imaging agents: EXAFS structural studies in aqeous 
solution. 1norg.Chem. 28,2899 - 2901. 
Jankowsky R., Noll B., Spies H. and Johannsen B. (1996) Synthesis and characterization of 
technetium and rhenium oligoglycine complexes and technetium tartrate. ibis repd, pp. 67 - 71. 
George G. N. and Pickering I. J. (1 995) EXAFSPAK, a suite of computer programs f0r analy~is 
of X-ray absorption spectra. Stanford Synchrotron Radiafion Laborafory, Stanford, CA. 
Rehr J. J.,Mustre de Leon J., Zabinsky S. and Albers R. C. (1991) Ab-initio curved wave X-ray 
absorption fine structure. Phys. Rev. B 44, 4146. 
Jankowsky R., Noll B., Spies H. and Johannsen B. (1996) X-ray absorption spectroscopy: 
A valuable tool for structural analysis of Tc and Re complexes. ibis report, pp. 76 - 78. 
References 
Almahamid I., Bryan J. C.,Bucher J. C., Burell A. K., Edelstein N. M., Hudson E. A., Kaltsoyannis 
N., Lukens W. W., Shuh D., Nitsche H. and Reich T. (1995) Electronic and structural investi- 
gations of technetium compounds by X-ray absorption spectroscopy. Inorg. Chem. 34, 193 - 198. 
Allen P. G., Siemering G. S., Shuh D. K., Bucher J. J., Edelstein N. M., Langton C. A., Clark S. 
B., Reich T. and Denecke, M. A. (1996) Technetium speciation in cement waste forms deter- 
mined by X-ray absorption fine structure spectroscopy. Radiochim. Acta, in press. 
Foerster M., Brasack I., Duhme A.-K., Nolting H.-F. and Vahrenkarnp H. (1996) Zinc complexes 
of oligopeptides containing histidine at both termini. Chem. Ber. 129, 347 - 353. 
Martin J. L., Yuan J., Lunte C. E. Elder R. C., Heineman W. R. and Deutsch E. (1989) 
Technetium diphosphonate skeletal imaging agents: EXAFS structural studies in aqeous 
solution. Inorg. Chem. 28,2899 - 2901. 
Jankowsky R., Noll B., Spies H. and Johannsen B. (1996) Synthesis and characterization of 
technetium and rhenium oligoglycine cornplexes and technetium tartrate. This report, pp. 67 - 71. 
George G. N. and Pickering I. J. (1995) EXAFSPAK, a suite of computer programs for analysis 
of X-ray absorption spectra. Stanford Synchrotron Radiation Laboratory, Stanford, CA. 
Rehr J. J.,Mustre de Leon J., Zabinsky S. and Albers R. C. (1991) Ab-initio curved wave X-ray 
absorption fine structure. Phys. Rev. B 44,4146. 
Jankowsky R., Noll B., Spies H. and Johannsen B. (1996) X-ray absorption spectroscopy: 
A valuable tool for structural analysis of Tc and Re complexes. This report, pp. 76 - 78. 
18. X-Ray Absorption Spectroscopy: a Valuable Tool for Structural Analysis of Tc and 
Re Complexes 
R. Jankowsky, B. Noll, H. Spies, T. Reich. H. Nitsche 
lntroduction 
X-ray absorption spectroscopy is a well-established tool in structural analysis of transition metals 
[I, 21. Despite its unique ability to provide structural data of complexes in solution, only a few studies 
have so far been made on radiopharmaceutically interesting complexes containing Tc or Re [3, 41. To 
emphasize the usefulness of the method, particularly for the third generation of ""'TC radiopharma- 
ceuticals, a short evaluation of the XAS method will be given in the following. 
Experimental 
Data of Tc and Re complexes were collected at Stanford Synchrotron Radiation Laboratory, Stanford, 
CA, and at HASYLAB, Hamburg, as elsewhere descnbed [5]. 
Resuits and Discussion 
Several aspects of X-ray absorption spectroscopy should be discussed. First, there are some unique 
advantages provided by XAS. 
Unlike XRD analysis, it is possible to determine the atomic environment of the central atom without 
availability of crystals. Thus, an in situ structural analysis can be performed. Cornplexes can be 
measured in reaction mixtures without any further purifrcation, if a single metal species can be 
ensured. Amorphous and solid sarnples can be investigated as weil, the latter prepared as a sample- 
Teflon or a sample-BN3 pellet. 
Conceming the data obtained, a lot of information is provided. It is possible to deterrnine the central 
atom oxidation stak by XANES (X-ray absorption near edge structure) measurements. For this a 
reference to a weil known oxidation state is required. The energy absorption edge position correiates 
with the central atom oxidation state, thus the absorption spectra derivatives of both the reference 
and the samples have to be mlculated and plotted as shown in Fig. I (Tc samples). 
A MAG3-denved cornplex with a known oxidation state of +5 was used as a reference. As can be 
seen, tfte absorption edge pocitions are the same, thus a +5 Tc oxidation state was concluded for a~ll 
samples. 
J"------ +5 wferencc 
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Fig. 1 : XANES data processing (Ref.: ~ c - ~ ' - r n e t h y l - ~ ~ ~ ~ )  
EXAFS rneasurements provide structural data about the atornic environment of the central atom, 
which are the atornic numbers of the backscattering atom, the coordination numbers and the DEBYE- 
WELLER factors as an expression of the thermic rnobilities of the backscattering atoms. Furthermore, 
it is possible to distinguish between protonated and deprotonated nitrogen atoms via their distances to 
the central atom. Amine (protonated) nitrogen atorns usually are bonded at a distance of around 
2.2 A, while arnide (deprotonated) nitrogen atoms are bound at around 2 A. One of the mOSt 
important characteristics of EXAFS is the ability to find out the complex stoichiometry. Taking the 
well-known ligand structure into consideration, the complex stoichiometry can be derived frorn the 
metal cornplexation mode, such as SNs or S2N2. Fig. 2 S ~ O W S  the EXAFS and the Fourier transform 
of both an  SN^ and an S2N2 coordinatio~ sphereI 
- 
16' 
Fig. 2: EXAFS and Fourier transfoim of complexes with different coordination spheres: 
Re-Gly2Cys and Re-(CysGIy)2 
It can easily be Seen that both the EXAFS and the Fourier transforrns of the two peptide complexes 
differ significantly. Another advantage is the ability to detect interrnolecular rnetal-metal distances, 
like Re-0-Re. Fig. 3 shows the EXAFS and the Fourier transform of a complex with an interrnolecular 
Re-0-Re bridge (Re cysteamine). 
Fig. 3: EXAFS and Fourier transform of a Re-0-Re bridged complex (Re-cysteamine) 
The Re-Re distance at a distance of 3.6 A is indicated, which is also proved by X-ray powder 
diffraction analysis.Quick EXAFS measurernents enable us to monitor complex-forming reactions in a 
time-resolved way. However, sorne drawbacks of XAS have to be rnentioned. 
The most irnportant problern is that no distinction is possible behiveen complexing atoms within the 
Same PSE period, like oxygen and nitrogen or sulphur and phosphorus. The error in coordination 
nurnbers is up to 30 % for first and second coordination shells and up to 50 % for third and higher 
coordination shells. Thus, a proper identification of third and higher coordination shells- except distant 
metal-metal distances- will not be possible. 
Depending on the recorded energy scan range and the data statistics, a resolution in distances of 0.1- 
0.17 A will be obtained. 
Conclusions 
XAS has proved to be a very ~Seful tool in structural analysis of Tc and Re cornplexes with 
insufficient crystallization properties. Though a good identification of the atomic environment of the 
central atom is possible, XAS results will not reach the possibilities in structural analysis that are 
provided by XRD analysis. 
XAS results always have to be complemented by supplemental analytical techniques, such as 
electrophoresis or elernental analysis. 
However, in the radiopharmaceutical chemistry of technetium and rhenium XAS measurernents are 
believed to be an increasingly widely applied analytical method. In the future XAS rneasurernents will 
be performed on a lot of Tc and Re complexes to obtain structural data regardless of the cornplex 
crystallization properties. 
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19. Technetium and Rhenium Complexes with Thioether Ligands 
8. X-Ray Structures of Mononuclear Oxorhenium(V) Complexes with Bidentate 
Thioether and Dithiaalcohol Ligands 
M. Reisgys, H.-J. Pietzsch, H. Spies, P. ~eibnitz' 
'~undesanstalt für Materialforschung Berlin 
lntroduction 
We recently found a new simple way of synthesizing neutral rhenium complexes with S,S 
coordinating thioether ligands [I]. By reduction of ammonium perrhenate with concentrated hydrohalic 
acid followed by addition of the ligand in glacial acetic acid, the expected complexes (Fig. 1) were 
obtained in a onepot reaction in a nearly quantitative yield. 
Fig. 1 : General stnicture of the trihalo("SS")rhenium(V) complex (X = Cl, Br) 
In this report we describe the X-ray structure of the tribromo("SS")rhenium(V) complex 1. For the 
synthesis of this complex See ref. [l]. Further the thioether complex 2 with the S,O,S coordinating 
sequence was synthesized and characterized by X-ray analysis [2]. 
Experimental 
Preparation of dichloro[S, gdifhiatndecan-7slato-(S, 0, S)]oxorfienium(V) 2 
To 40.2 mg (150 prnol) of NH4Re04, dissolved in 1.5 rnl of concentrated HCI. 47.3 mg (200 pmol) 0f 
5,9-dithiatridecan-7-01 [3], dissolved in I rnl of glacial acetic acid, was added. After 20 min a vioiet 
precipitate was filtered off and washed three times with glacial acetic acid and following three times 
with diethyl ether. 
Crystals for X-ray analysis wuld be obtained by recrystallization from CHClddiethyl ether. 
Yield: (53 mg, 69 K). 
M.p.1128 - 129 "C. 
Elemental analysis: (Found: C 25.44; H 4.44; S 12.31; C1 13.81, CllH23C1202ReS3 requires 
C 25.90, H 4.56, S 12.61, CI 13-94 %) 
IR absotptions: v ,~cm-"~~r)  1040 (C-0), 960 (Re=O), 532 (Re-0). 
Results and Discussion 
Ammonium perrhenate, dissolved in concentrated hydrobromic acid, was added to a solution of 5,8- 
dithiadodecane in glacial acetic acid [ I ,  41. 1 precipitates immediately as a yellowish green powder. 
Green crystals suitable for X-ray analysis were obtained by slow evaporation of the reaction solution. 
A strong vibration band at 976 cm-' in the infrared spectrum of 1 can be assigned to the [R~=o]~*  
core [5]. The X-ray structure shows a djstorted octahedral coordination sphere of the rhenium centre. 
The sulphurs of the ligand and Wo bromines form the equatorial plane, the oxygen and the third 
bromine are cis coordinated to the thioether ligand. In the crystal there is a statistical disorder of the 
n-butyl groups. This affects V ~ ~ O U S  positions of the carbons C(4), C(5), C(6), and C(1O) of structure A 
(darker balls in Fig. 2) and C(4'), C(5'), C(63, and C(lO1) of structure B (lighter balls). The mean 
probability for structure A and B lies at 49 and 51 %. Selected bond iengths and angles are 
summarized in Table I. 
Fig. 2: The ovedayed X-ray structures A (darker balls) and B (lighter balls) of complex 1. 
Tablel: Selected bond lengths and angles for compound 1 and 2. 
Reaction of nBu-S-CH2-CH(0H)-CH2-S-nBu in glacial acetic acid with ammoniumperrhenate in 
concentrated hydrochloric acid leads to the violet complex 2. Violet crystals suitable for X-ray analysis 
could be obtained by slow evaporation of the reaction solution. A strong vibration band at 960 cm-' in 
the infrared spectrum is characteristic for the O=Re-0 moiety [6]. The main structure (Fig. 3) is 
defined by the bicyclo-[2,2,1]-ReC* unit. Because of the ring strain of this bicyclic compound the 
octahedral coordination sphere of the rhenium atorn is distorted. 
All bond lengths and angles (Table I )  are in the normal range 171. 
Fig. 3: X-ray structure of compound 2 
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20. Rhenium and Technetium Carbonyl Complexes for  the Labelling of Bioactive 
Molecules 
2. Tricarbonylrhenium(l) Complexes with Mono-, Bi- and Tridentate Thioether 
Ligands 
H.-J. Pietzsch, M. Reisgys. H. Spies, R. ~lbe?o', U. ~ b r a m ~  
'~aul-~cherrer-institut Villigen (Switzerfand), inctitut für Anorganische Chemie Tübingen 
lntroduction 
A new way for the synthesis of technetium and rhenium carbonyl complexes of the oxidation state + I  
has recently been developed by Alberto et al. [I]. Starting from Tc04 or Re04 tncarbonyl complexes 
of the main formula [MX~(CO)~]~- (M = TC, Re; X = CI, Br) can be synthesized by reduction with 
borane under normal pressure of carbon monoxide and tetraalkylammonium halogenide in 
tetrahydrofuran. The characteristics of these carbonyl precursors for the desjgn of radiopharma- 
ceuticals are simple synthesis, easy cornplex forrnation with n-donor iigands, high stability of the 
complexes and the small volurne of the coordination sphere. 
In this report we introduce the synthesis and characterization of tricarbonyl complexes with mono-, bi- 
and tridentate thioether ligands. The structure of a dinuclear rhenium complex and a cationic compiex 
with a tridentate thioether ligand could be obtained by X-ray analysis. 
Experimental 
Preparation of complex I 
A solution of 38 mg (260 ymol) di-n-butylsulphide in 1 ml methanol was added to 100 mg (130 vmol) 
(NEf4)2[ReBr3(C0)3] in I ml rnethanol under an inert atmosphere. After stimng for 1 h the solvent was 
removed by vacuum. The residue was taken up in dry THF and filtered. The solvent of the filtrate was 
reduced, and white microcrystals precipitated from the oil. 
Yield: (83 mg, 91 %). 
M.p.: 89 "C. 
Elemental analysis: (Found: C, 32.23; H, 5.14; N, 1.98; S, 5.72, C19H38Br2N03ReS requires 
C, 32.30; H, 5.42; N, 1.98; S, 4.54 %). 
IR absorptions: vmicm-' (KBr) 2960 (C-H). 2872 (C-H), 2008s (C-0), 1908s (C-0), 1872s (C-0), 
1464,1184. 
Preparation of complex 2 
A solution of 24 mg (130 yrnol) 1,8-dihydroxy-3,6-dithiaoctane in I ml methanol was added to 100 mg 
(I30 ymol) (NEf4)2[ReBr3(C0)31 in 1 ml methanol under an inert atmosphere. After stirring for 1 h the 
solvent was removed by vacuum. The residue was taken up in dry THF and filtered. The solvent of 
the filtrate was reduced, and the remaining oil was washed with water and diethyl ether to obtain white 
microcrystals. 
Yield: (55 mg, 80 %). 
M$.: 72 - 75 "C. 
Elementai analysis: (Found: C, 20.47; H, 2.64; S, 11.99; Br, 14.98, C9H14BQReS2 requires 
C, 20.30; H, 2.65; S, 12.04; Br, 15.01 %). 
IR absorptions: vm/cm-" (KBr) 3406 (0-H), 2926 (C-H), 2032s (C-0), 1942s (C-O), 1912s (C-0), 
1508,1410,1208. 
Preparation of complex 3 
A solution of 51.3 mg (130 vmol) (pMeOPhCH2SCH2CH&S in 1 rnl methanol was added to 100 mg 
(130 vmol) (NEf4)2[ReBr3(C0)31 in I ml methanol under an inert atmosphere. After stirring for 1 h the 
solvent was removed by vacuum. The residue was taken up in dry THF and filtered. The solvent of 
the fiitrate was reduced, and the oii was washed with water and diethyl ether to obtain a white powder. 
Yield: (64 mg, 67 %). 
M.P.: 65 - 68 "C. 
Elemental analysis: (Found: C, 37.36; H, 3.53; S, 13.03; Br, 10.08, C23H25B~ReS3 requires 
C, 37.09; H, 3.52; S, 12.91; Br, 40.73 %). 
IR absorptions: ~ ~ l c m - '  (KBr) 2926 (C-H), 2030s (C-0), 1938s (C-O), 1898s (C-0), 1608,1512, 
1250. 
Preparation of complex 4 
b solution of 66 mg (390 pmol) AgN03 in water was added to a solution of 100 mg (130 pmol) 
(NEf4)2[ReBr3(C0)3] in 2 ml water. The immediately precipitating AgBr was filtered off, the solvent of 
the filtrate was removed by vacuum. The crystalline (NELI)~[R~(NO~)~(CO)~] was dissolved in 5ml 
tetrahydrofuran and a solution of 51 mg (130 pmol) (PM~OP~CH~SCH~CH~)~S in 2ml tetrahydrofuran 
was added. After 3 h the precipitate was filtered off and the filtrate was evaporated. The oit obtained 
was washed with diethyl ether and dried in vacuum. The beige powder was recrystallized in 
chloroform/n-hexane. 
Yield: (56 mg, 59 %). 
M.P.: 120 - 122 "C. 
Elemental analysis: (Found: C, 37.51 ; H, 3.68; N, 1.96; S, 13.25, C23H26N08ReS3 requires 
C, 38.06; H, 3.47; N, 1.93; S, 13.25 %). 
IR absorptions: v,,,/cm-' (KBr) 2928 (C-H), 2040s (C-0), 1948s (C-0), 1612,1512,1252. 
Preparation of complex 6 
A solution of 19 mg (130 pmol) 3-thia-I-heptanthiol in 1 ml methanol was added to 100 mg (130 
pmol) (NEf4)2[ReBr3(C0)3] in 1 ml methanol under an inert atmosphere. After stirring for 1 h the 
solvent was removed by vacuum. The residue was taken up in dry THF and filtered. The solvent of 
the filtrate was reduced, and the oil was washed with diethyl ether to obtain a nearly white powder. 
Recrystallization in chloroform/n-hexane produced crystab suitable for X-ray analysis. 
Yield: (10 mg, 9 %). 
M.P.: 123 - 125 "C. 
Elemental analysis: (Found: C, 25.56; H, 3.00; S, 14.60, C I B H ~ ~ O ~ R ~ ~ S ~  requires 
C, 25.28; H, 3.12; S, 15.28 %). 
IR absorptions: v„/cm-' (KBr) 2960 (C-H), 2016s (C-0), 1984s (C-0), 1920s (C-0), 1464,1424. 
Results and Discussion 
Reaction of (NEf4)2[ReBr3(C0)3] with thioether ligands in methanol leads to different complexes. 
Scheme 1: 
A A A  CO I HO S S OH 
OH 
MeOH 
C s  
2 
LOH 
Monothioether, such as di-n-butylsuiphide, produces the anion complex 1, in which only one bromide 
is subtiiuted by a ligand. Tetraethylammonium is the countenon. 
Starting from a bidentate thioether Wo coordination positions of the rhenium wiit be occupied by 
sulphurs. The neutral compiex 2 can be synthesised and characterized by infrared spectr0SCOpy 
(2032 cm-', 1942 cm-', 1912 cm-I) and elemental analysis. There are no signs of coordination 0f One 
of the hydroxyl groups. The tridentate iigand (pMeOPhCH2SCH2CH2)$3 reacts in the same way. In 
comparison with 2 the infrared spectrum of 3 shows anaiogous bands in the CU stretching region 
(2030 cm", 1938 cm", 1898 cm-'1. This leads to the conclusion %hat only Wo suiphur atOmS are 
coordinating, while one sulphur remains unwordinated. The third coordination position is occupied by 
a bromide. In contrast, the reaction of (NEb)2[Re(N03)3(CU)3] with the same ligand in tetrahydrofuran 
leads to complex 4 (Scheme 2). The X-ray stfucture (Fig. 3) shows an [S3(c0)3] coordination sphere 
of the rhenium centre. The infrared data (2040 Cm-', 1996 cm-') confirrn the high symmetrical 
structure of 4. 
Scheme 2: 
Fig. 1 : X-ray structure of wmplex 4. 
Whiie the reaction of (NEQ2[MX3(CO),] (M = Re, Tc; X = Cl, Br) with thiols leads to anionic dirhenium 
cornplexes with three p-S units (5, Scheme 3, 12, 3]), 3-thia-l-heptanthiol leads to a neutral dirhenium 
complex 6 with two p-S atoms. Coordination of one thioether sulphur per rhenium foms a 
[ReS(CH2)2SReS(CH2)2S] tncyclic compound in staircase conformation. The X-ray structure of 6 




X = CI, Br 
5 ,  
R 5 
Fig. 2: Molecular structure of 6. 
The rhenium(1) tricarbonyl complexes presented demonstrate manifold ways of complex bonding 
starting from (NEtQ)2[ReBr3(C0)3] with different thioether compounds. All complexes are stable in air 
and moisture as well as in organic solvents. We are now planning to assign the obtained results to the 
corresponding Tc-99 or Tc-99m tricarbonyl precursors. 
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21. Technetium and Rhenium Labelled Steroids 
1. First Synthesis of "3+Iw Mixed-Ligand Oxorhenium(V) Complexes Bearing a 
Pendant Estradiol Moiety 
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Introduction 
The introduction of technetium into steroid hormones by coupling it to the complete molecule or by 
the construction of Tc-steroid mimics Open a promising route to receptor-binding technetium-99m 
radiotracers which are potentially able to image hormone-depending tumors [I, 21. 
In order to investigate the possibilities for labelling steroids with the readily available radionuclide 
technetium-99m, a number of attempts have been made to combine steroids with metal cores. 
Especially the Katzenellenbogen group [3, 4, 51 developed various metal-labelled steroids with a high 
receptor-binding affinity. 
In extension of our current research which aims for at technetium tracers reactive in vivo, efforts are 
being made to explore results in the coordination chemistry of mixed-ligand "3+Iu-complexes for the 
design of steroid complexes of both technetium and rhenium. The latter element is involved in our 
investigations as an inactive surrogate for the radioactive technetium. The principle of preparing 
mixed-ligand complexes in which small-sized chelate units are bound to steroids has been applied to 
thiocholesterol as a substituent in an earlier work [6]. 
The present article describes some first investigations of the chemistry of estradiol-rhenium 
complexes, starting from easily available 2-substituted estradiol derivatives. 
13c NMR spectroscopy was used to elucidate the structure of the synthesized steroid compounds. 
Experimental 
1. General 
Solvents and reagents were purchased from the following commercial sources: Sigma, Fluka and 
Aldrich. THF and DMF were dried and distilled prior to use. The reagents were used as received. 
I3c NMR spectra were recorded at 75 MHz with an MSL Bruker spectrometer using BB decoupling 
and APT method for assignment. 30" pulses and a repetition time of 2 s were applied. The digital 
resolution was 1 Hz (0.013 ppm). All spectra were indirectly calibrated using the solvent peak of 
CDC13 at 77.0 ppm. 
2. Synfhesis 
2-if1iomethyI-estra-l,3,5(lO)-triene-3,17ßdiol7 (Fig . 1 ) 
The synthesis commenced by protecting 3,17ß-estradiol 1 with MOMCl by a modification of the 
general procedure of Stork and Takahashi [7] to give MOM ether 2. Deprotonation of 2 with s-BuLi 
and quenching the intermediate carbanion with DMF gave exclusively the 2-formyl product 3 in a 
87 % yield. Reduction of 3 with NaBH4 in MeOH led to the alcohol 4 which was converted with 
thioacetic acid under Mitsunobu condiiions [8] to the thioester 5. Cleavage of the MOM-protecting 
groups with dilute HCI and subsequen~t saponification of the thioester 6 by sodium methoxide gave 
the desired thiol7 in a total yield of 25 % related to 3,17ß-estradiol 1. 
(3-fhiapentane-1,5difholafo)(3,17~st?adiol-2-fhiomethylato)oxorhenium( 9 (Fig. 2) 
36.5 mg (94 pmol) chloro(3-thiapentanie-I ,5-dithiolato)oxorhenium(V) 8 [9] were dissolved in 4 ml hot 
acetonitrile while stirring. At 80 "C 61 mg (192 pmol) of the thiol 7 dissolved in 4 ml acetonitrile were 
added slowly, followed by addiiion of one drop of triethylamine. The colour of the mixture changed 
immediately from dark blue to red. The red mixture was stirred at 80 "C for 30 min. Afterwards it was 
evaporated to dryness. The residue was purified by passing througth a silica gel column with 
chloroform : methanol (5:l) as eluent. After evaporation of the eluate 28 mg (35 %) of a light brown 
solid were obtained. 
Melting point: 186 - 188 "C (decomposition) 
IR absorption v„&m-' (KBr) 960 cm-I (Re=O) 
MS (FAB positive): 693(68.1), 694(16.2), 695(100) M+l+Na*, 696(21.9), 697(20.9) 698(4.8) 
Eiemental anatysis: (Found C, 39.99; H. 5.14; S, 19.00; C23H3303ReS4 requires 
C, 41.1 1; H, 4.95; S, 19.08 %) 
(3-oxapenfane- I, 5-dithiolato)(3,17ßesfradiol-2-thiomethylato)oxorhenium( 12 (Fig . 3) 
103 mg (175 pmol) tetra-n-butylammonium-tetrachlorooxorhenate 10 1101 were dissolved in 2 ml 
EtOH and cooled to 0 "C. At this temperature 61 mg (191 pmol) thiol 7 and 21 PI (175 pmol) 3-oxa- 
pentane-I ,5-dithiol 11 in 2 ml chloroform were added while stimng. Stirring the mixture at 0 "C was 
continued for two hours. During this time a light brown solid was formed. The solid was separated and 
washed with chloroform. After drying 56 mg (49 %) of complex 12 were obtained. 
Melting point: 170 - 171 "C (decomposition) 
IR absorption v,,,/cm-' (KBr) 952 cm" (Re=O) 
MS (FAB positive): 677(69.5), 678(14.3), 679(100) M+I+N~', 680(20), 681 (15,3) 
Elemental analysis: (Found C, 40.69; H, 5.10; S, 14.33; C23H3304ReS3 requires 
C, 42.12; H, 5.07; S, 14.66 %) 
Remark: The elemental analysis was performed on a LECO CHNS 932 elemental analyser.The differ- 
ences in the carbon value are caused by technical problems. 
Results and Discussion 
Binding of rnetals at the steroid moiety requires the presence of a suitable donor group. For techne- 
tium and rhenium at the oxidation state (V) a mercaptide suiphur is the preferred group to provide 
stable binding of the metal. 
lntroduction of a thiol group into the steroid molecule is therefore the key step in the reaction 
sequence (Fig. 1) and succeeded via forming a thiolacetate using the Mitsunobu reaction starting 
from the corresponding alcohol. This reaction appeared to be an ideal method for introducing a 
sulphur rnoiety in a high yield under mild conditions into primary hydroxyl groups containing 
molecules. 
1. 5-BuLj THF, -7PC 
2. DMF, -78'C torR 
t 
F M  OMOM 
NaBH4. MeOH, 
O°C to r.t OoC to1.t. - t 
MOMO 65% MOMO 93% 
0 Ooc to 1.t. 
Fig. I :ReaGtion sequence for the synthesis of monothiol7 
I3c NMR spectroscopy as a suitable tool for structure elucidation of steroids 1111 was used for 
characterizing synthesized steroid compounds (Fig. 1). The chemical shifts of the carbon atoms of 
steroids 2 - 7 are listed in Table 1. The spectra confirm the structure of all prepared estradiol 
derivatives. The chemical modifications in position 2 of the steroid skeleton could be proved by 
observation of the new signals of the introduced substituents and the characteristic changes of the 
chemical shifts of the aromatic carbon atoms due to the substituent effects. Successful introduction 
and cleavage of the MOM-protecting group in positions 3 and 17ß could be observed in the Same 
way. 
Table 1: Chemical shifts (in ppm) of the carbon atoms of steroids 2 - 7 
Steroid RI R2 R3 
16 
2 CH30CH2 CH30CH2 H 
15 3 CH30CH2 CH30CH2 CHO 
4 CH30CH2 CH30CH2 CH20H 
5 CH30CH2 CH30CH2 CH2SCOCH3 

























CH~OCH~ ' - 
CH30sH2 ' 
P-- - 
1I' value position 3 12? value position 17 
probable ascignrnent 
Starting from the monothiol 7, two new rhenium "3+1" complexes bearing a receptor binding molecule 
were synthesized. 
The complex formation occurs according to the "3+1" concept [I21 with two different rhenium 
precursors in a 35 % and 49 % yield (Fig. 2 and Fig. 3). The complexes differ with respect to the 
neutral donor atom in the tridentate ligand part, which is S for 9 and 0 for 12. 
Fig. 2: Reaction of monothiol7 with rhenium precursor 8 
Fig. 3: Reaction of monothiol7 with rhenium precursor 10 
The resulting complexes are light brown solids soluble in DMSO of a reddish-brown wlour. In general 
the one-pot method of forming complexes like 12 starting from the tetrachlorooxorhenate01) 10 aS a 
precursor should produce lower yields compared with the two-pot method (Fig. 2) 191. The lower yield 
of complex 9 is due to its chromatographic purification. The expenments show that the mixed-ligand 
concept can be applied to biologically important steroid compounds, such as 3,17ß-estradiol 1. In 
further investigations we Want to study the influence of the chelating group on various positions Of the 
steroid molecule of biological interest, like 17a, 7a or 11ß. Furthermore, efforts in the construction Of 
steroid mimic chelating groups according to the mixed-ligand concept should be a beneficial route fOr 
designing potential estrogen receptor-binding technetium-based radiotracers. 
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22. Technetium and Rhenium Labelled Steroids 
2. Oxorhenium(V) Complexes of 1 -Mercapto-4-methylestra-I ,3,5(10)-trien-17-one 
F. Wüst, H. Spies, R. ~eckert', S. ~ ö l l e 3  
'~riedrich-schiller-~nivercität Jena, Institut für Organische und Makromolekulare Chemie 
lntroduction 
The rearrangement of 3-thioxo-~~~~steroids ffers a new approach to mercapto functionalized 
steroids [I]. The dienthion-thiophenol rearrangement (Fig. I) of 3-thioxoandrosta-I ,4-dien-17-one 1 in 
an aprotic solvent in the presence of an acid catalyst results in I-mercapto-4-methylestra-1,3,5(10)- 
trien-17-one 2 suitable for forming mixed-ligand "3+lU-complexes. The mercapto functionalized 
steroid compound 2 was synthesized by the group of Prof. Beckert at Jena university. 
Fig. I Dienthion-thiophenoi rearrangement 
Experimental 
(3-fhiapenfane-1,5-difhiolato)(l-mercapto-methylea-l, 3, ( 1 0 - t r i - 1 - o n e ) o x o e n i u m  3 
39 mg (100 pmol) chloro(3-thiapentane-1,5dithiolato)oxorhenium(V) 5 121 were dissolved in 4 ml hot 
acetonitrile while stimng. At 80 "C 61 mg (200 pmol) of the thiol 2 dissolved in 4 ml acetonitrile were 
added.The colour of the mixture changed from dark blue to red while stining and heating at 80 "C for 
2 h. Afterwards it was evaporated to dryness and the residue was redissolved in chioroform. The red 
solution was worked up by chromatography on a silica gel column with chlorofomlmethanol @:I) as 
an eluent. Slow evaporation of the eluate yielded 29 mg (44 %) of reddish brown crystals. 
Melting point: 244 - 246 "C 
IR absorption vmm1cm-' (KBr) 960 (Re=O) 
Elemental analysis: (Found C, 41 -78; H, 4.58; S, 18.94; C23H3102ReS4 requires 
C, 42.24; H, 4.78; S, 19.61 %). 
(3-oxapentane-I, 5-difhiolafo(l-mercapto4mefhylea-3 ( 1 0 - t r i - 1 7 n e ) x o e n i u (  4 
66.8 mg (1 14 pmol) tetra-n-butylammonium-tetrachlorooxorhenate 6 131 were dissolved in 2 rnf 
EtOH and cooled to 0 "C. At this temperature 37.6 mg (125 pmoi) thiol 2 and 13.6 pl (114 l;imOl) 
3-oxapentane-13-dithiol 7 in 2 ml chloroform were added while stimng. The colour of the mixture 
changed to red. The mixture was ctirred at 0 "C for another Wo hours. During this time a solid Was 
fomed. Evaporation of the solution and redissolving of the residue in chlorofom yielded a red 
solution, which was punfied by being passeci through a silica gel column with chloroform I rnethanol 
(5:l). Slow evaporation of the eluate yielded 26 mg (36 %) of bronm crystals. 
Melting point: 21 1 - 215 "C 
IR absorptions: vm&mml (KBr) 952,968 (Re=O) 
Elementat analysis: (found C, 42.97; H, 5.09; S, 13-94; C23H3103ReS3 requires 
C, 43.31; H, 4.90; S, 15.08 %). 
Results and Discussion 
f h e  steroid thiol 2 is readily available by rearrangement of the comsponding 3-thioxo-A' 4-steroid~. 
These steroid compounds were obtained by a method developed by Be&erf: ef al. $41. This rnethod 
involves the regioselective thionatian of 3-0x0-1,Uien steroids using tawesson's reagent. With 
steroid thioi 2 two heniurn "3+Iw complexes were synthesized wrth the appropriate rhlenium 
precursorc 5 and 6. The cornptexes 3 and 4 were obtained in 44% and 36 OJo yOeId (Fig. 2). 
Fig. 2: Complex formation of monothiol 2 
Complex formation by exchange of the Re-CI bond in 5 with thiol 2 requires heating for 2 hours due to 
the stericai requirements of thiol steroid 2. Using the more reactive rhenium precursor 6, the complex 
formation according to the 3+ln-concept occurs immediately at 0 "C. 
The complexes 3 and 4 were characterized by elemental analysis and ir-spectroscopy. In the ir- 
spectrum of complex 4 two strong bands of the Same intensity in the range of the Re=O absorption at 
952 cm-' and 960 cm-' were unexpectedly observed. Complex 3 only shows one strong band at 960 
cm-'. The reasons for giving Wo strong absorption bands for complex 4 with S-0-S coordination in 
the tridentate ligand part instead of the expected single one as in complex 3 with S-S-S coordination 
are not yet known. Further characterization of the well crystallized compounds 3 and 4 by X-ray 
crystal structure determination is intended. 
Recently we reported two new oxorhenium0l) complexes with functionalized estradiol [5]. In the 
complexes the chelate unit was bound via a mercaptomethyl group to the steroid moiecule. The 
present work descnbes labelling of the chelate directly to the steroid without any carbon spacer. 
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23. Structure and Reactivity of a "3+1" Mixed-Ligand Rhenium Complex Containing 
Thiobenzoate as a Monodentate Ligand [ReO(SSS)(SC(O)Ph)] 
B. Noll, P. ~eibnitz', St. Noll, R. M. ~ah fouz~ ,  H. Spies 
1 Bundesanstalt für Materialforschung, '~ssiut University, Egypt 
Introduction 
"3+Iw rhenium complexes with aliphatic or aromatic thiols as monodentate ligands are weil known as 
compounds having a relatively stable S4 coordination sphere [I] and subsequent reactions at 
pendent-substituted groups may be successfully carried out without any alteration of the coordination 
sphere. In this article we report on the synthesis and molecular structure of a rhenium complex with 
thiobenzoic acid as a CO-ligand [ReO(SSS)(SBz)]. This compound is expected to have some potential 
as a synthon for the complexes [ReO(SSS)SR], provided hydrolysis of the benzoylic group will lead to 
a [ReO(SSS)S-J intermediate. Preliminary experiments were carried out to cleave the S - CO bond. 
Experimental 
Polarographic measurements were carried out under an argon atmospere with a DCIAC polarograph 
(GWP 673, tastpolarography 5 mV steps, droptime 1 s, potential range from 0.0 mV to -1600 mV). 
X-ray data were collected at room temperature (296 K) with an ENRAF NONIUS CAD 4 
diffractometer, graphite monochromatized Mo K a  radiation (A = 0.71073). 
Synthesis of [(S-thiobenzoylato)(3-thiapentanedifhiolato-1.5)]oxorhenium(V) [ReO(SSS)(SBz)] 1 
96 mg [ReO(SSS)CI] complex (0.25 mmol) is dissolved in 10 ml acetonitrile while stirring and 
warming. 60 pl thiobenzoic acid (0.50 mmol) is dissolved in 2 ml methanol and then neutralized by 
adding about 400 p1 1.25 M NaOCH3 solution. This solution is added to the Re precursor while 
stiming. All manipulations were performed under argon or nitrogen. The colour of the reaction 
solution changed from blue to dark red. After 2 hours the solution is gently heated (40 - 50 "C) and 
the volume is halved in a stream of nitrogen (argon). The grey precipitate is separated by filtration. 
The filtrate is evaporated to dryness and the residue is extracted with ether. 
After evaporation of the ether the residue is dissolved in acetonitrile. Reddish-brown crystals are 
received. Yield: (87 mg, 71 %). 
M.p.: 203 - 203 "C (from ethanol) 
Elemental analysis: (Found: C, 26.94; H, 2.67; S, 26.08, requires 
C, 26.59; H, 2.62; S, 25.93 %) 
IR absorptions: v,,,/cm-' 1648 (CO) and 976 (ReO) 
Synthesis of [(methoxy)(3-fhiapentanedifhiolato-I. 5)]oxorhenium(V) [ReO(SSS)(OMe)] 2 
73.8 mg 1 (0.15 mmol) are dissolved in 10 ml acetonitrile while warming (about 50 "C) and stirring. 
200 pI 1 .I3 M NaOCH3 (0.23 mmol) are dropped into the solution, the colour changes from purple to 
brown, and after two hours a brown precipitate is separated, extracted with ether and dried in vacuum. 
Yield: (29 mg, 67 %). 
M-p.: 168 - 173 "C (from acetonitrile) 
Elemental analysis: (Found: C, 16.1 4; H, 2.76; S, 25.16, C5HI1O2S3Re requires 
C, 15.58; H, 2.88; S, 24.95 %) 
IR absorptions: vdcm- I  960 (ReO) 
Saponification studies of 1 
7.1 mg I (15 pmol) are dissolved in 8.0 ml supporting electroljrte. A 0.1 M Bu~N[PFE] solution in 
acetonitrile was used as supporting electrolyte. 1.13 M sodium methylate was added step by step 
(5 pmol at a time) and polarograms were recorded. 
Results and Discussion 
The complex [ReO(SSS)(SBz)] 1 was obtained as a pure, crystalline compound by reaction of 
thiobenzoic acid with (ReO(SSS)CI] according to Fig. 1. 
The structure of 1 was detennined by X-ray crystallography and is shown in Fig. 2. 
h 
Fig.2: Molecular siructure of 1 
The crystal syctern was faund to be orthorhombic, with a space group: P2(1)2(1)2(1), Z = 4, 
R = 2.9 %. Selected bond lengths and angles are listed in Table 1. The strudure of the 
trldentatefmonadentate compkx is related to jReO(&)(SR)], where R = -CH2C6H5 [I]. 
Table 1: Selected bond lengths and angles of 1 
Bond lengths[X] 
Re-0 (1) 1.682(4) Re-S (3) 2.351 (2) 
Re-S (I) 2.348(2) Re-S (4) 2.276(2) 
Re-S (2) 2.293(2) 
Bond angles ["I 
O(1)-Re-S(4) 11 5.9(2) O(1)-Re-S(3) 103.8(2) 
O(1)-Re-S(2) 11 4.9(2) O(1)-Re-S(l ) 102.0(2) 
S(4)-Re-S(2) 129.170 S(2)-Re-S(1) 84.36(6) 
S(2)-Re-S(3) 80.36(6) S(4)-Re-S(1) 83.65(6) 
S(4)-Re-S(3) 89.59(6) 
The saponification of the monodentate benzoic mercapto ester bound to the ReOSSS core by 
stepwise addition of sodium methylate was polarographically controlled. The increase in the anodic 
step with a half wave potential at -480 mV indicates the presence of the free mercapto group located 
at the Re core. The cathodic step at -1030 mV assigned to the redox step of the carboxylic group 
decreases at the Same time. From these results the existence of the [ReO(SSS)Sl intermediate can 
be assumed. 
Wsing a molar excess of sodium methylate a brown precipitate 2 was separated by filtration. There is 
some evidence that substitution of the negatively charged sulphur by methylate occurred and the 
complex 2 has the composition [ReO(SSS)(OMe)] (elemental analysis and infrared spectra). 
However, this assumption has to be confirmed by further analytical investigations, and studies of 
nucleophilic substitution reactions at a postulated S- centre will be carried out. 
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24. Nicotinamide-Substituted Rhenium(V) Mixed-Ligand Complexes 
T. Kniess, H. Spies 
Introduction 
The radiopharmaceutical research aims at present at tracers whose ultimate distribution is determined 
by specific biochemical or receptor-binding interactions [I]. One of the challenging tasks is the 
development of radiotracers able to indicate and to image certain redox processes. 
Bodor and CO-workers used the NAD INADH equilibrium as a model to develop a redox delivery 
system to move polar drugs through the blood-brain banier [2 - 51. Prompted by this work, we lookedl 
for potentialities of this principle for the design of new rhenium and technetium compounds. To our 
knowledge such types of chelates suitable+for coupling to a pyridinium salt or a dihydropyridine moiety 
- both of wich are constituents of the NAD INADH redox pair - are so far unknown. 
In this paper we report the synthesis of rhenium chelates bearing either a pyridinium or a 
dihydropyridine functionality as potential metal-based redox-active tracers. Nicotinamide was 
converted into the N-(2-mercaptoethyl) derivative which directly or after quatemization to the 3(2- 
mercaptoethyl-carbamoy1)-I-methylpyridinium as a monodentate ligand binds to an oxometal core. 
The rernaining coordination sites were occupied by the tridentate bis(2-mercaptoethyl)-sulphide 
(HSSSH) resulting in neutral "3+1" mixed-ligand complexes [6]. 
Experimental 
General 
Melting points were obtained on a Boetius apparatus and were uncorrected. lnfrared spectra were 
determined on a Specord M 80 spectrophotometer and UV-VIS spectra provided by a Specord M 40 
spectrorneter (Carl Zeiss Jena). The NMR spectra were recorded on an FT-Spectrometer DC 300 
(Bruker) in deuterated chloroform or dimethyl sulphoxide with tetramethyl silane as the intemal 
standard. Elemental analyses were perforrned On a LECO CHNS932 Elemental Analyser. 
Maferials and rnefhods 
Methyl nicotinate, ethanolamine, thionyl chloride, bis(mercaptoethyl)sulphide and sodium dithionite 
were obtained from FLUKA. Na3P03S X 12H20 was synthesized according to a literature procedure 
[7]. Methyl iodide was obtained from RIEDEL de HAEN. The precursor chloro(3-thiapentane-1,5- 
dithio1ato)oxo-rhenium01) was prepared according to the literature [8]. 
Preparation of 3(2-hydroxyefhyl-canbamoy~pyridine (2). 41.1 g (0.3 rnol) methyl nicotinate 1 were 
heated with 18.3 g (0.3 mol) ethanolamine to a temperature of 150 - 160 "C and the resulting 
methanol was mllected by distillation. After 3 hours the heating was removed and the product 
solidified as a yellowish mass. Recrystallization from I ,2dichlorethane gave the pure substance but 
the crude product was used for the next step. 
Yield: 49.8 g (98 %); melting point: 82 - 86 "C. 
Elernental analysis: (Found: C, 57.79; H, 5.97; N, 16.49, CBH~ON~O~ requires 
C, 57.83; H, 6.02; N, 16.86 %). 
'H NMR data: BH (200.13 MHz; solvent CDC13) 3.62 (ZH, q), 3.82 (IH, s), 3.83 (2H, t), 7.25 (IH, s), 
-1.38 (IH, m), 8.13 (1H, d), 8.66 (IH, d), 8.99 (IH, s). 
Preparation of 3(2-chlor-efh~I-canbamo~I)p~dine (3). 49 g (0.295 mol) 2 were dissolved in 200 ml 
chloroform and icooled to 0 "C. 42.8 g (0.36 mol) thionyl chloride were dropped into the solution, while 
stimng vigorously (glass stirrer), the rnixture was warrned up to room temperature and than refluxed 
four hours until the oily product solidified. 200 ml water and 45 g NaHC03 were added in portions 
after cooling. The organic layer was separated and the residue extracted two times with 200 mll 
chloroform. The unified organic solutions were dried over MgS04 and evaporated. The resulting 
produ& was purified by column chromatography on aluminium oxide with chloroform/acetone (1 :I) as 
the eluent to yield 3 as white needles. 
Yield: 25 g (45 YO); melting point: 89 - 91 "C. 
Elemental analysis: (Found: C, 51.82; H, 4.92; N, 14.91; CI, 18.61, C8H9CIN20 requires 
C, 52.03; H, 4.87; N, 15.17; CI, 19.24 %) 
'H NMR data: (200.13 MHz; solvent CDC13) 3.66 (ZH, q), 3.77 (2H, t), 7-02 (IH, s), 7.33 (1H, m), 
a.08 (IH, d), 8.66 (IH, d), 8.95 (IH, s). 
Preparation of 3(2-mercaptoefhyl-carbamoy1)pyridine (4): 3.7 g (20 mmol) 3 were dissolved in 20 ml 
water and stirred with a solution of 15.8 g (40 mmol) Na3P03S X 12 H20 in 150 ml water for 7 hours at 
40 - 50 "C. After cooling to room temperature the pH was adjusted to 4.0 by adding 3.5 % HCI. The 
mixture was allowed to stand ovemight and then extracted with CH2CI2 (4 X 100 ml). The organic 
layer was dried over MgS04 and evaporated. Purification by column chromatography on silica gel 
with acetonelchloroform (6:l) yielded 4 as white crystals . 
Yield: 1.8 g (48 %); melting point: 96 - 98 "C. 
Elemental analysis: (Found: C, 52.57; H, 5.58; N, 15.12; S, 16.93, C8HloN20S requires 
C, 52.74; H, 5.49; N, 15.38; S, 17.58 %) 
13c NMR data: 6C-13 (75.475 Mhz; solvent DMSO-d6) 23.32 (CH2), 42.80 (C&), 123.60 (Ca), 129.89 
(Ca), 135.10 (Car), 148.38 (Ca), 151.95 (Car), 165.00 (CO). 
Preparation of 3(2-mercaptoefhyl-carbamoyl)-I-methyl-p~diniumiodide (5): 370 mg (2.03 mmol) 4 in 
35 ml p.a. acetone were refluxed with 6.0 g (40 mmol) methyl iodide for 20 minutes. After cooling the 
mixture was concentrated by evaporation up to 5 ml and stored ovemight at -18 "C. The resulting 
yellow needles were separated. The product 5 was pure enough to be used without further 
purification. 
Yield: 490 mg (74 %); melting point: 102 - 104 "C. 
Elemental analysis: (Found: C, 33.46; H. 3.83; N, 8.52; 1, 38.37; S, 9.59, C9H13N210S requires 
C, 33.33; H, 4.01; N, 8.64; 1, 39.19; S, 9.87 %) 
13 C NMR data: 6~13 (125.70 MHz; solvent DMSO-d6) 23.07 (CHZ), 42.91 (CH2), 48.24 (CH3), 127.34 
(Car), 133.1 9 (Car), 142.66 (Car). 145.43 (Car), 147.16 (Ca), 161 -39 (CO)- 
Preparation of (3-pyridinyl-ethylcarbamoyl-fhiolato)-(3-fhiapentane- I, 5-difhiolafo)oxori-1enium(V) (6): 
1.06 g (2.7 mmol) chloro(3-thiapentane-1,5-dithiolato)oxorhenium0l) were dissolved in 60 ml boiling 
acetonitnle. 0.975 g (5.4 mmol) 4 in 20 ml acetonitrile was dropped to this solution and the mixture 
was refluxed for one hour. The solid product was separated, dried and purified by column 
chromatography (A1203, methanol). The eluate was concentrated to half 3s original volume and 
allowed to stand ovemight at -18 "C. The product 6 crystallized as fine red needles. 
Yield: 1.03 g (71 %); melting point: 186 - 188 "C. 
Elemental analysis: (Found: C, 26.43; H, 3.02; N, 5.13; S, 23.40, CI2Hl7N2O2S4Re requires 
C, 26.91; H, 3.17; N, 5.23; S, 23.92 %) 
13c NMR data: 8~13 (75.475 MHz; solvent DMSOd6) 35.41 (CH2), 42.42 (CHz), 43.13 (2xCH2), 45.61 
(~xCH~), 123.56 (Ca), 129.95 (Ca), 135.08 (Ca), 148.44 (Ca), 151.69 (Ca), 164.62 (CO). 
IR absorptions: vm/crn" (KBr) 960 (Re=O); 1664 (C=O). 
Preparation of (1-methyl-3-pyridiny1-ethylcarbamoyl-thio1ato)-(3-fhianane-1,5-diihiolato)-oxorhe- 
nium(\/)iodide (7): 
Route A: 535 mg (lmmol) 6 were refluxed with 1.42 g (10 mmol) methyl iodide in 150 ml p-a. 
acetone. After 4 hours the solution was nearly discoloured and a light red product had separated. lt 
was filtered and recrystallized from methanol to yield 7 . 
Yield: 336 mg (50 %); melting point: 197 - 198 "C. 
Route B: 83 mg (21 lpmol) chloro(3-thiapentane-1,5-dithiolato)oxorhenium0l) were refluxed in 5 ml 
acetonitrile. 137 mg (422 pmol) 5 in 2 ml acetonitrile were added and the mixture was refluxed for 30 
minutes. The solution was concentrated to 3 ml and after cooling 3 ml diethyl ether were added to the 
mixture. The solid product was separated and recrystallized. 
Yield: 86 mg (60 %); melting point: 198 - 200 "C. 
Elemental analysis: (Found: C, 22.86; H, 2.81; N, 4.08; 1.16.84; S, 18.65, C13H20N2i02S4Re r quires 
C: 23.04, H: 2.95, N: 4.13, 1: 18.75, S: 18.90 %). 
1 H NMR data: 6~ (500.13 Mhz, solvent DMSOd6) 2.26 (2H, m), 3.04 (2H, t), 3.68 (2H, q), 3.87 (2H, t), 
4.08 (2H, q), 4.32 (2H, d), 4.39 (3H, s), 8.24 (IH, t), 8.89 (lH, df, 9.10 (I& d), 9.34 
(IH, t), 9,41 (IH, s). 
IR absorptions: vm~1cm-' (KBr) 960 (Re=O); 1668 (C=O). 
Results and Discussion 
The synthesis of 3(2-mercaptoethyl-carbamoyl)-I-methylpyridine 4 is associated, as the Iiterature 
shows, with some difficulties and by-products [9, 101. We decided to start from the methyl nicotinate 1 
which was heated with ethanolamine at 150 "C to relieve methanol and form 3(2-hydroxyethyl- 
carbamoy1)pyridine 2 (Fig. 1). 
Treatment of the hydroxyl group with thionyl chloride leads to the 3(2-chlor-ethyl-carbamoy1)pyridine 
3. The introduction of the thiol group resulted in reacting 3 with sodium thiophosphate dodecahydrate 
in aqueous solution by modification of a literature procedure [ I  I]. Acid hydrolysis of the phosphoric 
acid thioester supplied the free thiol4 in high purity. 
Thiol 4 was methylated with excess methyl iodide. Alkylation of sulphur could be prevented by 
application of an inert solvent. 
Both thiolates 4 and 5 were reacted with the precursor chloro(3-thiapentane-1,5-dithio1ato)oxo- 
rheniumw according to the "3+Iw pnnciple [6]. In this way the new rhenium mixed-ligand complexes 
6 and 7 were obtained. Complex 7 can also be obtained by direct methylation of the complex 6 with 
excess methyl iodide in acetone (route A). 
I 1. Na3P03S 2. HCI 
route A 1 C*.] 
* 
route B 
Fig. 1 : Reaction pathway for preparation of nicotinamide-substituted Re-complexes 6 and 7 
The most convenient method of generating dihydropyridines from pyridinium saits is reduction with 
sodium dithionite in alkaline solution 112. 131. In this way it should be possible to reduce the 
pyridinium salt "3+1" complex 7 with Na~S.204 to the 1,4-dihydropyridine derivative. Because of the 
oxidation sensitivity of the dihydropyridines it is difficult to detect them analytically. Nevertheless, a 
significant identifying mark is the characteristic absotption in UV-VIS spectrometry at about 360 nm 
[2, 141. By stimng 7 in alkaline aqueous medium with Na2S204 a brick-red solid was separated 
(decomposition 105 - 115 "C). Attempts at purification resuited in a viswus red substance. Fig. 2 
shows the UV-VIS spectrum of wmplex 7 and the alteration of the spectrum after reduction to the 
dihydropyridine. A new band at 299.3 nm appeared and the absotption at 366 nm increased. The 
latter may serve as an indication for the existente of a dihydropyridine complex. 
Further investigations on the preparation and stability of dihydropyridines have been canied out with 
the technetium complexes and will be published in a subsequent Paper. 
Fig. 2. UV-VIS spectrum of complex 7 in water and after reduction with Na2S204 
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25. Dihydropyridine-Substituted Technetium(V) Mixed-Ligand Complexes 
T. Knies, H. Spies 
lntroduction 
In researching redox-active Tc-99m radiotracers based on the pyridinium saltldihydropyridine System 
we described the synthesis of 3(2-mercaptoethyl-carbamoyl)-l-methyl-pyndinium-iodide 1 and the 
preparation of corresponding rhenium0 mixed-ligand complexes [I]. In this paper the formation of 
the analogous technetium complexes starting from 9 9 / 9 9 m ~ ~  gluconate is reported. The reduction of 
pyridinium to the dihydropyndine group with sodium dithionite is documented for the free ligand and 
for the complex. UV-VIS spectrometric investigations were carried out conceming the characterizatiori 
and the stability of the dihydropyridines. 
Experimental 
General 
UV-VIS spectra were determined On a Specord M 40 spectrometer (Carl Zeiss Jena). The 
radioscanner was a TRACEMASTER 20 (Berthold). 
NaHC03, Na2S204, sodium gluconate and bis(mercaptoethyl)sulphide were obtained from FLUKA. 
3(2-mercaptoethyl-carbamoyl)-l-methyl-pyridiniumiodide 1 was synthesized according to the prece- 
ding report [I]. Stannous ~hloridg~dihydrate was obtained from ALDRICH. Sodium pertechnetate in 
saline solution was eluted fr0m a MOP% generator purchased from MALLINCKRODT. 
Thin-layer chromatography (TLC) was perforrned on silufol plates (KAVALIER). The RP-18 glass- 
backed plates were obtained from MERCK. 
Preparation of 3(2-mercaptoethylcarbamoyl)- I-methyl- I, 4dihydropyndine (4): 9 -75 mg (30 p mol) 1 
and 15 mg (180 pmol) NaHC03 were dissolved in 2 ml water. The mixture was cooled to almost 0°C 
and 10.5 mg (60 pmol) Na25204 were added so that the solution turned light orange. When the 
reduction was finished aRer 15 minutes, the nearly colourless dihydropyndine solution was used for 
further reactions. 
UV-VIS data: 361 -8 nm 
Radiolabelling with 9 9 B w ~ ~  
(l-methyl-3-pyndinylethyI~arbam0&-thiolato)-(3-thiantane-l,5-dithiolato)oxotechnetium(~iodide (3): 
1 pmol 94fc04 and (5-10 MBq) TcOi in 1 ml 0.1 M sodium gluconate was diluted with I ml 
0.9 % NaCl and then reduced with 100 p1 freshly prepared 0.01 M stannous chloride dihydrate in 
0.1 M HCI. 1.95 mg (6 pmol) 1 in 200 pi water were added to this 99'99m~~0 gluconate solution.
1.0 ml acetone was given to the yellow complex and then 0.3 mg (2 pmol) bis(mercaptoethyl)sulphide 
in 300 pI acetone. The reaction process was controlled by TLC (RP18 plates, butanollacetic 
acid/water = 2:l :I). 3 was determined as a peak with Rf = 0.54 in 73 % radiochemicai purity. 
[I-methyl-3-(I, 4)dihydropyn~inyl~~hylcarbamoyl-thiolato]-(3-thiantane-l, 5-dithioIato)oxo- 
technetiuml\/) (6): 
1ymoI (5-10 MBq) 99/99m~c(\l)gluconate prepared as above was reacted with 1 ml of dihydropyridine 
solution (containing 15 ymol 4). After 5 minutes 1 ml acetone and 0.3 mg (2 ymol) bis(mer- 
captoethy1)sulphide in 300 pI acetone were added. The reaction was obsewed by UV-VIS 
spectroscopy. 
Results and Discussion 
99iS9m The reaction Pattern for the synthesis of the nicotinamide-substituted Tc mixed-ligand complexes 
is visible in Fig. 1. The pyridinium salt 1 was reacted with 9 9 ' 9 9 m ~ ~  gluconate to the supposed 
intermediate 2. In a second step the tndentate ligand bis(2-mercaptoethyl)sulphide (HSSSH) was 
added. Three monodentate ligands were thereby replaced and the complex 3 was forrned. 
HSSSH I HSSSH 
Fig. 1 : Reaction pathway for preparation of pyridinium salt and dihydropyridine-substituted 
Tc complexes 3 and 4 
The Progress of the reaction was obsenred by TLC. Fig. 2 show typical thin layer chromatograms. In 
the first step af&er reaction of 1 with 99199mT~ gluconate the intermediate 2 is detectable with unreacted 
sodium gluconate near the start. When the tndentate HSSSH was added, the peak of complex 2 
disappeared and the new '3+11 compiex 3 was found as the major product. An investigation of 3 by 
capillary electrophoresis proved that 3 is a cationic complex. 
Fig. 2. TLC of the reaction of 99/99"'T~ gluconate with 1 before and after addition of HSSSH 
The rnost wnvenient way of generating 1,4dihydropyndines frorn pyridinium salts is reduction with 
sodium dithionite in alkaline solution [2, 31. In this way we tried to reduce the complex 3 to the 
dihydropyridine 6. After addition of the reducing agent a brown diswloration of the yellow cornplex 
was observed and within three hours a brown precipitate appeared. TLC showed that after 15 rninutes 
part of wmplex 3 was already dewrnposed and insoluble material was found at the stad that did not 
run on the TLC mobile solvent (Fig. 3). Three hours later only the insoluble precipitate at the start was 
visible. It can be assurned that the brown insoluble wmpound is reduced hydrolyzed technetiurn. A 
reduction of the metal has obviously occwrred. This wrnpetitive reaction is not surprising because the 
ligand 1 as well as the sodium dithionite have been used in great excess over the technetium. 
Fig. 3: TLC of 3 with Na2S204 after 15 min and 180 rnin 
To avoid reduction of the metaf, the free dihydropyiidine ligand 4 was prepared starting frorn 1 
followed by wmpfexation as an additional step. 1 was reduced with sodium diihionite within 15 
minutes. Because of the sensitivity of 4 to air oxidation, the product was not isolated in substance. 
The soluaion containing freshly reduced 4 was anaiysed by UV-VIS spedrometry. A strong absorption 
at 381.8 nrn was observed that disappeared within 45 minutes (Fig. 4). Ac the Iiterature showc, a 
significant identi@ing mark of 1,Mihydropyridines is their charaderistic absorption in UV-VIS 
spectrornetty at about 360 mn j4,53. 
Fig. 4: UV-VIS spectnim of 4 and of 5 in water over 45 rninutes 
If a solution of freshly reduced dihydropyndine 4 is given to 99/99"r~ gluconate, a cornplex of stnicture 
5 is expected. The UV-VIS spectnirn of 5 again showed a significant dihydropyridine absorption at 
360.4 nrn that disappeared over 45 rninutes (Fig. 4). By immediate addition of tridentate ligand 
HSSSH to 5, the desired dihydropyndine '3+1' complex 6 becornes available. In the UV-VIS spectnim 
of 6 a strong absorption at 365.6 nrn was observed that did not change over Wo hours 
(Fig. 5). This band overlaid the dihydropyndine absorption so that no detailed staternents can be 
made about the stability of 6. By analogy with 4 and 5 we assurne that wmplex 6 is also stable for 
approxirnate 45 rninutes. 
Fig. 5: UV-VIS spednirn of 6 in water over 120 rninutes 
Investigation of the stability of the dihydropyndines by UV-VIS spectrornetty shows that decom- 
Position occurs whithin a short time. Further efforts are needed to obtain cornplexes of a higher 
stability, suitable for in vivo tests. Irnprovernents in the stability of the dihydnpyddins compiexes rnay 
be achieved by introduction of various substituents on the pyndiniurn ring and rnodification of the 
tridentate ligand. In addiion the search for oiher ways of redudion by chernical, biochernical or 
electrochemical rnethods shoufd be continued. 
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26. Note on the Fast Hydrolysis of the Methyl Ester of MAG2 during Complexation with 
TclRe(V) gluconate 
St. Noll, B. Noll, H. Spies 
Introduction 
We report on the Iigand exchange of Tc gluconate with the methyl ester of mercaptoacetyl diglycine 
(MAG2) in alkaline solution. The reaction involves an unexpectedly fast saponification of the ester 
group resulting in formation of the known 1:l complexes of both Re and Tc with MAG2 as the 
tetradentate ligand. 
Experimental 
Preparation of [ReO(MAGd from Re gluconate and MAG2 methyl ester 
22 mg MAG2 methyl ester (0.1 mmol) was dissolved in 2.0 ml water and added to 2.0 ml 0.05 M Re 
gluconate (0.1 mmol) solution under an inert gas (nitrogen) atmosphere while stimng. After adding 
200 NI 1 N NaOH the reaction mixture was stirred for 30 minutes and then neutralized with 200 yI I N 
HCI. After addition of 48 mg Ph&sCI the solution was extracted with methylene chloride. The reddish- 
brown organic phase was dried over sodium sulphate, evaporated to dryness and the residue 
crystallized from ethanol. 49 mg (64 %) brown crystals, m.p. 201 - 202 'C. 
Preparation of the 9 9 m ~ ~  complex 
1.0 mg MAG2 methyl ester was dissolved in 120 yl methanol and added to 2.0 ml 99m~c  gluconate 
solution containing 400 yl 0.1 M NaOH. After 20 minutes the mixture was neutralized with 380 J.II 
0.1 N HCI and analysed by HPLC on an RP 18 column (Eurosphere), eluent A: 0.05M phosphate 
buffer pH 5.8, eluent B: methanol; 3 min 100 % A, 15 min from 100 % A to 20 % A 1 80 % B. 
Rt: 14.3 min; 
The resulting preparation was compared with a reference 9 9 m / 9 9 i c - ~ ~ ~ 2  complex prepared with MAG2 
as the ligand according to the above procedure. 
Results and Discussion 
Hydrolysis of the MAG2 methyl ester under these conditions is nearly quantitative and the MAG2 
formed reacts immediately with Re gluconate to form the complex [ReO(MAG$r. The identity of the 
isolated complex (as Ph&s salt) with the previously described Ph&s[ReO(MAG2)] [I] is confirmed by 
the identical retention time in HPLC, melting point and elemental composition. 
Analogously to the studies with rhenium, MAG2 methyl ester forms [TcO(MAG2)Im 221 when albwed to 
react with Tc gluconate as a precursor. It could also be proved that the saponification also takes place 
at the n.c.a. level so that attempts to labe1 the MAG2 methyl ester with -C result in the 
MAG2 complex. The Rt value in HPLC is the same both for the -C labelled MAG2 ester and MAG2. 
A mixture of both reaction products shows only one peak at Rt 14.3 min in the HPLC analysis. 
The results supply the evidence for hydrolysis of the MAG2 ester both for the c.a. and the n.c.a. level 
under conditions normally used for complexation reaction. This behaviour enables us to use the ester 
as a proctecting group in the ligand synthesis, when required. In complexation reactions, there is no 
need to split the protecting group pnor to the reaction, a fact that could could be beneflt in sensitive 
labelling procedures at the n.c.a. level of 99m~c. 
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27. Synthesis of " ~ e  Gluconate by Stannous Chloride Reduction of I 8 = ~ e 0 4  
B. Noll, T. Kniess, H. Spies 
Introduction 
The radioactive isotopes of rhenium, ' 8 6 ~ e  and Ia8Re, are of interest in nuclear medicine for 
therapeutical use because of their nuclear properties and the chemical analogy with technetium-99m 
[I, 21. The labelling of molecules with 99m~c  is often advantageously done by means of precursors 
such as T c 0  tartrate or T c 0  gluconate. Such starting materials are also required for rhenium 
complexes. The ability to form R e 0  gluconate in depending on the rhenium concentration up to a 
molar concentration of 10" by stannous chloride reduction of perrhenate has already been described 
in 121. Because of the different redox Potentials of pertechnetate and perrhenate, the formation of Re 
gluconate requires an excess of stannous chloride and sufficient reaction time. The lower the rhenium 
concentration, the longer is the reaction time with a constant amount of stannous chloride. To 
establish the conditions at the ' 8 6 ~ e  concentration level necessary for complete conversion of 
perrhenate into Re gluconate, experiments were carried out including variation of the amounts of the 
reactands and the reaction time. 
Experimental 
The samples are analysed by TLC on silica gel sheets (Kieselgel 6OlMerck) and acetone as the 
eluent. The distribution of radioactivity is measured with a linear analyzer (Berthold). Polarographic 
measurements were carried out with a DCIAC polarograph (GWP 673). 
'=Re activity was obtained from Mallinckrodt Medical as sodium perrhenate with a specific activity 
~29.6 GBqImg and a radioactive concentration 28.5 GBqlml. For better handling the stock solution 
was diluted with water l : l O ,  the total Re concentration amounts to 1.7.10~ molll. Depending on the 
age of the ' = ~ e  stock solution, 5 - 10 p1 are taken from this stock solution for the labelling 
experiments carried out in a volume of about 2 ml, the Re concentration amounted to 4.25 . IO-~ - 
8.5 - IO-~ molll. 
Preparafion of ' 8 6 ~ e  gluconate 
5 pl of the I a 6 ~ e  p rrhenate stock solution are added to a mixture of 2.0 ml 0.5 M sodium gluconate 
and 0.5 M hydrochlonc acid or 0.5 M sodium hydroxide. '=Re0i is reduced with 0.1 M stannoius 
chloride at neutral pH, using stannous tartrate. The content of perrhenate was determined by thin 
layer chromatography. (Rf.perrhenate 0.7; Rf Re guconate 0.0 - 0.1) 
Resuits and Discussion 
The formation of Re gluconate depending on the stannous chloride content is shown in Figure 1. The 
yield of the Re gluwnate has a maximum at about 60 min, after this time the complex decomposes 
into perrhenate at ilower stannous chloride concentrations. In our investigations an amount of 2001 
0.1 M stannous Chloride was nececsary to obtain an yield of nearly 100 %. The Ie6Re gluconate 
prepared in this way is stable for up to Wo hours without-cooling. 
0 50 100 150 200 250 
Time (Mn) 
Fig.1: The fomation of Re gluconate depending on the stannous chloride content and time by 
reduction of penhenate at pH 4. n i e  total Re concentration is about 4.3 . 10=/ Molll. 
Wrthin the pH range from 4 to 7 there are no differences in the yield of Re gluconate. At low pH (c2) 
and high pH e9) the yield of Re gluconate decreases dractically, only 20 - 30 % are found besides 
unreacted perrhenate. The tin(ll) content in the alkaline reaction mixture (pH 10) was controlled by 
means of dc polarographic measurernents. A steady decrease in the cathodic wave of the stannous 
chloride as a function of time was observed after addition of the ['86~e04], even though the molar 
excess of stannous chloride is about I000 times greater than the total content of rhenium. So, the 
decrease in the cathodic wave cannot have been caused by the presence of rhenium species. 
Instead, radiolytic processes should be taken into consideration. The corresponding measurement 
without addition of rhenium activity resulted in no decrease the cathodic wave and no stannous 
chloride was consumed. This behaviour may also be the reason for the instability of the la6Re 
gluconate in time, and a slight excess of stannous chloride is obviously necessary to prevent a rapid 
oxidation to perrhenate. Optimum conditions for labelling gluconate with la6Re at the concentration 
level frorn 4.25. 10-' to 8.5. IO-~ rnolll were the pH range from 4 - 7, concentration of stannous 
chloride of 2.0 mg / ml and a reaction time of 45 - 60 rnin. The 186~e  gluconate solution prepared 
under this conditions is at least stable for two hours and can be successfully used for ligand exchange 
reactions with various ligands. A procedure that can be modified within the above defined conditions 
is given in the experimental part. 
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8. Determination of Partition Coefficients for Coordination Compounds by Using the 
HPLC Column Nucleogel RP CI8 80-1 0 
R. Berger, T. Fietz, M. Glaser, H. Spies 
lntroduction 
The transport and distribution processes within biological Systems are to a large extent controlled by 
the lipophilicity of the systern cornponents. it is therefore not astonishing that the Iipophilicity also 
plays a dominating role both during penetration of potential brain agents through the biood-brain 
bamer (BBB) and in the binding of potential ligand-like substances to certain receptors. 
Lipophilicity is usually expressed by the partion coefficient (P or log P), a rnolecular parameter which 
describes the partitioning equilibrium of a solute molecuie between a water-immiscible lipid-Hke 
organic solvent (e.g. octanol) and an aqueous phase [I - 41. Ac the determination of log P by the 
"shaking flask" procedure has some drawbacks, other simpler methods have been tested Tor their 
suitability. A promising method for assessing the Iipophilicity of numerous interesting substances is 
the reversed-phase high-performance liquid chromatography (RP-HPLC). It represents a vew 
comfortable and reliable method for determining partition coefficients 14,s - 81. 
In order to obtain more insight into lipophilicity-dependent proceedings which play an important r0le 
during the Passage of substances through membranes (e.g. BBB) as well as in binding to receptors, 
lipophiiic numerical data of some rhenium complexes with the stnrctures % and 2 (Fig. I) synthesized 
by the (3+1) or (44) rnixed-ligand procedure [9,1Oj have been detemtind by using RP-HPLC 
Fig. I: General sinicturrr of the rhenium complexes 3 and 2 
columns with different stationary phases. Previous experiments made use of columns filled with 
octadecyl silica and poly(styrene-divinylbenzene) copolymer (RP 18 and PRP-1). For a better 
understanding of the behaviour of certain complexes with aliphatic and especially arylic residues on 
the aromatic PRP-I column, an additional column based on a poly(styrene-divinylbenzene) 
copolymer modified by matrix-linked octadecyl chains is included in the studies. (Because of possible 
specific X-X interactions in the case of a pure arylic stationary phase, an influence on the retention of 
arylic solutes is expected [I 1, 121). 
Experimental 
Before starting an HPLC run, a small quantity of the compounds selected was dissolved in a mixture 
of methanol and acetonitrile or dimethyl sulphoxide (about 2 mglml). (All reference chemicals were 
commercial products, and they were used without further purification.) Sample volumes of 5 - 10 pl 
were injected into the Rheodyne valve J125 connected with the Perkin Elmer Model 1020. A Perkin 
Elmer UVNlS spectrophotometric detector LC 290 with an operating wavelength of mostly 254 nm 
and the recorder Kodak Diconix 150 Plus were used throughout the study. The experiments were 
caffled out with the column NUCLEOGEL RP C18 80-1 0 (150 X 4.6 mm; PS/DVB/C18, 10 Pm; 
MACHEREY-NAGEL) under isocratic elution conditions at room temperature and with a flow rate of 
1.5 mllmin. For the buffer preparation reagent-grade chemicals were used. Water was prepared with 
an ion exchange unit. Acetonitrile from Baker, Roth, or Merck served as an eluent. For the mobile 
phase acetonitrile and 0.01 M KH2P041Nla2HP04 buffer in a volume ratio of 3:l (pH 7.4) were used. 
(The experimental conditions for the RP 18 and PRP-I columns are summarized in the last Annual 
Report [4]). 
The capacity factors (k3 were evaluated from the chromatograms by k' = (tR - to)lb, where tR and b 
are the retention times of a retained and an unretained solute. Methanol was applied as the non- 
retained reference compound. 
The capacity factors of the complexes of interest were changed to the corresponding log P values 
with the aid of the equation log P = a log k' + b. For a linear trend function the substances aniline 
(0.9), benzene (2.13), bromobenzene (2.99), and biphenyl (4.09) served as the log P references. 
Because these log P values depend on various unknown factors caused and influenced by the RP- 
HPLC system, the designation PHPLC for an apparent constant was employed throughout this work. 
Resuits and Discussion 
PHRC values of Re complexes containing the structure form I are listed in Table 1. The preliminaty 
PHPLC values by using the NUCLEOGEL RP C18 column (C) are compared with the corresponding 
values obtained by means of the RP 18 (A) and PRP-I column (B) [4]. Quotients formed by PHPLC 
value pairs (NC) and (BIC) of the corresponding columns are demonstrated in addition. 
Tab. I: Partition coefficients (PHPLC, log PHPLC) of V ~ ~ ~ O U S  rhenium complexes I by using different 
chomatography columns [RP 18, PRP-1, NUCLEOGEL RP C181 and their quotients formed 
by dividing the corresponding RP 18 and PRP-I by NUCLEOGEL RP values 
R' RP 18 PRP-1 NUCLEOGEL RP Cis 
(Al (B) (C) PHPLC 
log log log 
PHPLC PHPLC PHPLC PHPLC PHPLC PHPLC AIC BIC 
-CHrCO-OCH3 16 1.20 32 1.51 7.2 S.9 0.86 2.2 4.4 
-CH2-CO-OCzH5 39 1.59 74 I .87 13 k1.5 1.11 3.0 5.7 
-CHTCO-0-wC~H~ 132 2.12 173 2.24 26 %I .5 1.41 5.1 6.6 
-GHz-CO-O-WC~H~ 455 2.66 398 2.60 55 %3 1.74 8.3 7.2 
-CH3 25 11.40 146 2.16 51 9 1.71 0.5 2.9 
For Re complexes with the structure form 2 preliminary PHPLC values obtained by using the 
NUCLEOGEL RP Cia column are summarized in Table2. These values are compared with 
corresponding values obtained by using a PRP-1 column [4]. 
Tab. 2: Partition coefficients (PHPLC) of various rhenium complexes 2 by using the columns PRP-1 
and NUCLEOGEL RP C18 and their quotients forrned by dividing the corresponding PRP-I 
by NUCLEOGEL RP C18 values (eluent: acetonitrilelbuffer = 311, pH 7.4) 
NUCLEOGEL RP Cl8 
Considering the P H ~ ~ ~  values determined by the NUCLEOGEL RP Cis column in Tables 1 and 2, the 
rather high mean errors between about 2 and 60 per cent are remarkable. It can easily be recognized 
that with increasing PHPLC values the mean errors also grow. This depends on the non-linear trend of 
the calibration substances aniline, benzene, bromobenzene, and biphenyl on NUCLEOGEL RP CIS. 
The retention behaviour expressed as capacity factors of these calibration substances on the columns 
NUCLEOGEL RP Cis and PRP-1 is shown in Fig. 2. In comparison with the nearly linear trend On 
PRP-1 the curve for NUCLEOGEL RP Ci8 is better described by a polynominal regression function. 
1 2 -  0 PRP-1 
Linear Reqression 
1,o - Y = - 0.37125 + 0.34961~ 




cr, 0 4 -  
0 - NUCLEOGEL RPC„ 
Polvnomial Rearession 
y = - 0.53922 + 0.50253~ -0.030762 
R = 0.99975; n = 8 
t l '  l . I * i *  1 . 1 -  1 ' 1  
1 ,o 4 3  2,o 23 3,o 33 4.0 4,5 
log P„ 
Fig. 2: Capaciiy factors (log k') in dependence on the octanollwater partition coefficients 
(log P*) of some benzene derivatives as calibration substances by using the 
columns PRP-'I and NUCLEOGEL RP Cl8 
Using the NUCLEOGEL RP C18 column, the resulting PHPLC values of several Re chelates correlate 
well with both the values of the PRP-I and the RP 18 column. This includes such chelates which 
have either an ester group or a ring-like structure as benzene or morpholine in their monodentate 
ligand. That means that only log PHPLC values of chelates with the PHPLC ratio B/C of more than three 
are used for a linear correlation. 
The corresponding value pairs obtained by using the PRP-I and NUCLEOGEL RP Cls column aw 
plotted in Fig. 3. For better information an additional reference straight line (y = X) is outlined as well 
as the resulting linear regression function (y = 1.0041 7 X + 0.73691 ; R = 0.99499; n = 15). 
It is not quite clear why the log PHPLC values of the residual complexes investigated are outside this 
correlation. In case of the Re complexes bearing monodentate ligands with more or less long 
hydrocarbon chains, hydrophobic (non-specific) interactions and surface effects between aliphatic 
residues of the Re complexes and octadecyl carbon chains of the stationary phase can probably be 
taken into account [ l l ] .  This is the case particularly when the carbon chain has more than three 
carbon atoms. 
Using an RP 18 column consisting of silica-based reversed-phase packing bonded with n-octadecyl 
hydrocarbon chains a similar but not so pronounced appearance can be observed. In those cases, 
monodentate ligands with an aliphatic chain longer than C4 result in much higher log PHPLC values 141. 
Fig. 3: Plot of log P ~ p ~ ~ v a l u e s  of vanous rhenium complexes 3 and 2 
by using both a PRP-1 and NUCLEOGEL RP Cl8 column 
Among the Re cornplexes w8h the structure form 2 only the subctituted dimethyl-phenylphosphane 
shows a relative log PHPLC value mich  is presumably €00 high by using the NUCLEOGEL RP C18 
wlumn. tn this exampfe a more intensive interaction is supposed between the aliphatic columm 
packing material and the Wo methyl residues linked to phosphorus. 
A NUCLEOGEL RP CT8 column may also be used for assessment of the Iipophilicity of coordinatiorm 
cornpounds. However, in this wnnection the restrictions eonceming chelates with aliphatic ligand 
parts should be kept in mind. Analogous to the other columns tested, the Iipophilic properties of 
subctances are fefiected by this coiumn as relative partiion coefficients. They are not expected to 
correlate closely with the octanofhater partiiion coefficients. f o r  assessing the lipophilicity in a 
general way, an exclusive application of capacity factaw without conversion into the apparent 
partition coefficients is recomrnended because by using the NUCLEOGEL RP C18 column a linear 
trend relating to the above mentioned aromatic calibration compounds is not described well. 
Othewise, it should be tried to replace the aromatic compounds used until now by more aliphatic 
calibration compounds with known octanollwater partition coefficients. 
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29. Investigations into Serotonin Receptor Subtypes on the Blood-Brain Barrier 
J. Wober, C. Matys, P. Brust 
Introduction 
Serotonin (5-HT) is a neurotransmitter involved in regulation processes of the cardiovascular, 
gastrointestinal, and central nervous systems, such as contraction [ I ]  or relaxation [2] of vascular 
smooth muscle cells or contraction of the stomach fundus [3]. 
In the brain 5-HT is an mediator of important physiological processes, such as thermoregulation [4], 
sleep [5] or modulation of associative leaming [6]. Dysfunction of the serotonergic system is involved 
in certain neurological and psychiatric diseases and mental abnormalities, for instance depression [7, 
81, schizophrenia 19, 101, suicide [I I], anxiety [12], and also Alzheimer's disease 1131. 
The diverse effects of 5-HT are mediated by several distinct 5-HT receptor subtypes [14, 151. The 5- 
HT receptors have been classified into seven different families, from 5-HTl to 5-HT7. All but the 5-HT3 
receptor are members of the superfamily of G protein-coupled receptors and transduce extracellular 
signals by activating GTP binding protein. Furthermore, 5-HT1 receptors are subdivided into five 
subtypes, namely ~-HTIA, ~-HTIB. S-HTID, ~-HTIE, and 5-HTIF. The 5-HT2 receptor subclass is 
comprised of 5-HTw, ~ - H T ~ B ,  and 5-HT~c. All 5-HTI receptors are linked to the adenylate 
cyclase1cAMP system, while 5-HT2 receptors are linked to the phosphoinositide signalling system 
1161. 
~ h e r e  is evidence that serotonin receptors may also exist at the BBB. The blood-brain bamer (BBB) 
fonns an important part in brain physiology. It has three major functions: protection of the brain from 
the blood milieu, selective transport and metabolism or modification of blood- or brain-bome 
substances 1131. Neuropeptides Iike vasopressin and atriopeptin regulate the transport of substances 
through the BBB, possibly by receptor-mediated processes [17]. 5-HT may be involved in certain 
aspects of BBB dysfunction, like brain oedema and cerebral blood flow disturbances [IS, 191. 
However, the mechanism of the action of 5-HT on BBB permeability and endothelium-mediated 
changes of is unclear. 
In this study we try to identify the type of 5-HT receptor(s) mediating the effects on the brain 
endothelium by different models of the BBB and various radioligands with selectivity for various 5-HT 
receptor subtypes. 
Experimental 
Preparation of rat cortex and hippocampus 
Samples of the rat brain cortex and the hippocampus were homogenized in 10fold volumes of ice- 
cold TrisiHCI buffer (50 mM, pH 7.6) with an Ultra-Turm T25. The homogenate was centrifuged at 
20,000 g for 10 min. The resulting pellet was resuspended and centnfuged at 20,000 g for another 10 
min. After repeating the Same procedure, the pellet was resuspended in 10 volumes of buffer and 
stored at -70 "C until used in the binding studies. 
Preparation of microvessels from porcine brain nucleus caudatus 
Samples of the Nc. caudatus were isolated from porcine brains in a local slaughterhouse and were 
kept in ice-cold TnsIHCI buffer (50 mM, pH 7.4 with 120 mM NaCl and 5 mM KCI). After removing of 
the big blood vessels and the white matter, the tissue samples were macerated and filtrated through 
different nets of defined Pore size (243 Pm, 125 pm, 50 pm dia). The isolated microvessels were 
sampled in 30 ml ice-cold 0.25 M saccharose solution and washed twice in buffer (first centnfugation: 
10 min, 800 g, 4 "C; second centrifugation: 10 min, 1000 g, 4 "C). The pellet was removed in 20 ml 
buffer and stored at -70 "C until used in the binding studies. 
Preparation of choroid plexus from porcine and rat brain [method of Johnson et al., 1993 (2O)I 
Choroid plexus was isolated from porcine and rat brains and kept in ice-cold TrisIHCI buffer (50 mM, 
pH 7.4). After homogenization by sonification the homogenate was centrifuged (15 min, 40,000 g, 
4 "C). The pellet was resuspended in buffer and incubated at 37 "C for 15 min. After incubation the 
homogenate was twice washed in buffer and stored at -70 "C until used in the binding studies. 
Culfure of porcine brain endothelial cells 
Cryoconserved cells, isolated from porcine brain were used (21). Endothelial cells were grown on 
collagen-coated petri dishes in medium 199 containing 10 % FCS, 100 Ulml penicillin, 100 pglml 
streptomycin and 2.5 pglml amphotericin. The cells were incubated at 37 "C, with 95 % air and 5 % 
CO2. On the fourth day in culture the cells formed monolayers. For experiments the cells were 
removed by scraping, kept in TrisIHCI buffer of the appropriate binding assay and homogenized by 
short sonification. 
Culture of RBE4 cells (immortalized rat brain endothelial cells) 
Cells were grown on collagen-coated petri dishes in Alpha MEMI Ham's F10 (1:l) containing 10 mM 
HEPES, 2 mM glutamine, 100 pllml gentamycin, 300 pglml geneticin, 10 % FCS and 10 nglml bFGF 
[22]. The cells were incubated at 37 "C, with 95 % air and 5 % CO2. On the fourth day in culture the 
cells formed monolayers. For experiments the cells were removed by scraping, kept in TrisIHCI buffer 
of the appropriate binding assayand homogenized by short sonificafion. 
Binding assays 
The various binding assays followed the protocol outlined in Table 1. The binding assays were 
terminated by rapid filtration through GFIB glass fibre filters (Whatman). The filters were rapidly 
washed with four 4 ml portions of ice-cold buffer, transferred into 5 ml of scintillation fluid (Ultima- 
Gold, Packard) and analysed for radioactivity. The protein content of the membrane and cell 
suspensions was estimated according to the method of Lowry et al. [23]. 
Table I :Protocols of the binding assays of the 5-HT2~, ~ - H T ~ c ,  and 5-HTIA recepto!rs 
Receptor 










1 pM miansenn 
60 min 
- microvessels of porcine 
brain nucleus caudatus 
- porcine brain 
endothelial cells 
- RBE4 cells 
- rat brain frontal Cortex 
10 FM mianserin 
40 min 
- microvessels of porcine 
brain nucleus caudatus 
- porcine brain 
endothelial cells 
- RBE4 cells 
- rat and porcine brain 
choroid plexus 
10 pM serotonin 
50 mM, pH 7.4 
0.1 % ascorbic acid 
2 mM CaCI2 
120 min 
- micravessels of porcine 
brain nucleus caudatus 
- RBE4 celk 
- rat brain hippocampus 
Resuits and Discussion 
Up to now there has been no direct evidence that 5-HT3~ receptors are expressed on the BBB. But it 
is highly probable that the effects of 5-HT could be receptor-mediated pmcesses. in this study We 
want to try to identify 5-HT receptors on the brain endothelium. 
At present a great vanety of selective agonists and antagonists of the several serotonin WX?PtOr 
subtypes are known. They are used in radioligand binding assays [see for review, 161. Depending On 
the subtype studied, the type of radioligand had to be chosen and the tissue preparation used aS 
standard or BBB modei. 
Sharrna et al. [I81 found, that 5-HT given by intravenous infusion rnarkealy affect the cerebral 
circulation and the BBB permeabiiii in rats. They established the hypothesis that SHT, when 
introduced into the circuIation, binds on SHT2 receptors and stimulates the prostaglandin synthesis in 
the cerebral vessels. These prostaglandins stimulate cAMP in the vessel causing an increased 
vesicular transport in the endothelial cells resulting in extravasation of substances across the cerebral 
vessels. Following this hypothesis it is possible that 5-HT2 receptor subtypes exist on the luminal side 
of the BBB. 
From these facts and hypotheses we try to demonstrate the existence of receptors of this class on the 
BBB. Homogenate of porcine brain choroid plexus and homogenate of rat brain frontal cortex were 
used as standards for ~ - H T ~ A  and 5-HT2c receptors 124,281. 
Table 2 shows the results of our saturatio~ expenments with S~lketanserin, a selective 5-HT2 
receptor ligand [24], on rat frontal cortex and [ Hlmesulergine, a selective 5-HT2c receptor ligand [25], 
on porcine choroid plexus. In both cases analysis of the binding data by a non-linear fitting routine 
(Fig. P, Biosoft, Cambridge, UK) revealed a significant fit for a model with one binding site. This is 
confirmed by the linear type of the Rosenthal-Scatchard plot. 
Table 2. Results of the saturation analysis of the specific binding of radioligands on the 5-HT2A, 






Radioligand Brain region 1 7  
species I InMl 
frontal cortex 10.24 I 0.03 
choroid plexus 2.6 I 0.3 
Pig 
hippocampus / 0.32 I 0.04 
ear plot 
[fmollmg [fmollmg 
protein] I I -protein] 
The apparent dissociation constant b and the binding site density B, were analysed by a non-linear 
fMing routine (Fig. P, Biosoft, Cambridge, UK) and by a linear Rosenthal-Scatchard plot. The binding 
parameters for 5-HTx and 5-HT~c receptors were obtained from the plots of the single values of three 
expenments with ten concentrations of the radioligand. The binding parameters for the 5-HTIA 
receptors were obtai!ed from the plot of the single values of only one expenment with nine 
concentrations of the [ Hlligand. 
In the frontal cortex 5-HT= receptors were found in the greatest density 1291. This receptor subtype 
was well characterized by radioligand binding studies, using [3~]ketanserin as the selective ligand 124, 
30, 311. The specific binding of ketanserin was measured at free [3~lketanserin concentrations 
between 0.003 and 2 nM. The unspecific binding was estimated in the presence of 1 NM mianserin. 
The apparent dissociation constant (h) and the binding site density ( B 4  of the 5-HTX of the rat 
frontal cortex, which we obtained by a non-linear plot, were 0.24 I 0.03 nM and 890 I 45 fmollmg 
protein. The Same binding parameters were obtained by the linear plot. The KD values are 
comparable to data reported by others [24,32]. However, the reported B, values differ between 300 
and 1000 finol/mg protein [32, 241. The values obtained by Mayeda ef al. [32] are KD 0.32 nM and 
B„ 10.3 pmollg wet tissue. Leysen ef al- [24] found a )6 of 0.42 nM and a B„ of 30.9 fmollmg 
tissue. 
But ketanserin has also an affinity to the 5-HT2c receptor. The 5-HTx and the 5-HT2c receptors are 
very similar in their structure and their pharmacological profile. S~]mesuler~ine is also known to be 
an antagonist for the SHTX and 5-HT2c receptors however with a higher affinity to 5-HTZc than to 
5-HTU\ PS]. It is known that only one binding site for this radioligand exists on human, rat and porcine 
choroid plexus, the 5-HT2c receptor. The tight junctions of the choroid plexus epithelium represent the 
consfitutive efement of the bfood-liquor bader and could be used as a standard for the specific 
P~lmesulergine Mnding on the 5-HTzc3 receptor. For determination of the binding properties the 
specific binding was rneasured at free [ Hlmesulergine concentrations beiween 0.05 and 6 nM. The 
unspecific binding was estimated in the presence of 10 PM mianserin. The KD and B- values 
obtained were 2.6 k 0.3 nM and 306 i 21 fmol/mg protein. These are also confirmed by the linear 
type of the Rosenthal-Scatchard plot with similar values. KD was 2.3 L 0.4 nM and B, was 298 I 23 
fmollmg proZein . Pazos ef al. 1251 also found similar values, a KD of 1.1 nM and a B, of 300 
fmollmg protein. 
In addition to 5-HT2A and 5-HTZc receptors we also studied ~-HTIA. TWO principal localizations of 
5-HTIA in the brain were described [27]. They are found On the cell bodies of the 5-HT neurones, in 
the midbrain raphe nuclei, where they function as autoreceptors to modulate the activity of these 
neurons, and also on postsynaptic membranes in many forebrain areas, notably in the hippocampus. 
The classical radioligand binding assays for 5-HT1~ receptors use [3~]8-OH-DPAT and homogenized 
preparations of Cortex or hippocampus from rat, pig, or other species [33]. Other radioligands have 
been described for ~-HTIA sites, but none has surpassed fH18-OH-DPAT in its overall usefulness 
(16). We determined the binding Parameters of the specific 8-OH-DPAT binding on rat hippocampal 
homogenate (see Table 2). It was measured at free [ 3 ~ ] 8 - ~ ~ - ~ ~ ~ ~  concentrations between 0.05 and 
1.5 nM. The unspecific binding was estimated in the presence of 10 PM serotonin. We found a KD of 
0.32 I 0.04 nM and a B„ of 209 I 14 fmollmg protein by a non-linear plot of a one site model. The 
Scatchard transformation shows a linear regression. The values obtained were similar, KD was 0.33 I 
0.04 nM and B„ was 212 I 15 fmollmg protein. It is, however, described that [ 3 ~ ] 8 - ~ ~ - ~ ~ ~ ~  labels 
two binding sites. On rat hippocampus Mongeau et al. [34] found a KD of 0.51 I0.09 nM and a B„ of 
182 I 33 fmollmg protein for the high-affinity binding site, and a KD of 8.5 I 2.4 nM and a B„ of 225 
I 34 fmollmg protein for the low-affinity binding site. The second binding site was detectable because 
the free [ 3 ~ ] 8 - ~ ~ - ~ ~ ~ ~  concentrations used in the binding experiment were between 0.05 and 60 
nM. In our experiments we used free [3~]8-OH-DPAT concentrations only up to 1.5 nM. That is to say, 
we determined only the high-affinity binding site representing the JHT~A receptor [33]. The identity of 
the low-affinity binding site remains unknown [35]. We used the specific high-affinity [ 3 ~ ] 8 - ~ ~ - ~ ~ ~ ~  
binding on rat hippocampus as the standard of the J H T ~ A  receptor binding under our experimental 
conditions. 
After performing the standard binding assays we tried to determine the 5-HT receptor subtypes on the 
brain endothelial cells which form the BBB. We used different preparations of these cells: a) isolated 
microvessels from porcine brain caudate nucleus, b) cuftured porcine brain endothelial cells, and C) 
an immortalized rat brain endothelial cell line (RBE4 cells). lsolated microvessels are still a relative 
complex System because the vessel preparations do not only contain endothelial cells but also some 
impurities of other cell types. There are astrocyte feed, pericytes, microglia and neuronal endings. 
Cultured endothelial cells are more homogeneous. They form monolayers and contain less than 5 % 
other cells. However, they already tend to dedifferentiate. 
[3~]ketanserin (0.12 nM) was used for determination of 5-HTa binding sites. Total and unspecific 
binding to porcine brain microvessels, porcine brain endothelial cells and RBE4 cells is Show in 
C] total binding 
unspeciiic binding 
Fig. 1. f Hlketansenn binding on porcine brain microvessels and endothelial cels and on RBE4 cells. 
Unspecific binding was determined with 1 FM miansenn. The ~~~lketanserin concentration was 0.12 
nM. (1: p < 0.05; * 1: # p < 0.001) 
The total f~]ketanserin binding was inhibited by 1pM mianserin, an antagonist of Zhe 5-WT'a receptor. 
Binding in the presence of this specific inhibiior is defind as unspecific binding, Specific Mnding of 
f~lketanserin, i.e. the differente beWeen total and unspecific binding, was detectabk on micro- 
vessets (27 ftTKdfmg protein; p 0.001) and enclothelial cells &er 6 days in ~ufture (0.6 fmolJmg 
protein; p < 0.05)., but not on R E 4  cells. 
It is known that ketanserin does not only bind on 5-HT2* but also on 5-HT2c receptors. The binding of 
mesulergine on microvessels and RBE4 cells was therefore determined because this ligand has a 
higher affinity to the 5-HT2c than to the 5-HT2A receptor. Fig. 2 shows the total and the unspecific 
[3~]mesulergine binding on homogenate of porcine caudate nucleus, on microvessels isolated from 
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Fig. 2. [3~]mesulergine binding On microvessels and homogenate of porcine nucleus caudatus 
and on RBE4 cells. Unspecific binding was determined with 10 UM mianserin. 
The [3~]mesulergine concentration was 1 nM. (* p C 0.05; ** lC: p 0.001) 
The unspecific binding was defined by addition of 10 PM mianserin. Specific binding of [3~]mesul- 
ergine was detectable On microvessels (1.85 fmollmg protein; p 0.05) and on homogenate (0.74 
fmollmg protein; p 0.001). The increase in the specific binding on microvessels (about 2.5fold) 
supports the presumed endothelial localization of the receptors. 
Again, no significant difference between total and unspecific binding was found on RBE4 cells, 
indicating that no 5;HT2 receptors are expressed On these immortalized cells. On the other hand, 
specific binding of [ Hlmesulergine was also determined on cultured primary endothelial cells of the 
porcine brain (61 i 47 fmollmg protein) (Fig. 3), indicating the existente of 5-HT2c receptors on ths 
BBB. The binding was about 30 times as high as On microvessels under the Same experimental 
conditions. The reason for this discrepancy is unclear. It 5eems that the binding site densities 
estimated on microvessels and on endothelial cells using [ Hlketanserin and [3~]mesulergine as 
ligands are different. This could be explained by different affinity states of a 5-HT2-like receptor on ths 
two preparations. 
To further characterize the [3~]mesulergine binding on endothelial cells, it was compared with the 
specific binding on the choroid plexus. In addition, 50 nM ketanserin and 20 nM serotonin were used 
as inhibitors, At the given concentrations these drugs were able to displace about 50 % of the specific 
binding of [3~]mesulergine On the choroid plexus 1251. In our study ketanserin inhibits the specific 
mesulergine binding on choroid plexus by 62 % (p 0.05) and on endothelial cells by 30 %. Serotonin 
inhibis this binding by 80 % (p 0.01) on plexus and by 45 % on endothelial cells (Fig. 3). 
5 specific binding 
ketanserin 
Plexus choroideus endoihelial cells 
rat 
Fig. 3. Specific f'~]mesuler~ine binding on rat choroid plexus and porcine endotheliai cells. 
Unspecific binding was determined in the presence of 10 PM miansefln. The [ H]mesul- 
ergine concentration was 1 nM. The concentrations of the displacers ketanserin and 
serotonin were 50 nM and 20 nM. (* p -= 0.05; * * p C 0.01) 
These results show that the inhibition profiles of the chosen inhibitors are similar. In both cases 
serotonin inhibits the mesulergine binding more than ketanserin. It is known that ketanserin has a 
higher affinity to 5-HT2A than to 5-HTZc, and serotonin has a higher affinity to the 5-HT2c than to the 5- 
HT~A receptor [16]. Therefore our data support the existente of the 5-HT2, receptor subtype On 
porcine brain endothelial cells. 
It is known that 5-HTl-like receptors are present on the smooth muscle cells of cerebral blood vesseis 
[16]. Considering the fact that the microvessel preparations from brain homogenate may contain 
some impurities derivin from these cells, we measured the total and the unspecific binding of the 9 ~-HTIA receptor ligand [ H]8-OH-DPAT (0.13 nM) on homogenate of rat hippocampus, porcine brain 
microvessels and RBE4 cells (Fig. 4). 
U total Mnding 
- 
hippocarnpus microvesscls RBU ctifs 
rat 
Fig. 4. f3Hj8-OH-DPAT binding on rat hippocampal hornogenate, on porcine brain microvessels 
and on RBE4 cells. Unspecific binding was determined wrth 10 jiM serotonin. 
The [ 3 ~ ~ 8 - ~ ~ - ~ ~ ~ f  concentration was 0.13 nM. (* * * p .: 0.001) 
The unspeoific bindyg was defined by the presence af 1(1 pM serotonin in the binding assay. The 
specific binding of f Hf8-OH-DPAT on rat hippocampal homogenate, a 5-HTqw receptor-rich region. 
was 62 * 10 fmoilmg protein (p < 0.001). No specific 5-HTaA receptor binding was focsund On 
microvessels and RBE4 cells, which indicates that no S-HT~A receptors are present on brain 
endothelial cells. Furtherrnore, we expect from these data that impurities by smooth muscle cells are 
low or absent in these preparations. 
Summarizing, it can be said that there is clear evidence from our studies that serotonin receptors 
exist on the BBB. The significant [3~]ketanserin binding and [3~]mesulergine binding on isolated 
microvessels and cultured endothelial cells from porcine brain indicate that the receptor could belong 
to the 5-HT2 subclass. A comparison of the inhibition profiles of some specific inhibitors on choroid 
plexus and on endothelial cells suggests that it may be the 5-HT2c receptor subtype. However, the 
presence of 5-HTm receptors and of other subtypes of serotonin receptors, which we have not yet 
investigated, cannot be excluded. 
The evidence of the existente of 5-HT receptors on the BBB, their localization and characterization, 
should make a contribution to a better understanding of the function of the BBB. It is known that 5-HT 
is involved in many physiological processes and neurological diseases in the brain. The effects of 
5-HT could partly be imediated by 5-HT receptors on endothelial cells by activation or inhibition of 
second messenger Systems, followed by changes in the cerebral blood flow and the permeability of 
the BBB. This may also be related to the function of the 5-HT2c receptors on the choroid plexus where 
they are expected to regulate the composition and volume of the cerebrospinal fluid [36]. Knowing 
more about the 5-HT mediated processes on the luminal andlor abluminal side of the BBB may be of 
importance for a better understanding and perhaps treatment of certain brain diseases. 
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30. Comparison of a Microplate Assay with Conventional Binding Assay for the 
Screening of the Potential Receptor Ligands 
J. Wober, P. Brust 
lntroduction 
In the search of potential receptor-binding ligands the parameters, such as or Ki value, are 
conventionally used for selection [I, 21. These parameters are usually determined with filtration 
manifolds combined with an analysis of the radioactive samples by conventional liquid scintillation 
counting (LSC). Recently it became possible to increase the efticiency of binding experiments by the 
use of a combination of a microplate cell harvester with a microplate scintillation counter (MSC), 
which allowed the analysis of the radioactive samples on microfilter plates to take place in a shorter 
time. 
For evaluation of the potential receptor ligands the binding parameters obtained by both methods 
need to be comparable. Such a comparison of the two methods had not yet been performed. The 
inhibition of the binding of the specific 5-HT2 receptor ligand [3~]ketansenn to homogenate of rat brain 
cortex by a potential serotonin (5-HT) receptor-binding ligand is used as an example. It will be 
demonstrated that the Ki values obtained by both methods are similar. 
Experimental 
Preparation of raf brain corfex 
Samples of the rat brain cortex were homogenized in 10fold volumes of ice-cold TrisIHCI buffer (50 
mM, pH 7.6) with an Ultra-Turrax T 25. The homogenate was centrifuged at 20,000 g for 10 min. The 
resulting pellet was resuspended and centrifuged at 20,000 g for another 10 min. After repeating the 
Same procedure the pellet was resuspended in 10 volumes of buffer and stored at -70 "C until used in 
the binding studies. 
Binding assay using a 30-pori cell harvester combined with a conventional liquid scintillation counter 
(LSC) (convenfional assay) 
The incubation test contains 0.12 nM [3~]ketanserin, homogenate of membrane preparation (0.012 - 
0.02 mglml protein), various concentrations of the displacer in TrisIHCI buffer (50 mM, pH 7.6) in a 
final volume of 5 ml. The unspecific binding was defined in the presence of 1 pM mianserin. A 30-port 
cell harvester (from Brandel) contains places for 30 single samples. Three samples were used to 
define the unspecific binding and three samples for each of seven concentrations of displacers and 
for noninhibited binding. The samples were incubated at 25 "C for 60 rnin in 8 ml test tubes. The 
GFIB glass fibre filter (Whatman) was incubated in 0.3 % polyethylene imine for 90 rnin before use. 
The binding assays were terminated by rapid filtration through this filter at 4 "C. The filter was rapidly 
washed with four 4 mL portions of ice-cold buffer, transferred into 5 ml scintillation fluid (Ultima-Gold, 
Packard) and analysed for radioactivity in a conventional LSC (Tricarb; Packard Instrument 
Company). Aliquots of incubation fluid were also measured in scintillation fluid for determination of 
the real concentration of [3~]ketanserin in the incubation tests. The protein content of the membrane 
suspension was estimated according to the method of Lowry ef al. 131. 
Binding assay using a microplafe cell harvester combined with a microplate scinfilation counter (MSC] 
(microplate assay) 
The incubation tesl contains 0.36 nM [3~]ketanserin, homogenate of the membrane preparation (0.03- 
0.04 mglmL protein, estimated according to the method of Lowry ef al. [3]), various concentrations of 
the displacer in tris1HCI buffer (50 mM, pH 7.6) in a final volume of 1 ml. The unspecific binding was 
defined in the presence of I pM mianserin. A microplate cell harvester (Packard Instrument 
Company) has plates for 96 single samples. Thus 8 welk each were used to determine the unspecific 
and the noninhibited binding, and 4 wells for each of 18 concentrations of displacers. Eight places 
were reserved for standards (2 welk each for 4 radioligand concentrations with the same protein 
content as in the samples). The samples were incubated at 25 "C for 60 rnin in 1.5 ml-microtest 
tubes. The GF/B glass fibre filter plate (UniFilter, Packard) was incubated in 0.3 % polyethylene imine 
for 90 rnin before using. The binding assays were terminated by rapid filtration through this filter at 
4 "6. The filter was washed rapidly with 400 ml ice-cold buffer. After drying, 50 pI scintillation fluid 
(Ultima-Gold, Packard) were added to each fiiter well and the plate was analysed for radioactivity by a 
microplate scintillation counter (Packard Instrument Company). Aliquots of incubation fluid and the 
standards were measyed as well in 96-well plates in 200 pt of scintillation fluid to detemine of the 
real concentration of Hjketanserin in the incubation tests. 
Aliquots of the standards were also counted in 4 ml of scintillation fluid in a conventional LSC 
(Tricarb; Packard Instrument Company) to prepare a standard curve for converting cprn into dpm. 
Fig. I (A) shows that both relationships between the radioactivity concentration and the measured 
cprn values (MSC), on the one hand, and the measured dprn values (LSC), on the other, are 
described by linear regression. It is shown in Fig. 1 (B) that the relationship between the measured 
cprn and dprn is also described by linear regression. The dprn values nececcary for quantitative 
evaluation are calculated from such a calibration curve for each filter plate. 
cprn (MSC) 
Fig. 1. Relationship of (A) measured cprn (circles) by Microplate Scintillation Counter (MSC] and dprn 
(squares) by conventional Liquid Scintillation Counter (LSC) at various concentrations of [ Hlketan- 
serin and (B) between the measured cprn and dprn values. Aliquots of incubation fluid were 
measured in the same scintillation fluid. All points are means I SD, n = 16. 
The total binding of ~~~lketanserin on homogenate of porcine Nc. caudatus was measured at various 
protein contents (0.02 - 0.18 mg/mL) and vanous radioligand concentrations (0.03 - 3.36 nM). As 
expected, in both cases the binding was increased with increasing protein content or [ Hlketanserin 
concentration, described by linear regression (data not shown). This applies to all of binding'assays of 
which the experimental conditions will also be ranged in these linear areas. 
Results and Discussion 
In the search for potential receptor-binding compounds the equilibrium inhibition constant (K,) is one 
of the parameters that will be used for selection. The K, value indicates the molar concentration of the 
compound, which inhibits 50 % of the specific binding of the common radioligand, irrespective of the 
radioligand concentration in the incubation assay. In displacement experiments ICS0 values of vanous 
compounds are obtained. The ICm value represents the molar concentration of the tested compound, 
which under the particular experimental conditions can displace 50 % of the radioligand binding. The 
relation between IC50 and the K value is described by the following equation: I<i = [lC&l+ Clk] ,  with 
C the concentration and KD the equilibrium dissociation constant of the radiolabelled ligand 141. 
It is necessary to use a highly efficient screening method to select the potential receptor-binding 
compounds and determine their binding parameters. Up to now it has been usual to use filtration 
manifolds for 24, 30, or 40 samples [5 - 71 (conventional method). The radioactivity was counted in 
conventional LSC. Recently a rnicroplate assay has been developed based On a ceil harvester 
combined with a microplate scintitlation munter (MSC). The new equipment allows more binding 
expenments to be carried out in minimized incubation volumes in a shorter time. The aim of the 
present study is io find out whether the Same 6 will be obtained by both methods. The displacement 
of the specific [ Hlketanserin binding on rat brain cortex by a potential receptor-binding ligand is 
shown as an example. 
In order to estimate 6 values, the KD value of the radioligand has to be known (see above). ft is 
obtained by saturation experiments. The specific f~lketanserin binding, the difference3between the 
total and the unspecific binding, was estimated on rat brain cortex by various [ Hjketanserin 
concentrations ranging from 0.003 Zo 2 nM. The unspecific binding was determined by inhibition of the 
total binding with I PM miansenn. The saturation curves and the RosenthalScatcharcl plots, obtained 
by evaiuation of the Wo methods, are shown in Fig. 2. The single values of all experiments were 
plotted in one curve. 
Fig. 2: Saturation curves and Rosenthal-Scatchard plots of specific [3~]ketanserin binding on rat brain 
Cortex taken by (A) conventional assay and (B) microplate assay. Unspecific binding was determined 
with 1 pM mianserin. [3~]ketanserin concentration was between 0.003 and 2 nM. Single values of all 
experiments are shown. By conventional assay we found KD = 0.23 I 0.02 nM and B„ = 860 I 45 
fmollmg protein and by microplate assay KD = 0.38 f 0.04 nM and B„ = 830 I 45 fmollmg protein. 
The maximum number of binding sites B„ estimated by both methods is similar (conventional 
assay: B„ = 860 I 45 fmollmg protein; microplate assay: B„ = 830 I 45 fmollmg protein). 
However, the 6 values are slightly higher for the microplate assay (conventional assay: KD = 0.23 I 
0.02 nM; microplate assay: KD = 0.38 f 0.04 nM). The Scatchard plots of the binding curves confirm 
these data (conventional assay: KD = 0.24 nM; B„ = 890 fmollmg protein; microplate assay: KD = 
0.38 nM; B„ = 860 fmollmg protein). This difference between the KD values is not significant, as 
shown by student's t-test. 
The 16 values were used to calculate K values from the ICS0 values of a potential serotonin receptor 
Iigand (Table 1). 
Table 1. Cornparison of the binding Parameters of [3~]ketanserin and a potential serotonin receptor 
Iigand, using the conventional assay and the microplate assay 
Inhibition constant (IC50) 
Equilibnum inhibition constant (Ki) 
Equilibrium dissociation constant (KD) 
[3H]Ligand concentration (C) 
Number of single values (n) 
Conventional assay ! Microplate assay 
As expeded, the IC9 values are different beyuse of the different [3~]ketanserin mncentrations in 
the binding assays. The concentration of the [ Hlligand had to be increased 3fold in the microplate 
assay on account of the lower wunting efficiency. The protein content was also raised by a factor of 
3. Most important, the Ki values obtained by both methods are the sarne, allowing the comparison of 
binding data obtained with both methods. 
The advantages of the new method are a higher time efficiency, a decrease in the consumption of 
chemicals, such as buffer, washing agents, radioligand, scintiliation fluid, and also biological material. 
lt follows that the amount of radioactive waste also decreases. 
A disadvantage of the microplate asay is that the measured results obtained by MSC are given in1 
cpm. This rneans that a standard curve has to be plotted for each fiiter plate in order to convert cpm~ 
into dpm for the following quantitative evatuation. 
Summakzing, it can be said the microplate assay represents a new application rnethod for camng out 
binding experiments which produce more results in a shorter time. It is possible to cornpare the newly 
obtained data with the former results by use of Ki values. The saving of materials and time and the 
avoidance of waste is not only an important economic aspect in scientific work but also an ecological 
one in view of the world around us. 
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31. Functional Expression of P-Glycoprotein in an lmmortalized Rat Brain Endothelial 
Cell Line (RBE4) in vitro 
R. Bergmann, S. Matys, P. Brust 
Introduction 
In a previous study we used the reverse transcription-polymerase chain reaction (RT-PCR) to 
examine an immortalized brain endothelial cell line (RBE4) [I ] for expression of transport systems 
that may be important as conduits for drug delivery to the brain. We demonstrate that the RBE4 cell 
line [2 ] offers an in vitro System where the genes of multidrug resistance (rndrla and mdrlb) are 
expressed. This gene family encodes an -170 kDa integral membrane protein, the P-glycoprotein 
(PGP). A member of the ATP-binding cassette (ABC) transporter farnily, PGP is expressed in the 
plasrna rnembrane and appears to function as an energy-dependent efflux pump for a broad 
spectrum of natural and synthetic drugs. RBE4 cells may therefore be regarded as an in vitro 
alternative for studying drug transport across the blood-brain banier (BBB) [3 1. This is of particular 
interest for our institute's attempts to design diagnostic ""'TC radiopharmaceuticals for functional 
imaging of the brain 14 1. The uptake into the brain of such radioactive molecules requires that these 
compounds are transported through the brain capillary endothelial wall, which makes up the blood- 
brain bamer in vivo. However, the function of the PGP may restrict the blood-brain transfer. The 
functional expression and the specific inhibition of the PGP in RBE4 cells is therefore studied in the 
present Paper. Using a muitilabel tracer approach, we dernonstraie that the inhibition of this 
transporter does not influence basic metabolic Parameters of the cells. Such conditions are important 
for the future evaluation of new drugs with perhaps unknown cytotoxic properties. 
Experimental 
Reagenfs 
L-glutamine, basic fibroblast growth factor (bFGF), rat tail collagen were from Boehdnger Mannheim 
GmbH (Germany) and media were obiained from GIBCO-BR1 Life Technologies. 24-weil ceI1 cdture 
plates were from (Sarstedt). Fetal calf Serum, sodium ortho-vanadate, dinitrophenol (DNP) and 2- 
deoxy-D-glucose were obtained from (Sigma, Deisenhofen, Gemany). Stock solutions of verapamil, 
vinblastine, colchicine (Sigma, Deisenhofen, Germany) were prepared with dimethyl sulphoxide 
(DMSO). 
Tracers and radioactivity measurements 
Various tracers with different isotopic labels were used for the studies. [3~]vinblastine (670 
GBqImmol) as PGP substrate [5 1, [3~]leucine (577 TBqlmmol) as a measure of the function of the L- 
type amino acid transporter and the protein synthesis [6 ], [3~]thymidine (962 GBqImmol) as tracer of 
the DNA synthesis [7 , 8 ] were purchased from Amersham. [3~]colchicine (2.73 TBqImmol) from 
DuPont de Nemours (Germany) GmbH was used as PGP substrate [9 1. ["~lfluoride labels the OH- 
and Cl- space. 2-['8~]fluoro-2-deoxy-~-g~ucose is transported into the cells via the glucose transport 
protein (GLUT). Then it can be phosphorylated by hexokinase(s). The 2-['8~]fluoro-2-deoxy-~- 
glucose-6-phosphate, however, is thought to be trapped intracellularly because it is a poor substrate 
for further metabolism. It cannot be converted to fructose-6-phosphate and degraded to CO2 and 
H20, and it has low affinity to GLUT [I0 ,I1 1. The ["F]labelled tracers were prepared in the 
Rossendorf PET-centre [12]. The actual concentrations of the ['8~]-labelled compounds were 
calculated from the absolute amount of tracer activity used and from the specific activities given by 
the manufacturers and were lower than 10 nM in the tests. fgm~c]sestamibi (Cardiolite, Du Pont 
Pharma GmbH, Germany), as a PGP substrate [I3 1, and [ 9 9 m ~ c ] ~ ~ ~ ~  (ROTOP, VKTA Rossendorf, 
Germany) an extracellular tracer without any noticeable protein binding [I4 ] were prepared from 
commercial kits according to the manufacturer's instructions and added to cell rowth medium with a 
final concentration of 10 MBqlml. Knowledge of the elution history of the 99Molg'mTc generator an6 of 
the activity of stock solutions than made it possible to use generator equilibrium equations to 
calculate the absolute concentration of total ""'TC in the incubation medium (<I0 nM in all 
experiments) [I5 , 16 , 17 I. All samples were assayed for gamma activity in a multichannel well-type 
sodium iodine gamma counter (COBRA II, Packard). After a minimum of 10 half-lives of the short 
living isotopes used ("F, ""'TC) the Count vials were assayed in a multichannel well-type beta counter 
(TRICARB, Packard) to determine the contents of 3~ and "TC in the samples. The results are 
expressed as an accumulation ratio calculated by dividing the total specific cell uptake, after 
subtracting the nonspecific binding (NSB), by the total radioactivity (supematant and solubilized cells) 
per mg cell protein (%D/mg protein). The radioactivity recovery was calculated using appropriate 
incubation medium standards for control. The relation of the tracer content normalized to the protein 
mass in the test samples to that in the control samples, expressed as a percentage, was calculated to 
compare the influence of various drugs on the tracer accumulation in the cells. The remaining of 
supematant liquid in the solubilized cells was assayed with [ 9 9 ? ~ ] ~ ~ ~ ~ .  It was found to contribute 
<0.4 p1 supematant/well at a mean value of 80 pg cell proteinlwell. As a check on the specificity of 
d ~ g  accumulation under the conditions, control experiments were performed with ['8~fluoride or 
[ 9 9 m ~ ~ ] ~ ~ ~ ~  as additional labelled substances. 
Ce11 culture 
The RBE4 cells were a gift from F. Roux. The cells were seeded in a density of lo3  - lo4 cells/cm2, 
either (a) in 24-well plates coated with either rat type 1 collagen or (b) in 24-well ~ e l l '  plates 63. The 
cells were grown in culture medium consisting of a a-minimal essential medium (a-MEM)lHam's : F10 
(1:l vollvol), supplemented with 2 mM glutamine, 10 % heat-inactivated fetal calf Serum, I nglml of 
basic fibroblast growth factor (bFGF), and 300 pglml of geneticin (G41 8) in humidified 5 % C02/95 % 
air at 37 'C. In the multiwell plates the cells reached confluence after 3 - 4 days. The accumulation 
studies with radioactiv labelled compounds were conducted at cell densities between lo5 - 106 cells 
per well (106 cells were equivalent to 130 pg protein). 
Drug upfake sfudies 
In the common procedure tracer ulptake and retention experiments were initiated by incubation of the 
confluent cells in 24-well plates with the compiete growth medium supplemented by the appropriate 
tracers and modulators. This incubation was conducted at 37 'C in a 5 % C02/95 % air atmosphere or 
at 4 'C in a normal atmosphere. In previous experiments that were performed without equilibration of 
the cells with verapamil, a lag time of five minutes of the verapamil-induced enhanced tracer 
accumulation was detected. Hence, the experiments were started with a period of 60 min preincu- 
bation of the samples in growth medium with added test substances. In the experiments the 
appropriate amount of DMSO was added to the control samples, not exceeding I % @/V) of the 
wolume. lmmediately after preincubation, the solution was aspirated from the welk and replaced by 
0.5 ml per weil of the incubation medium to initiate transport. The media contained up to three tracers 
(details are given in the figure and table legends) labelled with different isotopes (""'TC, 1 8 ~ ,  3 ~ )  and 
various drugs in concentrations ranging between 1 nM and 10 mM. At the end of incubation the well 
plates were transferred onto a cooling plate (4 'C). I00 pI of the medium from each well was used to 
assess the free tracer concentration in the supematant. The remaining medium was then aspirated 
and the cells were carefully rinsed four times with 1 ml of ice-cold (4 'C) isotope-free phosphate 
buffered solution containing Mg+' (0.5 mM) and ~ a + +  (0.9 mM) for 8 s each column to clear the extra- 
cellular spaces. The remaining cells were solubilized with modified 500 p1 Lowry reagent (see protein 
determination) during shaking of the plates for 30 min. Afterwards 350 p1 aliquots were transferred 
into 4 ml scintillation cocktail (Ultima Gold, Packard) in PONY vials (Packard). Aliquots of the loading 
buffers and stock solutions were obtained for normalizing the cellular Counts to the extracellular 
concentration of the studied tracers. Additional plates were incubated at 4 'C to determine the non- 
specific binding and accumulation (NSB) of the tracers in the cells. All data points were determined in 
quadruplicate from preparations obtained from the Same culture. Statistical evaluation of the data was 
performed by Student's f test. Values of p 10.05 were considered significant. 
Protein determination 
Aliquots of the solubilized cells were used to assay the protein by the method of Lowry et al. [I8 ] 
(Protein determination Kit, SIGMA DIAGNOSTICS, Procedure No. P5656), using bovine Serum 
albumin as the standard. The method was slightly modified to measure the samples in a 96-well plate. 
50 pI of solubilized cells per sample were pipetted Mice into the 96-well plate. 150 pl Lowry reagent 
was added and the plate was shaken for 10 min. Then 70 p1 of Folin reagent was added to each well 
and the plate was again shaken for 20 min. Now the plate was measured using a microplate reader 
AT II (Anthos) at 605 nm. The calibiration curve was fitted from 20 pg proteinlml up to 400 pg proteinl 
ml and was used for protein mass determination in the samples. 
Results and Discussion 
The aim of the present paper is to study the functional expression of PGP at RBE4 cells and to 
demonstrate that the inhibition of this transporter does not influence basic metabolic parameters of 
the cells. In future experiments with various newly synthesized drugs we intend to study the cell 
transmembrane transport and the interactions of these drugs with the PGP. The unchanged cell 
metabolism is a prerequisite of such studies and should be used as a criterion for the selectivity of 
drug PGP interactions. This is expected to be important because cytotoxic effects of the drugs cannot 
be excluded at concentrations between 1 pM and 1 mM, which are normally invoived in these studies. 
The PGP activity is proportional to the measured difference between the accumulation of a PGP 
substrate in the cells in the control experiment and the substrate amount in the ceils by inhibition of 
the PGP. This is only true if the inflwx of the substrate used remains constant under both conditions. 
PGP has a broad substrate specificity. Drugs which may serve as substrates for the PGP include the 
antitumour alkaloids vinblastine, colchicine, and also the lipophilic organotechnetium cation 
[ggTc]sestamibi [19, 20, 21 1. We used these substances to characterize the PGP function in the 
RBE4 cells. Fig. I shows the time dependency of the accumulation of [3~]vinblastine, [3~]colchicine 
and [99"'~c]sestamibi, which occurs after inhibition of PGP with verapamil. A plateau was reached 
after about 60 min as had been previously shown with various tumour cell lines 1221. The 
development of plateau accumulation in the continued presence of extracellular [9?c]sestamibi 
implied that a steady state or equilibrium condition had been achieved. This includes the posibility of 
saturation of the investigated System with the PGP substrates [23 1. Therefore the incubation time 0f 
60 min was chosen for further experiments. 
Accurnulation of PGP substrates in RBE4 cells 
Time [niin] 
B [EariTc]sestamibi (Control) 
A [EanTc]sestamibi (Verapamil) 
O [%]colchicine (Control) 
A [%]colchicine (Verapamil) 
0 [%]vinblastine (Control) 
V [%]vinblastine (Verapamil) 
Fig. 1: Kinetics of fgmTc]sestamibi, [3~]vinblastine and [3~]colchicine accumulation in RBE4 cells. 
Cells were incubated in medium for vanous times in the absence of a drug (control) or in the 
presence of verapamil (1 0 wM). Each point represents the mean value of 4 determinations; 
bars represent iSD. 
The contribution of the extracellular radioactivity to the total accumulated activity of [99m~c]sestamibi 
was ectimated from experiments with [ 9 9 m ~ ~ ] ~ ~ ~ ~ ,  a tracer with negligible protein binding known to 
be excluded from uptake by various Cell types dunng short periods [24]. The recovery of the 
[~~"~CIDTPA from the solubilized cells and supematant nomalized to the initial activity of each 
sample was 95.3 I 5.0 % of the initial activity. The accumulation of [ 9 9 m ~ c ] ~ ~ ~ ~  was unchanged by 
inhibition of the PGP (the results with the highest inhibitor concentrations are shown in 
Table 1). At a cell number of 6.10~ Per weil an extracellular volurne of 0.07 p1 was calculated. 
However, the remaining [ 9 9 m ~ c ] ~ ~ ~ ~  in the cell fraction was temperature dependent and 4.5 times 
lower at 4 'C. 
Table 1 : Extracellular volumes of f g r n T c ] ~ ~ ~ ~  in %Dlmg protein determined 
by the common incubation procedure (60 min) at 37 'C and 4 'C. 
Each point represents the mean value of 4 determinations I SD 
PM 37 O c  4 O c  
Control 0 0.226 0.038 0.050 i 0.060 
Verapamil 50 0.200 i 0.059 0.079 I 0.125 
Colchicine 50 0.298 I 0.141 0.042 I 0.033 
VinbIastine 50 0.199 i 0.047 0.055 I 0.088 
Accumulation of '*F-fluoride and 
9 9 m ~ c - ~ ~ ~ ~  in RBE4 cells 
Time [min] 
Fig. 2: Kinetics of ~ g m ~ c ] ~ ~ ~ ~  and ["~]fluoride accumulation in the cell fraction. Each point 
represents the mean value of 12 determinations; bars represent I SD; the linear 
regression results I SEM and the dotted lines are the 95 % confidence intervals. 
But the linear time dependence of the [ 9 9 m ~ c ] ~ ~ ~ ~  accumulation (p <0.01). Fig. 2 may serve as an 
indicator of nonspecific binding and transpoit (e.g. vesicular transport) processes. Despite these 
eonsiderations the following uptake data were calculated as the difference in tracer accumulation 
between 37 'C and 4 'C volume and normalized to the total radioactivity and to the protein amount, 
expressed as %Dlmg protein, without correction for the extracellular compartment in each 
experiment. 
Changes in cell volume may also result in unspecific changes in tracer uptake. Cell swelling is 
accompanied by an increased permeability for chloride [25, 261 thereby increasing the chloride 
space which represents a measure of the total extracellular space under normal conditions. Fluoride 
resembles OH- and CI- in various physicochemical properties (Stokes radii, Pauling's crystal radii, 
binding orders to the carboxypeptidase or carbonic anhydrase) and may therefore imitate hydroxyl 
ions and chloride in biological systems. Bromide has been able to replace chloride in the measure- 
ment of chloride-dependent potassium transpoit [27].We therefore used ['8~]fluoride to check 
whether there are changes in cell volume during inhibition of PGP. The fluonde space (apparent cell 
wolume) after 60 min of incubation was 0.97 i 0.042 p1 (mean I S.E.M.) for controls. There were no 
significant differences to the samples in which the PGP was inhibited with verapamil, colchicine or 
winblastine (all concentrations 10 PM). Fig. 2 shows the kineticc of [?8~]fluoride accumulation in the 
cell fraction reaching a steady state after 50 min, probably because of specific transport mechanisms 
[28 1 and 1 or of exchange with OH- in the cells or by binding to the zinc center of the 
carboxypeptidase [29 1. 
Temperature dependence of 
[99mTc]sestamibi uptake 
0 37OC Verapamil 
0 37 'C Control 
4 'C Verapamil 
+ 4 'C Control 
0 10 20 30 
Time [min] 
Fig. 3: Kinetics of [99m~c]sestamibi, accumulation in RBE4 cells at different incubation temperatures. 
Cells were incubated in medium for various times in the absence of drug (control) or 
in the presence of verapamil (1 0 UM). Each point represents the mean value 
of 4 determinations; bars represent f SD. 
The 99m~c-sestamibi accumulation was temperature dependent (Fig. 3). The large negative trans- 
membrane potentials at the plasma and mitochondrial membrane, controlled by energy-dependent 
biochemical processes, are the driving force for the nonmediated [99m~c]sestamibi d ffusion to the 
mitochondria [30]. The drastic decrease in tracer uptake at low temperature indicates the energy- 
dependency of the ~gm~c]sestamibi accumulation process. A concentration-dependent increase in 
[99'"Tc]sestamibi accumulation was found when verapamil was added to in the incubation solution. 
This increase was absent at low temperature. Therefore the data from the 4 'C experiments were 
used to mrrect the uptake data at 37 'C for the nonspescific processes. 
Furthermore, uptake experiments were simultaneously perfomed in the presence of other substrates 
of PGP, such as [3~]colchicine (Fig. 4) and [3~]vinblastine. 
The accumulation of PGP substrates at steady state conditions depends on the substrate influx and 
on the activity of the PGP. It is therefore useful to measure the uptake of two PGP substrates with 
different accumulation and retention mechanisms at the Same time. In the cells [99m~c]sestamibi is
bound to the mitochondria [21], [3~]colchicine and [3~]vinblastine bind to the tubulin skeleton. The 
direct and linear correlation of the uptake of the two tracers at different levels of PGP inhibition may 
be interpreted as a sign of the main influence of the PGP on the drug accumulation process in the 
cells. 
Accumulation of [s9m~c]sestarriibi, 
[3~]colchicine and [ " ~ F D G  in RBE4 
cells 
Verapamil [vM] 
Fig. 4 Simultaneous measurement of the [99m~c]sestamibi, [3~]colchicine and [ 1 8 F ] F ~ ~  accumulation 
in RBE4 cells depending on various amounts of verapamil added (incubation at 37 'C; 60 rnin). Data 
expressed as a percentage of the accumulated activity in the control experiment without inhibitor. 
Fig. 5 shows the linear correlation between [99m~c]sestamibi, [3~]vinblastine and [3~]colchicine 
accumulation under control conditions (P: 0.9945, P value C 0.0001; P: 0.9110, P value C 0.0001) 
and in the presence of 10 pM vinblastine (P: 0.9977, P value C 0.0001; P: 0.8005, P value C 0.0001). 
The accumulation of [99m~c]sestamibi during inhibition of the PGP with verapamil is relatively higher 
than that of [3~]vinblastine or [ 3 ~ ] ~ ~ l ~ h i c i n e ,  orresponding to the slopes 1.367 I 0.026, 0.450 ): 0.006 
and 0.032 I 0.003, 0.01 7 I 0.002. 
Correlation between PTclsestamibi and 
PHlvinblastine, [JHIcolchicine 




g: D [3HJvinblastine (verapamil) 
3 
s 
3. [31+jcolchi~ine (control) 
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C g. A [3HJcolchicine (verapamil) 
Y 
Fig. 5: Correlation between [9~c]sestamibi and PH]vinblastine, [3~]colchicine uptake. 
Each point represents one of four measurernents at 5,10,20,39,60 min 
without (control) and with 10 PM veraparnil. 
Table 2: The influence of various drugs ( I  0 PM) on the accumulation of the PGP substrate in RBE4 
cells after 60 min incubation at 37 'C, expressed as a percentage of control I SD. Each point 
represents the mean value of 8 deterrninations I SD. 
Modulator [99m~c]sestamibi [3~]colchicine [3~ ]v in  blastine 
Control 100.00 I 21.29 100.00 I 10.99 
Verapamil 246.75 I 8.67 146.66 I 6.98 546.96 f 86.28 
Amytal 104.86 I 7.1 1 96.01 I 3.43 
DNP 88.27 I 6.46 100.73 i 6.06 100.56 f 34.52 
Rotenon 59.00 I 12.69 113.85 i 7.33 
Vinblasline 709.36 I 166.25 234.62 I 66.74 
Colchicine 112.12 I 6.09 106.09 I 14.41 165.89 f 2.30 
Chlorpromacine 214.91 36.62 111.26 I 7.93 
The potential of various drugs to enhance the cellular accumulation of the PGP-substrate is shown in 
Table 2. Vinblastine has the greatest ability to inhibit the PGP, followed by verapamil chlorpromacine 
and colchicine. This is consistent with studies of the influence of the agents on the drug binding site of 
PGP and the transport function of the protein [31 , 32 , 33 1. 
The L-amino acid transport system is symmetrically distributed between the luminal and abluminail 
membranes of brain endothelial cells [34 J. It is therefore assumed that the distribution of the carrier 
system is also homogeneous in the monolayer cultures of the RBE4 cells. The function of the ~ a *  
independent neutral amino acid transport is a useful measure of the intact transport of leucine. 
Verapamil, colchicine and vinblastine had no effect on the L-leucine accumulation in the cells, 
indicating that the eievated accumulation of the PGP substrates is a specific inhibition of the PGP 
1351. In addition, the accumulation of the neutral amino acid ~-[~H]leucin and the nucleoside 
fH]thymidine were measured under the Same conditions. They provide inforrnation about possible 
changes in the rates of protein andlor DNA synthesis. No significant changes were observed during 
incubation with verapamil, colchicine, DMSO or DNP (Fig. 6). 
Effects of various cornpound on the 
accurnulation of rnetabolic tracers 
Fig. 6: Effect of various compounds on the ["F]FDG, [3~~ieucine, [3~]thymidine uptake by RBE4 
cells, The cells were incubated according to a common procedure for 60 min at 37 'C in the 
absence of drugs (control) and together with verapamil(10 UM), colchicine (IOpM), DMSO 
(I % VIV) and DNP (10 PM). Each value represents the mean I SD of 4 measurements. 
Cordobes ef al. [22] found a different uptake of [99m~c]sestamibi n vanous tumour cells, which the 
authors attributed to different levels of metabolic activity of the cells without having measured it. We 
therefore used ['%F]FDG to measure the glucose uptake and metabolism of the cells. f8F]FDG is a 
glucose analogue which is expected to be transported into the cells by the glucose transporters 
GLUT1 and GLUT3. We previously showed that these transporters are expressed in RBE4 cells [I]. 
After 60 minutes mainly the phosphorylated compound, the product of the hexokinase reaction, is 
mainly found intracellularly [36 1. Under normal conditions the accumulation of f8F]FDG is strongly 
correlated with the cell number (r = 0.9377; p<0.001). 
Simultaneous measurement of 
[99m~c]sestamibi and ['*F]FDG or 
[3H]leucine or [3~]thymidine uptake 
Fig. 7: Simultaneous measurement of [99m~c]sestamibi and ['*F]FDG or [3~]leucine or [3~phymidine 
uptake in RBE4 cells. Each point represents one measurement in an uptake experiment with 
various verapamil concentrations (0, 1,2.5,5, 10,25 PM; incubation time 60 min; 37 'C). 
The uptake of [99m~c]sestamibi is not correlated with the uptake of [Z'F~FDG (P: 0.1204) nor with the 
uptake of [3~]leucine (P: 0.0721 1) nor with the uptake of ~~Hlthymidine (P: 0.01071) in the RBE4 cells 
under normal conditions in the absence and presence of verapamil up to 25 PM (Fig. 4, Fig. 7 ). Also, 
the PGP inhibitors verapamil and colchicine have no influence on the accumulation of "F-FDG, and 
verapamil did not change the uptake of [3~]leucine and ~~Hlthyrnidine. 
Taken together, our data show that the above system can be used to measure the functional 
characteristics of the PGP in the RBE4 cells, to study the interaction of various tracers and drugs with 
the PGP simultaneously with there influence on the cell metabolism. The system is therefore usef~l 
for identifying agents which underiie PGP-mediated drug transport ar modulate it. The functional 
interactions, which may lead to information about the potential of the dnigs to reverse PGP-mediated 
multidrug resistance and to freely pass cells expressing PGP, can be investigated. The sysiem may 
be valuable in the design of new and more potent tracers passing the various baniers in the 
organism. 
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32. Different Response of Cerebral and Non Cerebral Endothelial Cells to Cytotoxic 
Hypoxia 
B. Ahlemeyer, P. Brust, B. Johannsen 
lntroduction 
The endothelial cells of cerebral capillaries play a crucial role in Controlling the transfer of molecules 
from blood to brain and vice versa and they constitute the so called blood-brain barrier (BBB). Under 
normal conditions the integrity of the BBB is protected, which is essential for the correct function of 
the brain. Hypoxic brain injury - which is known to damage neurons and astrocytes - also affects the 
BBB e.g. leads to changes in the permeability [ I  - 51 as well as to an increase in the expression of 
intercellular adhesions molecules [6 - 81 preceding the migration of leukocytes across the BBB. It has 
been shown that reactive oxygen species account f0r at least Part of pathological damage 14, 5, 91. 
Only a few data have been published conceming the effect of hypoxia on the BBB in vitro [4, 5, 10, 
111. In these studies, hypoxia was performed by exposure of cerebral endothelial cells to 95 % 
nitrogen and 5 % carbogen. Although hypoxic response of endothelial cells of peripheral tissue has 
already been studied [ I2  - 181 no direct comparison between cerebral and non cerebral endothelial 
cells under the Same hypoxic conditions has been done. Therefore, it was the aim of the present 
study to find out whether the treatment with sodium cyanide is a suitable and practicable model to 
study hypoxic injury in cerebral endothelial cells, the major constituents of the blood-brain banier, and 




Medium 199, medium MCDB-131, fetal calf serum, collagen type I/III, dextran, Percoll, antibiotics, 
sodium fluorescein and the assay kits for the determination of lactate (735-IO), lactate 
dehydrogenase (DG1340k) and protein (P5656) were purchased from Sigma (Deisenhofen Gerrnany). 
L-glutamyl-a-methoxy-naphtylamide, dispase, collagenase/dispase, pnitrophenylphosphate, IgG 
fractions of mouse anti-human factor Vlll and sheep anti-mouse Ig-G fluorescein antibodies were 
from Boehnnger Mannheim (Germany). Plastic cell culture dishes were from Becton Dickinson 
(Heidelberg, Germany) and all other chemicals were of the purest grade available from Merck 
(Darmstadt, Germany). 
Ce11 cukures 
Primary cultures of cerebral endothelial cells were prepared from adult porcine brain microvessels 
[19]. The cells were maintained in medium M199, supplemented with 10 % fetal calf serum and 
antibiotics, in a humidified atmosphere of 5 % C02 and 95 % air for 4 days before experiments. 
lmmunohistochemical staining of the cultures using a mouse antibody to human Factor VIII-reiated 
antigen and a secondary fluorescein-labeled sheep anti-mouse F(ab')-fragment demonstrated that the 
cultures consisted of 95 % endothelial cells up to 5 days (data not shown). Human umbilical vein 
endothelial cells (non cerebral endothelial cells) were purchased from Promocell (Heidelberg, 
Germany) and were cultivated in medium MCDB-131 with 5 % fetal calf serum. Cell cultures of 
Passage V were used for the experiments. 
Hypoxia sfudies 
Hypoxic injury was induced by adding sodium cyanide (NaCN) to the culture medium to give a final 
concentration of I mM for periods of 10, 30, 60, 120 and 180 min. Control experiments (normoxia) 
were performed by adding sodium chloride (NaCI) instead of NaCN. Hypoxia in the absence of 
glucose was performed by incubation of the cells with Hanks' Balanced sait solution (HBSS, 145 mM 
NaCI, 5.4 mM KCI, 0.4 mM KH2P04, 3.2 mM Na2HP04, 0.5 mM MgC12, 1 mM CaCI2, 0.4 mM MgS04, 
4.2 mM NaHC03, pH 7.4) without glucose and with 1 mM NaCN. The effed of glucose deprivation 
alone was also tested with HBSS without glucose and 1 mM NaCI. 
Biochernical assays 
We quantified cell damage by trypan blue exclusion method and we deterrnined the protein wntent, 
the release of lactate as well as of lactate dehydrogenase (LDH, EC 1.1.1.27) using assay kits. The 
activities of alkaline phosphatase (ALP, EC 3.1.3.1) and y-L-glutamyltranspeptidase (Y-GT, EC 
2.3.2.1) were measured kinetically by the formation of pnitrophenol at 420 nm and of Ccarboxy- 
anilide at 410 nm, respectively as already described by Meyer ef al. (1991). 
Statistical analysis 
Values are given as means I standard deviation (SD) of n experiments. The one-way analysis of 
vanances (ANOVA-I) and Duncan-test were used for statistical analysis. 
Results 
The percentage of cell darnage increased as a function of time during hypoxia in cerebral endothelial 
cells (Fig. I ) ,  whereas there was no damage in non cerebral endothelial cells under the Same hypoxic 
conditions (data not shown). The deprivation of glucose did not alter hypoxia induced changes in both 
cell types (data not shown). Sirnilar results were found by measuring the release of LDH (Fig. 2) as an 
indication for membrane damage. In addition, we found an increase in the lactate release during 
hypoxia compared to controls in cerebral (Fig. 3) as weil as in non cerebral endothelial cells data not 
shown). Additional glucose deprivation reduced the release of lactate in both cell types (data not 
shown). 
time (niin) 
Fig. 1: The viability of cerebral endothelial cells after cytotoxic hypoxia with 1 mM NaCN 
compared to normoxic controls (time 0). Values are means f CD, n = 10; - P< 0.001; ** P< 0.01; * Pc 0.05 versus controls. 
0 -I 1 a 
0 30 60 90 I20 1 9  180 
time {min) 
Fig. 2: The release of LDH of cerebral endothelial cells after cytotoxi~ hypoxia with I mM NaCN 
(open symbols) compared to normoxic controls (clased syrnbols). Vaiuec are rneans I SD, 
n = 5; P< 0,001 versus controls. 
We also measured for the first time the activities of the marker enzymes of the BBB, ALP and y-GT, 
dunng hypoxia in the presence and absence of glucose. The ALP activity of cerebral endothelial cells 
was 0.522 +I- 0.017 U/mg protein after 4 days in culture with no change during hypoxia. In non 
cerebral endothelial cells the ALP activity was 10 times lower which was also unaffected during 
cytotoxic hypoxia. 
time (min) 
Fig. 3: The release of lactate of cerebral endothelial cells after cytotoxic hypoxia with I mM NaCN 
(open symbols) compared to normoxic controls (closed symbols). Values are means i CD, 
n = 5; - P< 0.001 ; * P< 0.05; versus controls. 
By measuring y-GT activity in cerebral endothelial cells, we found a significant decrease from 3.8 +/- 
1.3 to 1.09 +I- 0.3 after 3 hours of hypoxia in the presence and absence of glucose (Fig. 4), whereas 
the pGT activity in non cerebral endothelial cells was lower with 1.0 +I- 0.3 Ulmg protein under 
nomoxic with no significant change under hypoxic conditions (data not shown). 
Fig. 4: The activity of y-GT of cerebral endothelial cells aller cytotoxic hypoxia with 1 mM NaCN 
(is given in min under the column) in the presence (lefi columns) and in the absence of glucose 
(right columns) compared to nomoxic controls (in the presence of glucose = C; in the absence of 
glucose. = C;). Values are rneans I SD, n = 5; - P< 0.001; ** P< 0.01 versus controls (C,G). 
Discussion 
The eflect of hypoxia on cerebral endothelial ce&s 
In our study, 2 hours of hypoxic injury to cerebral endothelial cells led to cell damage as revealed by 
a decrease in viability by 24 % and a 2.7-fold increase in LDH release as an indication for membrane 
damage. We found no significant differences in the response to hypoxia in the presence and in the 
absence of glucose. Only few data have already been published conceming the effect of hypoxia on 
the BBB in vifro 15, 9, 1 I ]  and the authors have used different cell cultures models (different culture 
conditions, species, cultivation time) and different experimental designs of hypoxia. Our results are 
comparable to those of Mertsch ef al. [9] who measured in porcine brain endothelial cells after 10 
days in culture a reduction in cell viability to 84 % and an increase in the release of LDH by 91 % 
after 2 hours of hypoxia in the absence of glucose compared to controls. Gobbel et al. [11] and 
Plateel et al. [5] investigated the response of cerebral endothelial cells to longer periods of 24 and 48 
hours of hypoxia in the presence of glucose. Plateel et al. 151 have found in bovine brain endothelial 
cells, cocultured with astrocytes and astrocyte-conditioned medium for 12 days, a 50 % decrease in 
the ATP level and some apoptotic processes after 48 hours of hypoxia, but no increase in LDH 
release. Gobbel et al. [ I  I ]  showed that rat brain endothelial cells after 5 - 9 days in culture remained 
viable with no release of LDH up to 24 hours of hypoxia in the presence of glucose, but this 
dramatically changed after 48 hours of hypoxia with 70 % non-viable of all the cells. The mentioned 
studies were performed either in the presence 15, 111 or in the absence of glucoce [9]. Therefore we 
investigated both, the effect of hypoxia in the presence and in the absence of glucose and found no 
difference in the response of cerebral endothelial cells. We suggest that hypoxia itself is mainly 
responsible for the obsewed cell damage. 
In addition, we found after 2 hours of hypoxia an increase in lactate release by 93 % in the presence 
and by 51 % in the absence of glucose. Consistently, Mertsch et al. [9] measured a 30 % increase in 
lactate release in porcine brain endothelial cells after 2 hours of hypoxia in the absence of glucose. 
By measuring the activities of the marker enzymes of the BBB, ALP and y-GT, only the yGT showed 
a significant decrease after 3 hours of hypoxia. In addition to our study, a decrease in the glutathione 
level has already been shown in cerebral endothelial cells after 12 hours of hypoxia [5]. Because yGT 
mediate the transfer of the y-glutamyl residue from glutathione to amino acids, its activity may be 
reduced during the first time of hypoxia to maintain a sufficient level of glutathione as a protecfive 
mechanism. This would also explain why the Wo marker enzymes behave differently to hypoxia. 
However, further study have to clarify the importance of this finding. 
The eflecf of hypoxia on non cerebral endofhelial celk 
In the present study, non cerebral endothelial cells remained viable with no significant increase in 
LDH release even after 3 hours of hypoxia in the presence and absence of glucose. Simiiariy, only a 
2 - 5 % increase in LDH release was found in human umbilical vein endothelial cells [I31 as well as in 
bovine aortic endothelial cells [I61 and in rat coronary endothelial cells 1141 after 2 hours of hypoxia in 
the presence and absence of glucose. It is suggested from these studies that endothelial cells of other 
Organs than brain are relatively resistant to hypoxia regardless of the sipecies and tisssue origin of the 
vessel. 
The Same increase in lactate release as we measured in non cerebrai endothelial celis were also 
found in rat coronary [I41 and porcine aortic endothelial cells 1121 after 2 hours of hypoxia in the 
presence and absence of glucose compared to controls. 
We used sodium cyanide, an inhibitor of the respiratory chain, to study the effect of hypoxia in 
cerebral and non cerebral endothelial cells. Our results conceming the cellular damage are 
comparable with in vitro studies of other authors which were performed under wnditions of Iow 4 19, 
12 - 181. We conclude that the incubation with sodium cyanide is a suitable and easy rnodel to study 
hypoxic injury in cerebral endotheliai cells as the major ~onstituent of the blood-brain barrier. h 
addition, we found that cerebral endothelial ceils are damaged during cytotoxic hypoxia as revealed 
by a decrease in cell viabiiiiy and an increase in the retease of LDH and lactate into the incubation 
medium. In contrast, non cerebral endothelal cells showed no significant changes in cell viability as 
well as in the release of lactate and LDH during hypoxia wmpared to controis. We therefore condude 
that non cerebral endotheliat are fess sensitive to ccyttoxic hypoxia than erebraf endothelial cells. 
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33. Studies on an HPLC Method to Assay the Concentrations of Amines in Brain Micro- 
dialysis Perfusates Based on Naphthalene-2,3-Dicarbaldehyde Derivatization and 
Fluorescence Detection 
G. Voiwieger, R. Bergmann, P. Brust, B. Johannsen 
lntroduction 
The dopaminergic system in the immature brain is very sensitive to changes in tissue oxygen tension, 
as they occur under neonatal asphyxia. The pathogenesis of the resulting brain injury remains un- 
clear. However, it is accepted that extracellular neurotransmitter concentrations and their metabolism 
change during asphyxia. 
To study the dopamine metabolism under asphyxia we-together with the Institute of Patho- 
physiology in Jena - started PET experiments and brain microdialysis in newbom piglets. Brain 
microdialysis is expected to provide information about the changes in endogenous dopamine (DA), its 
metabolites and in excitatory amino acids as well. As a prerequisite, an ultrasensitive and reliable 
method for deterrnination of these substances down to the subnanomolar range was to be established 
(Table I). 
Table I :Reported brain microdialysis perfusate concentrations - in various animal species - of 
pertinent neurotransmitter candidates and some DA-metabolites, all accessible to naphtha 
lene-2,3-dicarbaldehyde (NDA) derivatization (DA dopamine, NE norepinephrine, 5-HT 
serotonin, DOPA 3,4-dihydroxyphenylalanine, 3-MT 3-methoxytyramine, Asp aspartic acid, 
GABA y-aminobutyric acid, Glu giutamic acid, Asn asparagine, Tau taurine, Gly glycine) 
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In the literature HPLC-based methods were used for this purpose, combined with electrochemical 
detection (ECD, for catechols, biogenic amines) or precolumn derivatization and subsequent fiuores- 
cence detection (for amino acids). 
For precolumn derivatization, naphthalene-2,3dicarbaldehyde (NDA) was developed as a rationally 
designed reagent for the derivatization of primary amines including amino acids to allow ultrasensitive 
fluorescence detection [I - 31. The reaction products are cyanobenzisoindole @BI) derivatives 
(Fig. I). 
Fig. I: Readion scheme of the N M  denvatizafion. 
Because of a number of advantages of this particular derivatization method, a procedure based on it 
should be established and adapted to our analytical tasks. 
Thus, the aim of this work was to study the performance of NDA precolumn denvatization 1 HPLC 
analysis of primary amines at concentrations of 10 nM or less. 
Experimental 
All experiments were camed out with the Hewlett Packard HPLC system 1050 in the following 
configuration: pump 79852A, automatic liquid sampler 709855A, fluorescence detector (FLD) 1046A 
and variable wavelength detector (VWD) 79853C, the detectors coupled in the above-mentioned 
series. 
As analytical column a 250x3 mm cartridge LiChroCART with LiChrospher 100 RP-18 (5 um) without 
precolumn was chosen. Various binary and temary gradients (low pressure mixing) were applied, with 
a common phase A (20 nmolll Na acetate, with acetic acid buffered to pH 7.2) and differing phases B 
(and C), consisting of Na acetate buffered solvents (MeOH, MeCN, THF). 
The applied autosampler programs controlled mixing and reaction in three different enclosures: in the 
seat capillary (APSI), in the sample via1 using sample transfer with the needle (APS2) and in the 
sample via1 with indirect fluid movement (APS3). All derivatization experiments were camed out in 
Hewlett Packard 100 yl microvial inserts (polypropylene or glass, HP 5182-0549 or 5181-1270). 
System control and chromatographic data analysis were accomplished with the software ChemStation . 
2D (Hewlett Packard). 
For blank examinations, borate buffer (pH 9.3) was first mixed with cyanide and then with NDA 
solution. Deproteinized plasma (using deproteinization methods 14 - 61, separate or in combination) 
was vacuum-concentrated and dissolved in borate buffer. Stock standard solutions of amino acids 
were prepared by dissolving amino acids in diluted NaOH or HCI, respectively. Serial dilution's were 
then prepared in borate buffer. For precolumn derivatization, dissolved plasma concentrate and 
diluted standard solutions were treated as blanks. 
Resuits and Discussion 
Prior to HPLC separation and fluorescence detection amino acids were derivatized with naphthalene- 
2,3dicarbaldehyde. Wishing to automate the procedure, an autosampler was used. Its use proved, 
however, to cause problems in the form of memory effects (peaks generated by contaminants) and 
insufficient reproducibility. 
The method will be characterized by its background Pattern (A) and reproducibility (C) under routine 
condiiions. Calibration linearity will be verified and the detection limit will be estimated (B). 
(A) chromatographic background and memory effects under routine conditions 
Practically, mixing in seat (APSI) and the two via1 mixing programs (APS2 and APS3) were 
compared. Considerable memory effects occurred with the programs APSI and APS2 (Fig. 2). 
Reasonable low background chromatograms were only achieved with the program APS3 (Fig. 2). 
Fig. 2: Blank chromatograms after some each 
identically handled plasma sample runs, respec- 
tively: (A) with the autosampler program APS3 
after 45 plasma runs (B) with APS2 after 3 p la r  
ma runs and (C) with APSI after 3 plasma mns. 
However, even such low background chromatograms exhibiied characteristic peaks, mich may result 
from reagent contamination's. 
Fig. 3: Examples of calibration runs with different 
concentrations of substance pairs I - V, revealing 
a repetitive structure of the background peaks 
(indicated by arrows); zoomed baseline details. 
Standard substance pairs I - V were combined on 
the basis of their similar Rt values. 
The zoomed baseline in Fig. 3 shows such peaks, indicated by arrows, together with five double 
peaks of five pairs of Standard amino acids. Remarkably, the retention times of the background peaks 
and - to a limited extent - their peak heights are reproducible, thus leaving a structured background 
chromatogram. This structure pattern is most helpful in achieving a low detection limit, expressed as 
3 o of the electronic noise. If they are subracted with the subtracf chromatogram function of the 
analysis soWare, these peaks can be at last ignored. 
(B) Calibration curves and limit of detection 
Calibration runs were performed with the autosampler program APS3 for most proteinogenic amino 
acids and some related compounds. Linear calibration curves were obtained for the concentration 
range from 1 - 70 FM (r > 0.9999). 
Fig. 4 was used for estimation of the electronic noise amplitude G, which was determined to be o = 
0.0036 % F. With the slope of the calibration curve being 1.2 % F / I UM for most substances, the 
detection limit (3 G) was found to be 9 nM. 
The calculated detection limit is valid for a sample dilution factor of 1:4 in the derivatization mixture 
and corresponds to a total injected amount of 22 fmol. By lowering the dilution factor a mass-based 
detection limit of 10 fmol might be feasible. 
Tm- 
In,- 
(C) Method reproducibiiify with plasma samples 
At this stage of the studies, arnino acids (except proline and lysine) in the deproteinized plasma were 
separated and detected photometric absorption (IMID) and fluorescence (FLD) detedion, as 
exemplified in Fig. 5. The reproducibility of the whole procedure, i.e. deproteinization, derivatization 
with the autosampler program APS3 and chromatographic separation, was determined. 
Fig. 4: Zoomed chromatogram detail for the 
estimation of the electronic noise amplitude and 
The large number of peaks makes time-programmed sensitivity switches of the FLD undesirable due 
to baseline shifting. Nevertheless, anaiytes causing a signal overflow in the FLD may be integrated as 
VWD signal, as can be cleariy Seen from a comparison of the two chromatograms in Fig. 5. However, 
an upward extrapolation of the FLD calibration curves is impemissibfe because of tfie individual 
fluorescence quantum efficiencies of eaeh Single analyte. Separate calibration curves are therefore 
necessary for the W D  signals. 
of the detection limit. 
The peak areas of the CBI derivatives of Gln, Gly, Val, Leu W D )  and of Glu, Asn, Carnosine, Met 
and He (FLD) were integrated with the sofhare in the percent area mode. Then the relative standard 
deviations (RSD) of all runs were calculated (Table 2). 
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Fig. 5: Representative W D  (variable wavelength detector) and FLD (fluorescence detector) 
chromatograms of deproteinized plasma (NDA derivatization with autosampler 
program APS3) obtained with a LiChrospher RP-18 (5 FM) 250x3 mm column. 
Only amino acids used for reproducibility studies are assigned. 
Table 2: Reproducibility data obtained for the variable wavelength detector P D )  and the 
fluorescence detector (FLD). VWD: n = 8; FLD: n = 11. RSD = relative standard deviation. 
i-LD signal ratios 
Detector VWD signals FLD signals ("pseudo internal standard") 
I 
I I Carno- Amino acid Gln Gly Val Leu Glu Asn Sine Met Ile I Asn1 Carnl Asn1 Carnl llel Glu Glu Carn Met Met 
Peak area 
mean 123.27 14-21 12.12 5.84 0.68 2-87 2.43 1.25 4.32 4.22 3.61 1.18 1.97 3.51 
[area percent] I 
RSD [%J 1.70 1.40 1.40 1.60 17.56 17-35 12.30 16.92 8.10 0.97 7.23 7.36 12.75 10.40 
More highly concentrated substances, as can be Seen from Table 2, were analyzed with good 
reproducibility. Furiherrnore, this table shows the deterioration of reproducibility with decreasing 
analyte concentration, mainly due to Iimited chromatographic resolution. Better results were obtained 
by the use of intemal Standards within a given chromatogram region. This is also shown in Table 2 by 
declaring peak area ratios (pseudo intemal standard). 
In conclusion it can be said that the combination of precolumn denvatization of amines with 
naphthalene-2.3-dicarbaidehyde (NDA) in combination with HPLC separation and fluorescence 
detection proved to be a promising method if specific background problems are solved as proposed in 
this paper- 
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34. High-Affinity Binding of t~ l~aroxet ine  to Caudate Nucleus and Microvessels from 
Porcine Brain 
P. Brust, R. Bergmann, B. Johannsen 
lntroduction 
The indolamine serotonin (5-hydroxytryptamine, 5-HT) plays not only a role as neurotransmitter in the 
brain, it represents a signal molecule also in various peripheral Organs. A plasma membrane transport 
system that is specific for this biogenic amine has been described in the brain as well as in a variety 
of other cell types including platelets, lymphocytes, placental epithelium and astrocytes [I]. It was 
also found on peripheral endothelial cells in particular in the lung [I]. Eariy evidence for the presence 
of a 5-HT transporter also on endothelial cells of the brain was obtained by studies of Spatz and CO- 
workers who have demonstrated specific energy-dependent uptake of 5-HT into brain microvessels 121 
and cultured endothelial cells [3]. However, the mechanisms of the 5-HT accumulation remained 
unclear. Active accumulation of 5-HT may also be mediated by the sodium-coupled noradrenaline 
transporter [I]. 
In a previous study, we have demonstrated that the tricyclic antidepressant f~limipramine binds 
specifically to endothelial cells of the porcine brain [4] indicating the presence of a 5-HT transporter 
with similarity to the neuronal transport system. However, binding studies in the brain have suggested 
that this ligand interacts with additional binding sites apart from labeling 5-HT uptake sites [SI. 
lmipramine exhibits significant affinity towards a,-adrenergic, histamine, and muscarinic receptors [6]. 
Recently, it was shown that the 5-HT transporter in brain membranes of humans, rats and mice can 
be labeled with the nontricyclic antidepressant [3~]paroxetine [I, 7 - 91. This tracer is a more potent 
and more selective 5-HT uptake inhibior which lacks the disadvantage of a complex binding 
behavior. Only a single class of high-affinity binding sites was demonstrated in both platelets and 
cerebral cortical membrane preparations from several mammalian species [I]. Recently, the kinetics 
of [3~]paroxetine in the rat brain was measured after i.v. injection IIO]. From the data obtained it was 
suggested that the presence of a 5-HT transporter in the cerebral microvessels have reduced the 
effective permeability of [3~]paroxetine in vivo. In the present study, we have used [3~]paroxetine to 
characterize in vitro a specific 5-HT transport system on endothelial cells of porcine brain. in oder to 
prove the similarity of the endothelial transport system with the neuronal transporter we have also 
used membranes of the porcine caudate nucleus, a region in which a high density of 5-HT 
transporters is expected. 
Experimental 
Radioligand binding assays were performed on brain membranes and microvessels from porcine 
brain. Samples of the caudate nucleus were obtained from a local slaughterfiouse. Microvessels were 
prepared from the samples as previously described [4]. They were stored at -20 'C untii use in the 
binding studies. For membrane preparation the brain tissue was homogenized in 10 volumes of ice- 
cold buffer (Tris-HCI buffer, pH 7.4, containing 120 mM NaCI, 5 mM KCI) with an Ultra-Turrax T25. 
The homogenate was centrifuged at 20,000 g for 10 min. The resulting pellet was resuspended with 
the Ultra-Turrax and centrifuged again at 20,000 g for 10 min. After repeating the same procedure the 
pellet was resuspended in 10 volumes of buffer and stored at -20 OC until use in the binding studies. 
All samples were re-homogenized before use. 
Binding of [phenyl-6'-3~]paroxetine (880.6 GBqImmol, NEN) to the tissue preparations was performed 
according to published methods [ I1 - 141. To study the time dependency of specific binding the 
samples (4 ml buffer, 0.5 ml isotope dilution, 0.5 ml microvessel Suspension containing 0.05 mg 
protein) were incubated at 22 'C for nine different times (between 1 min and 120 min) with 0.5 nM 
[3~]paroxetine. An incubation time of 60 minutes was chosen for saturation and competition studies. 
Non-specific binding was determined in the presence of I FM fluoxetine. The binding assays were 
terminated by rapid filtration over GFIB glass fiber filters (Whatman, Maidstone, England) on the 
Brandel cell harvester. The filters were presoaked in 0.3 % polyethylenimine. Following four washes 
with 4-ml portions of ice-cold buffer (see above) the filter paper containing the membrane-bound 
[3~]paroxetine was transferred into 10 ml of liquid scintillation cocktail (Ultima-Gold, Packard), and 
the radioactivity on each filter was counted in a Canberra-Packard liquid scintillation Counter. Aliquots 
of the incubation fluid were measured as well. Corrections were made for binding of [3~]paroxetine to 
the filters. Tracer concentrations between 0.07 and 1.6 nM were used to determine the binding 
Parameters. The Kd and B„ values were estimated directly from the binding data by non-linear 
regression analysis using the program Fig. P (Biosoft, Cambridge, UK) and from the Rosenthal- 
Scatchard plots by linear regrecsion analysis. Increasing concentrations (between 0.01 nM and 1 FM) 
of various unlabeled drugs (paroxetine, fluoxetine, citalopram, clomipramine, imipramine, nisoextine, 
protriptylin, desipramine, serotonin) were competed against a fixed concentration of the radiolabeled 
ligand (0.22 nM). From the competition curves lC50 values were calculated using the program Fig. P. 
From these data K, values were calculated using the following equation: Ki = IC5d(l + [L]IKd), where 
[L] is the free tracer concentration. Hill coefficients were calculated after appropriate linear 
transformation of tha data by regression analysis. Each experiment was repeated at least three times. 
The protein content of the membrane suspensions was measured according to Lowry. The 
enrichment of the capillary fraction detemined by measurement of alkaline phosphatase activity [ I  51 







Fig. 1: Saturation anaiysis of [3Pl]paroxetine binding to membranes and microvecsels prepared from 
porcine saudate nucleus. Filled Squares represent the specific binding of [3~]paroxetine to brain 
microvessels at free paroxetine wncentrations between 0.07 and 1.6 nM. Filled urcles represent the 
speeific binding of [3~]paroxetine on caudate nucleus membranes at Sree paroxetine concentrations 
between 0.05 and 0.7 nM. Data are means i S.E.M. The curves were analyzed by a non-linear faing 
routine (Fig. P, BiosoR, Cambridge, UK). Graphic analysis of the membrane binding data according Xo 
Rosenthal show a Inear piot (inset) in agreement with the existente of a single binding site. Linear 
regression was used to determine the best fE for the Rosenthal plot. 
Results 
Saturation studies 
The equilibrium of specific [3~]paroxetine binding on porcine brain microvessels was reached after 
about 60 minutes (data not shown). Therefore, an incubation time of 60 minutes was chosen for 
saturation and competition studies of both preparations, i.e. membranes of the caudate nucleus and 
microvessels. Fig. I describes the influence of increasing concentrations of t~lparoxetine (0.07 - 1.6 
nM) on the specific binding of the tracer. Kinetic analysis of these binding data, as computed by linear 
regression analysis from Rosenthal-Scatchard plots, yielded a density of binding sites (B„) of 392 
fmollmg and an equilibrium dissociation constant (Kd) of 0.1 1 nM in the caudate nucleus membranes 
and a Bmax of 398 fmollmg and a Kd of 0.53 nM in the microvessels. Moreover, the lineanty of the 
plots indicate the presence of only a single binding site. The values obtained are similar to the values 
estimated from non-linear regression of the saturation curves (membranes: B„ = 382 I 12 fmollmg, 
Kd= 0.10 f 0.01 nM; microvessel: B, = 392 I 59 fmollmg, Kd= 0.47 f 0.12 nM). Hence, the data 
consistently show that the transporter density in both preparations was similar. However, the affinity 
was about five-fold lower in the microvessels. 
Drug inhibifion studies 
A wide range of monoamine uptake inhibitors (Table 1) was used to compete with the specific binding 
of [3Hlparoxetine. In these experiments, the concentration of the drugs varied between 0.1 nM and 10 
PM. Inhibition of [3~]paroxetine binding to caudate nucleus membranes by these drugs revealed 
monophasic competition curves with Hill coefficients close to unity (Table I), additionally indicating 
the presence of a uniform set of binding sites with no cooperativity in this preparation. Paroxetine, 
fluoxetine and clomipramine inhibited the binding with Ki values in the subnanomolar range. All these 
compounds are powerful inhibitors of the 5-HT transporter in brain, platelets and placenta. 
Surprisingly, another substance with high selectivity for the 5-HT transporter, citalopram (Ki = 6-61), 
was less potent than imipramine (Ki = 2.90). Nisoxetine, which is known to be a selective NE uptake 
inhibitor, was still rather potent at the ~~~lparoxetine binding site (Ki = 57.9). This was also the case 
for other NE uptake inhibitors such as desipramine (Ki = 36.1) and protriptylin (Ki = 35.9). 
Table 1: Inhibition of [3~]paroxetine binding on membranes and microvessels prepared from porcine 
caudate nucleus. 
Concentration-dependent inhibiiion of [3H]paroxetine binding to membranes of porune caudate 
nucleus and microvessels was determined at a tracer concentration of 0.22 nM and competitor 
concentrations between 0.01 nM and 10 PM. The concentration of drug required to inhibi binding of 
the radiolabelled Iigand by 50 % (IC5~) was calculated using Fig, P (Biosoft). K, values (meanS 4 
S.E.M. ) were subsequently calculated using the formula K, = IC&(l+[L]lKd) where [L] is the 
concentration of the radioligand and Kd is the equiiibnum dissociation canstant ConStaI'Jt fOr 











A smaller range of compounds was used to charaderize the specific binding of f3Hjparoxetine t0 
isolated brain microvessels (Table I). The data reveal obvious differentes t6 those obtained on the 
caudate nucleus membranes. The Ki values of paroxetine (Kf = 2.48) and imiprarnine (K, = 31.6) wen? 
13-fold and 11-fold higher than those observed at the membrane preparation. Wowever, the K, v a h  
of fluoxetine (K, = 1.53) was only by factrtr 1.7 higher than in the membranes. Most SUI-PI~S~~~~Y, 
Caudate Nucleus Microvessels 
Ki 
0.19 f 0.05 
0.1 9 f 0.04 
0.89 f 0.12 
2.90 f 0.49 
6.61 rF. 0.64 
35.9 f7.1 
36.1 f 3.1 
57.9 f 14.0 
592 f 98 
& 
2.48 f 0.89 
n.d. 
1.53 f 0.48 
31.6 f 12.3 
n.d. 
n.d. 
205 f 145 
n.d. 





















despite the decrease of affinity towards all the selective uptake inhibitors the affinity for serotonin 
(Ki = 28.2) increased by a factor 21 in the microvessel preparation. The Hill coefficients are between 
0.31 (serotonin) and 0.81 (desipramine) indicating negative cooperativity between the binding sites. 
Discussion 
This study has shown that the affinity, but not the density, of [3~]paroxetine binding is diminished in 
brain microvessels as compared with membrane preparations from the porcine caudate nucleus. 
[3~]paroxetine represents a highly selective 5-HT uptake inhibitor without the disadvantage of a 
complex binding kinetics as observed using [3~]imipramine as ligand [4, 11 - 141. In consideration of 
the 100-fold enrichment of the microvessel preparation the data clearly indicate the presence of a 
distinct 5-HT transporter-like protein on the brain endothelial cells. 
There are only a few data describing the 5-HT transporter in pigs. Recently, Erreboe et al. have 
investigated [3~]paroxetine binding in the brain of four different species [8]. The authors found a Kd of 
0.11 nM for the pig, which is identical to our value obtained for the caudate nucleus membranes and 
close to the value calculated for the human brain, but about factor 10 higher than the values found for 
rat and mouse. Also the binding capacities and dissociation rates measured with different labeled 
5-HT uptake inhibitors support the suggestion that there is a greater homology between human and 
pig than between rat and pig [9]. The human and rat transporter proteins are both 630-amino acid 
polypeptides, with 92 % Overall sequence homology [I61 The sequence of the porcine transporter has 
not been evaluated yet. 
The BmaX value measured by Erreboe et al. was 108 fmollmg. However, whole brain minus cerebellum 
was used for the binding studies. This explains the higher Bmax values found in our study, because 
regional differences have to be considered. In human, Bmax values varied among the various brain 
regions between 60 fmollmg (cortical regions) and 250 fmollmg (caudate nucleus) [7, 91. 
There is a number of highly potent inhibitors of the 5-HT transporter such as paroxetine, fluoxetine, 
citalopram, clomipramine and imipramine 112 - 14, 17, 181. The pharmacological profile of inhibition 
of high-affinity [3~]paroxetine binding to platelets or brain membranes by these and other dnigs was 
reported to correlate significantly with the rank oder of potency of the dnigs to inhibit 5-HT uptake 
[12]. Therefore, it is generally accepted that this binding site is associated with the sodium-dependent 
5-HT transporter [I 1, 12,201. Only a single gene appears to encode 5-HT transporter proteins in brain 
and the periphery [161. In our study, the K values obtained with the non-tricyclic antidepressants 
paroxetine and fluoxetine as competitors of [3~]paroxetine binding were lower than the values of the 
tricyclic antidepressants imipramine and desipramine. This finding is in agreement with studies of the 
neuronal and placental 5-HT transporter [I  - 14, 191. On the other hand, citalopram was less potent 
than imipramin which may be due to species differences. In our membrane preparation of porcine 
brain the rank order Of potency found for various antagonists (clomipramine C fluoxetine C imipramine 
citalopram) closely resembles that observed by others in cloned human 5-HT transporters 
(clomipramine fluoxetine citalopram = imipramine) [21] and is different from that found in cloned 
rat 5-HT transporters (clomipramine = citalopram .: fluoxetine imipramine) 114, 211. Therefore, the 
pharmacological profile of various 5-HT uptake inhibitors supports the suggestion that the homology 
between the human and porcine transporter protein is greater than between the rat and pig. 
In the microvessels. the affinity measured for [3~]paroxetine was factor 5 less than in the caudat~e 
membranes. In a previous study, we have measured only a small difference of high-affinity 
[3~]imipramine binding between brain tissue and microvessels (brain: Kd, = 1.0 nM, microvessels: 
&, = 1.6 nM) [4]. The binding capacities in the rnentioned study differed by about factor two, whereas 
the present data reveal Similar B„ values for [=~]paroxetine binding. This indicates that paroxetine 
and imipramine bind, at least partly, to different protein domains as was already suggested by others 
[5, 81. Also, the phamawlogicat profile of V ~ ~ ~ O U S  5HT uptake inhibitors is different in caudate 
membranes and microvessels. All substances, with the notable exception of serotonin, expressed 
bwer affrnity towards the microvessel preparation. The decrease of affinity was smallest for fluoxetine 
(faetor 1.3 and highest for paroxetine (factor 13). Although the Rosenthal-Scatchard piot was linear in 
both preparations the Hill coefficients were different. In caudate membranes afl n~ values were close 
to unity white they were considerably smaller in the microvessels suggesting the presence of an 
additional atlosteric binding site as pmposed p o  in other models F, 8,211. 
Altogether these findings suggest that the [ Hlparoxetine binding sites, expected to represent the 
transport protein for 5-HT, are different or difierently regulated in brain tissue and brain microvessels. 
Interesiingly, sirniiar discrepancie~ were also found in humans. More than two-fold differences in the 
affin@ of paroxcrtine binding were obsewed between various brain regions P, 93. The affinities of 
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Introduction 
Dopamine is a major striatal neurotransmitter. Therefore, it has been given special attention in eariy 
brain disorders. Dopamine in immature brain plays an important role in the mechanisms of 
irreversible disturbances in neuronal metabolism due to moderate to severe brain hypoxia [I]. Age- 
related increases in the density of dopamine D, and dopamine D2 receptors dunng human brain 
development has been described [2, 31. Because the in viv0 dopamine synthesis appears to be 
regulated by Dg receptors 141 one may expect that changes of the rate of dopamine synthesis occur 
dunng brain development. Knowledge of these processes may be of importance for the understanding 
of the genesis of parkinsons disease and other brain disorders. 
However, available information On the catecholamine metabolism in the immature brain is very 
fragmentary. ~-6-f'q fluoro-3,4dihydroxyphenylalanine (FDOPA) has been used as a tracer to 
estimate the activity of the dopamine synthetizing enzyme DOPAdecarboxylase (DDC; EC 4.1 .I -28) 
with positron emission tomography (PET) in human brain [5, 61. The clinical significance of this 
method has been demonstrated P, 83, 
Data allowing insights in the regulation of dopamine synthesis dunng ontogenesis are difficuit to 
obtain in humans. In order to find a useful model, we have performed PET experiments with newbom 
piglets using FDOPA as tracer. 
Experimental 
Six male newbom piglets in age from 2 to 6 days and weighing between 1,8 and 3,2 kg were 
anesthetized with 0.5 % isoflurane in a gas mixture of 70 % nitrous Oxide and 30 % oxygen via 
endotracheal tube using a volume-controlled ventilator. Blood gases, blood glucose and lactate, blood 
pressure, EEG and ECG were monitored before and during the PET study. No statistically significant 
differences were found (data not shown). 
Cerebral blood flow (CBF) was measured using the reference sample method with coloured 
microspheres and was calculated from the following formula: CBF = (At X Qr)/(Ar X Wt)xlOO, where 
At, Q ,  Ar Wt are tissue absorption, reference blood withdrawal rate, reference blood absorption and 
tissue weight. 
Cerebral blood volume (CBV) was measured in separate animals of the Same age after i.v. injection 
of 20 - 30 MBq 9 9 m ~ ~ 0 i  in saline under the Same conditions as descnbed. Euthanization by i.v. 
injection of saturated KCI occured 5 min after injection. CBV was calculated from the following 
formula: CBV = (At X Wb)l(Ab X Wt)xlOO, where At, Ab, Wt, Wb are tissue activity, blood activity, 
tissue weight and blood weight. 
PET studies were performed using the positron emission tomograph POSITOME lllp (Montreal 
Neurological Institute). The 2-ring tomograph acquires three slices with an axial slice thickness 
(FWHM) of 15 mm, a spatial resolution (transaxial) of 11 mm and an axial field of view of 5 Cm. 
Attenuation correction was performed using transmission scans with two rotating 6 8 ~ e  point sources. 
FDOPA was produced according to the destannylation method 191 by direct fiuorination of the tin 
precursor with ["'F]F~ simplifying the procedure (to be published). The process takes 40 min, the 
overall decay corrected yield is in the range of 16 to 20 %. 
A total of 30 - 50 MBq FDOPA in 5-10 ml saline was injected into the lower caval vein over 1 min with 
an automated infusion pump. Emission scanning began simultaneously with the start of FDOPA 
injection. Dynamic scan data were acquired in list mode between 0 and 120 min with 35 frames 
between 30 and 600 s each. The time Course of plasma ' 8 ~  radioactivity was detennined by arterial 
blood sampling from the abdominal aorta. Twenty five 15 sec samples and fifteen I min samples 
were taken by a precision peristaltic pump. Nine discrete samples were taken during the remaining 
time penod. The samples were stored On ice and centrifuged to obtain plasma. Plasma activity in 
100 PI was measured in a well counter (COBRA 11) cross-calibrated with the tomograph. In additional 
nine blood samples taken at 2, 4, 8, 12, 16, 25, 50, 90 and 120 min p.i. plasma metabolites of 
FDOPA were measured using HPLC with radiochemical detection. 
The HPLC-system consisted of a Hewlett-Packard 1050 pump with autosampler (0.5 ml sample loop) 
and a flow-through radioactivity detector (Flow One Beta A 100, Caberra Packard) with high y-y 
coincidence detection efficiency. A C1 8 reverse-phase column (125 X 4 mm, LiChrospher 100, 5 pm) 
and a preguard column (4 X 4 mm, LiChrospher 100, 5 pm) were used for separation of metabolite 
peaks with the following eluents: A: H20 (0.1 % acetic acid), B: Acetonitril:H20 = 80:20 (0.1 % acetic 
acid) at a flow rate of 1 mllmin and a temperature of 30 "C (start: A:B = 100:0, end (15 min): A:B = 
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Fig. 1: Local cerebral blood volume and cerebral blood flow (CBF) in newborn pigfets (means tt S.D.). 
CBF was measured before and during the PET study. No significant differences were found. 
I49 
Results 
The values of CBV measured in separate animals are shown in Fig. 1. The data varied between 1 .I 8 
ml I 00g-' (white matter) and 3.41 ml 1 00g" (pons/medulla oblongata). They were given as a constant 
parameter in the fitting routine which was used to estimate the transfer coefficients of FDOPA. 
The CBF was measured before and simultaneously with the PET study (Fig. I). No significant 
differences were found between these two measurements. The values during the PET study varied 
between 40 ml 100 g-' min-' (white matter) and 84 ml 100 g-' min-' (mesencephalon). The respective 
data were used to calculate the regional permeability-surface (PS) product of the blood-brain barrier 







Fig. 2: Relative amounts of FDOPA metabolites in porcine plasma as function of time based on 
HPLC-determined plasma fractions of six piglets (means f S.D.). 
The distribution of FDOPA metabolites in plasma was measured by HPLC (Fig. 2). From the plasma 
time-activity curves of FDOPA and OMe-FDOPA the rate constants of peripheral synthesis (koD = 
0.0080 + 0.0014 min-') and elimination (k.lM = 0.0009 -: 0.0010 min-') of OMe-FDOPA were 
calculated. The plasma input function for the estimation of FDOPA transfer coefficients was obtained 
by wrrection of the plasma time-activity curves of "F with the fraction of metabolites calculated from 
the HPLC data. 
The distribution of radioactivity occurs between the intravascular space, the extravascular precursor 
pool and the metabolite compartmenit and is described by nine transfer coefficients [5, 61. This 
includes transfer coefficients for OMe-FDOPA since this compound is able to Cross the blood-brain 
barrier. This complicates the estimation of separate rate constants for FDOPA. Our estimation of the 
Parameters for blood-brain and brain-blood transfer, K, and k, (Table I), inciudes both FDOPA and 
OMe-FDOPA which is expected to result in an overestimation of the FDOPA precursor pool and an 
underestimation of the decarboxylation rate of FDOPA k3. 
Table I: Kinetic transfer coefficients of accumulation in the brain, partition volume (V,) 
and PS-product of blood-brain transfer in newbom piglets 
Transfer coefficients of FDOPA were obtained from brain time-activity curves of six individual 
experiments (Fig. 3) and the respective plasma input functions The values of Kl, k2 and k3 estimated 
in the striatum are 19 %, 45 % and 46 % higher than in the frontal cortex. The rate constant k4, which 
accounts for the clearance of labelled metabolites from tissue, is similar in frontal cortex and striatum. 
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Fig. 3: Normalized time-activity curves (n = 6) of '%F in plasma and brain of newbom piglets. 
Discussion 
We have measured the cerebral uptake and metabolism of FDOPA in newbom piglets in order to find 
a useful model to study the regulation of the dopamine synthesis during ontogenesis. There is a lack 
of data related to this aspect of dopamine synthesis. On the other hand, conflicting data regarding an 
influence of normal aging on the presynaptic nigrostriatal dopaminergic function exist [IO]. 
FDOPA is a potential substrate for DDC the ultimate enzyme in dopamine synthesis in terminals of 
the dopaminergic nigrostriatal pathway [?I, 121. From in vitro data it is expected that DDC activity is 
in great excess with respect to the synthesis of dopamine and that tyrosine hydroxylase is the rate 
limiting enzyme because it is nearly saturated with tyrosine [for references see 121. Despite this there 
is evidence that the activity of DDC is modulated by neuronal activity [13, 141 which may be related to 
the rate-limiting step in the synthesis of 2-phenylethylamine, a putative modulator of dopamine 
transmission. 
Until now there were no data available about the FDOPA metabolism in pigs. Using HPLC we have 
identified in plasma the major metabolites of FDOPA. In rats and humans [II, 15, 161 FDOPA 
undergoes a rapid metabolism by 0-methylation (k,4 which mainly reflects hepatic COMT activity. In 
our study a methylation rate was estimated which is 40 % and 90 % less than those observed in 
humans [5, I61 and rats [ I  I], respectively. The rate constant of elimination of OMe-FDOPA (k,M), 
which presumably is related to renal elimination, is about 50 % smaller than in rats but comparable to 
humans. 
Our values for Ki and k2 are about 50 % - 80 % higher than those in rats and humans [6, 171 which 
may be due to the inclusion of OMe-FDOPA in our estimation. It is reported that the blood-brain 
transfer (KI) and brain-blood transfer (k2) of OMe-FDOPA is about twice of FDOPA [17]. Jhe average 
value of the decarboxylation rate constant (k3) in striatum was 0.036 min-' which is close to values 
measured in the striatum of adult humans 15, 6, 181. We expect our value to be underestimated from 
the reason mentioned above and because of the partial volume effect which is related to the rather 
low spatial resolution of the tomograph. This may also explain the low ratio of k3 beiween stdatum 
and frontal cortex. We have found about 50 % higher rate of decarboxylation in striatum than in 
frontal cortex. In humans a five-fold difference was found [5, 183. 
We conclude that PET measurements with FDOPA may serve as a usefui tool to estimate the activity 
of DDC in the immature porcine brain. Some of the limitations of the present study will be overcome 
by future use of a tomograph with a higher spatial resolution and by inclusion of separate input 
functions of FDOPA and OMe-FDOPA. 
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lntroduction 
Because of the usefulness of 6-["~]fluoro-L-DOPA (V'F]F-DOPA) for assessing dopamine 
metabolism, [~'FIF-DOPA is one of the standard PET radiopharmaceuticals [I, 21. But in contrast to 
[~'F'JFDG, a method which yields large amounts of [ 2 8 ~ ] ~ - ~ ~ ~ ~  is not yet available despite enormous 
efforts [3, 41. 
Based on the regioselective destannylation method by Namavari et al. [3], we went to improving, 
simplifying the procedure and increasing the yield. Since 1994 we have been producing [~'FIF-DOPA 
for investigation of the effects of asphyxia and dopamine metabolism in newborn piglets. 
Experimental 
An apparatus for routine production based on electrophilic reaction was set up. 
The schematic layout of the ["F] F-DOPA preparation unit is shown in Fig. 1. 
""TL Pumpe 0,144 M WHAc, pH 4,7 
Heizung mit 
Them~ekmcnt 
Fig. 1 : Schematic presentation of the apparatus for routine production of ~'F]F-DOPA 
The device consists of two main parts, the processing unit situated inside the hot cell and its control 
unit. A pump and radiation monitors are used in addition. All park of the processing unit, such as the 
reaction vessel, purification columns, electro-magnetic and electric stream selection valves, fittings, 
tubes, a waste absorber, electrical and tube conneciors, Geiger-Müller tubes and the manorneter, are 
mounted on a stainless steel housing. The processing unit is remote controlled by the control unit. The 
PTFE tubes for the target gas, the compressed N2 (for delivering the liquids), and the U ~ S S ~ ~ S  
containing the liquids needed for the synthesis are wnnected to the syslthesis unit by tuer adapterc. 
t8FJF2 is produced by the 20~e(d,a)'8~ reaction, using the 13.5 MeV deuterons of the Rossendorf 
cyclotron U-120 with Ne + 0.2 % F2 (100 pmol) as target gas. The target gas is forced by its own 
pressure (2 MPa at the beginning) through the transporting capper tube (about 500 m). After being 
discharged from the target by its own pressure, the f ' 8 ~ ] ~ 2  is transported to the synthiesis unit using N2 
as a camer gas with a pressure of 0.5 MPa. 
AI1 parts of the equipment which come into contact with the precursors and the radiopharmaceutical 
are newly assembled for each production cycle from sterilized glassware and tubing. Before using the 
equipment, the liquid system and especially the chromatographic columns are cleaned by washing 
them with sterilized water to ensure that the system is free of endotoxins (apyrogenicity). 
To increase the efFiciency of absorption, the ["F] F2 is absorbed in a special Vigreux absorption 
column containing a precursor solution of 60 mg N-formyl-3,4-di-boc-6-(trimethylstanny1)-L-DOPA ethyl 
ester in 15 ml trichlorofluoromethane (CFC13, freon 11). This arrangement also makes it possible to 
measure the starting activity by a dose calibrator. Under these conditions the reaction between the 
precursor and the gaseous f8F]F2 takes about 13 minutes. The volume of the solvent is reduced to 
about 5 ml by evaporation during absorption. 
After absorption of [ 1 8 ~ ] ~ 2  2.5 ml48 % HBr are added and thic mixture is transferred into the reaction 
vessel. The temperature is increased to 70 "C while the remaining solvent is evaporated by blowing in 
gaseous N2 . After evaporation the temperature is increased to 130 "C for 5 minutes to reach the 
conditions for hydrolysis. 
After hydrolysis the reaction mixture is directly transferred to the 5 ml loop by on-line filtration through a 
0.22 pm filter without any treatment. After cooling down for 2 minutes the product is injected into the 
HPLC column. 
Conditions for preparafive HPLC: 
- column: 
- guard column: 
- sample volume: 
- injection loop: 
- eluent: 
- flow rate: 
- pressure: 
- detection: 
RP-18, LiChrosorb, 7 pm, 250 mm X 10 mm, 
LiChrospher RP-18,5-20 Pm, 30 mm X 9 rnm, 
2.5 ml, 
5 ml, 
105.6 mM of CH,COONa and CH3COOH, pH 4.7, 
isotonic, prepared with sterilized water, (aqua ad iniectabilia), 
3 mllmin, 
about 6 MPa, 
UV, I mm path length, 280 nm, 
radioactivity. 
Fractionation of the eluent in the foreruns and [ ' 8 ~ ] ~ - ~ ~ ~ ~ - f r a c t i o n  is arried out by monitoring 
radioactivity and the UV-signal on the outlet of the colurnn and by switching the stream selection valve 
accordingly. 
The main radioactive peak ( f 8 F I F - ~ 0 ~ ~ )  is eluted after about 11 minutes. The sterilization of the final 
product is achieved by sterile filtration of the eluent. 
According to the rules of good manufacturing practice (GMP), quality control of the final product is an 
essential part of the quality assurance of radiopharmaceutical production. The product has only been 
characterized by HPLC, GCIMS, pH and Osmorneter, because d its use for animal experiments. 
Results 
The total preparation tim:of PFIF-DOPA after EOB. including the radionuclide transport, takes about 
40 minutes. The total [ F]F;FOPA yield is between 30 and 35 % (decay wrrected) with good 
reproducibility. Starting from [ @F, a rnaximum yield of 50 % can be achieved due to the chemical 
background. Depending on the s t a l g  activity up to 1 GBq is availabk. 
The processing unit enables the [ @F-DOPA synthesis to be repeated twice without handling the 
processing unit in the hot celf. For an effective transport of the f8flF2 over a distance of 500 rn, the 
copper tube must be precondiiioned with cold F,. 
The in-line process control involved includes the monitoring of ithe reaction vessel temperature, of the 
radioactivity ievel on the transporting tube and of the reaction vessel as well as the pressure of the 
HPLC pump during Zhe whole procedure. Fig. 2 shows the process data of the seven integrated 
Sensors. 
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Fig. 2: Process data during ['?~F-DOPA preparatbn 
The product is characterized by the following quality Parameters: 
Parameter Method Limit Averacie value 
- Kadiochemical purity: HPLC >95 % > 98 % 
- Chemical purity: HPLC [F-DOPA] =- 95 % =- 98 % 
GCIMS [Freon 1 I ]  C 50 pglml C 3 pg/ml 
[Ethanol] C I mglrnl 10 pglrnl 
[Acetonitrile] C 50 pglrnl C 25 pglml 
- Pharrnaceutical PH 4 - 5  4.7 
pararneters: Osrnolality 280 - 320 mOsmol1kg 304 rnOsmol1kg 
The pH value of the eluent plays an irnportant role and should not exceed 5, otherwise the final product 
is not stable enough and the colour of the solution becomes light violet. 
The F-DOPA concentration was found to be between 1.5 and 2.5 pg/rnl depending on the cold F,- 
concentration of the target gas. 
We will shortly be setting up an automatically controlled synthesis unit for f 8 F ] F - ~ 0 ~ ~  production. 
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I 37. Modified Access t o  the Thioester Precursor of f lC](+)-~~~-5652-z  
J. Zessin, J. Steinbach 
lntroduction 
In the early eighties Maryanoff and CO-workers 11-31 synthesized a number of hexahydro-6- 
arylpyrroloisoquinolines (I) as potential antidepressants. Some of them are potent inhibiors of the uptake 
sites of dopamine, norepinephrine or serotonin (5-HT) and regulate the concentration of these 
neurotransmitters in the synaptical clefi. Such compounds can therefore be used as antidepressants. 
i i i .  1. General stnicture of pyrroloisoquinoline antidepressants 
Especially the compound McN-5652-2 (1, R = 4-S-Cl49 was identitied as a highly potent blocker of the 5- 
HT uptake site. This is reflected by a K, vaiue in the nanomolar range for inhibition of rfl5-HT binding to 
rat cerebral cortex. For example, K, of the racemic trans compound is 0.6 nM [4]. This is a prerequisite for 
its use as an "C labelled radiotracer for positron emission tomography (PET) [5]. Thii radiotracer can be 
used for studies of the serotonergic neurons in the case of depresions, suicidali or drug abuse. 
In cornparison to other potential PET radioligands for imaging the 5-HT uptake sites, such as 
rlC]citalopram or rlC]fluoxetine, riC]McN-5652-Z (racemic mixture) shows a saüsfactory ratio between 
hypothalamus and cerebellum. it reached 4.6 in the brain of mice after 90 min 161. Consequently, 
[llC]McN-5652-Z is known to be the most potent PET tracer for imaging the 5-HT transporter. 
The selecüvity of the inhibiion of serotonin uptake sites is strongly dependent on the stereochemistry of 
McN-5652. Of the four diastereomers and enantiomers the trans-(+)-6S,lObR compound ((+)McN- 
5652-2) has the highest potency as a 5-HT transporter blocker [4,7. In the case of injection of the 
radiolabelled enantiomerically pure rlC](+)McN-5652-2 into mice, the hypothalamus-to-cerebellurn ratio 
increased to 6 [8]. In the human brain the midbrain-tocerebellum ratio was 1.8 ((+)-enantiomer) after 
11 5 min 191. 
The radiotracer CIC]McN-5652-2 was prepared by S-methylation of normethyl McN-5652-2 with 
[llC]methyl iodiie [5,lO]. Thii precursor can be synthesized by demethylation of authentic McN-5652-Z 
with sodium thiomethoxide and subsequent esterification w%h aceiyl chloride to stabiliie it, 
The demethyiation reaction was canied out in dimethylformamide at 160 "C. Under these condiions this 
readion was accompanied by a cis-trans isomerization. After I h, the time needed for complete cleWage 
of the thiiether, a mixture of neariy 40 % trans diastereomer and 60 % cis diastereomer is obtained. This 
ratio represents the equilibrum concentrations and does not depend on the initial isomer ratio. In thic WaY 
the yield of the biologically a&e diastereomer is remarkably reduced. 
For #is reawn we developed an -mproved synthetic route based on the demethylation of McN-5652-2 wlth 
sodium amide (sodium in liquid ammonia). The isomerkation reaction was strongly supprecced in ttiis 
synthecic. Starb'ng with the pure trans diastereomer of McN-5652-Z, the yield of the trans compound was 
increased up to a b u t  80 %. 
Experimental 
General 
Reagents and solvents were obtained from Aldrich, Fluka and the BAYER AG. N-Vinyl-2-pyrrolidinone 
was freshly distilled before use. All other substances were used without further purification. 
(+)McN-5652-Z, general procedure 
The authentic McN-5652-Z 1 was prepared in a nine-step synthesis as described by Maryanoff and co- 
workers [2, 131. The synthetic route is represented in Scheme I. 2-Phenylpyrroline (4) was synthesized 
according to Jacob [ I  I]. 4nnethylthiomandelic acid (6) was prepared as described by Compere 1121. Most 
of the intermediate products in the following steps were used without further purification. Differences frolm 
this general synthetic route for 4,9 and 11 are described. 
Scheme 1. Scheme of McN-5652-Z synthesis 
2-Phenylpyrolidine (4) 
The hydrogenaüon of 2-phenyipyrroline was performed by dimethylamine borane, following the procedure 
of Billman ef al. [ I  51. 
A coluiion of freshly distilled 2-phenylpyrroline (3) (0.37 mol, 54.2 g) in acetic acid (1 00 ml) was added to 
a coluöon of boranedimethylamine complex (0.42 mol, 25 g) in acetic acid (1 00 ml) at 20 "C. This mixture 
was stirred for 4 h at room temperature. 
Sodium hydroxide solution (4 M) was added to the cooled reacüon mocture until a pH of 12 was reached. 
The temperature was not allowed to exceed 30 "C as 2-phenylpyrrolidine may reacted with acetic acid to 
the acetamide of 4. The resulting suspension was extracted three times with ether, the combined organic 
extra& were dried vvith d i u m  sulphate and the solvent was removed in vacuo. The residue was distilled 
under vacuo. 
Meld: 48.4 g (88 %) colourlecs iiquid 
Boiling point: 123 - 125 "Cl 3.5 kPa 
Melting point of picrate: 149 - 150 "C (from EtOH) 
(*)McN-56522 
Phe hydroxy lactam 9 was purified by flash chromatography (silica gel60, petroleum etherlethyl aceta~te, 
1 a4). After the next Wo steps the final product 1 (R=WCHJ was flash chromatographed (silica gel60, 
petroleum etherlethanofl dichloromethane 22.511515) to afford McN-5652-2 as a light brown viscous oil. 
The ratio between trans and cis isomer was 92:8 (determined by HPLC). 
For resoluüon purposes purified McN-5652-Z and (+)-L-tartaric acid (molar ratios) were cornbined in hot 
acetonibile and allowed to stand at ambient temperature for one week. The recovered solid was 
recrystallized two times from acetonibile to give light brown needles. 'H NMR of the free base with 
Mosher's acid confirms the enantiomeric puritiy of the resulüng (+)McN-5652-Z. 
Thioester precursor 11 (sodium thiomethoxide route) 
The synthesis pathway, which contains the demethylation of 1 and acetylation of the free thiol, is depicted 
in scheme 2. 
Scheme 2. Synthesis of the thioester precursor 
NaSCH3 in DMF or 
Na in liquid NH3 _______, 
Purified McN-5652-Z (0.34 mmol, 100 mg), sodium methoxide (2.4 mmol, 170 mg) and dry DMF (I ml) 
were combined in a reaction vessel, which was sealed and purged with argon. The reaction mixture was 
heated to 160 "C for 60 min and cooled to ambient temperature. A tenfold excess of acetyl chloride was 
added while cooling the solution with icehater. The resulting suspension was stirred for some minutes at 
room temperature and then quenched by addition of water by cooling with icehater. The thioester was 
ex3racted with dichloromethane, the combined organic phases were washed with water, dried with sodium 
sulphate and the solvent was removed under vacuo. The residue was purilied according to Mathews 1141 
by means of semipreparative HPLC (Macherey&Nagel Nucleosil Cl8, 7 Pm, 250 mm X 10 mm). The 
eluent concicis of a mixture of acetonittile and water (30/70) with 0.1 % trifluoroacetic acid. Because of this 
purifidon route, the thioester 11 was obtained in the form of the more stable ammonium trifluoroacetate. 
Thioester precursor 11 (sodium-liquid ammonia route) 
Sodium (1.7 mmol, 40 mg) was added to liquid ammonia (25 ml). (+)McN-5652-Z (0.5 mmol, 150 mg) 
was dissolved in 8 ml dry THF and was added to the sodium amide suspension. Two further porüons of 
sodium (2 times 1 mmol, e. g. 23 mg) were added and the deep blue suspension was stirred for 10 min. 
When the colour was stable, the excess of sodium amide was discharged with a small amount of solid 
ammonium chloride and the ammonia was evaporated. Otherwise further addition of sodium was 
necessary. 
An excess of acetyl chloride (40 mmol, 3.3 g) was added to the resulting solution of the free thiol while 
cooling with iced water. The suspension was stirred for 3 - 4 min at room temperature and then water 
(20 ml) was added. The thioester was isolated and purified as descnbed above. 
Yield: 80 mg (38 %) Siht brown, hiihlyviscous oil 
NMR data: 6, (75.475 MHz; solvent: CDCI,; internal standard: TMS) 21 .62.CH2 (Cl or C2), 30.25 CH3 
(Ac), 31 -61 CH, (C2 or Cl), 42.75 CH (C6), 53.31 CH, (C3 or C5), 55.86 CH, (C5 or Cs), 
62.22 CH (ClOb) 126.60,128.03, 128.08,128.34,128.88,129.74,131.15,133.77,135.17, 
140.04 (aromatic carbons), 194.0 CO (Ac), a quadruplet between 110 and 121 ppm and a 
singlet at 161 ppm (broad signals) were assigned to the trifluoroacetic acid 
McN-5652-Z from thioester 11 
A small amount of the thioester (30 mg) was hydrolysed with tetrabutylammonium hydroxide (250 PI 0f a 
1 M solution in methanoi), dissohred in DMF after 10 min and methylated with methyl iodide (6 Pi). The 
product was isolated by ex-traction with dichloromethane. The residue (18 mg) was used for 'H NMR 
investigation of the enantiomeric puriiy- 
Resuits and Discussion 
In the synthesis of the thioester precursor 11 the compound McN-5652-Z 1 was demethylated with sodium 
amide in liquid ammonia. In contrast to the demethylation performed with sodium thiomethoxide, this new 
synthesis required very low reaction temperatures and shorter reaction times. These conditions 
suppressed the undesirable isomerization. As a result the share of the highly specific binding trms 
diastereomer was clearly increased. Instead of the nearly 40 % yield as obtained by the sodium 
thiomethoxide route, about 80 % were now reached. This is demonstrated in Fin. 2, which compares the - 
HPLC chrornatograms of the products of both reaclb'on pathways. 
Fg. 2. HPLC chromatograms of normethyl McN-5652 obtained after dernethylation 
with sodiurn methoxide (above) and with sodium in liquid arnmonia (below) 
The percentages of the diastereomers are strongly dependent on the implementation of the reaction. 
When the demethylation is not complete, the ratio of the diastereomers rernains unchanged. After 
complete formaüon of the üiol, excess sodium amide causes isomerization. Consequently, demethylation 
and isornerization are consecutive reactions. For thic reason sodium should preferably be added to the 
reaction momire in portions. The end of demethylation can be recognized when the blue colour does not 
disappear within 10 to 15 rnin. Excess sodium amide must then be removed to avoid greater changes in 
the diastereorner ratio. 
W is afso possible that both reactions run as a compeütive reaction. In this case the isomenzation must be 
a very stow reaction in comparicon with the cleavage of the thioether. 
Asmall amount of the (+)thioecter precumr 11 was hydrolysed by tetrabutylammonium hydroxide and the 
thiol generated in siki was methylated with rnethyl iodiie. The 'H NMR spectrum of the recovered McN- 
5652-ZM Macher's acid indicates no racemization during the dernethylation with sodium amide in liquid 
ammonia. 
The thioester precursor obtained by the new synthetic route was also used in the synthesis of ~CIMGN- 
5652-2 as described by Suehiio etal. [I01 and gave comparabie radiochemical yieids of rlC]McN-5652-Z. 
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38. Substances Labelled in Metabolically Stable Positions: 
The Conversion of Pyrylium Salts with Nitro-flC]methane - a New Method for the 
Synthesis of N.C.A. "C-Ring-Labelled Nitroaromatics 
P. Mäding, J. Steinbach, H. Kasper 
lntroduction 
In earlier Papers we descnbed the labelling of the following benzenoid compounds with "C in their rings 
by reaction of pentamethinium salts with nitro-["Clmethane: nitro-[l-llC]benzene [I], 3-nitro-[3-"C]anisoI 
[2], 3-ni&0-[3-~'C]toluene and 4-nitro-[4-"C]toluene [3]. These syntheses are based on using the pnnciple 
of the synchronous six-electron cyclization of hexatriene systems into aromatics. However, this reliable 
method has Iimitations due to the availabilii of the nonradioactive precursors 141. 
We therefore investigated a new possibiii of synthesizing substituted nitro-[I-I1C]benzenes. The conden- 
sation of 2,4,6-bisubstituted pyrylium salts with nitrornethane into rnany aromatic 2,4,6-trisubstituted nitro- 
compounds according to Equ. 1 has been known for a long time [5-81 but was not used for labelling with 
the carbon isotopes "C, I3C or "C: 
+ t-BuOK t-BuOH qR Equ. 1 - KX; - H20 R 
NO2 
Although thii rnethod was not described for syntheang psubsütuted nitrobenzenes, we tried to apply it 
for prepanng 4-nitr0-[4-~~C]anisole by condensation of Crnethoxypyrylium perchlorate [9] with nitro- 
["C]methane according to Equ. 2: 
* 
(Xoi + .$-NO2 
+ base W & =  Equ. 2 
- base-HC104; - H20 * 
I 
NO2 
In this way Cnitr0-[4-~~C]anisoie was surprisingly obtained by ucing reaction conditions which are not 
deccribed in the Sierature. Thii was the reason for further investigations in view of the "C-ring labelling of 
two 2,4,6-trisubctituted nitrobenzenes. 
Experimental 
Materials 
For idenüiication of the labelled cornpounds by HPLC the following reference substances were used: 
nitrornethane 99 %, 44ioanisole 97 % (Aldnch, Germany), 2-nitromesiiylene 99 % (ABCR GmbH &. Co., 
Germany) and 2,6-dimethyl4methoxy-nitrobenzene (synthesized according to [8]). 
HMPT, t-BuOK and BuLi (1.6 M in hexane) were purchased frorn Merck, Germany and had for synthesis 
quaiii. Bu4NFSH2O (purum) and Bu4NF on silica gel(l.l rnmol F-/g resin) were obtained from FLUKA, 
Germany, t-BuOH (99.3 %) from Aldnch, Germany. 
Analysis 
To detemine the extent of conversion and the radiochernical pur@ and to identify the products, an HPLC 
system (JASCO) was used, including a pump, a Rheodyne injector with a 20 pI loop, a LiChrospher 100 
RP-I 8 endcapped column (5 prn, 150 rnm X 3.3 mm, Merck) and a W detector coupled in senes with a 
radiiadbitydetector FLWNEWeta 150TR (Canberra Packard). The HPLC analyses were carried out at 
a flow rate of 0.5 rnYmin with ihe following linear gradient of the eluents: 0 rnin - 70 % bufferl30 % MeCN; 
10 min - 0 % bufferliO0 % MeCN; 20 min - 0 % buffer/100 % MeCN; buffer = phosphate buffer pH 7 
(cpaH,POJ = 0,26 mM; cfNa,HPO J = 0.51 mM). 
Synfttesis ofreference substance 
2,6-dimeö,yI-4-mefhoxy-nbbenzene: A suspension of t-BuOK (0.946 g = 8.4 rnrnol) in t-BuOH (I 5 rnl) 
was slowly added to a solution of 2,6dirnethyl-4-rnethoxypyrylium perchlorate (1 g = 4.2 rnrnol) in nitro- 
rnethane (1 0 rnl = 185 mrnol) with an orange colour appeanng. The reaction mucture was heated under 
reflux for 45 rnin. The potassiurn perchiorate separated in the reddish brown reaction mixture was then 
filtered through a frit glass filter. The filtrate was evaporated and the residue recrystallized frorn a mixture 
of methanol and water (2 : 1,15 rnl). Pale needles, yield: (0.3 g, 39.5 %). 
Melüng point: 47.6-50.6 "C (lit. m.p. 49.5-50.5 "C [8]). 
NMR data: 5, in ppm (200.13 MHz; solvent CDCI,; standard SiMe,) 2.24 (6 H, s, 2 CH& 3.73 (3 H, s, 
OCHJ, 6.52 (2 H, s, 2 CH) 
b,in pprn (75.475 MHz; solvent CDCI,; standard SiMeJ 18.4 2-CH, and 6-CH,, 55.5 4-OCH3, 
113.8 CH (C3), 132.4 C (C2), 145.5 C (Cl), 160.0 C (C4) 
"C-ring labelling of the nifrobenzenes 
The gaseous nitro-riC]methane produced according to [I] was introduced into a mixture of 250 pl HMPT 
or t-BuOH and 8 - 9 mg (38 p o l )  pyryliurn salt. The bases t-BuOK and Bu,NF were added either before 
or after trapping the nitro-["Clmethane (see Table 1 with the appropnate footnotes), whereupon the well 
sealed vessel was heated at 120 "C for 20 rnin. 
Resuits and Discussion 
The radiochernical yields (decay-corrected) of the substituted nitro-[l-llC]benzenes synthesized according 
to Equ. 3 under vanous reaction condiions are listed in Table 1. 
Table I: Radiochernical yields of substituted nitro-[l-ilC]benzenes under various reaction condiions. 
General conditions: 38 pmol pyrylium salb (8-9 rng) in a solvent (HMPT or t-BuOH), addion 
of a base (t-BuOK, Bu,NF. 3H20) e-Wer before or atter trapping the nitro-[llC]rnethane, reac- 
tion temperature: 120 "C, reaction time: 20 min 
Arnounts of solvents and bases Radiochemical yields of the nitro-fl-ilC]benzenes 
(decay-corrected) [%] 
HMPT t-BuOH t-BuOK Bu,NF R1,R2=H; Ri,R2=Me; 
C 3H20) R3=OMe R1 ,R2, R3=Me R3=OMe 
[PI] wl tprnor] bm'4 
- 250b) 76b) - 8') Oc) - 
- 250b) 38b) - - 
* addiion after trapping of nitro-f 'Clrnethane 
b' addiion before trapping of nitro-PClrnethane 
") reaction temperature: 100°C 
* addion as 1 M soluüon in t-BuOH 9 beside 57.7 % of TiC]CH3N02 
use of Bu,NF on sifica gel 9) beside 57.3 % of ~1CjCH30N0 
With 8 mg 4-methoxypyrylium perchlorate (38 pmol) in 250 pI HMPT and addition of 25 p1 1.6 M BuLi in 
hexane (40 ymol) before or after trapping the nitro-rlC]rnethane, 4-nitro-[4-"C]anisole was not obtained 
by heating this reaction m'octure at 170 "C for 10 min. 
Potassiurn tert-butylate in tert-butanol proved to be necessary for this condensation reaction, and tetra- 
bu3qlammonium fluonde is a suitable audiary base . 
The best resultc in terms of extent of conversion were obtained by the synthesis of 4-nitr0-[4-~~C]anisole. 
It could be shown that the order of addiion of the bases concerning the trapping of nitro-['lCImethane in 
a solvent/ pyrylium satt mehre is of importance. The yields of 4-nitro-14-llC]anisole increased considerably 
(about 58 %) when the following order was used: addiion of 12 rng Bu4NF.3H,O (38 ymol) to a mixture of 
8 mg Pmethoxy-pyrylium perchlorate (38 pmol) in 250 pl HMPT, trapping of [%]CH,N02, addiiion of 38 y 1 
I M t-BuOK in t-BuOH, and heating the reaction mixture at 120 "C for 20 min. A further increase of thle 
yields of 4-nitr0-[4-~'C]anisoIe was achieved by using of a greater arnount of t-BuOH (250 PI). Thus, 
4-nitr0+-~'C]an6f01e was prepared with a radiochemical purity of up to 82 %. Related to [llC]CH,NO„ the 
reproducible radiochemical yields of 4-nitr0-[4-~~C]anisole are in the range of 7715 % (decay-corrected). 
An HPLC radiogram of unpunfied 4-r1itro-[4-~'C]anisole is shown in Fig. 1. 
radioactivity 
[X 10 cps] 
Fig. 1 : HPLC radiograrn obtained from the reaction mkture of the 4-nitr0-[4-'~C]anicole synthesis 
1 -83 min: ["C]CH,ONO; I I .6 % 
2.73 min: [11C]CH3N02; 6.5 % 
8.40 min: 4-nitr0-[4-~'C]anisole; 81 -9 % 
The synthesis of 2-nitr0-[2-"C]mesityiene and 2,6-dimethyl4meth0xy-nitro-[I-~~C]benzene from their 
appropriate pyryiium salb [Q] was not possible under the above-described optimized reaction condiions. 
This phenomenon cannot be interpreted. 
Other reacöon condiions had therefore to be worked out. 2-Ni0-[2-'~C]mesitylene was obtained in yields 
of about 21 % as follows: nitro-flC]methane was trapped in a m-otture of 250 yl t-BuOH, 8 mg 2,4,6-tri- 
methylpyryliuim tetrafiuoroborate (38 pmol), 34.6 mg Bu,NF on silica gel (I .I mmol Bu,NF/ g re in  e 
38 pmol Bu,NF) and 38 y l1  M t-BuOK in t-BuOH. Thii reaction m'otture was heated at 120 "C for 20 min. 
The yieldc of 2-r1iir~-~'C]me~itylene decreased when Bu,NF-3H,O (38 pmol) was used without a carrier. 
An HPLC radiograrn of unpuiifred 2-nitr0-[2-"C]mecitylene is shown in Fig. 2. 
These reactian condions have yet to be tested for the synthesk of 2,6dimethyl4metho~y-nitro-[l-~~C]- 
benzene. 
radioadivity 
[X 10 cps] 
i 
t 
0.00 5.88 1888 t5aw time [min] 
Fig. 2:HPLC radiogram obtained from the reaction mixture of the 2-nitr0-[2-*~C]mecitylene synthesis 
1.68 min: [1IC]CH,ONO; 32.2 % 
2.83 min: CIC]CH,NO,; 38.4 % 
11 2 3  min: 2-nitr0-[2-'~C]medylene; 20.9 % 
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39. Substances Labelled in Metabolically Stable Positions: 
The Synthesis of Pyrylium salts as Precursors for "C -~ ing  Labelling of Nitrobenzenes 
P. Mäding, J. Steinbach, H. Kasper 
lntroduction 
As defined, pyryliurn salb consist of a cyclic-conjugated oxoniurn cation with a TC-electron sextet and an 
anion such as perchlorate, tetrafluoroborate, tetrachloroferrate or chloride. The ground state of the 
pyryliurn cation can be described by rneans of oxoniurn-Kekul6 structures (I, II) and carbeniurn-pyran 
structures (111-V) according to Equ. 1 [1 ,2]: 
These resonance formulas express the Wo essential properties of the systern: the arornaticity and the high 
reactivity against nucleophilic attack in positions 2,4 and 6. 
Pyrylium saltc are "key" cornpounds in organic chernistry 11-31. They can be converted into rnanifold corn- 
pounds, mostly by an exchange of the oxygen atorn. 
In the foregoing paper 141 we described a new method for the synthesis of n.c.a. "C-ring-labelled nitro- 
aromatics which is based on the condensation of pywiurn salts with nitro-["CJmethane. For this purpose 
the following three pyrylium salb had to be synthesized and characterized: 6rnethoxypyryliurn perchlo- 
rate, 2,Mimethyl-4-methoxypyrylium perchlorate and 2,4,6-trimethylpyryliurn tetrafluoroborate. 
Experimental 
Materials 
y-Pyrone (99 %) and 2,6-dirnethyl-y-pyrone (99 %) were purchased frorn Aldrich, Gerrnany. Dirnethyl 
sulphate (for synthesis) and perchloric acid (p-a., 70 %) were obtained frorn Laborchernie Apolda, Ger- 
many, acetanhydride (p.a.) from Feinchemie Sebniiz, Germany, and tetrafluoroboric acid (purum, 40 %) 
frorn Chemiewerk Nünchntzl BT Dohna, Germany. 
Synthesis 
4Methoxypyrylium perchlorate: A mixture of y-pyrone (2.5 g = 26 rnrnol) and dimethyi sulphate (3.5 g = 
28 rnmoi) was heated at 60 "C for 1 h with a brownish colour appearing. Then a solution of perchloric acid 
(60 %, 5 ml = 46 rnrnol), acetanhydride (15 ml) and diethyl ether (20 rnl) was added at roorn ternperature. 
After ctining for 30 minutes the crystalline solid separated, was filtered through a fit glass filter, washed 
with n-propanol and diethyl ether and dned. Pale crystals, yield: (2.0 g, 36.5 %). 
Melting point: 84-88 "C (iit. rn.p. 76-77 "C [SI). 
Elernental anal-: (Found: C, 33.8; H, 3.2; CI, 16.2, C,H,CIO, requires 
C, 342; H, 3.3; Ci, 16.9 %). 
NMR data: 6,(i5.475 MHz; solvent CD,OD; standard SiMe,) 49.8 4-OCH„ 102.7 CH (C3), 1 13.6 
C (W), 167.7 CH (C2) 
2,&Dimeölyl4me&oxyp~ium perchlorate: A momire of 2,Mirnethyi-y-pyrone (2.5 g = 20 rnmal), 
dimethyl sulphate (4.0 g = 32 mmol) and methanol(0.25 rnt) was heated at 50 "C for 1 h with a complete 
solution occumng and a yellow colour appearing. Perchlonc acid (70 W, 9.5 g = 66 rnrnol) was added 
while cooiing the solution wi8i ice water. After stirring for 2 h at 0 "C, the crystalline solid separated, was 
filtered through a fnt glass fiiter, washed wiär acetone and diethyi ether and dried. In this way only 0.7 g 
coiourlecc cryctals could be obtained. The yield of the pyrylium sait was increased by addition of diethyl 
@%er to the solution cucked off, with grey crystals preci~~tating. The isolated crystals were purified by being 
dissalved in acetone and then precipitated with diethyl ether. Colourless cryctals, total yield: (2.1 g, 
43.3 %). 
Meiting point: 182-1 92 "C (iii m,p. - 190 "C 160. 
Elernentai anatysic: (Found: C, 39.7; H, 4.7; Ci, 152, C,H„CIO, requires 
C,40.2;H,4.6;CI, 14.9%). 
l ff i 
NMR data: 6, in pprn (200.13 MHz; solvent CD,CN; standard SiMe,) 2.73 (6 H, s, 2 CHJ, 4.24 (3 H, s, 
OCHJ, 7.32 (2 H, s, 2 CH) 
b, in pprn (75.475 MHz; solvent CD,CN; standard SiMe,) 21.4 2-CH, and 6-CH,, 60.9 
4-OCHS 1 09.6 CH (C3), 179.3 C (C2), 1 80.5 C (C4) 
2,4,6-Tnme~y/py?y/ium tehfluoroborafe: Tetrafluorobonc acid (40 %, 7 rnl = 39 rnrnol) was slowly added 
to a stirred rnixture of acetic anhydride (50 ml = 530 rnrnol) and t-BuOH (4 rnl = 42 mrnol) at such a rate 
that the final ternperature reached approximately 100 "C. The dark brown solution was allowed to cool 
sponianeously to 80 "C, and was then chilled to 5 "C in an ice bath. The separation of the salt began and 
was completed by addiion of 100 rnl diethyl ether. The crystalline solid was filtered through a frit glass 
filter, washed with 30 ml diethyl ether and dried. The pale yellow crystals (3.2 g) were recrystallized from 
a rnixture of ethanol and rnethanol (1 : 1,60 rnl) containing 3 drops of tetrafluoroboric acid. Colourless 
crystals, yield: (2.0 g, 24.4 %). Melting point: 207-213 "C ( l i i .  m.p. 224-226 "C m). 
Elemental analysis: (Found: C, 45.7; H, 5.4, C,H„BF40 requires 
C, 45.8; H, 5.2 %). 
NMR data: 6, in pprn (200.13 MHz; solvent CD,CN; standard SiMe4) 2.78 (3 H, s, CHJ, 2.93 (6 H, s, 
2 CH-J, 7.85 (2 H, s, 2 CH) 
Results and Discussion 
There are iwo synthetic pnnciples to prepare pyrylium salts 121: 
- Syntheses starbing frorn an existing heterocyclic compound; 
- Syntheses using ring closure reactions. 
The electrophilic addition of alkylating agents to y-pyrones is one method, starting from an existing hetero- 
cycli cornpound. In thii way many pyrylium salb can be synthesized. The poccible electrophilic attack On 
the oxygen of the carbonyl group can be explained by the rnesomeric structure of the y-pyrone according 
to Equ. 2: 
lÖie 15-R 
&-++b - o - 8' - E' E ~ U .  2 
In thii way we synthesized the 4-rnethoxypyrylium perchlorate (Equ. 3; R = H) frorn y-pyrone (4H-pyran-4- 
one) using dirnethyl sulphate as methylation agent, followed by addiion of a mDcture of perchloric acid, 
acetanhydride and ether 151. The 2,6-dimethyl-4-rnethoxypyryliurn perchlorate (R = Me) was synthesized 
frorn 2,6dimethyl-y-pyrone in the sarne manner according to Equ. 3 [6]: 
OMe 
Me2s04 Equ. 3 
R O R  
Athitd pyiylium eornpound, üie 2,4,6-tnrnethylpyrylium tetrafluoroborate, was synthecized by a ring CIOSU- 
re reaction. Thk synthecic is based on the diacetylation of icobutene, which is faned in d u  by dehydrafion 
of t-butanol. In thii case acetic anhydride, t-BuOH and tetrafluoroboric acid are converted according t0 
E ~ U .  4 m: 
A simiiiir synthesis ic b a d  on the acetylation of mesityl oxide using acetic anhydride and perchloric acid. 
In this way the explosible 2,4,6-trimethylpyrylium perchlorate was synthesized by Hafner and Kaiser [8] 
according to Equ. 5: 
mesiiyl oxide 
In both reactions, isomesityl oxide is the actual intermediate. The reaction mechanism [2] based on the - .  
attack of the acylium cationis shown in Equ. 6: 
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40. Substances Labelled in Metabolically Stable Positions: 
The Synthesis o f  [2-'1~]i-Hydroxy-2-nitro-l-(2-nitrophenyl)ethane and [ß1"~]2,ß 
Dinitrostyrene 
J. Zessin, J. Steinbach 
Introduction 
In the synthesis of I1C-ring-labelled heterocyclic cornpounds [ß-11C]2,ßdinitrostyrene (3) could be an 
interrnediate of interest. Reduction of this substance rnay give access to ["C]indole [I]. 
2,ßDinitrostyrene (3) can be prepared by condensation of nitrornethane with o-nitrobenzaldehyde (1) [I]. 
This is illustrated in Scherne 1. This so-called Henry reaction can be carried out base-catalysed or in the 
presence of amrnoniurn acetate in glacial acetic acid. The base-catalyced condensation leads to the 
intermediate I-hydroxy-2-nitr0-1-(2-nitrophenyl)ethane (2). Treatment with diluted hydrochlonc acid yields 
3. The Henry reaction in the presence of arnmoniurn acetate leads directly to the final product 3. 
Scherne I. Synthesis routes of 2,ßdinitrostyrenes 
Both routes were already adapted to the condensation of flC]nitrornethane with V ~ ~ ~ O U S  
hydroxybenzaldehydes and protected hydroxybenzaldehydes [2-6]. On the basis of these resultc we tried 
to prepare [ß-"C]-2,ßdinitroctyrene (3). 
Experimental 
General 
Reagents and solvents were purchased frorn Aldnch and Fluka and used without further punfication. 
HPLC rneasurernents were performed by an HPLC systern (JASCO) consisting of a pump with IOW 
precsure gradient systern, injector with 20 p1 loop, a LiChrospher 100 RPI 8 colurnn (5 pm, 150 mm X 3.3 
rnrn), a W M S  detector coupied in series with a radioactMty detector FLO-ONUbeta 150TR. A rnixture 0f 
50 % acetonitrile and 50 % water containing 0.1M arnrnoniurn formiate was used as eluent. The HPLC 
was run with a flow of 0.5 rnllrnin in an isocratic mode. 
[l'C]Niomethane was prepared as descnbed by Schoeps et al. m frorn flC]methyl iodide. This 
interrnediate was synthecized according to Crouzel et al. [8]. 
The base-cataiysed condensation of flC]nitromethane with I was camed out, using tetrabutyfammoniurn 
fluoride (TBAF, rnethod A) or sodiurn hydroxide (rnethod B) as catalysts where as rnethod C descnbes the 
condensation in the presence of arnmonium acetate in glacial acetic acid. 
TBA F cafalysed condensation (method A) 
The rlC]nitrornethane was trapped at 0 "C in a reaction vessel containing tetrahydrofuran (?HF, 200 PI), 
0-nitrobenzaldehyde (50 prnol, 7.5 mg) and TBAF (as Whydrate, 65 prnol, 20 mg). AAer ctimng at 0 "C for 
2 min, a srnall sarnple of the reaction rnixture was diiolved in the HPLC solvent and analyced. 
The sarne procedure was repeated at -d6 "C in a second experirnent. 
Sodium hydroxicie cataiysed condensation (method B) 
Methanol (250 pI) and 1 (33 prnol, 5 rng) were placed in a reaction vessel and [llC]nitromethane was 
trapped while cooling with acetoneldry ice. On reaching a constant radioactnnty level, sodiurn hydroxide 
(9 - 40 prnol, 0.36 - 1.6 rng) was added, dissolved either in water or in rnethanol. The reaction mocture was 
allowed to warm up to room ternperature for 5 to 8 min. On finishing the reaction, a small sarnple was 
analysed by HPLC as described above. 
For dehydration hydrochloric acid was added to the reaction rnixture obtained from condensation. The 
hydrochlonc acid was diluted either with water or rnethanol and the final concentration in the reaction 
rnixture vaned frorn 5-1 04M to 2.5M. The reaction was carried out at room ternperature for 3 to 10 rnin. 
For dehydration of 2, phosphonc acid (85 %, 5 pl) or toluene-psulphonic acid (as monohydrate, 5 mg) 
were used in a sirnilar rnanner. After the reaction at roorn ternperature (10 rnin), the solution was heated 
to 130 "C for 10 min. The dehydration products were analysed by HPLC. 
Condensation wiäl ammonium acetate/glacial acefic acid (mefhod C) 
Glacial acetic acid (250 PI), 1 (70 pmol, I I rng) and ammoniurn acetate (310 - 420 pmol, 24 - 32 rng) 
were placed in a reaction vessel. At 10 "C the [llC]nitromethane was trapped in this solution, followed by 
heating of the sealed vessel to 145 "C for 7 to 10 min. The reaction products were deterrnined as 
described above. 
Resuits and Discussion 
Three methods were tested for the condensation of rlC]nitromethane with o-nitrobenzaldehyde (1). All 
results are surnmanzed in Table 1. 
When the condensation was carried out under basic condiions, the interrnediate cornpound 2 was 
obtained. Method A using TBAF as a basic catalyst gave very low yields (7-9 %) of 2. At 0 "C the rnain 
products were a highly polar substance (46 %), probably ["Clrnethyl nitrite, and an unknown cornpound 
(23 %). In nonradioactive expenments the unknown substance was not obtained. It is therefore not 
possible to identify this substance. 
Table I. Radiochernical yields frorn condensation af o-nitrobenzaldehyde with ["Clnitromethane by 
rnethod A, B or C (related to riC]nitromethane, deterrnined by HPLC, decay corrected) 
When the reaction was camed out at -16 "C, the share of rlC]methyl nitrite decreased to 32 %. The 
percentage of the unknown substance increased to 47 %. 
In the sodiurn hydroxide cataiyzed condensation the radiochernical yield of 2 increased rernarkably to 68 
- 77 % (Fig. la). Such high yields were only obtained, when the base was added after trapping the 
CIC]nitrornethane in the rnethanolic solution of the precursor 1. Any other sequence leads to lower yields. 
rlC]Methyl nrtnte (2 - 10 %) was found as a side product. Its share was dependent on the reaction time. 
Shorter reaction tirnes prevent the forrnation of rlC]rnethyi nitnte. In the range frorn 9 to 40 pmol the 
wncentration of the base has no influence on the product cornposjtion. The use of water or rnethanol as 
sohrents of sodiurn hydroxide does not influence the cornposition. 
The desired [B"CjZ,&dinitroctyrene (3) is forrned by dehydration of 2. In the case of the isolated hydroxy 
cornpound 2, sodiurn acetate and acetic acid anhydnde can be used [I]. But this requires a tirne- 
wnsuming separation of the llC-labeiled 2. The similar compound 1-hydroxy-2-nitro-I-phenylethane was 
dehyhted in the presence of dil&ed hydrochionc acid @J. Thic route was also used in the synthecis of [B- 
lC ]~ ios@enes &2,3,63. Folldng ük procedure, the reaction colution resuiüng from condensation was 
treated with diluted hydrochtoric acid. A product m'bture containing CIC]rnethyt nitrite, f 'Clnitromethane, 
unreacted 2 and [ß-%]2,ßdinitrostyrene (3) was pcoduced. Thi was demonstrated by the HPLC 
radiirarn in Fa. 1 b. RIe highect yields of 3 were obtained with HCI concentrations between 0.15 and 0.5 
moüi and by dilution with rnethanol. After dehydration for 3 to 5 rnin at roorn temperature, 65 - 77 % of 2 
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diluted with water, this cornpetitive reaction increased. 
Besides HCI, phosphoric acid (85 %) and toluene-psulphonic acid were also used to avoid the cleavage 
of "C-labelled 2. Wkh these acids longer reaction times are necessary and the yields of 3 are lower 
cornpared with the dehydration by HCI. 
By application of method C the condensation of rlC]nitromethane with 1 gave 3. After heating the reaction 
mixture to 150 "C for 7 rnin, only 38 - 44 % of [llC]nitromethane were converted into 3 (Fig. 2). 
8.86 min 
Fig. 1. HPLC radiogram obtained from condensation of rlC]nitromethane with o-nitrobenzaldehyde 
according to meihod B (la) and from dehydration of 2 by treatment with hydrochloric acid (1 b) 
I: unknown cornpound, probably CIC]methyl nitrite; II: CIC]nitromethane; 111: 2; N: 3 
Prolongation of the reaction time up to 10 min does not result in a hiher degree of conversion. Also, 
higher reaction temperatures lead to decreasing yields of 3. The isornerization of rlC]nitromethane to 
rlC]methyl nitrite is of minor importance. 
iig. 2. HPLC radiogram afier condensation of flCJnitromethane with 1 (meffiod C) 
1: unknown cornpound, probably TIC]mehyt nitrite; 11: CICJnitrornethane; 111: 3 
171 
Conclusions 
Three methods were tested for condensation of CiC]nitromethane with o-nitrobenzaldehyde. Satisfactory 
yields of 2 were obtained by using sodium hydroxide (rnethod B) as a catalyst. Dehydration of this alcohol 
was camed out by treatment of the reaction rnixture with hydrochloric acid. The radiochemical yield of 3 
(related to [iiC]nitromethane) was in the order of 38 %. 
Similar results were obtained by condensation under acidic condiions (method C). 
The use of TBAF as a bacic catalyst leads to a small amounts of 2 as well as to an unknown product. 
Method A is therefore unsuitable for obtaining 2. 
For preperation of 3 methods B or C are prefered, depending on further synthetic work. 
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41. Substances Labelled in Metabolically Stable Positions: 
Synthesis of [2-"~]lndole Skwting with ~"q2,ß~initrostyrene 
J. Zessin, J. Steinbach 
Introduction 
@-IiC]2,ß-Dinitroctyrene (1) is the staröng compound in the synthecic of "C-ring-labelled indole (2). After 
preparation of 1 by condensation of ric]nitromethane with o-nitrobenzaldehyde (1) we investigated the 
synthesis of 2 starting with 1 (scheme I). Thii reacüon involves the reduction of 1 and the cyclization of the 
intermediate 2,ßdiaminostyrene accompanied by loss of ammonia. 
Scheme 1. Synthesis of 12-"C]indole by reducüon of [B-iiC]2,ßdinitrostyrene 
Various recdudion agents can be used for this reducüon. They are: 
- molecuiar hydrogen with platinum or palladium catalysts (2), 
- iron in acetic adfeäianoI(2), 
- ammonium forrnate with palladium catalyst and (3) 
- titanium (IN) chloride (43) 
With the exception of the latter, these reductants are not suitable for labelling with '!C, because a high 
technical expenditure is required, heterogeneous catalysts are necessary or the reduction was 
accompanied by intensive foaming. By contrast, titanium (111) chlonde allows a homogeneous reaction at 
room temperature with short reaction times. Thii agent is therefore most suitable for reduction of 1 and 
will be tested in the synthesis of [2-'1C]indole (2). 
Experimental 
General 
[P-11C]2,ß-Dinitrostyrene (I) was synthesized by condensation of CIC]nitrornethane with o-nitro- 
benzaldehyde in the presence of ammonium acetate in glacial acetic acid under conditions as previously 
described (1). 
Titanium (111) chloride was used either in the form of the commercially available solution in hydrochloric 
acid ( I  5 % TiCI, in HCI, 10 %, from Merck) or as a solid (Fluka). 
The reactions were monitored by HPLC (HPLC pump with low pressure gradient system, injector with 
20 pI sample loop, UVNlS detector in senes with a radioacüvity detector) with an RP18-colurnn (1 50 X 
3.3 mm; LiChrospher 5 prn) and an eluent of water-acetonitnle (50:50) containing 0.1M ammonium 
formate (flow rate: 0.5 rnllmin). 
Separafion of 1 
The dinitrostyrene 1 was separated after condensation by solid phase extraction with a C18-SepPak 
Classical Cartridge from Waters. One part (120 PI) of the reaction mixhire obtained from condensation 
was diluted with water (1 0 ml). The resulting solution was passed through the cartndge (prewashed with 
5 ml methanol and 5 ml water), followed by washing with water (5 rnl). The dinitrostyrene I was eluted 
either with acetic acid (1 ml) or methanol (1 ml). This eluate was used directly in the subsequent 
experiments. 
Redudion of 1 
Tianium (111) chloride was placed in a sealed reaction via1 and purged with nitrogen. The solution, which 
contained I, was added to the reduction agent. After 7 min at room temperature a sarnple of the reaction 
mDcture was diluted with the HPLC solvent and analysed. 
The condiions of the experiments are surnmarized in Table 1. 
Table 1. Reduction of [ßi1C]2,ßdinitroctyrene with titaniurn (111) chloride - reaction condiüons 






I I I 1 0.2 ml acetic acid 
1) Method A: reduction as one-pot synthesis in reaction solution resulting frorn condensation 




I ml acetic acid 
reacüon soluiion 
1 ml acetic acid 
Results and Discussion 
Reduction of [ß-"C]2,ßdinitroctyrene (1) with TiCl, was chosen as a way for synthecis of f2-"Cjindole (2). 
At first this reaction was camed out by using of titaniurn (111) chloride in the form of a solution in diluted 
hydrochloric acid. When the reaction solution resuiüng from condensation of piC]nitromethane wiäi 0- 
nitrobenzaldehyde was directiy applied (method A), (2) was not formed. The main products were 
rlC]nitromethane and CIC]methyl nitrite. 
TICI, 
1 10 prnol (as HCI solution) 
11 0 pmol (as HCI solution) 
100 pmol (as solid) 
100 um01 (as solid) 
After icolation bysolid phase extraction, 1 was obtained a s  an acetic acid solution. When this solution was 
combined with TiCI, in diluted HCI, [2-**C]indole (2) was formed in yields of 7 %. Most of I was converted 
into an unknown polar compound. This indicates decomposition of 1 under the influence of hydrochloric 
acid (from TICId. Similar effects were observed during the synthesis of 1 (1). 
TiC&wastherefore applied as a solid in the solution yielded by condensation in the following experiments. 
Compared with the product distribution after condensation, reduction according to method A did not 
change the product composition. That means that TC& was consumed in side reactions. 
Consequently, I was separated and the resulting acetic acid solution of 1 was mixed with solid TiCI,. PI 
product rnixture was obtained, which contained polar side products (57 %), 2 (19 %) and an unknown 
product (22 %) (see Fig. 1). This may be an intermediate compound, which would point to an incomplete 
reaction. 
The formation of this intermediate was repressed by reduction of isolated 1 (method B) with greater 
amounts of TC!, in an acetic acidlrnethanol m0mire. The resulting product mixture contains polar side 
products and 2 in a percentage of 21 % (Fig. 2). OnYy 1 % of the start substance I was detected. This . .
indicates a nearly complete reaction. 
Fig. I. HPLC radiogram afier reduction (method B) of 1 with TU, in acetic acid 
I: polar cide products; 11: unknown intermediate product, Ill:[2-'*C]indole (2) 
The radiochemical yield of I was 2 8 6  % (related to TIC]nitrornethane, decay corrected) after separation 
by solid phase extraction. After reduction of isoIated 1, [2-"Clindole was obtained in radiochemical yields 
(related to rlC]nitromethane, decay corrected) of 5 to 7 %. The overall decay corrected yield (related to 
clCfCOJ of 2 was in the order of 3 %. 
Fig. 2. HPLC radiogram after reduction (method B) of 1 with TiCI, in methanollacetic acid 
I: [2-"Clindole (2); 11: [ß-"C]2,ßdinitrostyrene (1) 
Conclusions 
The reduction of @-11C]2,ßdinitrosiyrene 1 by titanium (111) chloride was found to be the first synthetic 
approach to "C-ring-labelled indole 2. Besides the decired reaction, great amounts of 1 were 
decomposed, Mich decreases the radiochemical yield. Further work is necessary to increase the overall 
radiochemical yield of 2 by optimiking the reacüon condions. 
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42. Eledrophilic Fluorination: The Synthesis of [ ' 8 ~ ~ a e s i u m  Fluoroxysulfate - A New 
Reagent for Electrophilic Labelling 
Chr. Fischer, K. Neubert, J. Steinbach 
Introduction 
The manifold reactivity and chemical characteristics of substances to be radio-fluorinated demand 
appropriate tailor-made fluorinating agents. Nucleophilic and electrophilic substitution are the two general 
ways forthe introduction of fluorine into a molecule. Electrophilic introduction of the I8F radionuclide is of 
special interest in the case of activated aromatic compounds. Elemental [18F]fluorine and [18flacetyl 
hypofluorite are the Wo well-known electrophilic fluorinating agents for radiolabelling. Both substances 
have a high reacüvity and are in use for a wide application. In the case of highly reactive substances the 
fluorinating power of the reagent has to be adjusted. 
In our search for new electrophilic reagents for 'F introduction we found caesium fluoroxysulfate to be a 
suitable compound for radiolabelling. 
In 1979 Appelman [I] was the first to isolate fluoroxysulfate in form of its yellowish rubidium and caesium 
salts. Caesium fluoroxysulfate is the only known ionic hypofluorite. It is more powerfully oxidizing than 
peroxymonosulfate and decomposes in the course of a few hours. In this paper we are reporting on the 
synthesis of 'sF-labelled caesium fluoroxysulfate (in figure I), a new reagent for electrophilic labelling. 
Fig. 1 : r8F]caesium fluoroxysulfate 
Experimental 
[18FJCsS04F is synthesized by direct fluorination of C&S04 with r8FJF2 in aqueous solution. [18F]F2 was 
produced by explolng the %e(d,a)'sF reaction by irradiation of a 0.2 % FJNe mecture. After EOB the gas- 
mixture was passed through 0.1 ml of a 2 M CS~SO, solution in a quartz glass via1 in the course of 20 min. 
The colution was kept at -5 "C. During the absorption procedure yellowish r8F]CsS0,F precipitated. This 
crude product is ready for use without further purification. For absorption of non-reacted [I8F]F, a trap filled 
with NaOH solution was connected to the reaction vial. Proof of the synthesis of [18F]CsS04F was given 
indirectiy by reaction with N-formyl-3,kiiboc-6-trimethylstannyl-DOPA ethyl ester [2,3] and subsequent 
hydrolysis yielding 6-[18F]fluoro-DOPA, which was determined by HPLC [3]. 
Results and Discussion 
The modiied method by Appelman [I] issuitable for the synthesis of r8F]CsS0,F in general. The method 
has to be optimized because of an inefficient r8F]F2 absorption. Up to 65 % of the 18F were found in the 
NaOH solution. This result may be improved by increasing the volume of the absorption liquid and by an 
optimized geometric shape of the absorption vessel. 
[18ijCsS0,F might become a labelling reagent for special purposes, in the firct place for highly reactive 
substrates. 
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43. Eledrophilic Fluonnation: A New Route to ''F-labelled Compounds by 
r8F]Caesium Fluoroxysulfate: 6 -~F l~ luoro -DOP~  as an Example 
Chr. Fischer, K. Neubert, R. Scholz, J. Steinbach 
lntroduction 
6-[18F]fluoro-DOPA is one of the rouünely used PET-radiopharmaceuticals [I, 2, 31. lnitially it was 
synthesized by electrophilic attack of the versatile "F-labelled electrophilic fluorinating agents such as 
Xenon diiuonde, acetyl hypofluorite and elemental fluorine gas [4]. This is possible because of the highly 
reactive aromatic ring of the DOPA molecule. Beside the derived product, the other fluorinated isomers 
are also synthesized. In order to increase the radiochemical yield, precursor molecules with adjusted 
reactnrity are used [5]. On the other hand, the reactivity of the fluorinating agent should also be adapted. 
In our search for new electrophilic labelling agents we found ["F]caesium fluoroxysulfate to be a useful 
compound for introducüon of 'T [6,7]. AS a model system we used N-formyl-3,4diboc-6-trimethylstannyl- 
DOPA ethyl ester to generate 6-[1aF]fluoro-DOPA (equation I). 
H 
0 OBoc NCHO 
II 
O=S-&'F + C00C2H5 I. rt, 30 min 
I _ 2. hydrolysis HO 
0 Cs+ 
Sn(CH,), 
Eq. I : "F-labelling with r8F]caesium fluoroxysulfate 
Experimental 
[ 1 8 F ] ~ s ~ ~ , ~  is produced by pushing 100 pmol [I8F]F2 gas through an aqueous solution of 150 pI 2 M 
Cs2S04 solution m. To thii suspension of raF&sSO,F 1.5 ml of 0.1 M N-formyl-3,4-diboc-6- 
trimethylstannyl-DOPA ethyl ester in CFCI, are added and stirred vigorously at room temperature for 30 
min. After the CFCI, is evaporated, 1.0 ml of HBr (48 %) is added and refluxed for 5 min. This crude 
product can be handled as usual for further use. Analysis of the products was performed by HPLC 
(gradient: 0 min: 100 % l-&O + 0.1 % AcOH; 10 min: 100 % MeCN + 0.1 % AcOH; after 10 min: 100 % H20 
+ 0.1 % AcOH; column: RP 18.5 Pm, 240 X 2.1 mm (ODS, Hypersil) HP) . The assignment of the 
chromatographic data was accomplished by reference substances. 
Resuits and Discussion 
An HPLC radiogram of the labelled products (equation 1) is shown in Fii. 1. Even though the decay- 
corrected radiochemical yield of 6-r8F]fluoro-DoPA is only 14 %, raF]CsS04F proved to be a useful 
labelling agent. On the one hand, the reaction condiions are not optimized. On the other the reacüvity of 
the N-formyl-3,4-diboc-6-trimethylstannyl-D0 ethyl ester is adjusted to the [18F]F2 system. For 
substances of suitable reactivity to be electrophilically fluorinated with 18F, [18F]CsS04F can become a 
suitable agent. 
. . . .  . . L ,  
5 I ' 10 min 
Fig.1: HPLC radiogram of the reaction of [18flcaesium fluoroxysulfate with N-formyl-3,4diboc-6- 
trimethylstannyl-DOPA ethyl ester. 
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44. Electrophilic Fluorination: A New Route to the Barnette Reagents - N-Fluorination 
with Perchloryl Fluoride 
Chr. Fischer, J. Steinbach 
lntroduction 
N-fluoro-N-alkylsulfonarnides, known as Barnette reagents [Y]  (Fig. I), are useful electrophilic fluorinating 
reagents for the selective fluorination of a broad variety of carbanions, amide enolates and alkyl and aryl 
organornetallics under mild condiions. They are prepared from commercially available N-alkyl- 
Fig. 1 : Barnette-reagents (I), Perchloryl fluoride (11) 
I 
Eq. 1 : Common synthesis of N-fluoro-N-alkylsulfonarnides with fluorine gas 
sulfonamideswith elernental fluonne diluted in nitrogen [I] (equationl). Perchloryl fluoride [2] (Fig. I), also 
an electrophilic fluorinating agent but of a higher fluorinating powerthan the Barnette reagents, proved to 
be a N-fluorinating agent [31 and can be used to obtain N-fluoro derivatives. In this paper we are reporting 
about the new synthesis of some of the Bameite-reagentc with perchloryl fluoride instead of diluted 
fluorine gas (equation 2). 
I. NaOH, MeCN 
2. FCIO, 
Eq. 2: New synthesis of some Barnette-reagents with perchloryl fluoride 
Experimental 
Synthesis of perchloryl fiuoride 
2.0 g of diy crystalline potassium chlorate are placed in a colurnn, kept beWeen 50 "C and 60 "C and an 
F2-strearn (1 0 %) is passed through. The effluent gases were passed through a solution of aqueous 10 % 
sodiurn hydroxide containing sodiurn thiosulphate (5 %) and den over solid potassium hydroxide. 
Perchloryl fluoride was finally swept out of the syctem with nitrogen and passed through the readon 
rnixture, which contains the corresponding sulfonarnides I - 4 as described in the following. 
Fluo~nation of the sulfonamides 
1-7 mrnol of the sulfonarnides 1 - 4 and carefulty powdered NaOH (80 mg, 2 mmot) were stirred at room 
temperature in dry CfSCN (10 ml) for 3 h until the diiolution of NaOH was complete. Perchtoryl fluoride, 
which was synthesized as described by Engelbrecht ef al. [2], is passed through the rapidfy ctirred 
suspension at 0 - 5 "C over the Course of 30 min. The mixture was diluted with ether (15 rno and the 
resuhnt precipitate was filtered off and washed with water (3 X 10 ml). The organic iayer was dried over 
MgSO, and evaporated under reduced pressure. The residue was chrornatographed (in hexane : &her 
3:l) to afford the corresponding N-fluoro-sulfonamides. 
N-fluoro-N-methyl-p-toloenesuifonamide _5 was deterrnined by thin layer chrornatography and by 
cornparison with the corresponding standard cornpound. 
N-fhoro-N-t-bml-p-toIuenesulfonamide 5 : 
NMR data: b, (500 MHz; solvent CDCI,; standard SiMe4) 7.87 (2H, d, J 8 Hz, arornatic), 7.33 
(2H, d, J 8 Hz, arornatic); 2.45 (3H, s, CHJ; 1.43 (9H, d, J 2.7 Hz, C(CH,)J 
6„ (400 MHz; standard CFCI, : -77) -62.78, See Fig. 2. 
Fig. 2: 19F NMR spectrurn of N-fluoro-N-t-butyl-ptoluenesulfonamide 
N-fluoro-N-cyclohexyl-ptoluenesulfonarnide 1 : 
NMR data: b, (500 MHz; solvent CDCI,; standard SiMe4) 7.82 (2H, d, J 8 Hz, arornatic), 7.31 
(2H, d, J 8 Hz, arornatic), 3.63 (IH, drn, J 32 Hz, NCH), 2.40 (3H, s, CHJ, 
0.75-2.30 (1 OH, rn) 
b, (400 MHz; standard CFCI,: -77) -71.63, See Fig. 3. 
Fig. 3: 19F NMR spectrurn of N-fluoro-N-cyclohexyl-ptoluenesulfonarnide 
N-(2-fluorophenyl)-p4oluenesulfonarnide 8 : 
NMR data: 6, (500 MHz; solvent CDCI,; standard SiMeJ 7.72 (2H, d, J 8 Hz, arornatic(-S)), 7.55 (1 H, 
rn, arornatic (-N)), 7.38 (2H, d, J 8 Hz, aromatic(-S)),7.20 (2H, rn, arornatic(-N)), 7.10 
(1 H, rn, arornatic(-W). 2.88 (1 H, d, J 17 Hz, NH), 2.32 (3H, s, CHJ 
6 ,  (400 MHz; standard CFCI,: -77) -127.60, See Fig. 4. 
Fig. 4: 'F NMR spectrurn of N-(2-fluorophenyl)-ptoluenesulfonarnide 
Resuits and Diicussion 
The y i e k  of the N-rnethyl and the N-cyclohexyl derivatives 5 and 1 (Table 1) are lower than in procedures 
ucing fluorine gas as fluorinating agent. In the case of cornpound 2 perchloryl fluonde provides a higher 
yield of product 5. 
In contrast to the N-fluorination of the sulfonarnides 5, 6 and L, N-phenyl-ptoluenesulfonarnide is 
fluorinated in the or8io position of the phenyl ring. Thii is obviously caused by the high basicity of the 
phenyl ring of the sodiurn sait and the high stabilii of üie C-F bond. 
To sum up, perchloryl fluoride provides an N-fluorinating agent and can be a useful reagent in the 
synthesis of Bamette reagents. It may be important in cases were elemental fluorine gas cannot be used. 
Table 1: Yields of the reaction of ~erchlorvl fluoride with the various sulfonamides I - 4 to the 
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45. Sulfamates of 3-Hydroxyestra-1-35(1O)-triene Derivatives 
J. Römer, J. Steinbach, H. Kasch ' 
' HansKnöll-Institut Jena 
lntroduction 
3-Sulfamate of estrogens were reported in the seventies for the first time [I - 41. In those days orally 
effective, synthetic contracepüve steroids were to be converted into sulfamates, which were supposed toi 
be contraceptiva of a long lasting effect due to their lipophilic properties. Two findings of recent date 
caused estrogen sulfamates to be reinvestigated. Firstly, estrone-3-sulfamate was found to be the most 
potent estrone sulfatase inhibitor [SI, and in this respect the compound may ultirnately be of therapeutic 
uiili. Secondly, the ectrogenic sulfamates have an as yet unrecognized potential for overcoming the h e r  
barrier without being metabolized, and thus they possess a potent systemic estrogenic activity [6]. 
The known procedures for synthesizing estrogen sulfamates differ widely. Schwarz et al. [3] prepared 
N,N-dialkylated estrogen-3-sulfamate using a phase-transfer catalyzed procedure which even made it 
possible to selectively obtain 3-sulfamates of polyhydroxy-estrogens. But it failed in the case of N-monoal 
kylated and unsubstituted sulfamoyl chloride as a reagent. An interesting procedure which was not 
previously used in the steroid field was introduced by Spillane et al. m who replaced the aqueous-alkaline 
phase by solid codium carbonate and were able to obtain high yields of sulfamate alkyl esters and phenyl 
esters. Howarth ef al. [5] who converted estrone to several3-sulfamates, did not give any data about yield 
and reaction rate. After having deprotonated the estrone by NaH, they carried out the reaction at 0 'C in 
absolute DMF and used 2 equivalents of sulfamoyl chloride. Schwarz et al. [8] who tried to copy Howarth's 
procedure found only a low yield of estrone sulfamate and troublesome by-products. After comprehensive 
investigations they recommended CH,CI, as a solvent and 3 equivalents of sulfamoyl chloride in the 
presence of 2,6dCtert.-butyl4methyl pyridine. 
We are primarily interested in non-alkylated sulfamates of estradiol and estradiol derivatives. Therefore, 
we invectigated the possibilii of making good use of the recommended literature procedures to synthesize 
such sulfamates. The firct preparative results are described here. 
Seheme 1 
Experimental 
1. General procedure 
By converüng estrone (1) to estrone-3-sulfarnate (I*), the rnost potent estrone sulfatase inhibiior is 
obtained [5,9]. Thk sulfarnate I *  can be used as a reference cornpound for assessrnent of other estrogen- 
3-sulfarnates as regards the estrone sulfatase inhibitory effect. Analogously to 1 + I *  , a second referen- 
ce cornpound can be derived from estradiol (2) , namely estradiol-3sulfarnate (2"). As 2 should also 
form estradiol-17ß-sulfarnate (3) , we tned to prepare this cornpound as well (Scherne 1). 
18Epiesttiol(4) is a hydroxy derivative of estradiol and was used for preparing 3-0-rnethoxyrnethyl-16,17- 
O-sulfuryl-16-epiesttioI (S), which represents a suitable precursor for preparing 16a-fluoro-estradiol [ I  01 
and 16a-['BF]fluoroestradiol [I ]. Subjecting 5 to acid hydrolysis, 16,17-0-sulfuryl-16-epiestriol (6) was 
fomed which can be converted to 16,17-0-culfury1-16-epiestriol-3-sulfarnate (6*). 16-Epiestriol (4) reacts 
with acetone to 16,17-0-isopropylene-16-epiestnol (i) which can be converted to 16,17-0-isopropylene- 
16-epiestriol-3-sulfarnate (F) (Scherne 2). 
Scheme 2 
2. Materials and methods 
Solvents and reagents were obtained frorn ALDRICH, FLUKA or SIGMA. Sulfamoyl chloride (SCI) was 
prepared according to Appel and Berger 1121. Melting points were recorded by a Therrnogalen device and 
are uncorrected. The compounds were characteiized by their 13C NMR spectra reported in the following 
paper 1131 and by rnass spectra which were recorded by a High Resolution Mass Spectrorneter AMD 402 
(AMD-Intra, Harpctedt) and by a VG Quattro device (VG Biotech, Altnncharn). For the chrornatographic 
investigaiions an HPLC swtern Merck-Hiachi was used, including gradient pump L-6200A, detector L- 
4500 DAD, a rheodyne injector with a 20-pl loop and an analyöc RP colurnn ET 1251814 Nucleosil 120- 
5C18 (Macherey 8 Nagel). In the case of preparative HPLC an RP column SP 250/10 Nucleosil120-7Cl8 
WS used. W r e s  of MeCN and water or pure MeCN were used as the solvent. The analytic colurnn was 
eluted atv = 0.5 rnvrnin, the preparative colurnn at V = 2.2 mllrnin. The W absorption was recorded at 275 
nrn. TLC invectigations were camed out with analyücal TLC plates WERCK, alurninium sheets, silica gel 
60 F, 5x10 cm) and benzenelacetone(4:l) as the soivent. The spotc were visuafized under UV and after 
spraying with ethanolic vanillin-sulfuric acid and heating. 
3. Synfheses 
Esfrone-3-suffamate (17 : In a i i i e  bulb estrone (1) (135 mg = 0.5 rnrnol) was diccolved in MeCN (ab., 
15 ml). After cooling in an ice-bath, NaH (60%, 120 mg = 3 rnrnol) was added while stirring. Wihin 15 min 
SC1 (solid, 175 rng = 1.5 mmol) was added and stimng was continued for 2 h. Although only in-complete 
conversion was registered, water was added and after acidification the batch was extracted with ether. 
After removing eher under reduced pressure, MeCN (5 ml) was added to the recidue. Preparative HPLC 
was cariied out (10 separations, 0.5 rnl injeciion volume, pure MeCN as the solvent). I *  was eluted at R, 
= 7.7 min. The peaks wer@ cut and collected. The solvent was evaporated at roorn temperature to give 
whiie, fine crystals, yield: (92 mg, 53 96). Melting point: 203 - 207 OC (frorn MeCN). 
MS: rnh 349.1 351 (M+), 270.1614 (M+ - HNSOJ. 
UV : A d n m  270. 
Elemental analysis: (Found: C, 61.8; H, 6.8; N, 3.9; S, 9.0, C„HZ3O4NS requires 
C,61.9; H, 6.6; N, 4.0; S, 9.2%). 
Esfradiol-3-suifamate (2*) : Estrone-3-sulfamate (I*) (70 rng = 0.2 rnmol) was dissolved in THF (abs., 
2 rnl) and EtOH (99.9 %, 2 rni). After cooling in an ice-bath, NaBH, (solid, 20 mg = 0.54 rnrnol) was added 
while stirring. The batch was stirred for another 2 h at roorn ternperature, acidified and worked up and 
chrornatographed as descnbed above. 2* was eluted at R, = 8.3 rnin. After evaporating MeCN, the 
collected peaks gave a white product, yield:(37.8 mg, 54 %). Melting point: 175 - 182 'C (from MeCN). 
MS: rnlz 351 .I51 1 (M+) ,272.1769 (M+ - HNSOJ, 213.1283 (M+ - HNSO, - C3H,0). 
UV: A,Jnm 270. 
Elernental analysis: (Found: C, 59.5; H, 8.5; N, 3.9; S, 8.7. C18H,04NS requires 
C,61.5; H,7.1; N,4.0;S,9.1 %). 
Esfradiol-1713-suffamafe (3) : Estradiol(2) (120 mg = 0.45 mmol) was dissolved in MeCN (absolute, 10 ml) 
and after cooling in an ice-bath, NaH (60 %, 84 mg = 2.1 rnrnol) was added while stirring. Wihin 15 rnin 
SC1 (solid, 70 rng = 0.6 rnmoi) was added and stirring was continued at roorn temperature. HPLC controls 
after 2 and 6 h showed 3 peaks and unreacted estradiol. The solvent was evaporated, the residue 
extracted with ether, and then the ether removed. After adding MeCN (5 rnl), the solution was chroma- 
tographed (20 separations, 0.25 ml injection volume, pure MeCN as the solvent). 3 was eluted at R, = 7.5 
rnin. These peaks were cutand collected . Evaporation of solvent gave a whiie substance, yield: (21.5 mg, 
13 %). Melting point: 158 - 161 'C (from MeCN). 
MS: rnlz 351.1539 (M+), 333.1376 (M+ - H,O), 272.1769 (M+ - HNSOJ, 254.1672 (I00 %, M+ - H20 - 
HNSOJ. 
UV absorption: A,Jnm 284. 
Elemental analysis: (Found: C, 59.0; H, 6.6; N, 4.0; S, 8.6. C„H,04NS requires 
C, 61.5; H, 7.1; N, 4.0; S, 9.1 %). 
16J17-O-S~Mnyl-16epie~fßoC3-suKamate (6'9 : 3-0-Methoxyrnethyl-I 6,17-0-sulfuryl-I 6-epiestriol(5) [I I ]  
(147 rng = 0.373 rnrnol) was placed in a bulb. MeCN (5 rnl) and HCI ( I  M, 10 drops) were added and the 
batch was siirred in a bath (1 10 'C) for 10 rnin. After complete rernoval of the solvent in this bath, CH2C12 
(ab., 6 rnl), sodiurn carbonate (anhydrous, 700 mg) and SC1 (solid, 180 rng = 1.56 rnrnol) were added. 
Then the batch was vigorously sürred. HPLC revealed 75 % conversion to 6* after 3 h and 94 % after 6 h. 
After adding water (150 ml), the steroids were extracted with ether (50 rnl). After removing the ether, 
MeCN (6 ml) was added and preparative HPLC camed out (1 3 separations, 0.45 rnl injection volurne, pure 
MeCN as solvent). 6* was eluted at R, = 7.3 rnin. After evaporating MeCN, the collected peaks gave a 
white, fine product, yield: (34.7 rng, 60 %). Melting point: 195 - 198 'C (from MeCN). 
MS: rnlz 429.0934 (W), 350.1180 (55 %, M+- NHSOJ, 270.1617 (50 %, M+ - NHS0,- SO,). 
W absorption: AJnrn 270. 
Elemental analycis: (Found: C, 49.3; H, 6.1; N, 3.5; S, 14.2. C18H,0,NS2 requires 
C, 50.4; H, 5.4; N, 3.3; S, 14.9 %). 
16J17-O-/sopropylene-16-epiesoiol (7') : 16-Epiestriol (4) (100 rng = 0.347 rnrnol) was placed in a bulb. 
CH2C12 (ab., 12 rnl) and ptoluene sulfonic acid (20 mg) were added. Acetone (1 rnl) was added while 
stimng. The solution, which was at first cloudy, becarne clear after about 30 rnin while stirnng continued. 
After 2 h the dear solution was poured into NaHCO, soluüon. The CH2C12 extract was washed with water. 
Evaporation of the solvent gave whiie crystals, yield: (1 12 rng, 98.4 %). Melting point: 180 - 185 'C. 
Elemental analycis: (Found: C, 76.7; H, 8.5. C„H,O, requires 
C, 76.8; H, 8.5 %). 
16,17-O-lsoppyIene-ISe~es~ol-3-suffama~ (P) :Sodium carbonate (anhydrous, 500 mg) and SC1 
(30 mg = 0.26 rnmol) were added to 16,17-O-isopropylene-16-epiestriol (7) (75 mg = 0.228 rnrnol) 
dissolved in CH2CL, (absolute, 5 ml). The suspencion was vigorously stirred for 60 h. Frorn time to time 
srnall arnounts of SC1 (5 x 10 rng) were added. The batch was poured into NaHCO, solution and the 
steroids were extracted with ether (2 X 40 ml). After evaporating the ether and adding MeCN (4 rni), 
preparative HPLC (9 separations, 0.45 rnl injecüon volume, pure MeCN as solvent) was camed out. 7" 
was eluted at R, = 8.7 min. The solvent of the collected peaks was rernoved at room ternperature. W i e  
crystals were obtained, yield: (26.3 mg, 28.4 %). Melting point The cryctals softened at about 190 'C, 
from about 235 'C they turned brown while decomposing . 
MS: mlz 407.1 755 (Mq, 392.1 520 (M' - CHJ, 31 3.1 81 0 (M' - CH, - NHSOJ; 
UV:A,Jnm 270. 
Elemental analysis: (Found: C, 61.7; H, 7.1; N, 3.6; S, 7.9. C2,H,0,NS requires 
C,61.9; H,7.1; N,3.4: S,7.9%). 
Results and Discussion 
As preparative aspects we will discuss i) the yield of the sulfamates, ii) the synthesis rate, and iii) the 
simplicity of the procedure. These pointc will be very important if the condiions are to be applied to the 
synthesis of an 'F labelled compound. Some chromatographic results will also be mentioned. 
Estrone-3-sulfamate (I*) was prepared according to Howarth et al. [SI. But, because of its lower boiling 
point, MeCN was used instead of DMF. The reaction time was acceptable, the extent of conversion low. To 
prepare pure I *  preparative HPLC had to be applied with pure MeCN as a suitable HPLC solvent. In 
these attempts we found that A „(I*) = 270 nm whereas estrone (1) has A ,(I) = 284 nm. A „ = 270 
nm was generally found for all the 3-sulfamates investigated. 
The sulfamamoylation of estradiol (2) according to Howaräi's method did not result in estradiol-3- 
sulfamate (2*). Estradiol-17ß-sulfamate (3) and some by-products were formed in low yields. 3 did not 
show 270 nm but 284 nm as the absorption maximum. Unequivocal evidence ofthe structure of 3 was 
presented by recording its "C NMR spectnim [I 31. 
In oder to obtain ectradiol-3-sulfarnate (P) we used the method proposed by Schwarz ef al. [8] who were 
successful when subjecting estrone-3-sulfamate (I*) to NaBH, reduction. Ester cleavage did not occur 
during this treatrnent. We obtained 2* in about 80 % yield, after preparative HPLC in 54 %. Ac expected, 
the sulfamate P showed A = 270 nm as the absorption maximum. lts structure was also confirmed by I3C 
NMR spectroscopy [I 31. 
l6,l 7-OSuMiryLl6-epiestriol-3-sulfamate (6*) was prepared from 3-O-methoxymethyl-l6,17-0-sulfufyl- 
16-epiestriol (5) without isolating 16,17-0-sulfuryl-16-epiestriol (6). The fast and simple hydrolysis 
procedure 5 + 6 had been worked out previously [Al]. However, there were some problems in the 
sulfamoylation reaction according to [5] and [8] which did not resuR in 6* . Only when taking advantage of 
a phase-transfer procedure with sodium carbonate and CH& as solvent was 6" obtained in acceptable 
yields. We stated that the yield is the better, the more vigorously the reaction m'octure is stirred and that 
about 5 equivalents of SC1 should be used. Special attention must be paid to the fact that SC1 is sens-%ve 
to humidity with sulfamic and hydrochloric acids being formed. But before neutralization by sodium 
carbonate, acids impair the procedure. Thus, we believe that even under the most favourable conditions 
the reaction 6 + 6* on the IOO-rng scale will require a reaction time of several hours. 
The sulfamoylation reaction 7 + 7* also caused problems as regards the yield of 7" and the reaction 
time. Here, the reaction rate is obviously much lower than in the foregoing example. In this manner the 
side reaction 
H,N-S02-CI + Na,CO, + H2NS0,-ONa + NaCl + CO, 
begins to dominate and diurbs the reagent. We also found here that above all the acid medium due t0 
excescive SC1 is very disadvantageous. We tried to overcome this diadvantage by adding the reagent in 
small portions, of Course at the expense of time. In spite of alf hat the yield of 7 did not exceed 30 %. 
In order to characterize the new sulfamates I3C NMR spectroscopy, mass spectroscopy, W abSorption, 
elemental a n a w  and chromatographic procedures (HPLC, TLC ) were used. The I3C NMR spectra are 
diucced in the following paper 1131. The UV absorption of 3-sulfamates at 270 nm was atready mentio- 
ned. Now some interesting resuk of HPLC and TLC will be concidered. 
T0 prepare the new suifamates in pure form, preparaae RP-phaA HPLC wi8i MeCN as the sohrent Was 
used. Here it hokfc generally that the srnaller the R, value, the more polar is the compound. It can be Seen 
from the R, values liited in Table 1 that a sulfamate is basically more polar than B e  hydroxy compound 
from Mich  it was prepared, in other words R, (n*) < R, (n). The same result is found for the compounds 
3and2. 
Table 1: Retention times R, (in min) of some 3-hydroxy-estra-1,3,5(10)-triene derivatives (1 ,2 , 3  , 6  ,7) 
and some of their 3-sulfamates (I* ,2* ,6* ,7*) 
Numbering Steroid R, [mini 
1 estrone 8.6 
2 estradiol 10.5 
Ucing TLC on silica plates, it is also valid that the srnaller the R, value, the more polar is the compound. All 
the &values found are listed in Table 2. Except for estrone, we can state that the rule R, (n*) C R, (n) is 
fulfilled. Some Special features were fumished by colouring the spots with vanillin sulfuric acid the results 
of which are also surnmarized in Table 2. After spraying and heating the plate, the spots of the 3- 
suhärnates I *  and 2" tumed brown and then green as it was cooled. But the spots of the 3-sulfamates 6* 
and TI di not diicolour at all whereas the corresponding 3-hydro3 derivatives 6 and 7 became at least 
a pale pink. 
Table 2: TLC resuits of some 3-hydroxy-estra-l,3,5(10)-triene derivatives (I , 2  , 3  , 6  ,7) and some of 
their 3-sulfarnates (I* ,2f ,6* , T") 
Numbering R, value Colour of spots ...-.....-....-.....----....*.--..-.....*......-.-....-....*........-..-..-......... 
hot cold 
1 0.50 purple yellow 
1* 0.66 brown green 
2 0.33 purple yellow 
2* 0.29 brown green 
3 0.22 brown pink 
6 0.50 pink pink 
6* 0.40 not detectable not detectable 
7 0.53 pink pink 
TI 0.46 not detectable not detectable 
ln dtii paper, ssme Zr& procedures for psepanng estrogen sulfamates have been described. The procedu- 
res have ctifi to be optim~ed. Furthet exarnpfes are under invectigatian with 3-suifarnates as the main 
objects. 
Acknowledgement: We wich to express our gratitude to the Deutsche Forschungsgerneinschafi for its 
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contrastthe spectrum of estradiol-17ß-sulfamate (3) did not show iwo neighbouring signals in this region. 
Eslradiol (2), 16-epiestriol (4) and 3-O-methoxymethyl-l6,17-O-sulfuryl-16-epiestriol (compound 5 in [I]) 
were previously discussed 121. Therefore, we will now concentrate on the compounds 6 , 6" ,7, and 7* 
representing 16-epiestriol derivatives. Compared with 4 , 16,17-O-sulfuryl-16-epiestriol (6) and itc 3- 
sulfamate 6" reveal a great downfield shift of the signals of C(16) and C(17) and the Same tendency is 
found at 16,17-O-isopropylene-16-epiestriol (i) and its 3-sulfamate 7*. This downfield shift is due to the 
fact that after substitution the free rotation of the iwo hydroxy groups no longer exists. The simultaneous 
deshielding effect on C(14) being notable cannot be explained. It seems to have to do with distortion of the 
ring D. Ac expected, the spectra of 7 and 7" contain three addiional signals. One of these signals is found 
at 113.4 ppm. According to the DEPT spectrum, it represents the middle (hydrogen-free) carbon atom of 
the isopropylene group. 
Table 1 : 13C chemical shifts (in ppm) of some J-hydroxy-estra-I ,3,5(10)-triene derivatives and their 
3-sulfamates 
Carbon I 1' 2 T 3 4 ,  6 C 7 7 
atom 
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47. Synthesis of 168-Bromo-3-methoxy-estra-1,3,5(10)-trien-170-01 by a Novel 
One-Pot Reaction 
H. Kasch ' , U. Qintner ' , J. Römer, J. Steinbach 
' Hans-Knöll-Institut Jena 
lntroduction 
Estrogenic 16,17-bromohydrins are important starting compounds for 16,17-cis diols [I]. Except for 
16ß-bromo-17a-OH bromohydrin, all epimeric bromohydrins are available in two steps from 3- 
rnethoxy-estra-1,3,5(10)-trien-17-one (1) (see scheme) [2] with the CuBr, bromination according to 
Numazawa [3] being the first step to give pure 3-methoxy-16a -bromo-estra-1,3,5(10)-trien-17-one (2). 
We were interested in particular in 3-methoxy-l6ß-bromo-estra-l,3,5(10)-trien-17-one (3) and 3- 
methoxy-l6ß-bromo-estra-l,3,5(1O)-trien-l7ß-ol (4). 
Under alkaline conditions 3-methoxy-l6a -bromo-estra-1,3,5(10)-trien-17-one (2) isomerizes to a 
mixtUre of 2 and 3 . Pure 3 can be reduced by sodium borhydride to 3-methoxy-l6ß-bromo-estra- 
1,3,5(1 O)-trien-17ß-ol (4). We were able to combine both processes in a one-pot reaction. 
C 
168 (from 16a,17a- 
epoxid) 
Experimental 
3-Methoxy- 1613-bromo- estra- 1,3,5(lO)- trien- 17ß-ol(4) 
3-Methoxy-1 Ga-bromo-estra-1,3,5(10)-trien-17-one (2) (300 mg, 0.83 mmol) was dissolved in 
ethanol (15 ml), the solution was cooled to -5 "C and sodium hydroxide (14.6 mg, 0.384 mmol) 
was while stirring. After 15 min a suspension of NaBH, (13.8 mg) in EtOH (0.5 rnl) was added 
drop by drop . At the end excessive NaBH, was elirninated by adding a few drops of acetone and 
the reaction rnkture was poured into ice water. The cis-bromohydrin 4 was separated by 
filtration and then recrystallized from methanol ( 85 % yield). 
Melting point: 104 - 105 "C 
TLC(R,): 0.56 ; 0.34 (silica gel, tolueneiethylacetate = 5:1 I 20:l); 0.62 (toluene/methanol=20:1). 
IR absorption: V ,Jcm-' 3544 (OH), 1605,1570,1497' (aromatic). 
Masc cpectrum: miz 364.10510 (M') , calc. 364.1038 for C„H,O,Br; 284.17718 (MHBr) 
calc. 284.1766 for C„H20, ; 267.17569 (M'-H,O-Br) , calc. 267.1749 for C„H,O; 229.16020 
(M- C,H,OBr) , calc. 229.1 59 for C„H2,0. 
t3C NMR data: C(1) 126.3; C(2) 1 1 1 -6; C(3) 157.6; C(4) 1 13.8; C(5) 137.6; C(6) 29.6; C(7) 27.3; 
C(8) 38.3; C(9) 43.9; C(10) 132.1 ; C(11) 25.8; C(12) 37.2; C(13) 43.6; C(14) 
48.6; C(15) 37.3; C(16) 55.3; C(17) 79.5; C(18) 12.0; OCH, 55.2. 
Results and Discussion 
The chemistry of 16,17-substituted 14a-steroids is extremely influenced by the steric hindrance 
of the ß-face by the 130-methyl group and the 16ß-substituent, on the one side, and of the a- 
face by the 16a-substituent, on the other. 
Thermodynamic considerations (MM-2 calculations) of 16-bromoketones favour the I6ß-bromo 
compound. In practice, under basic and acidic isomerization conditions as well as on 
nucleophilic substitution by bromide in aprotic dipolar medium, a 60:40 percent mixture of 16ß- 
bromoketone 3 and 16a-bromoketone 2 was obtained [5]. We found that a mixture of the 
bromoketones 2 and 3 formed by isomerization with catalytic amounts of sodium hydroxide in 
pyridine or DMFI EtOH could be reduced to the cis-ß-bromohydrin 4 in a substrate-specific 
manner. The a-bromoketone 2 was nearly untouched under the kinetically controlled reaction 
conditions. 
This finding made it possible to combine the isomerization process and the reduction in a one- 
pot reaction. Using sodium borhydride at a low temperature, the reduction rate of the 16a- 
bromoketone 2 decreased extremely in comparison with the 16ß-bromoketone 3. The 
differences in reactivity attributed to a steric hindrance of the a-face by the 16a-Br proved to be 
advantageous for a high yield of 4 because 3 consumed by reduction was formed gradually by 
alkaline isomerization of 2. The low alkaline concentration as well as the low temperature were 
necessary in order to prevent that 4 was converted into estradiol- or estrone-3-methylether, 
respectively. 
The one-pot reaction was carried out with an ethanolic 0.015 M solution of sodium hydroxide in 
DMF or ethanol at a temperature of -5 "C. When the isomerization equilibrium was reached, 
sodium borhydride was added in small portions (0.5 mol per mol steroid). 
In this way the step by step isomerization , first by bromide 141 and then by alkali and reduction 
[5] could be simplified and replaced by a one-pot isornerization-reduction process. The cis- 
bromohydrin 4 was received in an overall yield of 85 %. 
To obtain pure 3-methoxy-l6ß-bromo-estra-l,3,5(10)-trien-17-one (3) Jones oxidation [6] of the 
cis-bromohydrin 4 can be used (see scheme). 
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48. Further I3C NMR Spectroscopic Proof of 16a-F Configuration in 16-Fluoroestradiol 
Derivatives 
J. Römer, J. Steinbach, D. Scheller ', H. Kasch 
' Technische Universität Dresden 
* Hans-KnöII-Institut Jena 
lntroduction 
In earlier Papers we reported on the synthesis [ I ]  and the 13C NMR spectroscopic characterization [2] of 
16-fluoroestradiol derivatives. We found similar substituent effects for 16-F as for 16a-OH and concluded 
that the fluorine atom was a-orientated in these 16-fluoro steroids. To prove the a -0rientation of 16-F we 
now cite further NMR spectroscopic arguments which are based on coupling constants and chemical 
shifts. 
Results and Discussion 
In the 13C NMR spectra of 16-fluoro steroids it was to be expected ------F 
that the signals of the ring D carbon atoms are split in doublets. 
This spiitting was found for C(16) ('J(C,F) = - 178.5 Hz), for C(15) 
and C(17) (2J(C,F) = 23.1 Hz and 22.0 Hz) alnd for C(13) (3J(C,F) 
= 7.4 Hz) but it did not occur at C(14). This means that here i 
3J(C,F) = 0 Hz and, due to KARPLUS equation 131, the dihedral 
angle 16-F - C(16) - C(15) - C(14) has to be about 90'. Molecular , 
modelling (minimizing the binding energy by optimizing the I : *  ' B , i  
geometry of 16a-fluoroestradiol, using the program MM-2 from HOA\- 
I 
Hyper-Chem) gave indeed 90' for this dihedral angle. All the 
I 
16~Fluorestradiol torsion angles calculated are listed in Table 1. Sirnilar dihedral 
I 
-. - 
angles were found for estradiol and other 16-fluoro steroids 
reported in 121. But no useful values were obtained in the case of 16 ß-fluoroestradiol. 
Table 1 : Calculated torsion angles of ring D structure elements of 16ß-fluoroestradiol 
No. Structure element Torsion 3J(C,F) 
angle [Hz] 
1 16a-F - C(16) - Ci(15) - C(14) 90.02 0 
2 16a-F - C(16) - C(15) - 15a-H 31.18 - 
3 16a-F - C(16) - Ci(15) - 15ß-H 151.28 - 
4 16ß-H - C(16) - C(15) - C(14) 147.34 - 
5 16ß-H - C(16) - C(15) - 15a-H 91.46 - 
6 16ß-H - C(16) - C(15) - 15ß-H 28.64 - 
7 16a-F-C(16) - Ci(17) -C(13) 121.95 7.4 
8 16a-F - C(16) - Ci(17) - 17ß-OH 115.93 - 
9 16ß-H - C(16) - Ci(17) - C(13) 116.56 - 
10 16ß-H - C(16) - Ci(17) - 17ß-OH 5.56 - 
To understand the 13C chernical shifts 121, these torsion angles are important. The DRElDlNG rnodel 
shows that the bonds of C(15) and C(16) are arranged in an eclipsed form. Such a form is energetically 
less favourable than a staggered one. But, distorting the ring D in such a way that 16a -H - C(16) - 
C(15) - Cf14) form a dihedral angle of about 90°, this unfavourable eclipsed arrangernent is eliminated 
and a practically syn-diaxial arrangernent of 14a-H and 16a-H is developed . The H-H interaction of a 
syn-diaxial arrangernent contributes to the hi~gh chemical shift of the C(14) atom in estradiol (49.8 ppm). 
According to Beierbeck et al. [4] elimination of an H-H interaction results in an upfield shifi of the carbon 
atorns concerned. Consequently, 47.5 ppm and 47.7 ppm were found for C(14) in estriol and 16a- 
fluoroestradiol [2]. 
The above-rnentiondl distortion of the ring D is energetically very advantageous although now the bonds 
of the atoms C(16) and C(17) form an eclipsed arrangement. Thus, substituents at C(16) are almost 
sirnilarly directed to C(13) (see Table 1, nos.7 and 9). As y „ substituents they should have the Same 
influence on C(l3). The y „, eflects of all the substituents rneasured at C(16) [2,5] were indeed of the 
Same low level. 
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49. lmprovements of the Rossendorf Radionuclide Transport System 
St. Preusche, F. Füchtner, H. Krug', J. Steinbach 
Scientific Dept. "Experimental Facilities and Information Technology" 
Introduction 
The 500 m long Radionuclide Iransport System (RATS) was designed to transport small volumes of the 
irradiated liquids ~80]H,0/['8iJF- and H20/r3N]NH, with a pneurnatic post system and the radioactive 
gases within capillaries frorn the cyclotron to the radiochemistry laboratories due to special local features 
(111, E2l). 
Improvements of the gas transport systern and the loading unit of the pneumatic post systern concerning 
safe activity transport, higher reliability and higher specific activity have been carried out and are 
surnrnarized in the present Paper. 
Gas Transport System: Peak Cutting by an Activity Dependent Control 
Our "C target contains 20 ml of (N, + 5 % H,) target gas at a pressure of (26 - 28) bars. During the 
unloading process after target irradiation the inactive gas which remains inside the 500 m long copper 
capillary (ca. 900 crn3) arrives at first at the hot cell 1 of the radiochemistry laboratory. In order to ensure 
high specific activity, this dead volume rnust not pass through the [11C]C02 trap and the ["CIHCN 
module. Inside the hot cell 1 an activity detector is mounted at the incoming capillary (cornp. Fig. 1) near 
the distribution unit. 
C-I1 target ~ H N o r n  distribution 
time 
module 
AC = activity Sensor 
Fig. 1 : Principle of "C transport 
193 
The detector controls a 3-way valve that is normally Open to a waste gas balloon. If the measured activity 
is higher than a predicted value, the valve switches to the CO, trap and the HCN module and the 
radiochemical processes can be started. With (26 -28) bars of push gas we reach a transfer time of 4:30 
minutes (EOB to BOS). 
Pneumatic Post System: LASER Sensor for lmproved Reliability 
A LASER sensor mounted in the loading unit of the pneumatic post box detects the following failures and 
stops the loading process immediately if: 
- there is no via1 within the pneumatic post box 
- there is no pneumatic post box inside the loading unit 
- the lid of the filled pneumatic post box is not in the right position. 
The LASER sensor prevents the unloading of an activated water target without the via1 as the primary 
Containment for the activity. Furthermore, it is not possible to transport the pneumatic post box with a not 
fully closed lid. 
In all cases of failure the "AUTOMATIC MODE" of operation of the loading process will be stopped and 
switched to "MANUAL MODE. In this mode the operator can interrupt the process at any step and finish 
it step by step. 
Pneumatic Post System: Pneumatic Post Box Running Time Measurement 
For a safe activity transport the ninning time of the pneumatic post box within the polyethylene tube is 
measured and displayed both on the MASTER and the SLAVE terminal in the cyclotron building and the 
radiochemistry building. If the ninning time exceeds the predicted value of 200 s there is a message to 
the operator on the screens. The entrance of the transportation tube is blocked and it is not possible to 
use the tube for the next run. In that case we can use the second transportation tube. 
For safety purposes there are special procedures for localizing the faulty pneumatic post box inside the 
tube and for removing it outwards. 
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introduction 
Myotonic dystrophy (MD) is a multisystemic disease with autosomal dominant inheritance. The 
abnormal gene for this disorder has been localized on chromosome 19. It is the second most common 
inherited degenerative myopathy with a prevalence of between 1:10 000 and 2.4 - 5.5 per 100 000 [I]. 
Apart from muscular atrophy, myotonia and cataract, patients often suffer from an increased tendency 
to sleep and intellectual impairment of various degrees. Brain abnormalities such as white-matter 
lesions on magnetic resonance images [2] and decreased cerebral glucose utilization on positron 
emission tomographic (PET) scans [3] have been described. 
The aim of this investigation was to address the question whether the anticipated impaired glucose 
utilization is reflected in an altered cerebral perfusion pattern. 
Materials and Methods 
Patients: 11 patients (8 female, 3 male), age 27 - 57 years (median 41 years) with genetically 
confirmed hereditary MD were investigated with Positron Emission Tomography (PET) and Single 
Photon Emission Tomography (SPECT). One female patient had a history of brain infarction 4 years 
previously, all other patients had no concomitant brain disease. None of the patients suffered from 
diabetes or abnormal fasting glucose levels. 
PET: The PET investigation to evaluate the metabolic rate of glucose consumption (MRGlu) was 
performed after an overnight fast. PET scans were performed on a two-ring, three-slice Positome Illp- 
Tomograph (Thompson, Montreal Neurological Institute 141) with an image resolution of 10.9 mm 
(FWHM) and an axial resolution of 15.9 mm (FWHM). The distance between the slices was 18 mm. 
The patient's heads were positioned in a headholder with a laserlight, transaxial slices parallel to the 
orbitomeatal line (OM-line). One intravenous line was placed in each forearm, one for injection of the 
[~'FIFDG, one to determine the blood glucose level and the [ ' 8 ~ ] ~ ~ ~  content of the blood during the 
study. After intravenous injection of 185 MBq f 8 F ] F ~ ~ ,  pseudoarterial blood samples were withdrawn 
from the contralateral hand, which was heated by a heatcushion. To check for true pseudoarterial 
sampling, the oxygen saturation of the blood was measured prior to the start of the study. The oxygen 
saturation of the blood sample exceeded 80 %. Scans were performed for 75 rnin post injection (p.i.). 
The first set of slices was obtained during the first 60 min p.i. in the first position. To obtain a closer 
spacing between slices, a second set of slices, interleaving with the first set, was obtained 60 - 75 min 
p.i.. The cerebral metabolic rate of glucose in pmo1/100mllmin was calculated according to Sokoloff [51. 
SPECT: The SPECT studies to evaluate the cerebral perfusion pattern were performed on a triple 
head gamma camera (Multi-SPECT 3, SIEMENS) equipped with fan beam collimators, starting 10 min 
after i.v. injection of 750 MBq [ 9 9 m ~ ~ ] ~ ~ ~ ~ ~  (CERETEC, Amersham). Images were obtained on a 128 
X 128 matrix, 90 angles, 50 s per angle. After filtered backprojection, transaxial slices were reoriented 
parallel to the OM-line. 
Quantification of regional glucose utilization and analysis of perfusion pattern was performed on Wo 
transaxial slices of each the PET and SPECT data sets. Level I included basal ganglia and thalamus 
(Figs. I + 3), the second level was placed approx. 3 cm above level I (Figs. 2 + 4). 
On PET slices circular regions of interest (ROI) were placed on representative cortical and subcortical 
structures Iike frontal, temporal and parietal cortex, basal ganglia, thalamus and white matter (Figs. 
1 +2). Results were expressed in pmo11100mllmin. 
On SPECT slices a semiautomated software for sector analysis, generating 12 regions per slice, was 
used (Figs. 3 + 4). The resutts were expressed in average counts per sector. 


Results and Discussion 
9/11 patients showed no left to right asymmetry in PET. There was no gross regional deviation of 
MRGlu in different grey matter structures within the individual patient. Grey and white matter values 
revealed a broad range of MRGlu values (18-42 pmo11A 00mllmin and 8-1 7 pmo11100mllmin ) within 
Table 1: Distribution of mean grey matter values Table 2: Distribution of mean white matter values 
anticip. normal value from the literature [6] 
Grey matter No. of 
pmo11100 mll min patients 
> 29 (29 - 42)* 4 
White matter No. of 
pmo11100 mll min patients 
> 14 (14- 17) 2 
this patient group (Table 1 + 2). Although all patients investigated suffered from genetically proved 
hereditary MD, 411 1 patients showed no reduced global MRGlu values. White matter values are to be 
regarded with caution, since they might include ventricular structures. When the MRGlu was irnpaired, 
no singular structure but the MRGlu of the whole brain seemed to be altered in most patients. Our PET 
results are in agreement with other publications, which describe a reduced MRGlu in patients with MD 
(3,7). In addition to a globally reduced MRGIu, Mielke et al. [7] found a marked decline in MRGlu in 
distinct cerebral structures, like frontal cortex and nucleus lentiformis, which was not noted in our 
patient group. 
10111 patients showed no left to right asymmetry in SPECT. There was no statistically significant 
regional deviation of average counts between sectors within the individual patient, therefore we found 
no evidence of local perfusion disturbances due to MD. Perfusion patterns were investigated by Chang 
et a1.[8 , who investigated the cerebral perfusion with " 3 3 ~ e  and [ 9 9 m ~ ~ ] ~ ~ ~ ~ ~ - ~ ~ ~ ~ ~  with SPECT. J With l3 Xe, they found globally reduced cerebral blood flow (CBF) values with the lowest values in both 
temporal regions and, to a lesser extent, in the frontal region. With they found a 
different perfusion pattern with hypoperfusion in the temporoparietal, frontal or frontoparietal regions. 
Since we were not able to compare our patient group with a group of match norrnal controls, slight 
differences of the perfusion pattern within the group could have been missed. Normal values of MRGlu 
had to be taken from the literature. Nevertheless, the broad range of MRGlu values indicates that 
patients with hereditary MD are not a homogeneous entity concerning cerebral glucose consumption. 
In our study altered MRGlu values were not accompanied by an altered perfusion pattern in SPECT. 
The further correlation of our results with the intelligente Score and hypersomnia as well as a 
comparison with clinically manifest, nonhereditary MD will be investigated. 
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51. Three-Compartment Model Software Tools to Analyse and Synthesize PET Data 
M. Obert, H. Linemann, E. Will 
Introduction 
The aim of this article is to give a short comprehensive Summary of the kinetic equations which are 
defined by three-compartment models, since these models serve as the basic key in the interpretation 
of data obtained by positron emission tomography, PET. Furthermore, we present some results 
obtained by a computer simulation program, which analytically calculates time activity curves of such 
models. The simulation program was developed to facilitate the study of the highly complex 
interaction of up to twenty different parameters that affect the time activity curves. An understanding 
of such curves is fundamental to the understanding of PET. 
We have written, implemented and tested some basic software programs for analysis of the data 
obtained with both our PET Scanners. The aim was to develop software that is capable of f:scribing 
the tracers that we use at the moment at the Forschungszentrum Rossendorf, which are [ Flfluoro- 
deoxyglucose, FDG, and 6 - [ ' 8 ~ ] f l u o r o - ~ ~ ~ ~ ,  FDOPA. Such a description is basically possible with 
the aid of a three-compartment model [I, 21: a three-compartment model is a simplified attempt to 
describe the biochemical behaviour of a radiotracer in the human body so that a mathematical 
estimation of kinetic parameters, k, is possible, see Fig. 1. 
Compartment I 
K1 
Compartment I1 Compartrnent IiI 
Fig.. 1: Compartment I is the vessel system, compartment II is the exchangeable tracer p o l ,  and 
wmpartment III is a trapped tracer pol .  
By definition, a compartment is a volume, real or kinetic, in which the wncentration of a tracer or its 
derivatives remains the Same everywhere 121. In the case of FDG investigations we assume a k4 of 0, 
which is due to the trapping of the tracer in the cell. For FDOPA investigations the model is a rough 
simplification of processes that are more complicated [I]. 
In addition we wanted to write a computer program that allows us to simulate the data of a PET 
investigation. This program enables us to study the complicated interaction of many parameters in a 
PET experiment in a numerically welldefined manner. 
Data analysis 
There are different levels of mathematical descriptions, established by various authors, to 
approximate a three-wmpartment model: 
The Sokoloff approximation 131 allows determination of the turnover rate of the glucose metabolism, 
MRGL, for FDG investigations. It is offen cailed the autoradiographic approach. It is based first on a 
single radioactivity measurement of a slice of interest with the PET Scanner at a certain time, CPETC~), 
second on the determination of the blood glucose concentration, Co,-, and third on the dynamic 
measurement of the radioactivity of the blood plasma, C-0.  The rate constants KI, k ~ ,  and k3, 
which are needed in the calwlation of MRGL, must be known from other expehments. MRGL is 
defined as follows, Eq. (I), where LC is the Lumped wnstant, M ich  eliminates the differentes 
between FDG and gluwse: 
CGb,iCPm ( T )  - Kieik+s>rf Cplmm(t)e(k2+S)'dt 1 
All the following approaches to the three-compartment model are defined to approximate the rate 
constants Ki, or the term Klk3/(k2+/(3) rather than MRGL. 
Thus, it is possible to obtain MRGL for FDG investigations by the following relation, Eq. (2): 
The next approach defines the term Klkd(k2+k3) as the slope of the plot Cp~(T)1CPlasma(T) versus 
T j o~pbm (t)dt I Cpiasm(T). lt is offen called Patlak plot 14, 51, Eq. (3). 
The approach defined by Blomqvist [6] allows an approximation of Ki, k2, and k3, See Eq. (4). It is 
assumed that kq is equal to 0. 
We now express K,, k2, and /(3 of Eq. (4) in terms of parametets Pi, where the i goes from 0 to 2: 
In th~e Blomqvist approximation, we calculate the different integrals for different time intervals, Ti, and 
determine the wefficients p, with the aid of multilinear regression m of an equation of the form y = 
+ plxl +M- We obtain the rate wnstants from K1 = h, k2 = @ - pl/po, and k3 = pIlh. 
Another setup by Evans [8] enables us to calculate the rate wnstants KI, k2, k3, and also kq, see Eq. 
(5). 
We now express KI, k2, k3, and kq of Eq. (5) in terms of the Parameters Pi, where i goes from 0 to 3: 
We determine the different integrals and double integrals for different time intervals, Ti, and calculate 
the p, by muitilinear regression m. Next, we describe the rate constants by the following relations: 
K1= P3 
kz=p1-polP3 
k 3 = ~ 1 - ( ~ 1 - ~ o / P 3 ) - ~ 2 ~ ( ~ 1 - ~ o ~ P 3 )  
k4= @/(PI -PO/!%) 
An attempt to describe the three-compartment model, which is most straightfoward from a 
mathematical point of view, is given e.g. by Herholz [9]. The nonlinear approach is described in Eq. 
(6). This attempt also takes care of the fraction of blood, VBlood, that is measured by the PET Scanner 
within the slice of interest. 
The different Pi are 
1 
= -(k2 +k3 +k4 -a). where 
2 
P = (k ,+k,+k4p -4k,k4. 
In order to be able to calculate a nonlinear regression [7] we have to determine the derivatives with 
resped to the different Pi of Eq. (6). The partial derivatives are: 
6' 
-C„ (T) = C„, (T )  
@, 
d T -Cpm (T)  = e-"T cP, (t)epztdt ,
8-3 0 
d T 
e - ~ '  p2 (t - T )  - Cph(t)ePztdt , - CPET (T) = - 
*2 P2 0 
d T 
-Cpm (0 = I" ~,,(t)e"dt. and 
@3 0 
d -cPET(~ = 3 e  P - p 4 ~  jP4 . (t - ~ ~ ~ ~ ( ~ ) e ~ ~ ~ m .  
@4 P4 0 
Ac initialization we now guess the parameters p, and then caicuiate the nonln 
constants can be obtained from the different p, ac follows: 
iear regression. The rate 
For a detailed description of the various approximations of the compartment model and their 
constraints, see the given references. 
The approaches given in Eq. (3) to (6) are implemented in IDL programs. Eq. (6) is the base for the 
nonlinear regression of a curve Cp~lCi). The program version realized so far has to be further 
modified in oKier to improve the robustness of the fit for practical applications. 
We used the Patlak plot to calculate the metabolic rates of glucose of all patients investigated so far 
with the Positome lllp Scanner. 
Dafa Simulation 
The motivation for the simulation program is as follows: it enables us to study many questions that 
arise in a model which is affected by at least 20 different parameters. How reliable are the different 
mathematical approximations of the three-compartment model? How does the curve CPiasma(T) 
influence the curve C m O ?  How many data points have to be taken at the beginning of the function 
CpiasmaO? 
We have therefore written a computer program that allows us to simulate a vector CPET(T) for 
arbitrary values of V~lwd, KI, k2, k3, and k4 according to Eq. (6). There are three different options of 
how to generate a vector C P ~ O ,  which must be known in Eq. (6) to be able to calculate the plasma 
integrals with the aid of numerical integration methods: First, experimental values of a plasma curve 
may be taken. Second, arbitrary values may be used. Third, we define a plasma curve, CPlasma(T), as 
follows, Eq. 0: 
In Eq. (i) A is a concentration, h, and k, are rate constants. Eq. (7) allows us to simulate a function 
with a strong initial increase and then a more or less fast decrease. This is possible for a large range 
of properly chosen values of A, & and ki,., where A > 0, and kin > kaut. 
Further, the simulation program has an option to vary the time schedule so that the User may 
determine at what time t and how often EI value of C m  and CPET is "measuredn by Eqs. (6) and (7). 
This allows us to study the influence of a certain time schedule and the frequency of measurements 
on the estimation of VBlood and the rate constants [IO]. 
In addition, it is possible to put some "scattenngn on either of the functions Chsma(T) and / or CPET(T). 
This enables us to study the influence of error sources on our data. 
The units of the parameters in the simulation program are as follows: Plasma curve: A 
[concentration], lbut [ I  / time unit], and kin [I /time unit]. PET-Curve: VM [volume unit / weight unit 
of tissue], K1 [volume unit / weight unit of tissue / time unit], kz [I / time unit], k3 [ I  / time unit], and k4 
[I /time unit]. 
A detailed description of the User friendly widget program, which is written in the computer language 
IDL, is given in ref. [I $1, The reader who wants to develop a "numerical feeling" for Eqs. (3) to (7') is 
forced to work with this program package [II]: There are 14 parameters that can be modified in the 
simulation program. The analysis that folllows Eq. (3) is affected by 3 parameters. the approximations 
given by Eqs. (4) and (5) are affected by 1 Parameter, whereas 8 parameters must be properly 
chosen to enable a descnption of the data according to Eq. (6). The approximations by Eqs. (3) to (6) 
are called "Patlak plotil, "Blomqvist analysis", "Evans analysisPf, and "nonlinear regression", We will 
now mention a few examples obtained with the aid of the simulation and analysis programs: 
Results of the autoradiographic approach are not shown. A linear dependency exists between the 
measured value of the radioactivity and MRGL for a given function Cm,,.&) and C=,-, See Eq. (I). 
We therefore consider this approach as rather easy to understand. 
We often find differences between the analytical term Klk3/(k2+k) and the result obtained by the 
Patlak plot of this term that are in the range of I 3.0 %. This is sufficiently small. 
Ex. 1 and 2 show the fit of a simulated PET curve, CPET(T). by the Blomqvist and the Evans analysis. 
The PET curve is simulated with the following parameter settings: VBlood = 0, Kl = 0.0500. k2 = 0.0400, 
k = 0.0300, and k4 = 0. 
Time 
Blamqvist Analysis: 
K1 = 0.0500 K2 = 0.0400 K3 = 0.0301 
Chi-Square = 1.0000 
Time 
Evans Analysis: 
K1 = 0.0500 K2 = 0.0401 K3 = 0.0302 K4 = 0.0000 
Chi-Square = 0.9997 
The graphs in Ex. 1 and 2 show the simulated data as triangles and the fd result as solid line, the 
units are arbitrary. The sarnpling of the curve C-(T) is identical to the sarnpling of the curve 
CPET(T). The fit results are given under each graph. 
We find that both fit attempts in Ex. 1 and 2 lead to the expected results. 
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52. Application of the Fractal Concept of the Analysis of Positron Emission 
Tomography lnvestigations of Patients Suffering from Dystrophia Myotonia 
M. Obert, B. Beuthien-Baumann, E. Will, H. Linemann, B. Kunath 
Introduction 
We earlier showed the possibility of describing a positron emission tomography (PET) image with the 
aid of the wncept of fractal geometty [I - 41. Now we study the question whether it is possible to 
distinguish different grades of altered cerebral glucose metabolism in dystrophia myotonia, DM, [5] of 
7 patients by this fractal concept. T0 do this, we investigated the numerical values defined either as 
global fractal dimension, D,, or the distributions of the local fractal dimensions, D,, or the multifractal 
description by the function D(q). We analysed dynamic &dimensional brain images of ['8~]2-fluoro-2- 
deoxy-D-gluwse investigations that were taken by the low resolution Positome lllp PET scanner. The 
different grades of the disease ranged from slight muscle symptoms up to severe movement 
disabilities. The cerebral glucose metabolism ranged from normal rate values to a strong decrease in 
the overall cerebral metabolic rates. Thus, all different fractal investigations show identical results that 
vary only within the standard deviation of the numerical methods for all different grades of DM. We 
therefore conclude that these numerical fractal tools are without clinical relevance for the diagnosis or 
charaderization of DM. 
Methods 
The protocol of the PET investigation is given in ref. 153. See ref. [I] for a description of the PET 
scanner. The numerical method to determine the global fractal dimension, D„ which is a measure of 
the global irregularity of a stnicture, is given in refs. [l, 41. The way to calculate the local fractal 
dimension, D,, which is a map of local dimension values, is shown in ref. [6]. The multifractal analysis, 
which describes the heterogeneity of a System by a function D(q), is carried out as shown in refs. [7, 
81. 
Resuits 
Table 1 shows the D, values of the radioactivity distributions of 3 different representative transaxial 
sedions through the brain. The cerebellar slice is positioned through the mid-cerebellum and the 
basal temporal lobes; the basal ganglia slice is drawn at the level of the basal ganglia and the 
thalamus; the cingulum slice shows the basal cingulum. We analysed the radioactivity measured by 
the PET scanner as a function of the spatial position of the 2-dimensional images. We assume a 
standard deviation of the D, values of f 0.05, which is known from other experiments (61. 
Table I. D, values of different sections of the brain 
Cerebellum Basal Ganglia Cingulum 
Patients with 2.02 2.27 2.05 
severe symptoms: 2.04 2.23 2.1 1 
2.01 2.24 2.03 
2.29 2.1 5 - 2.25 2.16 
weak symptoms: 2.06 2.22 2.1 I 
The results of Table 1 indicate different D, values for different sections: an average of 2.03 is found 
for the section that shows the cerebellum, whereas averages of 2.25 and 2.10 are found for the basal 
ganglia and for the cingular slice. No differences can be found between patients with normal or 
altered rnetabolic glucose rates. 
Fig. 1 shows a map of DI values for 9 different transaxial sections through a brain. The calculations of 
D1 were carried out on an affine 4-dimensional data Set (position X, y, z, and radioactivity). It is not 
possible to find any correlation between the anatomical structure of the brain and the distribution of 
D!. Furtherrnore, no differences in the structure of the different slices are visible. All positions in the 
brain that have a high DI value are surrounded by srnall DIS and vice versa. This leads to a granulated 
distribution of the DI values in the brain, Fig. 1. The values of D1 are shown on the right rnargin of Fig. 
1. No differences of such maps, Fig. 1, are visible arnong different patients. 
Fig. 1 : Map of D, values for 9 different transaxial brain sections. 
The curves D(q) versus q (not shown) are identical, within the Standard deviations, for all patients 
regardless of the rnetabolic rate in DM. 
Discussion 
The application of the concept of fractal geornetry is not fruitful if one wishes to describe differences 
between grades of DM. 
The spatial resolution of the Positorne lllp PET Scanner [ I ]  is probably not sufficient to allow a 
reasonable investigation of fractal properties of these brain sets. 
It remains to be explored whether this geornetrical concept is able to describe the behaviour of 
receptor distributions in the brajn and differences thereof between patients that suffer from other 
diseases. 
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Private Institute of Radiology and Nuclear Medicine Wünsche MD, Neumann MD, Wehr MD, Leipzig. 
Cooperation on the biochemical aspects of radiotracer research exists with the PET Centre Aafhus 
(Prof. A. Gjedde), the University of Minnesota in Duluth (Prof. L.R. Drewes, Department of Bio- 
chernistry and Molecular Biology) and the Friednch-Schiller Universitat Jena (Dr. Bauer, Inst. of 
Pathophysiology). 
In helpful discussions both abroad and at Rossendorf numerous colleagues have contnbuted to defin- 
ing areas of cooperation and shaping projects. 
Special thanks go to Dr. E. Chiotellis, National Research Centre, Athens, Greece, Dr. L. M. 
Dinkelborg, Schering AG Beriin, Dr. G. Ensing, Mallinckrodt Medical B. V., Petten, Netheriands, Dr. 
P.A. Schubiger, Paul-Scherrer-Institut, Villigen, Switzeriand. 
Wihin the scientific cooperation with the Arabic Republic Egypt, University of Assiut, Prof. R. M. 
Mahfouz started research on chemistry and radiopharmacology of technetium and rheniurn. 
LABORATORY VlSlTS 
Brust P. 
Kommune Hospital Aarhus, Denmark, 
Dec. 9-21, 1996 
Friebe M. 
Institute of Radioisotopes and Radiodiagnostic Products of the National Center for Scientific 
Research "Demok~tos", Athens, Greece, 
Sept. 14-28, 1996 
Jankowski R. 
Stanford Synchrotron Radiation Lab. at SUC, Palo Alto, California, USA, 
June 8-1 8,1996 
Jankowski R., Fnebe M., Kirsch S. 
HASYLAB at DESY, Hamburg, Germany, 
July 29-Aug. 5, 1996 and Nov. 19-23, 1996 
Johannsen B., Spies H. 
institute of Radioisotopes and Radiodiagnostic Products of the National Center for Scientific 
Research "Dernokritos", Athens, Greece, 
NOV. 8-12,1996 
Johannsen B. 
PSI Villigen, Switzeriand, 
June 27-29.1996 
Lehneri S. 
Institut für Bioanalytik, Göttingen, Germanl 
Dec. 15-1 7, 1996 
Preusche S. 
Herz- und Diabeteszentrum NRW, Bad Oeynhausen, Germany, 
May 7-9 and Nov. 5-8,1996 
M. Reicgys 
PSI Villigen, Switzerland, 
Jan. 8-March 18, i996 
GUESTS 
Dr. R. Atberto, PSI Villigen. Switzerland, 
NOV. 4-7,1996 
Prof, R. M. Mahfouz, Assiut University, Dept. of Ghemistry, Assiut, Egypt, 
Aprr'l3O-July 20, $996 
Dr. Th. Meina, Institute of Radioisotopes and Radiorfiagnosfic Products of the National Center for 
Scientific Research "Demokritoc", Athens. Greece, 
Od. 12-N0v, 3,1996 
Dr, B Nock, tnstitute of Radioisotopes and Radiodiagnostic Pr&uds of the Natianat Center for 
Scientific Research "Drrmokntose'. Athens. Gresce, 
Oet. ~ ~ - N o v ,  3,1996 
MEETINGS ORGANIZED 
I. Symposium on "Blood-Brain Bamer - Structure and Function" within the First Congress of the 
German Neuroscientific Soc., Beriin 24.-27.2.1996. 
2. First International Workshop of the CYCLONE 1819 User Community, Rossendorf, 10.-I I .I 0.1996. 
3. First IAEA Research Co-ordination Meeting of the Co-ordinated Research Programme on 
"Development of Agents for imaging Central Neural System Receptors based on 
Technetium-99mn, Rossendorf, 4.- 7.1 1.1 996. 
OTHER ACTlVlTlES 
1. H. Spies: 
Coordinator of Working Group 5 in the COST B3 program "New radiotracers and methods of 
quality assurance for nuclear medical application." (Coordinator: P. A. Schubiger) 
2. B. Johannsen: 
Chairman of the DGN Working Group on Radiochemistry and Radiopharrnacy. 
3. B. Johannsen: 
Co-editor of the journal Nuclear Medicine and Biology. 
IV. SEMINARS 
TALKS OF VlSlTORS 
Prof. A. Gjedde, Universität Aarhus, Dänemark 
Dopaminergic neurotransmission with emphasis on regulation of neuronal excitability in the striatum 
15.03.1996 
Prof. G. Seidel, Wuppertal 
Pharmaindustrie - Quo vadis? 
21.03. 1996 
Dr. F. Oberdorfer, DKFZ Heidelberg 
Neue Methoden zur Halogenierung und Radiohalogenierung von Hexopyranosen 
12.04. I996 
Prof. Dr. H. Schelbert, Universität Los Angeles, USA 
PET in der Kardiologie 
15.04.1996 
Prof. W. Vaalburg, PET-Center Universitäts-Hospital Groningen, Niederlande 
The Development, Evaluation and Clinical Application of PET-Radiopharmaceuticalc 
15.05. I996 
Prof. W. Görner, BAM Berlin 
Die Aktivierungsanalyse - ein Verfahren mit hohem dynamischen Bereich (Zentrumskolloquium) 
21.06. 1996 
Frau Dr. A. B. Fischer, Hygiene-Institut, Universität Gießen 
Chelatbildnertestung in vitro mit Säugeizellkulturen 
30.07.1996 
Prof. Dr. U. Hahn, Institut für Biochemie, Universität Leipzig 
Protein Design 
26.09.1996 
Prof. Dr. C. Anderson, Washington University, Medical Center, St. Louis, USA 
Copper-64-labeled Proteins and Peptides for PET lmaging and Therapy 
09.10. 1996 
Dr. P. Elz, Institut für Pharmazie, FU Berlin 
Ketanserin-analoge 5-HT2A-Rezeptorliganden: Synthese, Pharmakologie und Struktur-Wirkungs-Bez. 
Dr. J. Kropp, Universitätsklinikum Dresden 
Markierung und erste pharmakologische Untersuchungen von IQNP 
14.11.1996 
Prof. R. Beckert, Friedrich-Schiller-Universität Jena 
Stickstoff- und schwefelhaltige Chelatkomplexbildner aus einfachen Ci-Bausteinen 
22.11.1996 
Prof. Centos-Navarro, Institut für Neuropathologie der FU Beriin 
Das Gehim unter den Bedingungen einer chronischen Hypoxie 
6. 12.1996 
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